Import_Date,ISID,Project,Protein,Modality,Control_Type,Stress_Condition,Temp_C_,Time_Days_,Well_ID,Protein_Conc_mg_mL_,Sample_Name,Notebook_,pH,Buffer,Arginine_mM_,NaCl_mM_,PS80_,Sucrose_,Trehalose_,Additional_Excipient_Name,Additional_Excipient_Unit,Additional_Excipient_Conc,CE_SDS_NR_Purity_Sum,CE_SDS_NR_chg_Purity,CE_SDS_NR_Abs_chg_Purity_,CE_SDS_Red_Purity_Main_Peak,CE_SDS_Red_Purity_Sum,CE_SDS_Red_chg_Purity,CE_SDS_Red_Abs_chg_Purity_,UV_Vis_A350_A500,cIEF_Main,cIEF_Acidic,cIEF_Basic,cIEF_chg_Main,cIEF_chg_Acidic,cIEF_chg_Basic,cIEF_Abs_chg_Main_,cIEF_Abs_chg_Acidic_,cIEF_Abs_chg_Basic_,DSF_Tm1_C_,DSF_Tm2_C_,FC_Initial_0_22_m_conc_cells_mL_,FC_Initial_0_45_m_conc_cells_mL_,FC_Initial_0_88_m_conc_cells_mL_,FC_Initial_1_m_conc_cells_mL_,FC_Initial_1_35_m_conc_cells_mL_,FC_Initial_2_m_conc_cells_mL_,FC_Initial_5_m_conc_cells_mL_,FC_Initial_10_m_conc_cells_mL_,FC_Initial_25_m_conc_cells_mL_,FC_Stress_0_22_m_conc_cells_mL_,FC_Stress_0_45_m_conc_cells_mL_,FC_Stress_0_88_m_conc_cells_mL_,FC_Stress_1_m_conc_cells_mL_,FC_Stress_1_35_m_conc_cells_mL_,FC_Stress_2_m_conc_cells_mL_,FC_Stress_5_m_conc_cells_mL_,FC_Stress_10_m_conc_cells_mL_,FC_Stress_25_m_conc_cells_mL_,AVG_2_UM,AVG_5_UM,AVG_25_UM,AVG_2_50_UM,AVG_100_UM,AVG_PARTICLE_COVERAGE_,RP_UPLC_Main,RP_UPLC_Pre_Peak,RP_UPLC_Post_Peak,RP_UPLC_chg_Main,RP_UPLC_chg_Pre_Peak,RP_UPLC_chg_Post_Peak,RP_UPLC_Abs_chg_Main_,RP_UPLC_Abs_chg_Pre_Peak_,RP_UPLC_Abs_chg_Post_Peak_,UP_SEC_Monomer,UP_SEC_LMW,UP_SEC_HMW,UP_SEC_chg_Monomer,UP_SEC_chg_LMW,UP_SEC_chg_HMW,UP_SEC_Abs_chg_Monomer_,UP_SEC_Abs_chg_LMW_,UP_SEC_Abs_chg_HMW_,BATCH_BIOREG_ID,C_BIOREG_ID,FRAMEWORK,MERCK_NAME,PI,MW,IMPORTED_DATA_FILE_NAME,TARGETS,REAGENT_TYPE,Simplified_Excipients,1st_Excipient_in_Sample,2nd_Excipient_in_Sample,_Conc_for_Excipient1,Origin_of_data
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,98.91,-0.79,,0.054,,,,,,,,,,59.8,61.8,7922.0,465.0,61.0,61.0,40.0,20.0,0.0,0.0,,569870.0,178327.0,39983.0,21528.0,5296.0,2224.0,20.0,20.0,,,,,,,,,,,,,,,,,78.5,7.48,14.0,-15.5,1.6,13.87,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,99.67,-0.02,,0.096,,,,,,,,,,62.0,63.4,16734.0,404.0,61.0,0.0,0.0,0.0,0.0,0.0,,887488.0,259555.0,27130.0,6004.0,121.0,20.0,0.0,0.0,,,,,,,,,,,,,,,,,92.1,6.46,1.47,-1.94,0.6,1.34,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,99.49,-0.21,,0.09,,,,,,,,,,62.6,67.6,16067.0,445.0,40.0,20.0,0.0,0.0,0.0,0.0,,889286.0,207321.0,13808.0,2163.0,20.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,93.2,5.56,1.26,-0.83,-0.3,1.13,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,97.03,-2.67,,0.057,,,,,,,,,,56.2,60.4,6386.0,505.0,61.0,40.0,20.0,20.0,0.0,0.0,,498903.0,114609.0,8651.0,4851.0,2082.0,1092.0,121.0,0.0,,,,,,,,,,,,,,,,,51.6,4.4,43.99,,-1.5,43.86,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,99.49,-0.21,,0.055,,,,,,,,,,62.2,64.0,8913.0,768.0,364.0,323.0,243.0,141.0,20.0,0.0,,103765.0,14916.0,3537.0,2041.0,546.0,202.0,40.0,20.0,,,,,,,,,,,,,,,,,81.6,5.86,12.56,-12.42,0.0,12.43,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,98.81,-0.88,,0.056,,,,,,,,,,59.6,62.8,6649.0,384.0,121.0,81.0,81.0,81.0,0.0,0.0,,56953.0,17886.0,4365.0,2082.0,707.0,263.0,0.0,0.0,,,,,,,,,,,,,,,,,82.8,4.45,12.81,-11.26,-1.4,12.68,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,99.28,-0.42,,0.061,,,,,,,,,,60.6,63.0,10105.0,364.0,61.0,40.0,20.0,20.0,0.0,0.0,,906987.0,17794.0,1456.0,789.0,121.0,20.0,0.0,0.0,,,,,,,,,,,,,,,,,73.6,5.5,20.9,-20.41,-0.4,20.77,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,0.31,,0.094,,,,,,,,,,63.2,64.6,15198.0,323.0,40.0,20.0,0.0,0.0,0.0,0.0,,433171.0,81702.0,3719.0,566.0,20.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,92.3,5.42,2.26,-1.69,-0.4,2.13,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,99.47,-0.22,,0.056,,,,,,,,,,61.6,63.8,6245.0,323.0,81.0,81.0,61.0,61.0,0.0,0.0,,123112.0,15968.0,4467.0,2870.0,606.0,303.0,40.0,20.0,,,,,,,,,,,,,,,,,89.3,4.26,6.41,-4.69,-1.6,6.28,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,B11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,99.17,-0.52,,0.059,,,,,,,,,,62.2,64.0,8690.0,445.0,141.0,81.0,20.0,20.0,0.0,0.0,,2000000.0,258955.0,4694.0,2266.0,607.0,182.0,20.0,20.0,,,,,,,,,,,,,,,,,86.2,4.47,9.3,-7.78,-1.4,9.17,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,,,,,98.08,-1.62,,0.362,,,,,,,,,,57.4,59.2,10186.0,445.0,40.0,0.0,0.0,0.0,0.0,0.0,,4000000.0,4000000.0,3000000.0,3000000.0,1000000.0,77004.0,20.0,0.0,,,,,,,,,,,,,,,,,0.0,0.0,100.0,-94.01,-5.9,99.87,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,,,,,99.65,-0.04,,0.178,,,,,,,,,,62.8,64.6,18957.0,647.0,61.0,0.0,0.0,0.0,0.0,0.0,,588908.0,416164.0,195137.0,109099.0,13178.0,4952.0,1011.0,0.0,,,,,,,,,,,,,,,,,89.0,9.04,2.01,-5.06,3.2,1.88,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0.0,0.0,0,,,,,,,,99.6,-0.09,,0.107,,,,,,,,,,62.0,63.8,18331.0,808.0,0.0,0.0,0.0,0.0,0.0,0.0,,1000000.0,604704.0,202478.0,84957.0,1799.0,222.0,61.0,0.0,,,,,,,,,,,,,,,,,90.0,8.52,1.48,-4.0,2.7,1.35,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,,,,,92.69,-7.0,,0.215,,,,,,,,,,56.6,58.8,14369.0,546.0,40.0,0.0,0.0,0.0,0.0,0.0,,3000000.0,3000000.0,2000000.0,2000000.0,202228.0,1597.0,20.0,0.0,,,,,,,,,,,,,,,,,16.1,18.56,65.29,,12.7,65.16,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,,,,,99.24,-0.45,,0.423,,,,,,,,,,60.0,61.8,10368.0,889.0,101.0,40.0,0.0,0.0,0.0,0.0,,4000000.0,3000000.0,3000000.0,2000000.0,1000000.0,407079.0,141.0,20.0,,,,,,,,,,,,,,,,,88.7,8.45,2.89,-5.35,2.6,2.76,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,,,,,99.55,-0.15,,0.35,,,,,,,,,,60.6,61.8,2587.0,263.0,61.0,20.0,20.0,0.0,0.0,0.0,,1000000.0,580990.0,130832.0,46401.0,5742.0,3154.0,0.0,0.0,,,,,,,,,,,,,,,,,88.6,5.92,5.46,-5.38,0.1,5.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,,,,,98.09,-1.61,,0.338,,,,,,,,,,59.2,62.0,8266.0,222.0,20.0,0.0,0.0,0.0,0.0,0.0,,4000000.0,4000000.0,3000000.0,2000000.0,594094.0,8913.0,0.0,0.0,,,,,,,,,,,,,,,,,36.6,15.36,48.07,,9.5,47.94,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,,,,,100.0,0.31,,0.145,,,,,,,,,,61.2,63.2,4749.0,303.0,20.0,20.0,0.0,0.0,0.0,0.0,,1000000.0,674854.0,222977.0,91426.0,2870.0,404.0,101.0,20.0,,,,,,,,,,,,,,,,,91.0,7.89,1.14,-3.04,2.0,1.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,,,,,99.81,0.12,,0.239,,,,,,,,,,61.6,63.0,17603.0,505.0,61.0,20.0,0.0,0.0,0.0,0.0,,1000000.0,804665.0,295364.0,139161.0,6348.0,950.0,0.0,0.0,,,,,,,,,,,,,,,,,91.3,7.06,1.65,-2.73,1.2,1.52,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,C11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,,,,,100.0,0.31,,0.106,,,,,,,,,,62.0,64.2,243.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,,766134.0,460157.0,134797.0,48328.0,1354.0,323.0,61.0,20.0,,,,,,,,,,,,,,,,,95.1,4.47,0.46,1.06,-1.4,0.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,96.32,-3.38,,0.357,,,,,,,,,,57.8,59.8,22817.0,748.0,61.0,0.0,0.0,0.0,0.0,0.0,,1000000.0,1000000.0,635052.0,451079.0,72987.0,7155.0,485.0,101.0,,,,,,,,,,,,,,,,,10.4,12.47,77.12,,6.6,76.99,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,,,,,99.82,0.13,,0.269,,,,,,,,,,62.2,64.0,9337.0,525.0,20.0,20.0,0.0,0.0,0.0,0.0,,3000000.0,1000000.0,333804.0,149319.0,31263.0,11466.0,182.0,0.0,,,,,,,,,,,,,,,,,88.9,9.73,1.38,-5.12,3.9,1.25,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0.0,0.0,0,,,,,,,,99.14,-0.55,,0.224,,,,,,,,,,63.2,64.6,12369.0,970.0,121.0,61.0,20.0,0.0,0.0,0.0,,4000000.0,2000000.0,798747.0,407753.0,67423.0,17730.0,384.0,0.0,,,,,,,,,,,,,,,,,86.0,12.44,1.56,-8.0,6.6,1.43,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,,,,,90.07,-9.63,,0.555,,,,,,,,,,52.2,57.6,13743.0,748.0,81.0,20.0,0.0,0.0,0.0,0.0,,1000000.0,1000000.0,674495.0,439705.0,61224.0,12148.0,647.0,61.0,,,,,,,,,,,,,,,,,0.0,36.91,63.09,-94.01,31.1,62.96,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,,,,,99.28,-0.42,,0.226,,,,,,,,,,60.0,63.2,17886.0,1900.0,162.0,61.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,761375.0,528535.0,94960.0,6490.0,243.0,20.0,,,,,,,,,,,,,,,,,93.1,5.79,1.09,-0.89,-0.1,0.96,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,,,,,96.58,-3.11,,0.323,,,,,,,,,,59.8,56.0,7882.0,323.0,20.0,0.0,0.0,0.0,0.0,0.0,,3000000.0,3000000.0,2000000.0,1000000.0,142620.0,8146.0,263.0,0.0,,,,,,,,,,,,,,,,,0.0,0.0,100.0,-94.01,-5.9,99.87,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,,,,,100.0,0.31,,0.192,,,,,,,,,,61.4,62.8,9923.0,505.0,61.0,0.0,0.0,0.0,0.0,0.0,,1000000.0,777896.0,331004.0,180734.0,19688.0,5599.0,323.0,20.0,,,,,,,,,,,,,,,,,91.5,7.92,0.62,-2.55,2.1,0.49,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,,,,,98.92,-0.77,,0.23,,,,,,,,,,61.6,60.0,12672.0,1758.0,141.0,40.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,399539.0,219969.0,14599.0,2608.0,162.0,0.0,,,,,,,,,,,,,,,,,90.5,7.61,1.9,-3.52,1.8,1.77,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,,,,,99.71,0.01,,0.263,,,,,,,,,,60.4,61.8,10954.0,1011.0,283.0,121.0,20.0,0.0,0.0,0.0,,2000000.0,1000000.0,431357.0,242050.0,19529.0,3477.0,121.0,20.0,,,,,,,,,,,,,,,,,91.6,7.9,0.48,-2.39,2.1,0.35,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,50.0,10.0,D11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,0.31,,0.159,,,,,,,,,,60.0,62.6,11277.0,869.0,121.0,81.0,20.0,20.0,0.0,0.0,,1000000.0,899317.0,413817.0,236170.0,28281.0,5822.0,243.0,20.0,,,,,,,,,,,,,,,,,92.7,6.82,0.5,-1.33,1.0,0.37,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,5.0,0.0,H03,1.0,,NB-ferguhei-5069961-0004,5.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.011,,,,,,,,,,61.4,62.6,895524.0,367092.0,115814.0,59413.0,13241.0,2951.0,182.0,61.0,,,,,,,,,,,,,,,,,,,,,,,,,,96.7,2.99,0.28,8.85,-8.83,-0.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E03,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,99.63,0.37,,0.055,,,,,,,,,,62.0,66.0,72617.0,3840.0,586.0,465.0,222.0,182.0,0.0,0.0,,1000000.0,622256.0,150721.0,25703.0,815.0,407.0,34.0,34.0,,,,,,,,,,,,,,,,,92.4,5.32,2.26,-2.56,2.58,-0.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E04,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,99.61,0.35,,0.055,,,,,,,,,,56.4,62.4,7922.0,465.0,61.0,61.0,40.0,20.0,0.0,0.0,,157067.0,55892.0,8436.0,1409.0,85.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,90.3,7.34,2.34,-4.67,4.6,0.07,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E05,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,99.6,0.33,,0.06,,,,,,,,,,61.0,63.6,16734.0,404.0,61.0,0.0,0.0,0.0,0.0,0.0,,41276.0,10523.0,2766.0,849.0,119.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,94.3,3.43,2.28,-0.68,0.69,0.01,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E06,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,99.65,0.39,,0.055,,,,,,,,,,62.8,67.6,16067.0,445.0,40.0,20.0,0.0,0.0,0.0,0.0,,258651.0,134426.0,45861.0,17991.0,1256.0,187.0,0.0,0.0,,,,,,,,,,,,,,,,,94.0,4.05,1.94,-0.97,1.31,-0.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E07,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,99.65,0.38,,0.055,,,,,,,,,,62.0,63.2,6386.0,505.0,61.0,40.0,20.0,20.0,0.0,0.0,,225466.0,117163.0,41464.0,15123.0,849.0,51.0,0.0,0.0,,,,,,,,,,,,,,,,,94.0,4.05,1.94,-0.97,1.31,-0.33,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E08,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,99.57,0.31,,0.054,,,,,,,,,,55.2,56.6,8913.0,768.0,364.0,323.0,243.0,141.0,20.0,0.0,,2000000.0,881709.0,106412.0,8575.0,441.0,204.0,0.0,0.0,,,,,,,,,,,,,,,,,93.5,3.51,2.99,-1.48,0.77,0.72,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E09,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,99.66,0.39,,0.054,,,,,,,,,,59.2,63.8,6649.0,384.0,121.0,81.0,81.0,81.0,0.0,0.0,,1000000.0,543933.0,82398.0,11749.0,170.0,34.0,0.0,0.0,,,,,,,,,,,,,,,,,94.4,3.3,2.27,-0.55,0.56,0.0,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,99.59,0.32,,0.054,,,,,,,,,,61.8,63.8,10105.0,364.0,61.0,40.0,20.0,20.0,0.0,0.0,,584357.0,175988.0,9812.0,2071.0,492.0,373.0,102.0,17.0,,,,,,,,,,,,,,,,,95.7,2.48,1.78,0.76,-0.26,-0.49,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,03BHZ,mAb,Single Control,,45.0,10.0,E11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,99.47,0.21,,0.052,,,,,,,,,,61.8,63.2,15198.0,323.0,40.0,20.0,0.0,0.0,0.0,0.0,,217779.0,27515.0,3989.0,1765.0,509.0,289.0,34.0,17.0,,,,,,,,,,,,,,,,,95.9,2.3,1.83,0.88,-0.44,-0.44,,,,03BHZ,03BHZ,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,99.14,-0.55,,0.053,,,,,,,,,,64.0,64.6,48870.0,3496.0,404.0,263.0,101.0,61.0,0.0,0.0,,2000000.0,598840.0,151782.0,68036.0,22503.0,8067.0,202.0,101.0,,,,,,,,,,,,,,,,,89.6,3.63,6.78,1.71,-8.19,6.49,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,99.12,-0.57,,0.078,,,,,,,,,,64.6,68.2,13197.0,505.0,61.0,40.0,20.0,0.0,0.0,0.0,,1000000.0,180714.0,8532.0,1355.0,61.0,40.0,0.0,0.0,,,,,,,,,,,,,,,,,95.3,4.57,0.17,7.38,-7.25,-0.12,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,99.18,-0.52,,0.075,,,,,,,,,,64.0,67.2,11075.0,445.0,81.0,61.0,20.0,20.0,0.0,0.0,,1000000.0,249255.0,13284.0,1597.0,20.0,20.0,0.0,0.0,,,,,,,,,,,,,,,,,95.7,4.06,0.27,7.79,-7.76,-0.02,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,98.22,-1.48,,0.059,,,,,,,,,,59.4,61.8,45857.0,3294.0,263.0,162.0,101.0,61.0,20.0,0.0,,2000000.0,658957.0,89197.0,31485.0,13225.0,5541.0,61.0,40.0,,,,,,,,,,,,,,,,,74.2,4.68,21.17,-13.73,-7.14,20.88,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,99.43,-0.26,,0.053,,,,,,,,,,65.0,66.6,62835.0,3456.0,222.0,81.0,81.0,81.0,0.0,0.0,,862200.0,80534.0,28691.0,18319.0,7865.0,3943.0,162.0,40.0,,,,,,,,,,,,,,,,,89.6,4.63,5.74,1.76,-7.19,5.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,99.5,-0.2,,0.054,,,,,,,,,,59.6,64.6,48101.0,3072.0,283.0,162.0,101.0,61.0,0.0,0.0,,1000000.0,481073.0,93202.0,47855.0,19004.0,6187.0,142.0,101.0,,,,,,,,,,,,,,,,,89.6,3.8,6.61,1.72,-8.02,6.32,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,99.25,-0.45,,0.059,,,,,,,,,,65.2,67.0,47434.0,2021.0,182.0,121.0,40.0,40.0,0.0,0.0,,466361.0,9077.0,2446.0,1435.0,505.0,222.0,61.0,40.0,,,,,,,,,,,,,,,,,87.2,4.51,8.33,-0.72,-7.31,8.04,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,99.67,-0.03,,0.09,,,,,,,,,,65.6,68.6,10792.0,121.0,40.0,20.0,20.0,20.0,20.0,0.0,,447701.0,91525.0,5195.0,970.0,61.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,95.5,3.89,0.63,7.6,-7.93,0.34,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,99.44,-0.25,,0.056,,,,,,,,,,65.4,68.0,48647.0,2526.0,263.0,121.0,40.0,20.0,20.0,20.0,,193675.0,48490.0,15483.0,10288.0,3578.0,1233.0,40.0,40.0,,,,,,,,,,,,,,,,,92.2,3.21,4.57,4.34,-8.61,4.28,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,E11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,99.2,-0.5,,0.058,,,,,,,,,,65.4,66.8,72617.0,3840.0,586.0,465.0,222.0,182.0,0.0,0.0,,3000000.0,112820.0,17643.0,8235.0,1841.0,486.0,20.0,0.0,,,,,,,,,,,,,,,,,91.2,3.23,5.56,3.34,-8.59,5.27,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,,,,,99.48,-0.22,,0.352,,,,,,,,,,61.8,62.6,43109.0,546.0,40.0,20.0,0.0,0.0,0.0,0.0,,2000000.0,2000000.0,2000000.0,2000000.0,2000000.0,1000000.0,3173.0,0.0,,,,,,,,,,,,,,,,,59.5,15.87,24.6,,4.05,24.31,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,,,,,99.62,-0.07,,0.102,,,,,,,,,,65.0,68.0,78762.0,4123.0,222.0,81.0,40.0,20.0,0.0,0.0,,1000000.0,775782.0,333255.0,174087.0,8835.0,465.0,40.0,0.0,,,,,,,,,,,,,,,,,93.5,5.85,0.63,5.65,-5.97,0.34,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0.0,0.0,0,,,,,,,,99.43,-0.26,,0.075,,,,,,,,,,65.0,67.6,88079.0,5235.0,404.0,101.0,20.0,20.0,0.0,0.0,,1000000.0,320351.0,29661.0,5803.0,142.0,40.0,20.0,0.0,,,,,,,,,,,,,,,,,94.7,4.94,0.33,6.85,-6.88,0.04,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,,,,,95.25,-4.45,,0.374,,,,,,,,,,56.6,58.0,16047.0,202.0,40.0,40.0,40.0,40.0,20.0,0.0,,2000000.0,2000000.0,2000000.0,2000000.0,1000000.0,1000000.0,40178.0,20.2,,,,,,,,,,,,,,,,,11.5,8.4,80.06,,-3.42,79.77,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,,,,,99.47,-0.22,,0.287,,,,,,,,,,62.6,64.0,9681.0,344.0,40.0,40.0,0.0,0.0,0.0,0.0,,3000000.0,2000000.0,2000000.0,2000000.0,1000000.0,826104.0,183219.0,50436.0,,,,,,,,,,,,,,,,,93.5,4.81,1.72,5.59,-7.01,1.43,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,,,,,99.1,-0.59,,0.313,,,,,,,,,,52.8,61.2,7255.0,101.0,40.0,40.0,20.0,20.0,20.0,20.0,,3000000.0,3000000.0,3000000.0,2000000.0,2000000.0,273649.0,0.0,0.0,,,,,,,,,,,,,,,,,74.9,10.03,15.07,-12.98,-1.79,14.78,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,,,,,90.0,-9.69,,0.082,,,,,,,,,,57.4,64.2,2930.0,162.0,81.0,61.0,40.0,20.0,0.0,0.0,,1000000.0,722818.0,246916.0,108692.0,3113.0,323.4,60.6,0.0,,,,,,,,,,,,,,,,,93.9,5.71,0.39,6.02,-6.11,0.1,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,,,,,99.63,-0.06,,0.229,,,,,,,,,,60.2,65.0,65604.0,2264.0,61.0,40.0,40.0,20.0,0.0,0.0,,3000000.0,1000000.0,142434.0,46595.0,9545.5,3134.6,80.9,0.0,,,,,,,,,,,,,,,,,93.8,5.73,0.47,5.92,-6.09,0.18,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,,,,,99.49,-0.21,,0.293,,,,,,,,,,62.2,63.6,2668.0,263.0,20.0,20.0,0.0,0.0,0.0,0.0,,735295.0,271640.0,67253.0,33333.0,12836.0,5922.8,121.3,0.0,,,,,,,,,,,,,,,,,94.1,4.67,1.27,6.18,-7.15,0.98,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,F11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,,,,,99.62,-0.07,,0.095,,,,,,,,,,63.8,65.2,344.0,81.0,40.0,40.0,40.0,0.0,0.0,0.0,,706105.0,393931.0,103505.0,37210.0,1091.4,161.7,0.0,0.0,,,,,,,,,,,,,,,,,95.8,4.08,0.17,7.87,-7.74,-0.12,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,98.45,-1.24,,0.391,,,,,,,,,,58.0,60.2,101903.0,5073.0,61.0,40.0,20.0,0.0,0.0,0.0,,3000000.0,3000000.0,2000000.0,1000000.0,273513.0,10349.0,141.5,0.0,,,,,,,,,,,,,,,,,0.0,0.0,0.0,,-11.82,-0.29,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,,,,,0.0,-99.69,,0.211,,,,,,,,,,60.2,65.0,21342.0,728.0,20.0,0.0,0.0,0.0,0.0,0.0,,4000000.0,3000000.0,2000000.0,2000000.0,646859.0,124359.0,20.2,0.0,,,,,,,,,,,,,,,,,92.1,7.12,0.78,4.21,-4.7,0.49,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0.0,0.0,0,,,,,,,,99.66,-0.03,,0.13,,,,,,,,,,64.2,65.6,21524.0,869.0,101.0,40.0,40.0,20.0,0.0,0.0,,4000000.0,2000000.0,580345.0,266708.0,37749.0,10251.0,283.1,0.0,,,,,,,,,,,,,,,,,92.0,7.6,0.38,4.14,-4.22,0.09,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,,,,,93.59,-6.1,,0.543,,,,,,,,,,48.8,56.2,75366.0,2102.0,121.0,81.0,0.0,0.0,0.0,0.0,,2000000.0,2000000.0,1000000.0,863640.0,122999.0,12896.0,727.7,101.1,,,,,,,,,,,,,,,,,21.3,12.52,66.21,,0.7,65.92,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,,,,,98.66,-1.03,,0.323,,,,,,,,,,56.4,62.8,56690.0,1334.0,81.0,61.0,20.0,20.0,0.0,0.0,,3000000.0,2000000.0,1000000.0,789485.0,142234.0,19770.0,404.3,20.2,,,,,,,,,,,,,,,,,91.2,8.1,0.74,3.28,-3.72,0.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,,,,,98.3,-1.39,,0.37,,,,,,,,,,54.2,60.4,28699.0,465.0,20.0,0.0,0.0,0.0,0.0,0.0,,4000000.0,3000000.0,2000000.0,2000000.0,185672.0,4931.8,141.5,0.0,,,,,,,,,,,,,,,,,24.7,18.31,0.0,,6.49,-0.29,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,,,,,99.66,-0.03,,0.146,,,,,,,,,,64.2,68.4,32114.0,849.0,202.0,81.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,441331.0,240963.0,22926.0,3537.9,363.9,0.0,,,,,,,,,,,,,,,,,89.1,10.58,0.35,1.19,-1.24,0.06,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,0.31,,0.303,,,,,,,,,,64.2,63.0,29689.0,768.0,61.0,40.0,20.0,0.0,0.0,0.0,,3000000.0,1000000.0,600805.0,337546.0,34292.0,6348.9,60.7,0.0,,,,,,,,,,,,,,,,,85.3,13.96,0.74,-2.58,2.14,0.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,0.31,,0.28,,,,,,,,,,58.8,63.8,36560.0,829.0,61.0,40.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,390941.0,218946.0,22930.0,5277.5,121.3,0.0,,,,,,,,,,,,,,,,,87.5,11.93,0.61,-0.42,0.11,0.32,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,50.0,10.0,G11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,,,,,99.53,-0.17,,0.114,,,,,,,,,,60.4,64.6,36500.0,869.0,40.0,0.0,0.0,0.0,0.0,0.0,,1000000.0,837125.0,368282.0,198351.0,12916.0,1313.9,101.1,0.0,,,,,,,,,,,,,,,,,89.6,10.3,0.06,1.76,-1.52,-0.23,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,5.0,0.0,H08,1.0,,NB-ferguhei-5069961-0004,5.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.011,,,,,,,,,,64.4,65.6,1000000.0,668219.0,281459.0,153576.0,32527.0,5782.0,303.0,20.0,,,,,,,,,,,,,,,,,,,,,,,,,,90.6,9.37,0.04,2.71,-2.45,-0.25,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D03,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,99.28,0.53,,0.054,,,,,,,,,,60.4,65.0,48870.0,3496.0,404.0,263.0,101.0,61.0,0.0,0.0,,1000000.0,368618.0,23941.0,1545.0,119.0,68.0,0.0,0.0,,,,,,,,,,,,,,,,,94.1,4.04,1.82,-1.33,1.01,0.32,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D04,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,98.63,-0.12,,0.055,,,,,,,,,,64.4,65.6,13197.0,505.0,61.0,40.0,20.0,0.0,0.0,0.0,,103890.0,34353.0,2240.0,204.0,51.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,92.9,5.0,2.06,-2.53,1.97,0.56,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D05,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,99.22,0.46,,0.057,,,,,,,,,,63.8,65.6,11075.0,445.0,81.0,61.0,20.0,20.0,0.0,0.0,,158218.0,47829.0,9114.0,3089.0,390.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,95.4,2.6,1.97,-0.03,-0.43,0.47,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D06,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,99.01,0.26,,0.056,,,,,,,,,,65.0,67.6,45857.0,3294.0,263.0,162.0,101.0,61.0,20.0,0.0,,180471.0,70810.0,17686.0,6433.0,679.0,85.0,0.0,0.0,,,,,,,,,,,,,,,,,95.4,2.7,1.95,-0.12,-0.33,0.45,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D07,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,99.16,0.41,,0.052,,,,,,,,,,63.8,67.2,62835.0,3456.0,222.0,81.0,81.0,81.0,0.0,0.0,,48099.0,15852.0,2682.0,560.0,51.0,34.0,17.0,17.0,,,,,,,,,,,,,,,,,95.5,2.61,1.88,0.05,-0.42,0.38,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D08,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,99.38,0.63,,0.053,,,,,,,,,,56.2,60.8,48101.0,3072.0,283.0,162.0,101.0,61.0,0.0,0.0,,2000000.0,738484.0,40397.0,1885.0,272.0,187.0,51.0,34.0,,,,,,,,,,,,,,,,,94.6,3.33,2.11,-0.92,0.3,0.61,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D09,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,98.75,-0.01,,0.054,,,,,,,,,,63.4,65.6,47434.0,2021.0,182.0,121.0,40.0,40.0,0.0,0.0,,2000000.0,1000000.0,219368.0,29221.0,255.0,68.0,0.0,0.0,,,,,,,,,,,,,,,,,94.6,2.42,2.94,-0.83,-0.61,1.44,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,98.72,-0.03,,0.053,,,,,,,,,,59.6,66.2,10792.0,121.0,40.0,20.0,20.0,20.0,20.0,0.0,,327887.0,90765.0,6858.0,679.0,102.0,51.0,17.0,17.0,,,,,,,,,,,,,,,,,95.1,2.67,2.2,-0.34,-0.36,0.7,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,69BHV,mAb,Single Control,,45.0,10.0,D11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,99.06,0.31,,0.053,,,,,,,,,,64.6,66.2,48647.0,2526.0,263.0,121.0,40.0,20.0,20.0,20.0,,518950.0,10663.0,764.0,289.0,51.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,95.9,2.17,1.98,0.38,-0.86,0.48,,,,69BHV,69BHV,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,99.0,0.67,,0.044,,,,,,,,,,59.4,61.8,29854.0,655.0,67.0,17.0,0.0,0.0,0.0,0.0,,2000000.0,526696.0,24622.0,10528.0,3243.0,1053.0,17.0,0.0,,,,,,,,,,,,,,,,,81.9,1.72,16.36,-15.8,0.4,15.46,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,0.94,,0.044,,,,,,,,,,64.8,69.6,117961.0,2235.0,101.0,17.0,0.0,0.0,0.0,0.0,,1000000.0,460155.0,72377.0,30493.0,7793.0,2716.0,68.0,34.0,,,,,,,,,,,,,,,,,94.2,1.56,4.21,-3.53,0.2,3.31,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,0.78,,0.045,,,,,,,,,,65.2,70.0,141006.0,4185.0,50.0,17.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,140414.0,47710.0,11885.0,4958.0,51.0,0.0,,,,,,,,,,,,,,,,,94.2,1.67,4.13,-3.55,0.3,3.23,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,97.0,-1.67,,0.047,,,,,,,,,,56.0,59.6,91493.0,8704.0,807.0,134.0,0.0,0.0,0.0,0.0,,824575.0,204573.0,19982.0,10390.0,3209.0,1375.0,51.0,17.0,,,,,,,,,,,,,,,,,30.0,3.14,66.89,,1.8,65.99,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,100.0,0.92,,0.045,,,,,,,,,,56.8,62.2,86873.0,2756.0,168.0,17.0,0.0,0.0,0.0,0.0,,201781.0,52906.0,5279.0,2631.0,967.0,611.0,170.0,85.0,,,,,,,,,,,,,,,,,86.4,1.94,11.7,-11.39,0.6,10.8,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,99.0,0.49,,0.044,,,,,,,,,,59.4,65.6,3638.0,748.0,162.0,81.0,40.0,0.0,0.0,0.0,,130995.0,37136.0,6738.0,3853.0,1494.0,645.0,34.0,17.0,,,,,,,,,,,,,,,,,80.0,1.88,18.09,-17.72,0.5,17.19,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,100.0,1.16,,0.047,,,,,,,,,,63.2,60.2,31690.0,445.0,0.0,0.0,0.0,0.0,0.0,0.0,,84624.0,27003.0,3955.0,1511.0,51.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,95.6,2.12,2.27,-2.14,0.8,1.37,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,1.11,,0.046,,,,,,,,,,63.4,69.0,7599.0,606.0,40.0,40.0,0.0,0.0,0.0,0.0,,84098.0,31501.0,9674.0,5584.0,1782.0,645.0,102.0,34.0,,,,,,,,,,,,,,,,,93.4,1.87,4.77,-4.4,0.5,3.87,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,100.0,0.95,,0.047,,,,,,,,,,62.0,62.0,30477.0,1637.0,344.0,162.0,40.0,0.0,0.0,0.0,,21232.0,3072.0,594.0,289.0,153.0,136.0,68.0,34.0,,,,,,,,,,,,,,,,,89.3,1.51,9.23,-8.49,0.2,8.33,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,B11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,100.0,0.94,,0.103,,,,,,,,,,62.6,65.0,31468.0,768.0,121.0,81.0,0.0,0.0,0.0,0.0,,3000000.0,2000000.0,2000000.0,1000000.0,193226.0,10474.0,68.0,0.0,,,,,,,,,,,,,,,,,95.8,2.05,2.17,-1.97,0.7,1.27,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,,,,,99.0,0.55,,0.141,,,,,,,,,,58.4,65.0,43733.0,756.0,50.0,34.0,17.0,0.0,0.0,0.0,,3000000.0,2000000.0,994799.0,459346.0,73065.0,19382.0,1111.0,154.0,,,,,,,,,,,,,,,,,91.5,1.7,6.79,-6.23,0.3,5.89,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,,,,,99.0,0.44,,0.045,,,,,,,,,,64.4,69.4,140303.0,7261.0,67.0,0.0,0.0,0.0,0.0,0.0,,662809.0,201890.0,19895.0,7962.0,1748.0,509.0,17.0,17.0,,,,,,,,,,,,,,,,,93.5,1.9,4.66,-4.3,0.5,3.76,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0.0,0.0,0,,,,,,,,100.0,0.8,,0.047,,,,,,,,,,65.2,69.4,150157.0,8487.0,118.0,34.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,244538.0,87540.0,15043.0,4975.0,68.0,34.0,,,,,,,,,,,,,,,,,93.6,1.95,4.48,-4.17,0.6,3.58,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,,,,,93.0,-5.66,,0.27,,,,,,,,,,53.4,57.2,78490.0,2336.0,168.0,84.0,0.0,0.0,0.0,0.0,,3000000.0,1000000.0,267873.0,78689.0,9272.0,3464.0,51.0,0.0,,,,,,,,,,,,,,,,,0.0,0.0,100.0,,-1.4,99.1,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,,,,,100.0,1.11,,0.072,,,,,,,,,,61.8,65.8,53397.0,2235.0,252.0,84.0,0.0,0.0,0.0,0.0,,132101.0,12305.0,1528.0,900.0,204.0,51.0,0.0,0.0,,,,,,,,,,,,,,,,,93.3,2.23,4.49,-4.48,0.9,3.59,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,,,,,99.0,0.5,,0.109,,,,,,,,,,57.8,58.8,8791.0,1314.0,263.0,61.0,0.0,0.0,0.0,0.0,,766086.0,434407.0,172374.0,87961.0,6297.0,458.0,17.0,0.0,,,,,,,,,,,,,,,,,94.6,1.65,3.76,-3.16,0.3,2.86,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,,,,,100.0,1.16,,0.067,,,,,,,,,,62.8,65.6,20453.0,606.0,40.0,0.0,0.0,0.0,0.0,0.0,,155034.0,9488.0,153.0,51.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,96.5,1.5,2.02,-1.27,0.1,1.12,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,,,,,98.0,-0.67,,0.046,,,,,,,,,,62.2,68.0,6245.0,1233.0,283.0,101.0,20.0,0.0,0.0,0.0,,90141.0,29464.0,7672.0,4549.0,1731.0,1018.0,221.0,136.0,,,,,,,,,,,,,,,,,91.5,1.79,6.73,-6.27,0.4,5.83,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,,,,,100.0,1.1,,0.079,,,,,,,,,,62.2,65.8,25141.0,3658.0,1011.0,445.0,61.0,40.0,0.0,0.0,,153558.0,12679.0,238.0,51.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,94.8,2.64,2.51,-2.91,1.3,1.61,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,C11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,,,,,100.0,1.11,,0.061,,,,,,,,,,63.2,65.4,26536.0,2001.0,384.0,182.0,40.0,20.0,0.0,0.0,,211958.0,6603.0,221.0,85.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,96.2,2.2,1.57,-1.52,0.8,0.67,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,0.0,-98.73,,0.076,,,,,,,,,,56.8,61.0,24578.0,1159.0,151.0,84.0,0.0,0.0,0.0,0.0,,361053.0,183217.0,63618.0,31996.0,2054.0,153.0,51.0,34.0,,,,,,,,,,,,,,,,,100.0,0.0,0.0,2.25,-1.4,-0.9,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,1.12,,0.046,,,,,,,,,,63.4,68.8,52105.0,1092.0,134.0,0.0,0.0,0.0,0.0,0.0,,960710.0,351451.0,40557.0,14889.0,3344.0,1341.0,68.0,68.0,,,,,,,,,,,,,,,,,93.2,1.88,4.94,-4.57,0.5,4.04,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,0.96,,0.046,,,,,,,,,,63.2,64.6,48625.0,1630.0,134.0,34.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,354808.0,160901.0,27572.0,7572.0,17.0,0.0,,,,,,,,,,,,,,,,,93.6,1.74,4.67,-4.16,0.4,3.77,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,,,,,92.0,-6.81,,0.391,,,,,,,,,,51.8,52.6,32458.0,1378.0,235.0,67.0,0.0,0.0,0.0,0.0,,223729.0,161967.0,89563.0,58045.0,11762.0,1680.0,85.0,17.0,,,,,,,,,,,,,,,,,0.0,0.0,100.0,,-1.4,99.1,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,,,,,100.0,1.1,,0.091,,,,,,,,,,60.8,66.0,25755.0,991.0,84.0,0.0,0.0,0.0,0.0,0.0,,2000000.0,557801.0,156909.0,73911.0,13790.0,5621.0,323.0,0.0,,,,,,,,,,,,,,,,,95.1,1.9,3.01,-2.66,0.5,2.11,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.073,,,,,,,,,,57.6,61.2,10489.0,2829.0,950.0,303.0,121.0,61.0,0.0,0.0,,433300.0,148886.0,35800.0,14768.0,696.0,153.0,17.0,0.0,,,,,,,,,,,,,,,,,100.0,0.0,0.0,2.25,-1.4,-0.9,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,,,,,100.0,1.15,,0.046,,,,,,,,,,62.2,67.4,7154.0,687.0,101.0,40.0,0.0,0.0,0.0,0.0,,22064.0,5872.0,1884.0,1273.0,560.0,339.0,85.0,34.0,,,,,,,,,,,,,,,,,92.0,2.08,5.97,-5.79,0.7,5.07,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,1.1,,0.085,,,,,,,,,,61.0,67.2,6366.0,2041.0,303.0,121.0,0.0,0.0,0.0,0.0,,4000000.0,3000000.0,1000000.0,619327.0,16251.0,815.0,68.0,23.0,,,,,,,,,,,,,,,,,92.8,2.02,5.15,-4.92,0.7,4.25,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,1.08,,0.051,,,,,,,,,,61.6,66.2,13824.0,3779.0,1112.0,566.0,202.0,40.0,20.0,20.0,,2000000.0,32184.0,5387.0,3161.0,1733.0,1240.0,204.0,51.0,,,,,,,,,,,,,,,,,90.7,2.48,6.79,-7.02,1.1,5.89,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,MK-2032,mAb,Single Control,,50.0,10.0,D11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,1.11,,0.045,,,,,,,,,,59.4,64.0,8650.0,2324.0,889.0,445.0,101.0,20.0,0.0,0.0,,96490.0,32045.0,8402.0,4820.0,2088.0,1341.0,85.0,17.0,,,,,,,,,,,,,,,,,92.4,2.59,5.06,-5.4,1.2,4.16,,,,Tox Batch 19K-2032-19003 UFP ,Tox Batch 19K-2032-19003 UFP ,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,99.0,0.74,,0.05,,,,,,,,,,59.8,64.0,68706.0,2033.0,218.0,84.0,0.0,0.0,0.0,0.0,,3000000.0,372924.0,39875.0,17451.0,4304.0,1847.0,59.0,39.0,,,,,,,,,,,,,,,,,40.7,0.46,58.87,,-0.6,58.87,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,0.79,,0.054,,,,,,,,,,64.0,65.4,81195.0,521.0,17.0,17.0,17.0,0.0,0.0,0.0,,286494.0,20675.0,492.0,153.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,97.2,1.55,1.23,-1.72,0.49,1.23,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,0.86,,0.06,,,,,,,,,,64.8,,113200.0,2033.0,17.0,0.0,0.0,0.0,0.0,0.0,,576640.0,194975.0,36411.0,12714.0,373.0,51.0,0.0,0.0,,,,,,,,,,,,,,,,,97.4,1.74,0.84,-1.52,0.68,0.84,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,97.0,-2.21,,0.051,,,,,,,,,,56.6,60.0,122812.0,1664.0,67.0,34.0,0.0,0.0,0.0,0.0,,1000000.0,130226.0,17677.0,10545.0,4551.0,2394.0,221.0,17.0,,,,,,,,,,,,,,,,,4.0,2.87,93.08,,1.81,93.08,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,100.0,0.82,,0.195,,,,,,,,,,62.2,,141619.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2000000.0,332103.0,94860.0,59481.0,25613.0,10480.0,272.0,0.0,,,,,,,,,,,,,,,,,84.8,1.37,13.83,-14.13,0.31,13.83,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,99.0,0.4,,0.046,,,,,,,,,,59.4,,13783.0,1718.0,707.0,485.0,141.0,81.0,40.0,0.0,,1000000.0,182729.0,21890.0,14333.0,5927.0,3142.0,170.0,34.0,,,,,,,,,,,,,,,,,46.6,0.58,52.8,-52.31,-0.48,52.8,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,100.0,0.8,,0.054,,,,,,,,,,46.4,62.8,29164.0,546.0,40.0,20.0,0.0,0.0,0.0,0.0,,193631.0,19553.0,2733.0,917.0,85.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,97.7,1.43,0.84,-1.22,0.37,0.84,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,,,,,100.0,1.27,,0.111,,,,,,,,,,57.8,59.2,41566.0,1462.0,202.0,84.0,0.0,0.0,0.0,0.0,,180706.0,97744.0,36728.0,19722.0,2054.0,102.0,0.0,0.0,,,,,,,,,,,,,,,,,0.0,0.0,0.0,,-1.06,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,100.0,0.89,,0.055,,,,,,,,,,63.4,66.0,56105.0,1738.0,101.0,61.0,20.0,0.0,0.0,0.0,,181568.0,3768.0,255.0,153.0,34.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,97.9,1.4,0.74,-1.08,0.34,0.74,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,100.0,1.01,,0.058,,,,,,,,,,62.0,65.2,51638.0,2122.0,647.0,424.0,162.0,40.0,20.0,0.0,,6000000.0,2000000.0,2487.0,829.0,265.0,166.0,99.0,33.0,,,,,,,,,,,,,,,,,79.9,1.27,18.78,-19.0,0.21,18.78,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,E11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,98.0,-0.48,,0.27,,,,,,,,,,62.8,65.0,41210.0,647.0,61.0,61.0,40.0,20.0,0.0,0.0,,1000000.0,871036.0,549734.0,367152.0,123001.0,29095.0,34.0,0.0,,,,,,,,,,,,,,,,,97.7,4.07,0.27,-1.25,3.01,0.27,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,,,,,100.0,0.84,,0.061,,,,,,,,,,62.6,65.2,117960.0,2487.0,34.0,0.0,0.0,0.0,0.0,0.0,,280730.0,21149.0,594.0,187.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,96.2,1.5,2.35,-2.79,0.44,2.35,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,50,0.0,0.0,0,,,,,,,,100.0,0.86,,0.056,,,,,,,,,,63.0,65.4,131992.0,4117.0,118.0,34.0,0.0,0.0,0.0,0.0,,378955.0,59716.0,5551.0,1630.0,204.0,51.0,0.0,0.0,,,,,,,,,,,,,,,,,96.7,1.73,1.56,-2.22,0.67,1.56,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,,,,,95.0,-4.17,,0.352,,,,,,,,,,54.8,57.4,141797.0,5042.0,50.0,0.0,0.0,0.0,0.0,0.0,,869508.0,475883.0,219855.0,131451.0,20115.0,2920.0,51.0,0.0,,,,,,,,,,,,,,,,,13.7,18.24,151.0,-85.21,17.18,151.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,,,,,100.0,1.27,,0.067,,,,,,,,,,61.0,62.0,152740.0,5412.0,134.0,34.0,0.0,0.0,0.0,0.0,,519983.0,71538.0,4465.0,1681.0,136.0,51.0,34.0,17.0,,,,,,,,,,,,,,,,,97.7,4.21,0.17,-1.23,3.15,0.17,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,,,,,100.0,1.27,,0.074,,,,,,,,,,57.8,59.2,22150.0,1253.0,303.0,222.0,61.0,61.0,0.0,0.0,,67279.0,23117.0,6467.0,3327.0,441.0,85.0,0.0,0.0,,,,,,,,,,,,,,,,,100.0,0.0,0.0,1.06,-1.06,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,,,,,100.0,0.8,,0.064,,,,,,,,,,63.4,,42239.0,1192.0,81.0,20.0,0.0,0.0,0.0,0.0,,378855.0,8437.0,696.0,306.0,34.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,97.6,1.99,0.38,-1.3,0.93,0.38,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,,,,,100.0,1.27,,0.069,,,,,,,,,,62.2,66.6,43392.0,2183.0,182.0,81.0,0.0,0.0,0.0,0.0,,366656.0,80508.0,7706.0,1867.0,68.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,97.7,1.56,0.74,-1.24,0.5,0.74,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,,,,,100.0,1.27,,0.07,,,,,,,,,,61.8,65.4,35267.0,2829.0,909.0,505.0,162.0,101.0,20.0,20.0,,459600.0,32050.0,1681.0,594.0,85.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,98.0,3.85,0.09,-0.92,2.79,0.09,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,F11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,,,,,100.0,0.88,,0.056,,,,,,,,,,62.6,65.2,29952.0,1637.0,303.0,121.0,0.0,0.0,0.0,0.0,,294678.0,8912.0,764.0,492.0,102.0,34.0,17.0,0.0,,,,,,,,,,,,,,,,,98.0,2.04,0.0,-0.98,0.98,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.123,,,,,,,,,,57.0,59.0,34844.0,722.0,50.0,17.0,0.0,0.0,0.0,0.0,,36626.0,14240.0,5533.0,3004.0,645.0,102.0,0.0,0.0,,,,,,,,,,,,,,,,,0.0,0.0,0.0,,-1.06,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G03,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,0.88,,0.076,,,,,,,,,,63.6,66.8,67985.0,924.0,50.0,0.0,0.0,0.0,0.0,0.0,,1000000.0,512978.0,200464.0,112559.0,13839.0,985.0,51.0,0.0,,,,,,,,,,,,,,,,,96.8,1.85,1.33,-2.11,0.79,1.33,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G04,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,0.84,,0.095,,,,,,,,,,63.4,64.0,64203.0,689.0,50.0,0.0,0.0,0.0,0.0,0.0,,3000000.0,1000000.0,273073.0,132798.0,15108.0,1561.0,34.0,0.0,,,,,,,,,,,,,,,,,96.6,1.85,1.57,-2.36,0.79,1.57,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,,,,,93.0,-5.44,,0.513,,,,,,,,,,53.2,57.2,81916.0,1159.0,67.0,17.0,0.0,0.0,0.0,0.0,,61557.0,49372.0,34470.0,26578.0,9267.0,1969.0,85.0,34.0,,,,,,,,,,,,,,,,,0.0,0.0,100.0,,-1.06,100.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G06,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.073,,,,,,,,,,60.0,61.2,114492.0,1949.0,151.0,17.0,0.0,0.0,0.0,0.0,,845211.0,319038.0,58396.0,18554.0,611.0,85.0,0.0,0.0,,,,,,,,,,,,,,,,,97.3,2.75,0.0,-1.69,1.69,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G07,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.067,,,,,,,,,,57.6,59.0,27102.0,728.0,61.0,20.0,0.0,0.0,0.0,0.0,,77042.0,4770.0,1392.0,832.0,34.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,100.0,0.0,0.0,1.06,-1.06,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G08,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.067,,,,,,,,,,62.6,65.2,32053.0,1192.0,81.0,0.0,0.0,0.0,0.0,0.0,,501124.0,150106.0,17891.0,4312.0,51.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,98.1,1.86,0.0,-0.8,0.8,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G09,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.067,,,,,,,,,,61.2,65.8,32478.0,1779.0,182.0,61.0,0.0,0.0,0.0,0.0,,671205.0,239024.0,50161.0,18316.0,611.0,102.0,34.0,0.0,,,,,,,,,,,,,,,,,97.6,2.43,0.0,-1.37,1.37,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,,,,,100.0,1.27,,0.063,,,,,,,,,,61.6,65.2,38945.0,1273.0,101.0,61.0,20.0,0.0,0.0,0.0,,667571.0,211343.0,29350.0,8165.0,119.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,97.8,2.2,0.0,-1.14,1.14,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,50.0,10.0,G11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,,,,,99.0,0.72,,0.059,,,,,,,,,,62.2,63.4,39107.0,1900.0,344.0,141.0,20.0,0.0,0.0,0.0,,457168.0,94971.0,7672.0,1613.0,170.0,68.0,34.0,0.0,,,,,,,,,,,,,,,,,97.5,2.55,0.0,-1.49,1.49,0.0,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,5.0,0.0,H08,1.0,,NB-ferguhei-5069961-0004,5.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,64.0,62.2,68290.0,22171.0,8690.0,5174.0,1071.0,202.0,40.0,20.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C02,1.0,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,99.53,-0.02,,0.052,,,,,,,,,,60.8,63.8,68706.0,2033.0,218.0,84.0,0.0,0.0,0.0,0.0,,2000000.0,1000000.0,168516.0,20205.0,391.0,153.0,0.0,0.0,,,,,,,,,,,,,,,,,96.2,1.26,2.58,1.09,-1.71,0.63,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C03,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,99.52,-0.03,,0.053,,,,,,,,,,62.2,63.8,81195.0,521.0,17.0,17.0,17.0,0.0,0.0,0.0,,167625.0,44520.0,2274.0,221.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,95.8,1.42,2.76,0.74,-1.55,0.81,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C04,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,99.52,-0.03,,0.055,,,,,,,,,,62.6,64.0,113200.0,2033.0,17.0,0.0,0.0,0.0,0.0,0.0,,22658.0,5244.0,119.0,68.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,95.4,1.54,3.03,0.35,-1.43,1.08,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C05,1.0,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,99.57,0.03,,0.055,,,,,,,,,,61.6,67.2,122812.0,1664.0,67.0,34.0,0.0,0.0,0.0,0.0,,20383.0,8978.0,2359.0,747.0,85.0,68.0,34.0,0.0,,,,,,,,,,,,,,,,,96.4,1.26,2.34,1.32,-1.71,0.39,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C06,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,99.53,-0.01,,0.056,,,,,,,,,,62.2,65.2,141619.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,104940.0,62730.0,23150.0,9114.0,645.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,97.0,0.85,2.19,1.88,-2.12,0.24,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C07,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,,,,,99.56,0.01,,0.054,,,,,,,,,,62.6,66.8,13783.0,1718.0,707.0,485.0,141.0,81.0,40.0,0.0,,122574.0,60795.0,15207.0,4090.0,102.0,17.0,17.0,17.0,,,,,,,,,,,,,,,,,96.8,0.95,2.23,1.74,-2.02,0.28,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C08,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,95.13,-4.42,,0.054,,,,,,,,,,56.2,60.8,29164.0,546.0,40.0,20.0,0.0,0.0,0.0,0.0,,1000000.0,251376.0,2920.0,458.0,119.0,85.0,17.0,17.0,,,,,,,,,,,,,,,,,92.5,1.21,6.26,-2.55,-1.76,4.31,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C09,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,98.03,-1.52,,0.053,,,,,,,,,,59.2,60.6,56105.0,1738.0,101.0,61.0,20.0,0.0,0.0,0.0,,521123.0,178913.0,19419.0,3191.0,136.0,102.0,17.0,0.0,,,,,,,,,,,,,,,,,95.4,1.3,3.35,0.27,-1.67,1.4,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C10,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,99.53,-0.02,,0.052,,,,,,,,,,61.4,62.8,51638.0,2122.0,647.0,424.0,162.0,40.0,20.0,0.0,,5431.0,713.0,136.0,102.0,51.0,34.0,34.0,0.0,,,,,,,,,,,,,,,,,94.9,2.02,3.04,-0.14,-0.95,1.09,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,aTau,68BHS,mAb,Single Control,,45.0,10.0,C11,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,99.54,-0.01,,0.055,,,,,,,,,,61.4,63.4,41210.0,647.0,61.0,61.0,40.0,20.0,0.0,0.0,,883564.0,5010.0,85.0,17.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,95.9,1.62,2.45,0.85,-1.35,0.5,,,,68BHS,68BHS,,,,,aTau historical data.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B02,1.32,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,98.61,4.6,,0.0423,37.7,51.2,11.1,-29.1,,,,,,64.0,66.8,21836.0,3512.0,791.0,339.0,85.0,36.0,3.0,1.0,,14142.0,916.0,158.0,67.0,19.0,7.0,2.0,0.0,,,,,,,,93.6,0.74,5.71,-3.0,0.7,2.0,,,,95.5,3.61,0.94,1.0,0.0,-0.4,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B03,1.29,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,98.53,-1.47,,,100.0,6.0,,0.0441,35.4,56.1,8.5,-31.4,,,,,,66.4,65.8,2867.0,823.0,259.0,160.0,57.0,30.0,3.0,1.0,,32115.0,4083.0,949.0,465.0,55.0,7.0,0.0,0.0,,,,,,,,96.3,0.8,2.95,0.0,0.8,0.0,,,,94.1,3.91,1.99,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B04,1.3,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,94.39,-5.61,,,100.0,6.0,,0.0445,31.4,61.1,7.5,-35.4,,,,,,68.0,69.4,90853.0,8961.0,1123.0,362.0,42.0,10.0,2.0,0.0,,106872.0,20664.0,3666.0,1432.0,70.0,7.0,0.0,0.0,,,,,,,,94.3,0.84,4.85,-2.0,0.8,1.0,,,,94.0,3.5,2.49,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B05,1.31,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.79,5.8,,0.0435,36.2,55.2,8.6,-30.6,,,,,,66.4,65.4,105993.0,28146.0,1847.0,310.0,30.0,9.0,0.0,0.0,,3227.0,207.0,38.0,22.0,8.0,5.0,1.0,0.0,,,,,,,,84.0,0.8,15.23,-13.0,0.8,12.0,,,,94.1,4.03,1.92,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B06,1.3,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,98.26,-1.74,,,94.72,0.7,,0.0427,30.8,61.7,7.5,-36.0,,,,,,66.6,70.0,73538.0,4680.0,229.0,107.0,15.0,2.0,0.0,0.0,,2454.0,241.0,53.0,28.0,6.0,1.0,0.0,0.0,,,,,,,,81.7,0.84,17.45,-15.0,0.8,14.0,,,,94.0,3.67,2.3,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B07,1.3,,NB-ferguhei-5069961-0004,6.8,Acetate,0,0,0.0,0.0,0,,,,50.84,-49.16,,,100.0,6.0,,0.0433,23.8,69.3,6.9,-43.0,,,,,,66.8,70.2,25536.0,862.0,202.0,99.0,18.0,6.0,1.0,0.0,,919.0,207.0,60.0,24.0,3.0,1.0,1.0,1.0,,,,,,,,81.3,0.81,17.91,-15.0,0.8,15.0,,,,93.0,4.6,2.36,-2.0,1.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B08,1.3,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,84.33,-15.67,,,99.49,5.5,,0.0457,42.2,37.8,20.0,-24.6,,,,,,62.4,59.0,3255.0,755.0,215.0,106.0,26.0,10.0,0.0,0.0,,2351.0,447.0,78.0,34.0,9.0,5.0,0.0,0.0,,,,,,,,95.1,0.66,4.19,-1.0,0.6,1.0,,,,92.3,6.42,1.33,-2.0,3.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B09,1.3,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,6.0,,0.0462,44.6,41.7,13.7,-22.2,,,,,,64.8,63.8,5580.0,1571.0,397.0,213.0,59.0,16.0,0.0,0.0,,3768.0,784.0,153.0,82.0,27.0,7.0,0.0,0.0,,,,,,,,94.5,0.75,4.71,-2.0,0.7,1.0,,,,93.7,4.75,1.53,-1.0,1.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B10,1.3,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,92.17,-7.83,,,100.0,6.0,,0.0532,40.7,49.7,9.6,-26.1,,,,,,63.6,64.8,9597.0,2465.0,745.0,373.0,97.0,26.0,0.0,0.0,,18812.0,567.0,128.0,71.0,7.0,0.0,0.0,0.0,,,,,,,,94.1,0.86,5.08,-3.0,0.8,2.0,,,,93.7,4.61,1.65,-1.0,1.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,B11,1.29,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,96.6,2.6,,0.0498,34.7,55.9,9.4,-32.1,,,,,,67.8,70.0,102949.0,10193.0,1863.0,787.0,152.0,48.0,7.0,5.0,,42644.0,2465.0,223.0,105.0,28.0,7.0,1.0,0.0,,,,,,,,94.0,0.9,5.08,-3.0,0.9,2.0,,,,94.2,4.24,1.56,-1.0,0.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C02,1.31,,NB-ferguhei-5069961-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,98.32,-1.68,,,100.0,6.0,,0.043,35.0,30.45,34.55,-31.8,,,,,,62.6,64.0,19597.0,2155.0,955.0,602.0,207.0,89.0,5.0,0.0,,53714.0,6264.0,363.0,85.0,8.0,3.0,0.0,0.0,,,,,,,,86.3,0.73,13.01,-10.0,0.7,10.0,,,,94.3,4.11,1.64,0.0,0.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C03,1.3,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,90.56,-9.44,,,100.0,6.0,,0.0435,34.2,29.33,36.47,-32.6,,,,,,66.6,66.8,94843.0,6157.0,1096.0,676.0,213.0,70.0,4.0,1.0,,625.0,84.0,21.0,11.0,4.0,2.0,0.0,0.0,,,,,,,,85.0,0.79,14.25,-12.0,0.7,11.0,,,,93.5,4.52,2.03,-1.0,1.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C04,1.31,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,78.0,-22.0,,,100.0,6.0,,0.0454,32.5,29.65,37.85,-34.3,,,,,,67.6,69.6,94832.0,8935.0,1180.0,651.0,196.0,57.0,2.0,0.0,,1387.0,135.0,29.0,15.0,5.0,1.0,0.0,0.0,,,,,,,,85.0,0.8,14.21,-12.0,0.8,11.0,,,,93.3,4.39,2.36,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C05,1.29,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,99.54,-0.46,,,97.98,4.0,,0.044,36.2,54.8,9.0,-30.6,,,,,,66.8,67.0,73679.0,5542.0,1340.0,836.0,267.0,89.0,5.0,1.0,,813.0,152.0,55.0,35.0,13.0,7.0,2.0,0.0,,,,,,,,81.4,0.79,17.87,-15.0,0.7,14.0,,,,94.5,3.79,1.74,0.0,0.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C06,1.3,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,95.25,-4.75,,,100.0,6.0,,0.0438,24.6,63.4,12.0,-42.2,,,,,,66.8,69.8,60240.0,3701.0,1381.0,858.0,299.0,103.0,8.0,1.0,,983.0,125.0,24.0,12.0,3.0,2.0,0.0,0.0,,,,,,,,80.0,0.82,19.16,-17.0,0.8,16.0,,,,93.5,4.36,2.1,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C07,1.29,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,48.27,-51.73,,,100.0,6.0,,0.0443,23.9,68.4,7.7,-42.9,,,,,,67.0,68.2,19376.0,3067.0,1383.0,926.0,325.0,108.0,3.0,0.0,,599.0,73.0,18.0,10.0,6.0,4.0,1.0,1.0,,,,,,,,79.8,0.79,19.38,-17.0,0.7,16.0,,,,93.8,3.59,2.57,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C08,1.3,,NB-ferguhei-5069961-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,57.19,-42.81,,,98.26,4.2,,0.0473,31.3,25.8,42.9,-35.5,,,,,,59.2,69.4,76078.0,3904.0,1520.0,917.0,277.0,93.0,1.0,0.0,,32526.0,883.0,94.0,41.0,7.0,3.0,1.0,1.0,,,,,,,,92.8,0.82,6.41,-4.0,0.8,3.0,,,,87.8,5.73,6.46,-7.0,2.0,5.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C09,1.29,,NB-ferguhei-5069961-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,65.39,-34.61,,,100.0,6.0,,0.0463,43.4,39.8,16.8,-23.4,,,,,,61.6,59.8,97941.0,8643.0,1844.0,1104.0,352.0,102.0,5.0,1.0,,26042.0,3399.0,97.0,30.0,6.0,2.0,0.0,0.0,,,,,,,,90.1,0.78,9.13,-6.0,0.7,6.0,,,,93.3,4.59,2.15,-1.0,1.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C10,1.29,,NB-ferguhei-5069961-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,91.3,-8.7,,,94.01,0.0,,0.0516,41.3,48.0,10.7,-25.5,,,,,,66.0,67.4,84628.0,6224.0,1686.0,1046.0,354.0,112.0,4.0,0.0,,8617.0,287.0,32.0,16.0,2.0,2.0,1.0,0.0,,,,,,,,85.2,0.81,13.96,-11.0,0.8,11.0,,,,94.4,3.8,1.77,0.0,0.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,C11,1.26,,NB-ferguhei-5069961-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,98.64,-1.36,,,99.97,5.9,,0.0511,38.2,51.5,10.3,-28.6,,,,,,66.8,68.4,77647.0,4896.0,1507.0,898.0,279.0,92.0,3.0,0.0,,3954.0,413.0,49.0,25.0,9.0,5.0,0.0,0.0,,,,,,,,83.3,0.81,15.89,-13.0,0.8,13.0,,,,94.7,3.58,1.7,0.0,0.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D02,1.32,,NB-ferguhei-5069961-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,77.28,-22.72,,,100.0,6.0,,0.0426,,,,,,,,,,61.8,61.8,67914.0,3515.0,1026.0,676.0,197.0,76.0,2.0,0.0,,7355.0,140.0,18.0,12.0,2.0,1.0,0.0,0.0,,,,,,,,82.0,0.76,17.27,-15.0,0.7,14.0,,,,92.9,4.13,3.01,-2.0,0.0,2.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D03,1.3,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,39.97,-60.03,,,89.64,-4.4,,0.0431,,,,,,,,,,62.2,66.6,37780.0,2482.0,1034.0,637.0,211.0,81.0,7.0,2.0,,941.0,73.0,25.0,19.0,8.0,3.0,0.0,0.0,,,,,,,,78.8,0.81,20.37,-18.0,0.8,17.0,,,,93.4,4.33,2.31,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D04,1.3,,NB-ferguhei-5069961-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,68.17,-31.83,,,96.86,2.8,,0.0437,,,,,,,,,,67.0,68.2,12190.0,2774.0,1222.0,728.0,261.0,98.0,4.0,0.0,,529.0,72.0,16.0,8.0,2.0,2.0,0.0,0.0,,,,,,,,80.0,0.81,19.16,-17.0,0.8,16.0,,,,93.5,3.98,2.51,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D05,1.32,,NB-ferguhei-5069961-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,76.71,-23.29,,,98.63,4.6,,0.0435,,,,,,,,,,65.4,63.4,77056.0,3106.0,1336.0,856.0,309.0,101.0,2.0,0.0,,2890.0,133.0,27.0,16.0,6.0,5.0,1.0,0.0,,,,,,,,78.2,0.73,21.03,-18.0,0.7,18.0,,,,93.3,4.3,2.41,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D06,1.3,,NB-ferguhei-5069961-0004,6.2,Phosphate,0,150,0.0,0.0,0,,,,11.93,-88.07,,,99.84,5.8,,0.0428,,,,,,,,,,66.8,67.8,59324.0,3281.0,1406.0,925.0,360.0,146.0,9.0,1.0,,580.0,109.0,17.0,9.0,4.0,1.0,0.0,0.0,,,,,,,,76.3,0.73,22.95,-20.0,0.7,20.0,,,,93.9,3.88,2.22,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D07,1.31,,NB-ferguhei-5069961-0004,6.8,Phosphate,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,6.0,,0.0419,,,,,,,,,,66.2,69.4,53944.0,3133.0,1279.0,805.0,269.0,101.0,2.0,1.0,,774.0,86.0,22.0,13.0,3.0,3.0,0.0,0.0,,,,,,,,76.9,0.75,22.36,-20.0,0.7,19.0,,,,93.7,3.83,2.51,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D08,1.3,,NB-ferguhei-5069961-0004,5.0,Phosphate,0,150,0.0,0.0,0,,,,1.72,-98.28,,,99.03,5.0,,0.0503,,,,,,,,,,56.8,56.8,128536.0,3971.0,1539.0,989.0,328.0,104.0,5.0,1.0,,14469.0,81.0,5.0,4.0,0.0,0.0,0.0,0.0,,,,,,,,91.1,1.1,7.82,-5.0,1.1,4.0,,,,67.5,6.73,25.78,-27.0,3.0,24.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D09,1.31,,NB-ferguhei-5069961-0004,5.6,Phosphate,0,150,0.0,0.0,0,,,,97.59,-2.41,,,100.0,6.0,,0.0465,,,,,,,,,,61.4,60.4,87756.0,3824.0,1617.0,963.0,313.0,96.0,2.0,0.0,,13144.0,231.0,9.0,5.0,2.0,1.0,0.0,0.0,,,,,,,,83.3,0.71,16.04,-13.0,0.7,13.0,,,,91.9,3.49,4.61,-3.0,0.0,3.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D10,1.3,,NB-ferguhei-5069961-0004,6.2,Phosphate,0,150,0.0,0.0,0,,,,100.0,0.0,,,98.52,4.5,,0.0522,,,,,,,,,,61.4,65.8,78794.0,3700.0,1553.0,970.0,326.0,122.0,7.0,0.0,,568.0,120.0,41.0,22.0,4.0,3.0,0.0,0.0,,,,,,,,78.1,0.77,21.15,-18.0,0.7,18.0,,,,94.6,3.1,2.29,0.0,-1.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,D11,1.32,,NB-ferguhei-5069961-0004,6.8,Phosphate,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,6.0,,0.0524,,,,,,,,,,61.4,66.8,52427.0,3655.0,1471.0,916.0,285.0,98.0,6.0,1.0,,574.0,115.0,31.0,23.0,11.0,6.0,3.0,0.0,,,,,,,,76.9,0.77,22.37,-20.0,0.7,19.0,,,,94.1,3.75,2.14,-1.0,0.0,1.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,E02,1.26,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.96,5.94,,0.0441,34.8,56.8,8.4,-32.0,,,,,,64.8,66.4,133515.0,5796.0,1229.0,570.0,105.0,42.0,2.0,1.0,,4965.0,1777.0,828.0,551.0,191.0,100.0,12.0,5.0,,,,,,,,93.4,0.77,5.86,-3.2,0.72,2.47,,,,93.9,4.13,1.97,-0.81,0.23,0.59,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,E03,1.29,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,5.98,,0.0447,36.8,54.5,8.7,-30.0,,,,,,67.2,70.0,42251.0,992.0,292.0,180.0,53.0,23.0,2.0,0.0,,13193.0,645.0,143.0,76.0,20.0,9.0,0.0,0.0,,,,,,,,84.7,0.78,14.56,-11.9,0.73,11.17,,,,94.7,3.23,2.08,-0.03,-0.67,0.7,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,E04,1.3,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.9,5.88,,0.0463,44.7,32.46,23.0,-22.1,,,,,,62.8,62.4,151111.0,10033.0,576.0,283.0,70.0,26.0,4.0,0.0,,11942.0,1504.0,499.0,369.0,200.0,108.0,7.0,2.0,,,,,,,,95.5,0.68,3.82,-1.1,0.63,0.43,,,,94.1,4.24,1.7,-0.66,0.34,0.32,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,E05,1.28,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,96.35,-3.65,,,100.0,5.98,,0.0455,45.7,39.7,14.6,-21.1,,,,,,67.4,65.0,55553.0,2971.0,1051.0,576.0,167.0,60.0,4.0,1.0,,5834.0,1025.0,224.0,119.0,36.0,11.0,1.0,0.0,,,,,,,,95.0,0.72,4.24,-1.5,0.67,0.85,,,,94.2,4.02,1.75,-0.49,0.12,0.37,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,50.0,10.0,E06,1.29,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.66,5.64,,0.0476,45.2,41.0,13.8,-21.6,,,,,,68.0,65.2,156600.0,13898.0,477.0,228.0,41.0,9.0,2.0,0.0,,19056.0,1928.0,445.0,276.0,110.0,47.0,5.0,2.0,,,,,,,,95.3,0.7,3.97,-1.2,0.65,0.58,,,,94.1,4.37,1.56,-0.65,0.47,0.18,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,CD40,TDI,mAb,Single Control,,-80.0,0.0,H03,1.270215827,,NB-ferguhei-5069961-0004,6.5,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,94.02,0.0,,0.04,66.8,25.5,7.7,0.0,,,,,,68.6,68.8,177759.0,16097.0,1085.0,471.0,67.0,8.0,0.0,0.0,,24101.0,4859.0,1080.0,460.0,33.0,3.0,0.0,0.0,,,,,,,,96.6,0.05,3.39,0.0,0.0,0.0,,,,94.7,3.9,1.38,0.0,0.0,0.0,,,,TDI_Y_003,TDI,,,,,TDI_Y_003 Results Template_Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,0,0.0,0.0,0,,,,81.18,-3.18,,,99.86,-0.09,,0.0425,41.8,48.04,10.16,-19.1,,,,,,64.0,,116439.0,7026.9,835.7,358.2,119.4,51.2,0.0,0.0,,1178887.7,4980.3,849.9,509.9,153.0,51.0,17.0,0.0,,,,,,,,98.6,1.15,0.22,0.3,-0.45,0.18,,,,96.6,1.48,1.94,-0.02,0.92,1.12,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0.0,0.0,0,,,,82.82,-1.54,,,99.92,-0.03,,0.0439,43.0,48.2,8.79,-17.9,,,,,,66.4,,104017.2,4264.0,526.6,271.8,101.9,51.0,0.0,0.0,,1145917.1,6117.3,1461.3,662.7,186.9,51.0,17.0,0.0,,,,,,,,97.7,2.19,0.13,-0.7,0.59,0.09,,,,96.2,1.36,2.44,-0.02,0.8,1.62,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0.0,0.0,0,,,,82.91,-1.45,,,99.92,-0.03,,0.0453,38.1,52.78,9.15,-22.9,,,,,,68.0,,19077.4,2189.5,746.8,526.2,237.6,220.6,186.7,186.7,,914232.3,4909.8,1019.3,475.7,135.9,51.0,0.0,0.0,,,,,,,,98.4,1.16,0.26,0.1,-0.44,0.22,,,,96.1,1.32,2.62,-0.03,0.76,1.8,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,0,0.0,0.0,0,,,,93.85,9.49,,,99.88,-0.07,,0.045,36.8,54.61,8.6,-24.1,,,,,,66.4,,11184.6,1765.1,441.3,186.7,67.9,17.0,0.0,0.0,,149026.4,6484.6,2020.1,1188.3,492.3,152.8,50.9,34.0,,,,,,,,98.5,1.3,0.19,0.2,-0.3,0.15,,,,95.7,1.08,3.18,-0.03,0.52,2.36,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0.0,0.0,0,,,,94.48,10.12,,,99.89,-0.07,,0.0448,34.8,57.82,7.39,-26.1,,,,,,66.6,,14137.9,2138.5,339.4,220.6,84.9,50.9,17.0,0.0,,33928.2,6823.0,2376.2,1663.3,526.1,186.7,0.0,0.0,,,,,,,,98.2,1.66,0.17,-0.2,0.06,0.13,,,,95.6,1.18,3.21,-0.03,0.62,2.39,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0.0,0.0,0,,,,91.32,6.96,,,99.88,-0.07,,0.0457,30.3,63.7,6.05,-30.7,,,,,,66.8,,15258.6,2579.9,577.1,356.4,135.8,67.9,33.9,33.9,,70811.4,8826.0,1714.3,831.7,237.6,84.9,33.9,0.0,,,,,,,,98.2,1.6,0.19,-0.1,0.0,0.15,,,,94.9,1.09,4.02,-0.04,0.53,3.2,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,89.82,5.46,,,99.72,-0.23,,0.05,34.0,19.31,46.71,-27.0,,,,,,62.4,,11337.3,2528.8,424.3,118.8,33.9,0.0,0.0,0.0,,32977.8,3784.9,746.8,441.3,135.8,17.0,0.0,0.0,,,,,,,,98.4,1.48,0.12,0.1,-0.12,0.08,,,,96.5,1.22,2.33,-0.02,0.66,1.51,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0.0,0.0,0,,,,89.19,4.83,,,99.81,-0.14,,0.0477,34.7,17.76,47.53,-26.2,,,,,,64.8,,10319.0,2053.6,560.1,373.4,186.7,84.9,0.0,0.0,,56725.9,3174.1,746.8,339.5,118.8,67.9,0.0,0.0,,,,,,,,98.1,1.87,0.07,-0.3,0.27,0.03,,,,97.2,1.08,1.69,-0.01,0.52,0.87,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0.0,0.0,0,,,,83.05,-1.31,,,99.94,-0.01,,0.0503,33.9,18.75,47.32,-27.0,,,,,,63.6,,43585.4,2732.6,458.3,203.7,50.9,33.9,0.0,0.0,,54551.1,4260.2,814.7,492.2,118.8,33.9,0.0,0.0,,,,,,,,98.6,1.32,0.08,0.3,-0.28,0.04,,,,97.4,1.09,1.51,-0.01,0.53,0.69,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,B11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0.0,0.0,0,,,,83.6,-0.76,,,99.91,-0.04,,0.0471,32.0,18.9,49.08,-28.9,,,,,,67.8,,208217.4,3208.3,560.2,254.6,67.9,50.9,17.0,0.0,,238501.7,6925.9,984.6,543.2,152.8,34.0,0.0,0.0,,,,,,,,98.6,1.33,0.07,0.3,-0.27,0.03,,,,97.3,1.08,1.59,-0.01,0.52,0.77,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,50,0.0,0.0,0,,,,88.41,4.04,,,99.83,-0.12,,0.0435,64.7,30.45,4.85,3.8,,,,,,62.6,,34970.0,2801.0,814.8,526.2,186.7,101.9,0.0,0.0,,201539.6,4023.3,1290.2,763.9,169.8,84.9,0.0,0.0,,,,,,,,98.4,1.51,0.12,0.0,-0.09,0.08,,,,93.9,1.42,4.7,-0.05,0.86,3.88,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0.0,0.0,0,,,,87.98,3.62,,,99.9,-0.05,,0.0443,66.6,29.33,4.11,5.6,,,,,,66.6,,11965.2,2545.8,967.4,577.0,203.7,101.8,0.0,0.0,,137327.7,5465.9,1629.6,1154.3,305.5,118.8,33.9,17.0,,,,,,,,98.5,1.38,0.13,0.1,-0.22,0.09,,,,94.8,1.44,3.78,-0.04,0.88,2.96,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0.0,0.0,0,,,,91.21,6.85,,,99.9,-0.05,,0.0459,65.8,29.65,4.54,4.9,,,,,,67.6,,8231.4,1476.6,305.5,254.6,118.8,33.9,0.0,0.0,,137193.5,3972.2,1273.1,848.8,237.7,101.9,0.0,0.0,,,,,,,,98.4,1.51,0.12,0.0,-0.09,0.08,,,,94.8,1.46,3.73,-0.04,0.9,2.91,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,50,0.0,0.0,0,,,,92.06,7.69,,,99.79,-0.16,,0.0461,28.0,66.81,5.19,-32.9,,,,,,66.8,,8214.4,1765.1,560.1,407.3,186.7,33.9,17.0,0.0,,179754.4,4006.2,1595.7,882.7,305.6,135.8,17.0,0.0,,,,,,,,97.4,2.4,0.16,-0.9,0.8,0.12,,,,94.7,1.33,3.96,-0.04,0.77,3.14,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0.0,0.0,0,,,,91.88,7.52,,,99.86,-0.09,,0.0454,29.2,65.55,5.27,-31.8,,,,,,66.8,,7841.1,1748.1,594.0,407.3,118.8,33.9,0.0,0.0,,221559.4,5381.5,1935.3,1120.4,356.5,118.8,17.0,0.0,,,,,,,,96.9,1.3,0.17,-1.5,-0.3,0.13,,,,94.4,1.52,4.07,-0.04,0.96,3.25,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0.0,0.0,0,,,,92.49,8.13,,,99.74,-0.21,,0.046,26.7,69.02,4.25,-34.2,,,,,,67.0,,7247.0,1663.2,390.4,271.6,84.9,84.9,0.0,0.0,,223646.7,2020.2,662.1,390.5,50.9,34.0,0.0,0.0,,,,,,,,97.4,2.49,0.16,-1.0,0.89,0.12,,,,94.2,1.27,4.53,-0.04,0.71,3.71,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,50,0.0,0.0,0,,,,92.25,7.88,,,99.48,-0.47,,0.0488,39.2,24.04,36.74,-21.7,,,,,,59.2,,8655.7,2342.1,746.8,577.0,288.5,67.9,17.0,0.0,,167019.2,4566.3,1476.8,848.8,152.8,84.9,0.0,0.0,,,,,,,,97.7,2.15,0.17,-0.7,0.55,0.13,,,,90.3,1.38,8.32,-0.08,0.82,7.5,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0.0,0.0,0,,,,91.66,7.3,,,99.76,-0.19,,0.0482,41.6,22.9,35.53,-19.4,,,,,,61.6,,9266.7,2070.6,695.8,407.3,152.7,50.9,17.0,0.0,,83002.3,4226.5,1256.1,695.9,220.7,50.9,0.0,0.0,,,,,,,,98.0,1.91,0.11,-0.4,0.31,0.07,,,,95.0,1.08,3.9,-0.04,0.52,3.08,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0.0,0.0,0,,,,83.88,-0.48,,,99.93,-0.02,,0.0524,38.9,23.52,37.63,-22.1,,,,,,66.0,,8214.5,3071.9,1120.2,916.5,458.2,220.6,50.9,17.0,,100402.7,4362.4,1714.4,1086.4,339.5,101.8,17.0,0.0,,,,,,,,97.9,2.0,0.08,-0.4,0.4,0.04,,,,96.3,1.0,2.67,-0.02,0.44,1.85,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,C11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0.0,0.0,0,,,,88.24,3.87,,,99.89,-0.06,,0.0483,36.0,22.07,41.9,-24.9,,,,,,66.8,,607742.4,97945.7,458.8,339.9,203.9,169.9,0.0,0.0,,93816.1,7434.7,2172.7,1290.0,373.4,169.7,17.0,17.0,,,,,,,,97.9,2.02,0.07,-0.4,0.42,0.03,,,,96.6,0.98,2.47,-0.02,0.42,1.65,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,150,0.0,0.0,0,,,,97.56,13.2,,,100.0,0.05,,0.0427,,,,,,,,,,61.8,,27292.1,5128.9,1630.4,1120.9,424.6,203.8,67.9,67.9,,450004.3,32645.4,11787.7,6709.1,1189.0,288.7,67.9,34.0,,,,,,,,97.7,2.13,0.16,-0.6,0.53,0.12,,,,90.1,1.44,8.5,-0.09,0.88,7.68,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0.0,0.0,0,,,,94.28,9.92,,,99.92,-0.03,,0.0453,,,,,,,,,,62.2,,16057.1,3564.5,1459.7,1154.2,865.7,712.9,577.1,577.1,,473302.5,10322.8,3158.0,1782.7,543.3,135.8,34.0,34.0,,,,,,,,97.2,2.66,0.13,-1.1,1.06,0.09,,,,93.3,1.42,5.29,-0.05,0.86,4.47,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0.0,0.0,0,,,,96.66,12.3,,,99.92,-0.03,,0.0455,,,,,,,,,,67.0,,8282.4,1697.2,475.2,288.5,152.7,67.9,17.0,17.0,,448740.2,11859.5,2820.4,1716.1,611.7,407.8,288.8,237.9,,,,,,,,97.5,2.37,0.13,-0.8,0.77,0.09,,,,93.7,1.46,4.81,-0.05,0.9,3.99,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,150,0.0,0.0,0,,,,94.96,10.59,,,99.91,-0.04,,0.0453,,,,,,,,,,65.4,,11710.7,2189.4,594.0,390.4,118.8,33.9,0.0,0.0,,775194.9,3922.8,934.0,509.4,17.0,0.0,0.0,0.0,,,,,,,,97.5,2.38,0.18,-0.9,0.78,0.14,,,,93.3,1.35,5.34,-0.05,0.79,4.52,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0.0,0.0,0,,,,94.57,10.2,,,99.89,-0.07,,0.0439,,,,,,,,,,66.8,,10675.5,1510.5,560.1,373.4,118.8,50.9,0.0,0.0,,911271.3,8803.7,2141.4,1257.7,305.9,119.0,0.0,0.0,,,,,,,,97.0,2.85,0.16,-1.4,1.25,0.12,,,,93.5,1.8,4.72,-0.05,1.24,3.9,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0.0,0.0,0,,,,93.96,9.6,,,99.89,-0.07,,0.0438,,,,,,,,,,66.2,,9385.5,1951.8,628.0,373.4,67.9,33.9,0.0,0.0,,561308.9,2207.3,832.0,628.2,407.5,237.7,169.8,135.8,,,,,,,,96.9,2.97,0.16,-1.5,1.37,0.12,,,,93.5,1.7,4.81,-0.05,1.14,3.99,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,150,0.0,0.0,0,,,,93.58,9.22,,,99.36,-0.59,,0.0505,,,,,,,,,,56.8,,9725.0,2189.4,950.4,644.9,271.6,118.8,17.0,0.0,,943523.6,7115.4,2037.8,1358.5,339.6,169.8,0.0,0.0,,,,,,,,97.5,2.27,0.19,-0.8,0.67,0.15,,,,80.6,1.54,17.82,-0.18,0.98,17.0,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0.0,0.0,0,,,,95.62,11.26,,,100.0,0.05,,0.0481,,,,,,,,,,61.4,,8536.9,2274.3,865.6,577.0,288.5,84.9,0.0,0.0,,370497.1,4312.4,1205.4,747.0,254.7,135.8,17.0,0.0,,,,,,,,97.8,2.13,0.11,-0.6,0.53,0.07,,,,92.3,1.14,6.53,-0.06,0.58,5.71,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0.0,0.0,0,,,,97.25,12.89,,,99.92,-0.03,,0.0526,,,,,,,,,,64.6,,6873.7,1866.9,780.7,407.3,135.8,101.8,33.9,0.0,,201148.5,6620.6,2376.6,1409.0,543.2,118.8,17.0,0.0,,,,,,,,97.7,2.17,0.1,-0.6,0.57,0.06,,,,94.8,1.04,4.12,-0.04,0.48,3.3,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,50.0,10.0,D11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0.0,0.0,0,,,,94.32,9.96,,,99.92,-0.03,,0.0502,,,,,,,,,,66.8,,10149.2,2596.7,712.8,526.1,339.4,186.7,33.9,0.0,,174248.4,3922.4,1137.7,628.3,288.7,101.9,34.0,17.0,,,,,,,,97.9,2.03,0.1,-0.5,0.43,0.06,,,,95.4,1.01,3.62,-0.03,0.45,2.8,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0411,BsAb,Single Control,,5.0,0.0,H02,1.232278481,,NB-ferguhei-5069961-0003,5.5,Acetate,0,0,0.0,0.0,0,,,,84.36,0.0,,,99.95,0.0,,0.0383,60.9,24.87,14.2,0.0,,,,,,66.6,,447194.5,50264.0,1022.7,750.0,545.4,511.3,477.2,477.2,,1083749.6,16347.3,2432.5,1462.9,527.3,255.2,221.1,221.1,,,,,,,,98.4,1.6,0.04,0.0,0.0,0.0,,,,98.6,0.56,0.82,0.0,0.0,0.0,,,,AB0411,AB0411,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,0,0.0,0.0,0,,,,99.46,-0.54,,,99.88,-0.07,,0.0424,36.3,55.24,8.46,-25.4,,,,,,64.6,,12762.9,3224.7,1018.3,611.0,288.5,118.8,0.0,0.0,,283973.0,4346.1,1392.1,933.7,458.4,135.8,0.0,0.0,,,,,,,,96.4,2.59,0.97,-1.1,0.78,0.36,,,,97.4,1.43,1.19,-0.02,1.15,0.35,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0.0,0.0,0,,,,99.46,-0.54,,,99.89,-0.06,,0.0435,38.4,53.4,8.17,-23.3,,,,,,67.8,,11999.3,3292.6,1154.1,628.0,254.6,33.9,17.0,0.0,,267006.9,4244.1,1171.4,730.0,305.6,101.9,0.0,0.0,,,,,,,,96.2,2.63,1.13,-1.3,0.82,0.52,,,,97.1,1.31,1.62,-0.02,1.03,0.78,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0.0,0.0,0,,,,99.14,-0.86,,,99.87,-0.07,,0.0457,38.1,54.33,7.61,-23.6,,,,,,68.0,,11252.4,2817.3,780.7,458.2,118.8,67.9,0.0,0.0,,299660.4,3955.6,1052.6,407.4,186.7,67.9,17.0,0.0,,,,,,,,96.2,2.75,1.09,-1.4,0.94,0.48,,,,97.1,1.24,1.62,-0.02,0.96,0.78,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,0,0.0,0.0,0,,,,99.26,-0.74,,,99.86,-0.08,,0.0449,33.7,60.76,5.57,-28.0,,,,,,67.0,,8163.5,2291.2,797.7,509.2,169.7,50.9,17.0,17.0,,110063.5,2766.9,831.8,509.2,169.7,118.8,33.9,17.0,,,,,,,,96.1,2.76,1.1,-1.4,0.95,0.49,,,,97.4,1.0,1.56,-0.01,0.72,0.72,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0.0,0.0,0,,,,99.79,-0.21,,,99.85,-0.1,,0.0441,31.9,62.5,5.56,-29.8,,,,,,65.0,,9283.7,2698.5,1035.3,695.9,169.7,67.9,0.0,0.0,,84632.9,2478.2,814.8,424.4,186.7,84.9,0.0,0.0,,,,,,,,95.9,2.92,1.2,-1.7,1.11,0.59,,,,97.2,1.11,1.68,-0.02,0.83,0.84,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.81,-0.14,,0.0441,29.3,65.89,4.78,-32.4,,,,,,68.8,,8316.2,2138.5,577.0,339.4,101.8,50.9,0.0,0.0,,65110.8,2121.7,560.1,237.6,67.9,17.0,17.0,17.0,,,,,,,,95.6,3.12,1.26,-2.0,1.31,0.65,,,,97.3,1.09,1.65,-0.02,0.81,0.81,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,99.5,-0.5,,,99.67,-0.28,,0.0481,36.4,18.77,44.81,-25.3,,,,,,61.4,,11642.7,4327.8,1697.2,1120.1,356.4,135.8,0.0,0.0,,149262.2,4583.3,1035.5,458.3,152.8,50.9,0.0,0.0,,,,,,,,96.6,2.47,0.91,-1.0,0.66,0.3,,,,97.5,1.21,1.3,-0.01,0.93,0.46,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0.0,0.0,0,,,,99.64,-0.36,,,99.82,-0.12,,0.0476,36.0,17.82,46.17,-25.7,,,,,,65.4,,182003.4,6060.0,1833.3,1035.5,271.6,84.9,0.0,0.0,,295729.0,4719.4,1307.2,645.1,152.8,67.9,0.0,0.0,,,,,,,,96.7,2.34,0.97,-0.9,0.53,0.36,,,,97.9,0.98,1.11,-0.01,0.7,0.27,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0.0,0.0,0,,,,99.86,-0.14,,,99.87,-0.08,,0.052,35.3,19.66,45.0,-26.4,,,,,,68.0,,12813.8,4463.6,2036.6,1374.7,509.2,203.7,17.0,0.0,,188600.1,6348.9,2359.6,1595.7,526.2,305.6,50.9,0.0,,,,,,,,96.3,2.4,1.29,-1.3,0.59,0.68,,,,98.0,0.96,1.07,-0.91,0.68,0.23,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,E11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0.0,0.0,0,,,,96.73,-3.27,,,99.88,-0.07,,0.0469,34.0,20.13,45.88,-27.7,,,,,,68.8,,12576.2,4073.3,1222.0,729.8,339.4,152.7,0.0,0.0,,305333.7,6230.6,1477.0,797.9,152.8,67.9,17.0,0.0,,,,,,,,96.8,2.17,1.01,-0.8,0.36,0.4,,,,98.0,0.9,1.08,-0.85,0.62,0.24,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,50,0.0,0.0,0,,,,99.8,-0.2,,,99.78,-0.16,,0.0421,33.4,60.58,5.99,-28.3,,,,,,64.8,,89823.9,5280.8,2054.6,1477.3,645.2,373.6,17.0,0.0,,289068.4,8675.3,2886.1,1833.5,780.9,288.6,17.0,0.0,,,,,,,,96.4,2.72,0.9,-1.2,0.91,0.29,,,,97.1,1.36,1.52,-1.77,1.08,0.68,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0.0,0.0,0,,,,99.8,-0.2,,,99.85,-0.1,,0.0433,33.7,60.36,5.98,-28.0,,,,,,67.2,,15597.7,4871.1,2053.7,1357.8,492.2,186.7,17.0,17.0,,223528.1,9133.3,2699.2,1629.7,611.1,220.7,67.9,50.9,,,,,,,,96.2,2.76,1.01,-1.4,0.95,0.4,,,,97.0,1.35,1.68,-1.91,1.07,0.84,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0.0,0.0,0,,,,99.38,-0.62,,,99.85,-0.09,,0.0462,63.0,32.46,5.0,1.3,,,,,,62.8,,12185.9,3733.8,1476.6,933.5,407.3,169.7,17.0,0.0,,488781.8,5195.3,1069.6,713.1,305.6,135.8,17.0,0.0,,,,,,,,96.2,2.77,1.03,-1.4,0.96,0.42,,,,97.1,1.37,1.52,-1.77,1.09,0.68,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,50,0.0,0.0,0,,,,99.81,-0.19,,,99.85,-0.1,,0.0449,30.2,64.61,5.24,-31.5,,,,,,67.4,,12864.7,4293.9,1799.0,1069.2,475.2,67.9,0.0,0.0,,536908.5,4363.5,1001.7,611.2,237.7,101.9,17.0,17.0,,,,,,,,96.1,2.9,1.02,-1.5,1.09,0.41,,,,97.2,1.23,1.61,-1.72,0.95,0.77,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0.0,0.0,0,,,,99.76,-0.24,,,99.82,-0.12,,0.045,30.8,64.48,4.71,-30.9,,,,,,68.0,,12712.1,4395.8,2138.5,1425.7,661.9,373.4,50.9,0.0,,117635.0,4040.0,2003.0,1442.9,729.9,339.5,33.9,0.0,,,,,,,,95.8,3.11,1.07,-1.8,1.3,0.46,,,,97.0,1.48,1.57,-1.92,1.2,0.73,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0.0,0.0,0,,,,99.32,-0.68,,,99.82,-0.12,,0.0453,28.5,67.65,3.84,-33.2,,,,,,68.2,,15512.4,5872.3,2681.6,1680.2,763.7,254.6,0.0,0.0,,87161.9,3072.3,1357.9,1018.4,373.4,101.8,0.0,0.0,,,,,,,,95.6,3.27,1.1,-1.9,1.46,0.49,,,,97.1,1.26,1.63,-1.77,0.98,0.79,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,50,0.0,0.0,0,,,,99.19,-0.81,,,99.29,-0.66,,0.0499,37.7,24.34,37.93,-24.0,,,,,,59.6,,15105.2,5176.5,2070.6,1425.7,594.0,220.6,0.0,0.0,,263849.4,8725.9,2903.0,1646.7,475.3,237.7,17.0,0.0,,,,,,,,96.4,2.7,0.86,-1.1,0.89,0.25,,,,96.4,1.42,2.23,-2.53,1.14,1.39,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0.0,0.0,0,,,,97.08,-2.92,,,99.72,-0.23,,0.0486,39.0,22.32,38.7,-22.7,,,,,,62.6,,13221.2,4599.4,2189.4,1493.5,746.8,373.4,50.9,0.0,,189991.7,8606.7,2631.2,1697.6,662.1,254.6,0.0,0.0,,,,,,,,96.5,2.58,0.92,-1.1,0.77,0.31,,,,97.6,1.02,1.42,-1.32,0.74,0.58,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0.0,0.0,0,,,,99.85,-0.15,,,99.85,-0.09,,0.0523,37.1,23.61,39.31,-24.6,,,,,,66.4,,11710.6,4514.5,2019.7,1612.3,899.5,390.4,33.9,17.0,,95768.9,6263.5,2563.1,1816.2,628.0,237.6,50.9,33.9,,,,,,,,96.4,2.6,0.98,-1.2,0.79,0.37,,,,97.9,0.92,1.23,-1.02,0.64,0.39,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,F11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0.0,0.0,0,,,,99.85,-0.15,,,99.85,-0.09,,0.0484,37.2,23.27,39.54,-24.5,,,,,,68.2,,29545.7,5756.3,2326.3,1681.1,594.3,356.6,0.0,0.0,,49409.1,3445.6,1374.8,933.5,543.1,305.5,17.0,0.0,,,,,,,,96.5,2.42,1.12,-1.1,0.61,0.51,,,,98.0,0.83,1.12,-0.84,0.55,0.28,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,150,0.0,0.0,0,,,,99.7,-0.3,,,99.73,-0.21,,0.0422,,,,,,,,,,63.0,,500871.0,61942.1,2531.4,1546.0,560.6,237.8,34.0,17.0,,636338.3,38186.8,3463.8,1850.8,645.2,356.6,101.9,17.0,,,,,,,,96.4,2.7,0.89,-1.2,0.89,0.28,,,,96.6,1.41,1.96,-2.25,1.13,1.12,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0.0,0.0,0,,,,99.79,-0.21,,,99.83,-0.11,,0.0433,,,,,,,,,,65.8,,270493.5,6431.0,2024.6,1378.1,731.6,425.3,306.2,289.2,,2432216.3,28342.9,3995.5,2210.3,765.1,272.0,34.0,34.0,,,,,,,,96.5,2.7,0.78,-1.1,0.89,0.17,,,,97.1,1.29,1.64,-1.81,1.01,0.8,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0.0,0.0,0,,,,99.78,-0.22,,,99.82,-0.12,,0.0437,,,,,,,,,,67.8,,31966.3,5469.3,2004.3,1477.7,832.3,509.6,322.7,305.7,,860421.8,10788.2,3194.0,1783.9,611.6,220.9,101.9,84.9,,,,,,,,96.1,2.95,1.0,-1.5,1.14,0.39,,,,97.1,1.31,1.55,-1.74,1.03,0.71,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,150,0.0,0.0,0,,,,99.8,-0.2,,,99.81,-0.14,,0.0449,,,,,,,,,,64.8,,40819.2,4448.7,1409.3,1069.7,441.5,237.7,34.0,0.0,,984927.2,6642.1,2242.3,1579.8,526.6,305.8,17.0,17.0,,,,,,,,96.2,2.86,0.97,-1.4,1.05,0.36,,,,97.2,1.23,1.58,-1.69,0.95,0.74,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0.0,0.0,0,,,,98.04,-1.96,,,99.82,-0.13,,0.0438,,,,,,,,,,67.6,,26128.9,5942.3,2207.1,1545.0,865.9,356.5,169.8,169.8,,678407.8,6895.0,2598.4,1800.2,628.4,339.7,67.9,50.9,,,,,,,,96.0,2.96,1.03,-1.6,1.15,0.42,,,,97.0,1.58,1.47,-1.93,1.3,0.63,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0.0,0.0,0,,,,98.83,-1.17,,,99.81,-0.13,,0.0434,,,,,,,,,,68.4,,32298.3,7841.2,3156.8,1816.0,831.6,441.3,67.9,50.9,,213224.4,6930.3,2089.3,1324.9,492.6,186.8,51.0,51.0,,,,,,,,95.9,2.99,1.08,-1.7,1.18,0.47,,,,96.8,1.69,1.56,-2.12,1.41,0.72,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,150,0.0,0.0,0,,,,96.02,-3.98,,,99.04,-0.91,,0.0484,,,,,,,,,,58.8,,38836.0,7179.9,2427.3,1799.2,865.7,373.4,17.0,0.0,,445846.6,7083.9,1698.8,985.3,288.8,169.9,68.0,68.0,,,,,,,,96.5,2.62,0.83,-1.0,0.81,0.22,,,,94.7,1.64,3.69,-4.21,1.36,2.85,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0.0,0.0,0,,,,99.84,-0.16,,,99.83,-0.11,,0.0482,,,,,,,,,,62.4,,29811.8,6739.9,2190.0,1527.9,645.1,339.5,17.0,0.0,,264989.4,6285.4,1681.8,1155.2,526.6,271.8,101.9,84.9,,,,,,,,96.5,2.54,0.93,-1.1,0.73,0.32,,,,97.3,1.11,1.58,-1.57,0.83,0.74,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.84,-0.11,,0.0525,,,,,,,,,,61.8,,46188.7,7166.0,2954.7,2037.7,849.1,475.5,118.9,67.9,,582971.3,5862.5,2141.1,1580.3,577.8,305.9,85.0,85.0,,,,,,,,96.8,2.38,0.81,-0.8,0.57,0.2,,,,97.9,0.91,1.24,-1.03,0.63,0.4,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,50.0,10.0,G11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.85,-0.09,,0.049,,,,,,,,,,67.4,,122653.7,7184.0,2734.3,1698.3,730.3,203.8,17.0,17.0,,332363.6,6730.6,1716.6,1138.8,509.9,339.9,85.0,68.0,,,,,,,,96.9,2.17,0.97,-0.7,0.36,0.36,,,,98.1,0.86,1.08,-0.82,0.58,0.24,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,CEACAM5,AB0621,BsAb,Single Control,,5.0,0.0,H07,1.254620253,,NB-ferguhei-5069961-0003,5.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.95,0.0,,0.0377,61.7,28.04,10.27,0.0,,,,,,68.6,,370816.4,26832.6,560.4,186.8,101.9,84.9,50.9,34.0,,610050.8,9907.1,2570.4,1412.9,425.6,187.2,51.1,34.0,,,,,,,,97.6,1.81,0.61,0.0,0.0,0.0,,,,98.9,0.28,0.84,0.0,0.0,0.0,,,,AB0621,AB0621,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B02,1.269,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,96.0,-4.0,,,99.0,-0.59,,0.036,,,,,,,,,,61.2,63.2,21435.7,7382.9,1171.1,390.4,84.9,33.9,33.9,0.0,,51496.0,5737.0,1714.0,1205.0,102.0,17.0,0.0,0.0,,,,,,,,73.3,0.61,26.1,4.0,-6.0,-2.0,,,,93.4,3.08,3.52,-4.0,2.0,2.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B03,1.27,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,97.0,-3.0,,,99.0,-0.55,,0.037,,,,,,,,,,68.2,66.2,24813.2,5787.5,1476.6,797.7,254.6,101.8,0.0,0.0,,55012.0,6671.0,1460.0,815.0,255.0,34.0,0.0,0.0,,,,,,,,73.9,0.62,25.49,5.0,-6.0,-3.0,,,,92.4,4.32,3.33,-5.0,3.0,1.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B04,1.27,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,97.0,-3.0,,,99.0,-0.67,,0.038,,,,,,,,,,67.8,64.6,17345.3,3784.7,1018.3,373.4,118.8,33.9,17.0,0.0,,48169.0,4549.0,475.0,221.0,102.0,51.0,0.0,0.0,,,,,,,,75.3,0.65,24.08,6.0,-6.0,-4.0,,,,90.9,5.05,4.04,-6.0,4.0,2.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B05,1.274,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.0,-1.24,,0.038,,,,,,,,,,65.2,67.8,108035.7,5533.3,1171.2,390.4,50.9,17.0,0.0,0.0,,22318.0,3276.0,594.0,305.0,68.0,34.0,17.0,17.0,,,,,,,,77.6,0.7,21.66,8.0,-6.0,-7.0,,,,92.0,2.23,5.76,-5.0,1.0,4.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B06,1.275,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,99.0,-1.0,,,100.0,-0.11,,0.038,,,,,,,,,,65.0,67.4,112686.7,7230.7,1748.3,729.9,50.9,33.9,0.0,0.0,,22064.0,5397.0,832.0,441.0,102.0,34.0,0.0,0.0,,,,,,,,79.0,0.7,20.34,10.0,-6.0,-8.0,,,,90.8,2.65,6.53,-6.0,2.0,5.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B07,1.284,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,99.0,-1.0,,,99.0,-0.53,,0.038,,,,,,,,,,66.2,68.2,133478.0,7977.4,1935.0,780.8,203.7,101.8,33.9,0.0,,35302.0,3717.0,543.0,272.0,102.0,51.0,0.0,0.0,,,,,,,,80.7,0.66,18.65,11.0,-6.0,-10.0,,,,90.1,2.95,6.91,-7.0,2.0,5.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B08,1.278,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,99.0,-1.0,,,99.0,-1.04,,0.04,,,,,,,,,,61.2,59.4,20977.4,5295.3,1510.5,797.7,203.7,101.8,50.9,33.9,,31399.0,7807.0,1680.0,883.0,238.0,85.0,0.0,0.0,,,,,,,,75.3,0.46,24.2,6.0,-6.0,-4.0,,,,91.3,2.79,5.9,-6.0,2.0,4.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B09,1.283,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.0,-0.46,,0.04,,,,,,,,,,63.4,65.2,23319.5,4548.5,1239.0,644.9,322.5,186.7,0.0,0.0,,66141.0,12067.0,2800.0,1494.0,339.0,85.0,34.0,0.0,,,,,,,,72.6,0.59,26.81,3.0,-6.0,-2.0,,,,94.1,2.04,3.81,-3.0,1.0,2.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B10,1.271,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,,,,0.045,,,,,,,,,,66.0,67.4,17633.9,4039.3,1018.3,458.2,118.8,50.9,0.0,0.0,,26103.0,5346.0,1171.0,577.0,204.0,68.0,0.0,0.0,,,,,,,,76.3,0.64,23.03,7.0,-6.0,-6.0,,,,94.6,1.96,3.4,-2.0,1.0,1.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,65BKD,mAb,Single Control,,50.0,10.0,B11,1.253,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,,,,0.043,,,,,,,,,,65.2,68.2,72422.7,7756.5,1273.0,526.2,84.9,33.9,17.0,0.0,,39341.0,7094.0,1341.0,696.0,272.0,187.0,102.0,0.0,,,,,,,,75.1,0.67,24.24,6.0,-6.0,-4.0,,,,94.6,1.96,3.41,-2.0,1.0,1.0,,,,65BKD,65BKD,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D02,1.271,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,99.0,0.0,,,99.0,-0.47,,0.036,,,,,,,,,,63.0,64.8,15478.4,2834.3,356.4,135.8,17.0,17.0,0.0,0.0,,22743.0,5431.0,849.0,373.0,68.0,34.0,0.0,0.0,,,,,,,,74.4,0.49,25.12,9.0,0.0,-1.0,,,,92.4,5.33,2.28,-3.0,4.0,-1.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D03,1.277,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,97.0,-2.0,,,99.0,-0.76,,0.038,,,,,,,,,,67.8,66.4,15902.7,4344.8,899.5,407.3,84.9,33.9,17.0,17.0,,69420.0,5533.0,747.0,306.0,119.0,68.0,0.0,0.0,,,,,,,,76.8,0.69,22.55,9.0,0.0,-4.0,,,,91.7,6.54,1.76,-4.0,5.0,-1.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D04,1.271,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.76,,0.038,,,,,,,,,,67.6,69.2,17158.6,4361.8,1052.3,424.3,67.9,17.0,0.0,0.0,,27291.0,5312.0,815.0,238.0,34.0,17.0,0.0,0.0,,,,,,,,72.6,0.62,26.79,4.0,0.0,1.0,,,,91.2,6.81,2.0,-4.0,5.0,-1.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D05,1.28,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,1.0,,,100.0,-0.01,,0.038,,,,,,,,,,68.2,66.2,14986.3,3530.2,644.9,254.6,67.9,17.0,0.0,0.0,,13781.0,3106.0,798.0,407.0,34.0,17.0,0.0,0.0,,,,,,,,76.7,0.69,22.61,9.0,0.0,-4.0,,,,93.1,4.15,2.8,-2.0,2.0,0.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D06,1.258,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,99.0,0.0,,,100.0,0.0,,0.038,,,,,,,,,,68.2,66.2,63342.4,5193.7,1357.8,560.1,101.8,50.9,0.0,0.0,,12797.0,3310.0,747.0,322.0,51.0,0.0,0.0,0.0,,,,,,,,77.9,0.67,21.4,10.0,0.0,-5.0,,,,92.6,4.61,2.83,-3.0,3.0,0.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D07,1.262,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,99.0,0.0,,,99.0,-0.82,,0.038,,,,,,,,,,68.6,67.2,97219.0,7994.1,1884.0,797.7,67.9,17.0,0.0,0.0,,15156.0,3836.0,662.0,289.0,34.0,0.0,0.0,0.0,,,,,,,,77.8,0.67,21.57,10.0,0.0,-5.0,,,,91.7,5.35,2.98,-4.0,4.0,0.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D08,1.261,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,99.0,0.0,,,100.0,-0.28,,0.04,,,,,,,,,,60.0,62.0,40122.2,8554.0,1289.9,390.4,67.9,0.0,0.0,0.0,,20417.0,4090.0,577.0,238.0,34.0,0.0,0.0,0.0,,,,,,,,73.0,0.46,26.58,5.0,0.0,0.0,,,,92.4,5.04,2.59,-3.0,3.0,0.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D11,1.253,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,1.0,,,100.0,-0.19,,0.044,,,,,,,,,,68.6,72.8,194929.6,10983.1,2138.9,899.7,203.7,67.9,17.0,17.0,,36762.0,9284.0,1765.0,866.0,221.0,68.0,17.0,0.0,,,,,,,,73.6,0.66,25.77,5.0,0.0,-1.0,,,,94.9,3.42,1.71,0.0,2.0,-1.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D09,1.28,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,1.0,,,100.0,0.0,,0.041,,,,,,,,,,63.4,65.0,618556.1,111889.1,6688.6,1986.2,288.6,84.9,17.0,0.0,,832729.0,14723.0,1817.0,645.0,85.0,17.0,0.0,0.0,,,,,,,,73.5,0.59,25.96,5.0,0.0,0.0,,,,94.4,3.65,1.96,-1.0,2.0,-1.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,98BLE,mAb,Single Control,,50.0,10.0,D10,1.26,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,1.0,,,100.0,-0.12,,0.046,,,,,,,,,,66.2,68.8,22742.6,4073.3,848.6,373.4,67.9,33.9,0.0,0.0,,243535.0,9303.0,1409.0,713.0,119.0,34.0,0.0,0.0,,,,,,,,72.2,0.67,27.17,4.0,0.0,1.0,,,,94.5,3.63,1.85,-1.0,2.0,-1.0,,,,98BLE,98BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F02,1.271,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,99.0,-1.0,,,99.0,-0.6,,0.035,,,,,,,,,,63.8,61.6,65585.5,4296.5,475.5,152.8,0.0,0.0,0.0,0.0,,128105.0,5663.0,884.0,357.0,85.0,34.0,17.0,0.0,,,,,,,,72.1,0.5,27.42,3.0,-4.0,1.0,,,,92.9,4.98,2.15,0.0,3.0,-3.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F03,1.284,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.64,,0.036,,,,,,,,,,69.0,67.4,16821.1,4566.0,594.1,305.5,84.9,33.9,0.0,0.0,,265423.0,5993.0,1171.0,611.0,119.0,17.0,17.0,17.0,,,,,,,,72.5,0.64,26.83,3.0,-4.0,1.0,,,,92.8,5.86,1.39,0.0,4.0,-4.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F04,1.279,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.76,,0.038,,,,,,,,,,68.0,69.2,212460.1,42566.8,765.0,255.0,85.0,34.0,17.0,17.0,,39257.0,8062.0,1324.0,611.0,85.0,34.0,17.0,0.0,,,,,,,,76.3,0.67,22.99,7.0,-4.0,-3.0,,,,91.8,6.47,1.71,-1.0,5.0,-4.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F05,1.287,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.14,,0.037,,,,,,,,,,67.8,66.6,134559.2,3005.3,713.1,237.7,34.0,34.0,17.0,0.0,,16734.0,4158.0,1035.0,577.0,136.0,34.0,0.0,0.0,,,,,,,,77.3,0.7,22.03,8.0,-4.0,-4.0,,,,94.0,3.86,2.12,1.0,2.0,-3.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F06,1.274,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,97.0,-3.0,,,100.0,-0.16,,0.039,,,,,,,,,,68.4,69.8,94608.2,3192.1,628.2,339.6,34.0,34.0,34.0,34.0,,21673.0,4124.0,747.0,255.0,51.0,17.0,0.0,0.0,,,,,,,,77.6,0.7,21.66,8.0,-4.0,-4.0,,,,93.0,4.47,2.5,0.0,3.0,-3.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F07,1.298,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.81,,0.039,,,,,,,,,,69.2,67.6,267391.1,7559.2,1647.7,951.3,186.9,101.9,84.9,67.9,,15377.0,3581.0,560.0,187.0,34.0,17.0,0.0,0.0,,,,,,,,75.0,0.68,24.29,5.0,-4.0,-2.0,,,,92.4,4.9,2.7,-1.0,3.0,-3.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F08,1.275,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,99.0,-1.0,,,99.0,-0.45,,0.04,,,,,,,,,,62.4,59.0,124648.7,5612.5,1105.5,357.2,119.1,85.0,85.0,85.0,,26799.0,5771.0,1120.0,611.0,170.0,68.0,0.0,0.0,,,,,,,,72.3,0.46,27.24,3.0,-4.0,1.0,,,,92.9,4.82,2.3,0.0,3.0,-3.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F09,1.291,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.0,-0.47,,0.041,,,,,,,,,,68.8,64.8,203951.7,9086.8,2564.7,1613.5,730.3,356.7,101.9,51.0,,82097.0,11762.0,3310.0,1765.0,560.0,119.0,0.0,0.0,,,,,,,,69.7,0.62,29.64,0.0,-4.0,4.0,,,,94.8,3.64,1.54,2.0,2.0,-4.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F10,1.273,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,99.0,-1.0,,,100.0,-0.12,,0.047,,,,,,,,,,68.0,66.0,246033.4,4076.2,1070.0,475.6,101.9,51.0,34.0,34.0,,30227.0,6551.0,1494.0,730.0,272.0,51.0,0.0,0.0,,,,,,,,69.4,0.67,29.9,0.0,-4.0,4.0,,,,95.0,3.43,1.58,2.0,2.0,-4.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,99BLE,mAb,Single Control,,50.0,10.0,F11,1.274,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.31,,0.043,,,,,,,,,,69.2,63.2,607302.2,9484.6,2362.6,1240.8,238.0,119.0,17.0,17.0,,52653.0,9390.0,2004.0,1104.0,238.0,85.0,17.0,0.0,,,,,,,,76.1,0.67,23.2,7.0,-4.0,-3.0,,,,95.1,3.3,1.63,2.0,2.0,-4.0,,,,99BLE,99BLE,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G02,1.211,,NB-ferguhei-5069961-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,99.3,-1.0,,,99.6,-0.33,,0.037,,,,,,,,,,60.0,61.4,19263.2,3937.5,458.2,237.6,135.8,101.8,33.9,33.9,,207018.9,3955.3,560.2,254.6,84.9,34.0,17.0,0.0,,,,,,,,82.7,0.91,16.39,5.0,1.0,-5.0,,,,86.6,4.64,8.81,-9.0,1.0,8.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G03,1.231,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,99.1,-1.0,,,99.7,-0.26,,0.037,,,,,,,,,,61.8,63.0,20213.7,3224.7,424.3,220.6,67.9,17.0,17.0,0.0,,233303.6,3276.4,407.4,237.7,50.9,17.0,0.0,0.0,,,,,,,,86.6,0.92,12.52,8.0,1.0,-9.0,,,,86.4,5.01,8.6,-9.0,2.0,8.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G04,1.225,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,98.8,-1.0,,,99.7,-0.24,,0.039,,,,,,,,,,62.4,60.0,15716.1,2002.7,322.5,169.7,118.8,67.9,33.9,33.9,,518162.2,6553.9,899.9,356.6,135.8,67.9,0.0,0.0,,,,,,,,83.8,1.01,15.21,6.0,1.0,-7.0,,,,83.4,5.7,10.93,-12.0,3.0,10.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G05,1.245,,NB-ferguhei-5069961-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.9,-0.09,,0.046,,,,,,,,,,60.4,58.8,2494.9,475.2,152.7,101.8,33.9,33.9,0.0,0.0,,6664942.8,95217.0,534.5,213.8,71.3,35.6,0.0,0.0,,,,,,,,82.6,1.1,16.34,4.0,1.0,-6.0,,,,39.1,2.26,58.69,-57.0,-1.0,58.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G06,1.247,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,91.7,-8.0,,,99.9,-0.04,,0.056,,,,,,,,,,57.6,61.2,74899.3,3954.6,203.7,152.8,84.9,33.9,33.9,17.0,,7396183.4,326119.3,38.9,38.9,38.9,38.9,0.0,0.0,,,,,,,,80.7,1.29,18.05,2.0,1.0,-4.0,,,,24.5,2.65,72.83,-71.0,-1.0,72.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G07,1.02,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,96.2,-4.0,,,99.8,-0.14,,0.053,,,,,,,,,,60.0,58.0,152535.2,30619.1,1391.8,101.8,0.0,0.0,0.0,0.0,,4110626.4,312.8,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,78.6,2.61,18.78,0.0,3.0,-3.0,,,,34.0,4.21,61.84,-62.0,1.0,61.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G08,1.234,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,99.1,-1.0,,,99.6,-0.43,,0.041,,,,,,,,,,61.6,59.8,14680.8,2460.9,339.4,203.7,135.8,50.9,33.9,17.0,,126412.1,3581.7,543.2,271.6,67.9,17.0,0.0,0.0,,,,,,,,84.6,0.71,14.7,6.0,1.0,-7.0,,,,82.3,4.17,13.53,-13.0,1.0,13.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G09,1.248,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,99.5,0.0,,,99.8,-0.18,,0.041,,,,,,,,,,61.2,56.6,14052.8,2308.2,712.8,475.2,237.6,220.6,0.0,0.0,,66757.0,3326.8,678.9,271.6,50.9,0.0,0.0,0.0,,,,,,,,85.3,0.81,13.86,7.0,1.0,-8.0,,,,89.4,3.95,6.67,-6.0,1.0,6.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G10,1.235,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,99.4,-1.0,,,99.9,-0.06,,0.048,,,,,,,,,,62.6,60.2,13628.5,1934.8,560.1,288.5,118.8,50.9,0.0,0.0,,89946.2,3513.7,611.1,288.6,67.9,17.0,17.0,0.0,,,,,,,,81.3,0.89,17.86,3.0,1.0,-4.0,,,,90.7,2.53,6.82,-5.0,-1.0,6.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
2/1/2023,ferguhei,CEACAM5,64BLJ,mAb,Single Control,,50.0,10.0,G11,1.231,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,99.4,-1.0,,,99.7,-0.26,,0.045,,,,,,,,,,61.4,62.8,1126363.6,6726.0,696.4,288.7,118.9,51.0,17.0,0.0,,2252640.2,13657.8,1121.2,441.7,169.9,84.9,17.0,0.0,,,,,,,,81.1,0.88,17.98,3.0,1.0,-4.0,,,,89.2,2.52,8.25,-7.0,-1.0,7.0,,,,64BLJ,64BLJ,,,,,CEACAM5 Truncated Results Template.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E02,1.0,DAB013887_E02,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,98.7,,,47.29,98.3,,,0.0523,25.08,69.8,5.13,-28.52,30.67,-2.14,28.52,30.67,2.14,68.0,77.8,7128.2,950.4,84.9,50.9,0.0,0.0,0.0,0.0,,8757.5,1578.4,203.7,101.8,50.9,0.0,0.0,0.0,,,,,,,,81.03,3.32,15.65,,,,,,,98.09,0.47,1.45,-1.24,0.47,0.78,1.24,0.47,0.78,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E03,1.0,DAB013887_E03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0.0,0.0,0,,,,97.3,,,49.91,98.63,,,0.0539,23.87,69.08,7.05,-29.73,29.95,-0.22,29.73,29.95,0.22,69.8,77.8,73951.1,1391.8,186.7,33.9,0.0,0.0,0.0,0.0,,12678.0,1968.7,424.3,186.7,84.9,33.9,17.0,0.0,,,,,,,,81.32,3.16,15.52,,,,,,,97.96,0.67,1.37,-1.37,0.67,0.7,1.37,0.67,0.7,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E04,1.0,DAB013887_E04,NB-jarvcass-5073893-0001,6.0,Acetate,0,0,0.0,0.0,0,,,,96.3,,,50.26,97.42,,,0.0544,27.02,68.0,4.98,-26.58,28.87,-2.29,26.58,28.87,2.29,71.2,77.5,73204.5,1951.9,305.5,118.8,0.0,0.0,0.0,0.0,,27341.9,4276.9,712.8,220.6,17.0,17.0,0.0,0.0,,,,,,,,80.1,3.84,16.06,,,,,,,98.15,0.61,1.24,-1.18,0.61,0.57,1.18,0.61,0.57,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E05,1.0,DAB013887_E05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,96.1,,,49.05,98.91,,,0.0553,23.79,71.86,4.35,-29.81,32.73,-2.92,29.81,32.73,2.92,69.2,78.0,49746.2,5125.7,492.2,203.7,0.0,0.0,0.0,0.0,,13815.2,1255.9,220.6,118.8,33.9,17.0,0.0,0.0,,,,,,,,80.27,3.12,16.61,,,,,,,97.66,0.92,1.42,-1.67,0.92,0.75,1.67,0.92,0.75,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E06,1.0,DAB013887_E06,NB-jarvcass-5073893-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,95.7,,,49.86,98.21,,,0.0536,21.37,74.49,4.14,-32.23,35.36,-3.13,32.23,35.36,3.13,69.7,76.5,55805.3,2834.4,424.3,169.7,50.9,17.0,0.0,0.0,,5685.6,1188.0,237.6,152.7,101.8,67.9,33.9,0.0,,,,,,,,78.84,3.55,17.61,,,,,,,98.03,0.34,1.63,-1.3,0.34,0.96,1.3,0.34,0.96,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E07,1.0,DAB013887_E07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,93.1,,,45.38,93.21,,,0.0552,18.35,77.72,3.93,-35.25,38.59,-3.34,35.25,38.59,3.34,70.0,75.0,132476.5,10727.1,1680.4,594.1,84.9,17.0,0.0,0.0,,11235.4,3818.7,644.9,254.6,50.9,0.0,0.0,0.0,,,,,,,,79.72,3.3,16.98,,,,,,,97.75,0.41,1.84,-1.58,0.41,1.17,1.58,0.41,1.17,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E08,1.0,DAB013887_E08,NB-jarvcass-5073893-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,96.6,,,45.46,94.37,,,0.0573,29.6,61.86,8.54,-24.0,22.73,1.27,24.0,22.73,1.27,62.3,73.8,5804.4,1001.3,135.8,50.9,0.0,0.0,0.0,0.0,,8010.7,1374.7,220.6,118.8,33.9,33.9,0.0,0.0,,,,,,,,80.25,4.63,15.12,,,,,,,96.87,0.53,2.6,-2.46,0.53,1.93,2.46,0.53,1.93,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E09,1.0,DAB013887_E09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,98.2,,,46.63,96.59,,,0.0561,32.57,60.49,6.94,-21.03,21.36,-0.33,21.03,21.36,0.33,65.8,76.3,76683.0,3156.9,424.3,135.8,0.0,0.0,0.0,0.0,,20162.9,3479.3,339.4,152.7,33.9,33.9,17.0,0.0,,,,,,,,80.98,3.48,15.54,,,,,,,98.63,0.15,1.23,-0.7,0.15,0.56,0.7,0.15,0.56,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E10,1.0,DAB013887_E10,NB-jarvcass-5073893-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,97.6,,,50.0,99.6,,,0.0612,33.17,60.64,6.19,-20.43,21.51,-1.08,20.43,21.51,1.08,68.7,77.9,81248.7,3411.5,441.3,169.7,0.0,0.0,0.0,0.0,,31703.7,5125.6,611.0,254.6,84.9,33.9,0.0,0.0,,,,,,,,80.45,3.93,15.62,,,,,,,98.8,0.15,1.05,-0.53,0.15,0.38,0.53,0.15,0.38,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,E11,1.0,DAB013887_E11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,97.2,,,48.98,98.24,,,0.0645,31.92,61.51,6.57,-21.68,22.38,-0.7,21.68,22.38,0.7,70.9,78.0,87953.7,8164.0,1120.2,712.9,220.6,101.8,0.0,0.0,,43534.2,8265.6,1595.4,967.4,339.4,101.8,17.0,17.0,,,,,,,,81.21,3.31,15.48,,,,,,,98.86,0.17,0.97,-0.47,0.17,0.3,0.47,0.17,0.3,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F02,1.0,DAB013887_F02,NB-jarvcass-5073893-0001,5.0,Acetate,0,75,0.0,0.0,0,,,,93.5,,,47.45,99.18,,,0.0528,18.76,76.26,4.98,-34.84,37.13,-2.29,34.84,37.13,2.29,64.2,75.4,8061.7,1340.8,254.6,84.9,17.0,17.0,0.0,0.0,,10522.6,2359.1,475.2,322.5,152.7,67.9,0.0,0.0,,,,,,,,79.3,4.11,16.59,,,,,,,96.21,0.64,3.16,-3.12,0.64,2.49,3.12,0.64,2.49,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F03,1.0,DAB013887_F03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0.0,0.0,0,,,,94.7,,,47.67,98.57,,,0.0532,18.93,76.9,4.17,-34.67,37.77,-3.1,34.67,37.77,3.1,67.4,76.7,4243.0,763.7,135.8,50.9,17.0,17.0,0.0,0.0,,8519.9,1289.9,237.6,67.9,33.9,0.0,0.0,0.0,,,,,,,,79.14,3.96,16.9,,,,,,,97.84,0.73,1.43,-1.49,0.73,0.76,1.49,0.73,0.76,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F04,1.0,DAB013887_F04,NB-jarvcass-5073893-0001,6.0,Acetate,0,75,0.0,0.0,0,,,,96.4,,,48.15,98.77,,,0.0547,20.49,75.98,3.53,-33.11,36.85,-3.74,33.11,36.85,3.74,69.5,76.6,4429.7,712.8,118.8,67.9,17.0,17.0,0.0,0.0,,4412.7,865.6,118.8,84.9,17.0,0.0,0.0,0.0,,,,,,,,78.63,4.15,17.23,,,,,,,97.88,0.78,1.34,-1.45,0.78,0.67,1.45,0.78,0.67,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F05,1.0,DAB013887_F05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0.0,0.0,0,,,,96.6,,,48.86,98.5,,,0.0551,19.83,76.18,3.99,-33.77,37.05,-3.28,33.77,37.05,3.28,67.9,76.6,13357.0,3275.6,712.8,339.4,118.8,33.9,0.0,0.0,,6619.0,763.7,186.7,84.9,17.0,17.0,0.0,0.0,,,,,,,,78.51,3.67,17.82,,,,,,,98.02,0.55,1.43,-1.31,0.55,0.76,1.31,0.55,0.76,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F06,1.0,DAB013887_F06,NB-jarvcass-5073893-0001,6.0,Citrate,0,75,0.0,0.0,0,,,,92.2,,,50.32,97.26,,,0.0542,19.73,76.78,3.49,-33.87,37.65,-3.78,33.87,37.65,3.78,70.3,76.3,5566.8,1748.1,492.2,186.7,0.0,0.0,0.0,0.0,,3530.2,814.7,203.7,84.9,33.9,33.9,0.0,0.0,,,,,,,,78.47,3.59,17.93,,,,,,,97.65,0.79,1.56,-1.68,0.79,0.89,1.68,0.79,0.89,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F07,1.0,DAB013887_F07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0.0,0.0,0,,,,91.9,,,47.03,95.94,,,0.0557,17.2,79.25,3.56,-36.4,40.12,-3.71,36.4,40.12,3.71,69.9,75.3,15139.0,5532.9,1765.1,933.5,254.6,67.9,0.0,0.0,,3360.4,831.6,305.5,186.7,33.9,0.0,0.0,0.0,,,,,,,,78.79,3.46,17.75,,,,,,,97.59,0.75,1.65,-1.74,0.75,0.98,1.74,0.75,0.98,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F08,1.0,DAB013887_F08,NB-jarvcass-5073893-0001,5.0,Histidine,0,75,0.0,0.0,0,,,,83.4,,,42.72,95.94,,,0.0585,21.48,70.88,7.65,-32.12,31.75,0.38,32.12,31.75,0.38,59.1,70.3,7077.3,1442.6,254.6,118.8,17.0,0.0,0.0,0.0,,11048.8,2257.3,678.9,424.3,118.8,33.9,17.0,0.0,,,,,,,,77.55,6.11,16.34,,,,,,,85.65,1.33,13.02,-13.68,1.33,12.35,13.68,1.33,12.35,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F09,1.0,DAB013887_F09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0.0,0.0,0,,,,91.6,,,46.99,99.12,,,0.0582,23.61,70.85,5.53,-29.99,31.72,-1.74,29.99,31.72,1.74,63.3,74.0,10098.3,1951.8,356.4,186.7,33.9,17.0,0.0,0.0,,19908.1,3139.8,543.1,220.6,101.8,33.9,0.0,0.0,,,,,,,,79.27,4.14,16.58,,,,,,,98.17,0.32,1.51,-1.16,0.32,0.84,1.16,0.32,0.84,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F10,1.0,DAB013887_F10,NB-jarvcass-5073893-0001,6.0,Histidine,0,75,0.0,0.0,0,,,,94.3,,,47.75,99.46,,,0.062,24.56,70.99,4.45,-29.04,31.86,-2.82,29.04,31.86,2.82,66.8,76.4,18686.1,2206.4,322.5,135.8,33.9,17.0,0.0,0.0,,20994.5,3241.7,628.0,509.2,254.6,118.8,0.0,0.0,,,,,,,,79.77,3.41,16.82,,,,,,,98.59,0.22,1.19,-0.74,0.22,0.52,0.74,0.22,0.52,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,F11,1.0,DAB013887_F11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0.0,0.0,0,,,,93.5,,,48.6,99.33,,,0.0642,23.7,71.01,5.29,-29.9,31.88,-1.98,29.9,31.88,1.98,69.3,77.2,18873.0,3530.2,644.9,339.4,84.9,33.9,0.0,0.0,,13119.3,2783.4,560.1,322.5,84.9,33.9,0.0,0.0,,,,,,,,79.59,3.54,16.87,,,,,,,98.61,0.25,1.14,-0.72,0.25,0.47,0.72,0.25,0.47,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,G02,1.0,DAB013887_G02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7.0,0,,,,97.7,,,50.13,99.74,,,0.0562,32.14,61.18,6.68,-21.46,22.05,-0.59,21.46,22.05,0.59,67.7,78.1,34522.5,814.7,67.9,67.9,17.0,17.0,0.0,0.0,,252999.8,3056.0,322.6,169.8,84.9,67.9,17.0,0.0,,,,,,,,80.68,3.43,15.89,,,,,,,98.57,0.32,1.11,-0.76,0.32,0.44,0.76,0.32,0.44,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,5.0,10.0,H07,1.0,DAB013887_H07,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,99.4,,,50.45,100.0,,,0.0472,53.6,39.13,7.27,0.0,0.0,0.0,0.0,0.0,0.0,,,34097.0,5312.3,729.8,458.2,169.7,67.9,0.0,0.0,,34843.6,4921.9,695.9,288.5,50.9,0.0,0.0,0.0,,,,,,,,83.02,2.44,14.53,,,,,,,99.33,0.0,0.67,0.0,0.0,0.0,0.0,0.0,0.0,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB013887,BsAb,SINGLE CONTROL,Thermal Stress,5.0,10.0,H08,1.0,DAB013887_H08,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,7.0,0,,,,96.4,,,50.49,99.75,,,0.0494,55.05,37.57,7.38,1.45,-1.56,0.11,1.45,-1.56,0.11,,,70166.6,6178.2,1035.4,577.1,220.6,101.8,33.9,0.0,,207154.9,11304.9,2614.0,1544.7,339.5,118.8,17.0,0.0,,,,,,,,83.44,2.06,14.51,,,,,,,99.21,0.0,0.79,-0.12,0.0,0.12,0.12,0.0,0.12,DAB013887,DAB013887,Humanized,AB3250_F3'_VL-VH scFv (AB2135_F3'_VH_W101G_VL_H6Q_(BCC.MVR002.12E9(DAB010213))_A49_M/I_NKG2D_FAb,8.3,123494.5839,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B02,1.0,DAB014071_B02,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,97.3,,,87.74,99.73,,,0.0527,,,,,,,,,,70.0,76.2,13000.5,1408.7,118.8,50.9,17.0,0.0,0.0,0.0,,27732.5,3699.9,577.1,288.5,118.8,33.9,0.0,0.0,,,,,,,,,,,,,,,,,97.27,1.67,1.06,0.6,1.35,-1.95,0.6,1.35,1.95,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B03,1.0,DAB014071_B03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0.0,0.0,0,,,,97.8,,,86.09,99.47,,,0.0538,,,,,,,,,,70.6,75.2,15817.8,2087.5,118.8,50.9,17.0,17.0,17.0,17.0,,142195.3,49899.0,10251.4,5108.7,1544.5,577.1,101.8,50.9,,,,,,,,,,,,,,,,,94.98,1.73,3.3,-1.69,1.41,0.29,1.69,1.41,0.29,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B04,1.0,DAB014071_B04,NB-jarvcass-5073893-0001,6.0,Acetate,0,0,0.0,0.0,0,,,,97.8,,,85.58,98.53,,,0.0549,,,,,,,,,,70.9,75.6,26425.6,4192.1,984.4,712.8,475.2,271.6,67.9,33.9,,172046.7,11457.3,1408.8,628.0,118.8,33.9,0.0,0.0,,,,,,,,,,,,,,,,,94.86,1.54,3.6,-1.81,1.22,0.59,1.81,1.22,0.59,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B05,1.0,DAB014071_B05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,97.0,,,58.37,99.23,,,0.0541,,,,,,,,,,69.7,78.0,148986.5,16955.7,611.0,186.7,17.0,0.0,0.0,0.0,,14494.0,4073.3,644.9,237.6,67.9,17.0,0.0,0.0,,,,,,,,,,,,,,,,,94.14,1.47,4.39,-2.53,1.15,1.38,2.53,1.15,1.38,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B06,1.0,DAB014071_B06,NB-jarvcass-5073893-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,95.9,,,56.59,97.82,,,0.054,,,,,,,,,,69.9,77.5,171681.3,20588.2,1035.3,203.7,0.0,0.0,0.0,0.0,,144458.8,4769.5,220.7,67.9,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,94.01,1.4,4.59,-2.66,1.08,1.58,2.66,1.08,1.58,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B07,1.0,DAB014071_B07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,95.5,,,55.08,95.85,,,0.0547,,,,,,,,,,69.6,77.6,160449.8,15734.4,763.8,67.9,0.0,0.0,0.0,0.0,,134188.9,4345.1,135.8,33.9,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,93.13,1.4,5.47,-3.54,1.08,2.46,3.54,1.08,2.46,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B08,1.0,DAB014071_B08,NB-jarvcass-5073893-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,97.6,,,47.48,97.39,,,0.0564,,,,,,,,,,61.8,68.2,17175.7,1239.0,101.8,33.9,17.0,17.0,0.0,0.0,,34538.2,9131.0,1306.9,628.0,186.7,67.9,0.0,0.0,,,,,,,,,,,,,,,,,94.7,2.12,3.18,-1.97,1.8,0.17,1.97,1.8,0.17,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B09,1.0,DAB014071_B09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,98.6,,,53.69,99.23,,,0.0566,,,,,,,,,,69.5,77.0,25661.7,2444.0,135.8,84.9,0.0,0.0,0.0,0.0,,42939.4,10336.0,1222.0,543.1,118.8,33.9,0.0,0.0,,,,,,,,,,,,,,,,,95.25,1.74,3.01,-1.42,1.42,0.0,1.42,1.42,0.0,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B10,1.0,DAB014071_B10,NB-jarvcass-5073893-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,99.2,,,56.12,99.49,,,0.0595,,,,,,,,,,70.3,77.1,69622.7,2512.0,101.8,50.9,50.9,50.9,0.0,0.0,,52749.7,9691.1,1069.3,237.6,33.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,94.11,2.81,3.07,-2.56,2.49,0.06,2.56,2.49,0.06,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B11,1.0,DAB014071_B11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,96.5,,,55.19,99.43,,,0.0622,,,,,,,,,,71.2,77.0,47318.7,5091.7,526.1,254.6,84.9,50.9,0.0,0.0,,128296.0,26579.1,4463.8,2138.6,458.3,169.7,0.0,0.0,,,,,,,,,,,,,,,,,92.71,3.94,3.35,-3.96,3.62,0.34,3.96,3.62,0.34,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C02,1.0,DAB014071_C02,NB-jarvcass-5073893-0001,5.0,Acetate,0,75,0.0,0.0,0,,,,97.1,,,55.62,99.57,,,0.0526,,,,,,,,,,67.2,74.0,16802.4,644.9,118.8,84.9,67.9,50.9,0.0,0.0,,44585.9,7976.9,1171.1,678.9,135.8,84.9,0.0,0.0,,,,,,,,,,,,,,,,,92.5,1.56,5.94,-4.17,1.24,2.93,4.17,1.24,2.93,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C03,1.0,DAB014071_C03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0.0,0.0,0,,,,93.4,,,49.81,89.98,,,0.0528,,,,,,,,,,69.0,74.2,16870.4,763.8,67.9,50.9,17.0,17.0,0.0,0.0,,42684.8,5736.6,1052.3,526.1,135.8,50.9,0.0,0.0,,,,,,,,,,,,,,,,,94.02,1.48,4.5,-2.65,1.16,1.49,2.65,1.16,1.49,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C04,1.0,DAB014071_C04,NB-jarvcass-5073893-0001,6.0,Acetate,0,75,0.0,0.0,0,,,,93.8,,,49.35,88.94,,,0.054,,,,,,,,,,69.8,74.0,71154.1,1086.3,322.5,152.8,67.9,33.9,0.0,0.0,,34911.8,4124.2,780.7,288.5,50.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,93.94,1.55,4.52,-2.73,1.23,1.51,2.73,1.23,1.51,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C05,1.0,DAB014071_C05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0.0,0.0,0,,,,95.3,,,55.98,99.09,,,0.0547,,,,,,,,,,69.1,73.9,137051.3,1188.2,101.8,17.0,17.0,17.0,0.0,0.0,,31398.2,3343.5,644.9,288.5,118.8,101.8,67.9,33.9,,,,,,,,,,,,,,,,,94.2,1.06,4.75,-2.47,0.74,1.74,2.47,0.74,1.74,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C06,1.0,DAB014071_C06,NB-jarvcass-5073893-0001,6.0,Citrate,0,75,0.0,0.0,0,,,,90.8,,,55.49,98.5,,,0.0543,,,,,,,,,,70.0,77.7,53040.6,1086.3,67.9,17.0,17.0,0.0,0.0,0.0,,4209.0,1527.5,475.2,271.6,67.9,17.0,0.0,0.0,,,,,,,,,,,,,,,,,94.0,1.25,4.75,-2.67,0.93,1.74,2.67,0.93,1.74,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C07,1.0,DAB014071_C07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0.0,0.0,0,,,,91.2,,,54.39,95.86,,,0.0555,,,,,,,,,,70.0,77.2,96547.8,1408.8,237.6,84.9,17.0,0.0,0.0,0.0,,5380.1,1459.6,288.5,118.8,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,93.49,1.22,5.29,-3.18,0.9,2.28,3.18,0.9,2.28,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C08,1.0,DAB014071_C08,NB-jarvcass-5073893-0001,5.0,Histidine,0,75,0.0,0.0,0,,,,93.8,,,44.29,89.28,,,0.0581,,,,,,,,,,60.7,66.1,594690.9,1341.4,237.7,84.9,17.0,0.0,0.0,0.0,,60710.4,6381.6,1357.8,661.9,135.8,84.9,0.0,0.0,,,,,,,,,,,,,,,,,85.05,1.87,13.08,-11.62,1.55,10.07,11.62,1.55,10.07,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C09,1.0,DAB014071_C09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0.0,0.0,0,,,,94.5,,,54.12,99.52,,,0.0571,,,,,,,,,,66.6,68.9,499211.1,899.9,0.0,0.0,0.0,0.0,0.0,0.0,,44653.5,6415.4,1120.2,373.4,84.9,33.9,0.0,0.0,,,,,,,,,,,,,,,,,92.65,1.18,6.17,-4.02,0.86,3.16,4.02,0.86,3.16,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C10,1.0,DAB014071_C10,NB-jarvcass-5073893-0001,6.0,Histidine,0,75,0.0,0.0,0,,,,91.1,,,55.27,100.0,,,0.0605,,,,,,,,,,68.4,75.3,487176.2,1154.6,118.9,0.0,0.0,0.0,0.0,0.0,,47793.6,5719.6,814.7,390.4,84.9,17.0,0.0,0.0,,,,,,,,,,,,,,,,,94.16,0.95,4.89,-2.51,0.63,1.88,2.51,0.63,1.88,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C11,1.0,DAB014071_C11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0.0,0.0,0,,,,82.8,,,55.64,100.0,,,0.0657,,,,,,,,,,69.9,75.0,448766.9,1901.7,186.8,84.9,0.0,0.0,0.0,0.0,,27426.9,3394.4,695.9,305.5,67.9,17.0,0.0,0.0,,,,,,,,,,,,,,,,,91.65,4.05,4.29,-5.02,3.73,1.28,5.02,3.73,1.28,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,D02,1.0,DAB014071_D02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7.0,0,,,,99.1,,,54.53,99.65,,,0.0571,,,,,,,,,,70.8,78.5,96698.5,1256.0,271.6,135.8,17.0,0.0,0.0,0.0,,289552.2,8164.8,1086.4,424.4,152.8,50.9,17.0,0.0,,,,,,,,,,,,,,,,,95.52,0.89,3.59,-1.15,0.57,0.58,1.15,0.57,0.58,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,5.0,10.0,H02,1.0,DAB014071_H02,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,99.3,,,58.16,99.63,,,0.0478,,,,,,,,,,,,752340.7,11921.2,1783.1,849.1,169.8,101.9,34.0,17.0,,88052.4,14341.6,1629.3,611.0,118.8,33.9,0.0,0.0,,,,,,,,,,,,,,,,,96.67,0.32,3.01,0.0,0.0,0.0,0.0,0.0,0.0,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014071,BsAb,SINGLE CONTROL,Thermal Stress,5.0,10.0,H03,1.0,DAB014071_H03,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,7.0,0,,,,95.8,,,54.51,99.25,,,0.0494,,,,,,,,,,,,293182.9,12409.0,2953.7,1510.8,288.6,50.9,0.0,0.0,,114483.0,7858.5,1714.3,814.7,237.6,152.8,33.9,17.0,,,,,,,,,,,,,,,,,97.39,0.31,2.3,0.72,-0.01,-0.71,0.72,0.01,0.71,DAB014071,DAB014071,Humanized,AB3252_F3_(BCC.MVR002.11D8_VH_D88A)_FAb_A49_M/I_NKG2D_LH_ScFv,8.42,123574.7208,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B02,1.0,DAB014072_B02,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,93.6,,,45.57,98.73,,,0.0529,23.73,71.26,5.01,-22.01,24.94,-2.93,22.01,24.94,2.93,68.2,77.8,6143.8,1374.7,322.5,169.7,50.9,17.0,0.0,0.0,,19195.3,2477.9,356.4,169.7,17.0,0.0,0.0,0.0,,,,,,,,89.22,2.52,8.26,,,,,,,95.21,0.93,3.86,-3.11,0.93,2.18,3.11,0.93,2.18,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B03,1.0,DAB014072_B03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0.0,0.0,0,,,,95.5,,,45.98,98.45,,,0.0542,24.19,70.92,4.88,-21.55,24.6,-3.06,21.55,24.6,3.06,69.3,76.8,8163.5,1171.1,203.7,135.8,33.9,0.0,0.0,0.0,,33163.8,2817.4,373.4,220.6,33.9,0.0,0.0,0.0,,,,,,,,88.76,2.5,8.75,,,,,,,96.73,0.84,2.43,-1.59,0.84,0.75,1.59,0.84,0.75,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B04,1.0,DAB014072_B04,NB-jarvcass-5073893-0001,6.0,Acetate,0,0,0.0,0.0,0,,,,94.5,,,45.75,98.16,,,0.0573,25.05,70.24,4.71,-20.69,23.92,-3.23,20.69,23.92,3.23,69.6,76.5,119271.6,2732.7,339.5,84.9,0.0,0.0,0.0,0.0,,16445.9,2953.1,441.3,152.7,50.9,17.0,0.0,0.0,,,,,,,,88.42,2.46,9.12,,,,,,,97.36,0.82,1.82,-0.96,0.82,0.14,0.96,0.82,0.14,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B05,1.0,DAB014072_B05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,94.4,,,45.45,98.27,,,0.055,21.67,74.17,4.16,-24.07,27.85,-3.78,24.07,27.85,3.78,67.9,77.9,144916.0,10862.8,882.6,305.5,101.8,67.9,0.0,0.0,,6211.7,1035.3,254.6,152.7,33.9,17.0,0.0,0.0,,,,,,,,88.69,1.64,9.67,,,,,,,96.13,0.34,3.53,-2.19,0.34,1.85,2.19,0.34,1.85,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B06,1.0,DAB014072_B06,NB-jarvcass-5073893-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,87.4,,,44.61,97.07,,,0.055,17.68,78.77,3.55,-28.06,32.45,-4.39,28.06,32.45,4.39,68.9,76.5,168306.3,11151.4,848.7,390.4,186.7,50.9,17.0,0.0,,460445.5,26891.3,1867.5,713.0,152.8,34.0,17.0,0.0,,,,,,,,86.92,2.13,10.95,,,,,,,96.04,1.06,2.9,-2.28,1.06,1.22,2.28,1.06,1.22,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B07,1.0,DAB014072_B07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,90.3,,,41.57,93.62,,,0.0546,15.87,80.53,3.6,-29.87,34.21,-4.34,29.87,34.21,4.34,69.0,75.9,257591.1,31265.3,1850.1,882.6,101.8,50.9,0.0,0.0,,12762.9,5465.0,1272.9,373.4,33.9,33.9,0.0,0.0,,,,,,,,87.54,1.93,10.53,,,,,,,96.75,0.65,2.6,-1.57,0.65,0.92,1.57,0.65,0.92,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B08,1.0,DAB014072_B08,NB-jarvcass-5073893-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,87.5,,,43.25,92.14,,,0.0583,27.52,64.65,7.83,-18.22,18.33,-0.11,18.22,18.33,0.11,63.0,71.0,76765.6,30567.1,11948.5,8316.4,3207.8,1374.8,203.7,33.9,,92924.9,39648.0,15343.2,10149.6,4192.2,1289.9,118.8,0.0,,,,,,,,89.14,2.67,8.2,,,,,,,94.84,0.89,4.26,-3.48,0.89,2.58,3.48,0.89,2.58,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B09,1.0,DAB014072_B09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,97.9,,,44.12,98.65,,,0.0584,28.14,64.84,7.02,-17.6,18.52,-0.92,17.6,18.52,0.92,66.7,75.3,174507.5,5482.5,712.9,322.5,50.9,17.0,0.0,0.0,,27562.5,4871.0,763.7,356.4,118.8,33.9,0.0,0.0,,,,,,,,89.68,2.09,8.23,,,,,,,95.67,0.45,3.88,-2.65,0.45,2.2,2.65,0.45,2.2,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B10,1.0,DAB014072_B10,NB-jarvcass-5073893-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,95.9,,,44.96,98.03,,,0.0628,29.59,64.08,6.33,-16.15,17.76,-1.61,16.15,17.76,1.61,68.8,76.4,116230.0,4141.4,424.3,305.5,186.7,101.8,17.0,17.0,,462533.9,10135.5,1680.8,1120.5,577.2,169.8,34.0,0.0,,,,,,,,90.03,1.96,8.01,,,,,,,97.64,0.39,1.96,-0.68,0.39,0.28,0.68,0.39,0.28,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,B11,1.0,DAB014072_B11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,97.2,,,45.47,98.74,,,0.0638,27.61,66.13,6.26,-18.13,19.81,-1.68,18.13,19.81,1.68,70.4,76.9,57197.5,7281.2,916.5,373.4,33.9,17.0,0.0,0.0,,111168.4,43160.5,19535.1,13934.2,6551.3,3394.5,356.4,67.9,,,,,,,,89.88,2.05,8.07,,,,,,,97.85,0.46,1.69,-0.47,0.46,0.01,0.47,0.46,0.01,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C02,1.0,DAB014072_C02,NB-jarvcass-5073893-0001,5.0,Acetate,0,75,0.0,0.0,0,,,,92.6,,,45.17,98.76,,,0.0529,17.57,77.02,5.42,-28.17,30.7,-2.52,28.17,30.7,2.52,64.5,76.2,6822.7,1086.2,237.6,118.8,50.9,17.0,0.0,0.0,,9809.8,1765.1,407.3,203.7,50.9,17.0,0.0,0.0,,,,,,,,87.65,2.36,9.98,,,,,,,90.14,0.96,8.9,-8.18,0.96,7.22,8.18,0.96,7.22,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C03,1.0,DAB014072_C03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0.0,0.0,0,,,,92.1,,,45.73,99.12,,,0.0542,18.39,77.82,3.79,-27.35,31.5,-4.15,27.35,31.5,4.15,67.2,77.4,5329.2,356.4,84.9,17.0,0.0,0.0,0.0,0.0,,8112.6,1731.1,152.7,84.9,67.9,17.0,0.0,0.0,,,,,,,,88.34,2.41,9.25,,,,,,,92.8,1.01,6.19,-5.52,1.01,4.51,5.52,1.01,4.51,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C04,1.0,DAB014072_C04,NB-jarvcass-5073893-0001,6.0,Acetate,0,75,0.0,0.0,0,,,,95.0,,,44.95,98.84,,,0.0561,18.56,77.74,3.69,-27.18,31.42,-4.25,27.18,31.42,4.25,68.4,76.4,8163.5,933.5,152.7,84.9,0.0,0.0,0.0,0.0,,6042.0,814.7,84.9,33.9,17.0,0.0,0.0,0.0,,,,,,,,88.17,2.45,9.38,,,,,,,95.22,1.09,3.69,-3.1,1.09,2.01,3.1,1.09,2.01,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C05,1.0,DAB014072_C05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0.0,0.0,0,,,,96.9,,,46.01,99.31,,,0.0556,18.05,78.3,3.65,-27.69,31.98,-4.29,27.69,31.98,4.29,67.3,77.8,15325.7,3920.5,509.2,186.7,17.0,17.0,0.0,0.0,,9826.7,1595.4,203.7,101.8,50.9,17.0,0.0,0.0,,,,,,,,87.48,1.97,10.55,,,,,,,94.36,0.78,4.86,-3.96,0.78,3.18,3.96,0.78,3.18,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C06,1.0,DAB014072_C06,NB-jarvcass-5073893-0001,6.0,Citrate,0,75,0.0,0.0,0,,,,94.6,,,45.53,98.08,,,0.0555,16.7,80.07,3.23,-29.04,33.75,-4.71,29.04,33.75,4.71,68.9,75.7,8231.4,1748.1,373.4,169.7,33.9,17.0,17.0,0.0,,3699.9,729.8,237.6,135.8,67.9,17.0,0.0,0.0,,,,,,,,86.92,2.51,10.57,,,,,,,95.0,1.62,3.38,-3.32,1.62,1.7,3.32,1.62,1.7,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C07,1.0,DAB014072_C07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0.0,0.0,0,,,,93.6,,,44.0,97.21,,,0.056,15.14,81.89,2.97,-30.6,35.57,-4.97,30.6,35.57,4.97,69.2,75.7,18584.3,6025.0,1646.3,899.5,152.7,67.9,0.0,0.0,,1883.9,458.2,271.5,186.7,33.9,33.9,0.0,0.0,,,,,,,,86.85,2.19,10.96,,,,,,,96.51,1.05,2.44,-1.81,1.05,0.76,1.81,1.05,0.76,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C08,1.0,DAB014072_C08,NB-jarvcass-5073893-0001,5.0,Histidine,0,75,0.0,0.0,0,,,,95.8,,,42.05,96.62,,,0.0592,20.0,72.58,7.42,-25.74,26.26,-0.52,25.74,26.26,0.52,59.8,73.4,10879.0,1069.2,67.9,33.9,17.0,17.0,0.0,0.0,,14833.5,3682.9,1069.2,628.0,220.6,50.9,0.0,0.0,,,,,,,,85.81,3.03,11.16,,,,,,,81.95,1.59,16.45,-16.37,1.59,14.77,16.37,1.59,14.77,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C09,1.0,DAB014072_C09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0.0,0.0,0,,,,96.9,,,45.2,98.9,,,0.0582,21.3,73.17,5.52,-24.44,26.85,-2.42,24.44,26.85,2.42,63.8,76.8,20519.2,2511.9,322.5,203.7,33.9,17.0,0.0,0.0,,18160.1,3122.9,492.2,254.6,50.9,33.9,0.0,0.0,,,,,,,,88.11,2.08,9.81,,,,,,,91.94,0.71,7.35,-6.38,0.71,5.67,6.38,0.71,5.67,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C10,1.0,DAB014072_C10,NB-jarvcass-5073893-0001,6.0,Histidine,0,75,0.0,0.0,0,,,,94.1,,,46.37,99.23,,,0.0647,21.52,73.87,4.61,-24.22,27.55,-3.33,24.22,27.55,3.33,66.7,76.1,154489.9,10642.2,712.9,322.5,101.8,33.9,0.0,0.0,,72642.8,10149.6,2783.5,1646.3,678.9,356.4,33.9,0.0,,,,,,,,89.47,1.8,8.73,,,,,,,95.4,0.53,4.08,-2.92,0.53,2.4,2.92,0.53,2.4,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,C11,1.0,DAB014072_C11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0.0,0.0,0,,,,95.3,,,45.77,97.85,,,0.0705,21.13,74.59,4.28,-24.61,28.27,-3.66,24.61,28.27,3.66,68.4,76.5,83861.5,8299.6,1306.9,729.8,169.7,67.9,33.9,0.0,,6636.0,1442.6,492.2,390.4,186.7,84.9,0.0,0.0,,,,,,,,89.07,1.79,9.14,,,,,,,97.2,0.56,2.24,-1.12,0.56,0.56,1.12,0.56,0.56,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,50.0,10.0,D02,1.0,DAB014072_D02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7.0,0,,,,88.9,,,42.92,96.46,,,0.057,27.87,65.33,6.8,-17.87,19.01,-1.14,17.87,19.01,1.14,68.4,77.1,42178.0,1188.1,169.7,118.8,67.9,50.9,17.0,17.0,,31364.7,1782.1,339.4,254.6,84.9,67.9,17.0,0.0,,,,,,,,89.39,1.95,8.65,,,,,,,96.6,0.37,3.03,-1.72,0.37,1.35,1.72,0.37,1.35,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,5.0,10.0,H02,1.0,DAB014072_H02,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,94.3,,,45.8,99.6,,,0.048,45.74,46.32,7.94,0.0,0.0,0.0,0.0,0.0,0.0,,,53920.6,9911.7,1374.7,763.7,67.9,50.9,0.0,0.0,,63119.9,9911.8,1629.3,661.9,50.9,33.9,0.0,0.0,,,,,,,,90.73,1.23,8.04,,,,,,,98.32,0.0,1.68,0.0,0.0,0.0,0.0,0.0,0.0,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014072,BsAb,SINGLE CONTROL,Thermal Stress,5.0,10.0,H03,1.0,DAB014072_H03,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,7.0,0,,,,96.9,,,46.07,96.69,,,0.052,46.52,45.48,8.01,0.78,-0.84,0.07,0.78,-0.84,0.07,,,101703.0,12356.4,1425.7,492.2,33.9,17.0,0.0,0.0,,107151.2,10744.0,2053.7,1035.4,237.6,118.8,17.0,0.0,,,,,,,,90.7,1.19,8.11,,,,,,,98.14,0.0,1.86,-0.18,0.0,0.18,0.18,0.0,0.18,DAB014072,DAB014072,Humanized,AB3233_F3'_VL-VH scFv (MVR002.38H3.1E1_(DAB006522_DP))_A49_M/I_NKG2D_FAb,8.29,124335.4526,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E02,1.0,DAB014074_E02,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.052,,,,,,,,,,,,10980.8,2240.3,101.8,67.9,17.0,17.0,0.0,0.0,,5617.7,1272.9,118.8,50.9,50.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E03,1.0,DAB014074_E03,NB-jarvcass-5073893-0001,5.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.054,,,,,,,,,,,,5668.6,712.8,101.8,17.0,0.0,0.0,0.0,0.0,,7196.1,1561.4,220.6,101.8,67.9,50.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E04,1.0,DAB014074_E04,NB-jarvcass-5073893-0001,6.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.054,,,,,,,,,,,,5668.6,899.5,67.9,33.9,17.0,0.0,0.0,0.0,,7009.4,1289.9,271.6,101.8,33.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E05,1.0,DAB014074_E05,NB-jarvcass-5073893-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0543,,,,,,,,,,,,8129.6,780.7,84.9,33.9,17.0,17.0,0.0,0.0,,1510.5,526.1,169.7,84.9,33.9,17.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E06,1.0,DAB014074_E06,NB-jarvcass-5073893-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0543,,,,,,,,,,,,20095.0,933.5,84.9,33.9,33.9,0.0,0.0,0.0,,1782.0,254.6,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E07,1.0,DAB014074_E07,NB-jarvcass-5073893-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0544,,,,,,,,,,,,53632.8,2308.2,135.8,67.9,0.0,0.0,0.0,0.0,,3004.0,695.8,67.9,17.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E08,1.0,DAB014074_E08,NB-jarvcass-5073893-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0569,,,,,,,,,,,,5431.0,1137.1,339.4,169.7,0.0,0.0,0.0,0.0,,6143.8,1697.2,339.4,220.6,50.9,33.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E09,1.0,DAB014074_E09,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0572,,,,,,,,,,,,7739.2,1629.3,135.8,50.9,0.0,0.0,0.0,0.0,,9606.2,2240.3,186.7,101.8,50.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E10,1.0,DAB014074_E10,NB-jarvcass-5073893-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0607,,,,,,,,,,,,11439.1,1833.0,135.8,84.9,33.9,17.0,0.0,0.0,,14222.5,3088.9,373.4,169.7,33.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,E11,1.0,DAB014074_E11,NB-jarvcass-5073893-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0634,,,,,,,,,,,,19280.4,3428.4,390.4,135.8,17.0,0.0,0.0,0.0,,22216.4,5091.6,644.9,322.5,152.7,67.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F02,1.0,DAB014074_F02,NB-jarvcass-5073893-0001,5.0,Acetate,0,75,0.0,0.0,0,,,,,,,,,,,0.0518,,,,,,,,,,,,6076.0,678.9,67.9,17.0,0.0,0.0,0.0,0.0,,8129.5,1629.3,237.6,118.8,50.9,17.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F03,1.0,DAB014074_F03,NB-jarvcass-5073893-0001,5.5,Acetate,0,75,0.0,0.0,0,,,,,,,,,,,0.0531,,,,,,,,,,,,10624.5,356.4,101.8,33.9,17.0,17.0,0.0,0.0,,8519.9,1306.8,305.5,237.6,135.8,101.8,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F04,1.0,DAB014074_F04,NB-jarvcass-5073893-0001,6.0,Acetate,0,75,0.0,0.0,0,,,,,,,,,,,0.0539,,,,,,,,,,,,11490.0,373.4,33.9,17.0,17.0,17.0,0.0,0.0,,14511.2,424.3,17.0,17.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F05,1.0,DAB014074_F05,NB-jarvcass-5073893-0001,5.5,Citrate,0,75,0.0,0.0,0,,,,,,,,,,,0.0536,,,,,,,,,,,,3309.6,746.8,118.8,33.9,0.0,0.0,0.0,0.0,,5295.2,594.0,152.7,135.8,118.8,118.8,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F06,1.0,DAB014074_F06,NB-jarvcass-5073893-0001,6.0,Citrate,0,75,0.0,0.0,0,,,,,,,,,,,0.0538,,,,,,,,,,,,2681.6,661.9,135.8,33.9,17.0,0.0,0.0,0.0,,2121.5,237.6,33.9,17.0,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F07,1.0,DAB014074_F07,NB-jarvcass-5073893-0001,6.5,Citrate,0,75,0.0,0.0,0,,,,,,,,,,,0.054,,,,,,,,,,,,3801.7,1306.8,339.4,135.8,50.9,33.9,0.0,0.0,,1120.1,220.6,33.9,33.9,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F08,1.0,DAB014074_F08,NB-jarvcass-5073893-0001,5.0,Histidine,0,75,0.0,0.0,0,,,,,,,,,,,0.057,,,,,,,,,,,,6619.1,1086.2,169.7,101.8,17.0,0.0,0.0,0.0,,9521.2,2002.7,356.4,271.6,67.9,33.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F09,1.0,DAB014074_F09,NB-jarvcass-5073893-0001,5.5,Histidine,0,75,0.0,0.0,0,,,,,,,,,,,0.0581,,,,,,,,,,,,4361.8,797.7,101.8,50.9,17.0,17.0,0.0,0.0,,18754.0,6483.3,2172.4,1510.5,865.6,509.2,135.8,50.9,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F10,1.0,DAB014074_F10,NB-jarvcass-5073893-0001,6.0,Histidine,0,75,0.0,0.0,0,,,,,,,,,,,0.0607,,,,,,,,,,,,3716.8,746.8,101.8,33.9,17.0,17.0,0.0,0.0,,7382.8,1306.8,152.7,84.9,50.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,F11,1.0,DAB014074_F11,NB-jarvcass-5073893-0001,6.5,Histidine,0,75,0.0,0.0,0,,,,,,,,,,,0.0627,,,,,,,,,,,,6636.0,1442.6,407.3,237.6,84.9,67.9,17.0,17.0,,6771.8,1731.1,254.6,169.7,17.0,17.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,NaCl 75 mM,NaCl 75 mM,-,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,50.0,10.0,G02,1.0,DAB014074_G02,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.02,7.0,0,,,,,,,,,,,0.0555,,,,,,,,,,,,10641.6,169.7,33.9,0.0,0.0,0.0,0.0,0.0,,16106.5,780.7,67.9,50.9,17.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,PS80,-,PS80,1,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,5.0,10.0,H07,1.0,DAB014074_H07,NB-jarvcass-5073893-0001,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0462,,,,,,,,,,,,8214.4,1222.0,118.8,50.9,17.0,0.0,0.0,0.0,,18686.1,2613.7,339.4,101.8,50.9,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
12/14/2023,jarvcass,FAP-TriNKET,DAB014074,BsAb,,Thermal Stress,5.0,10.0,H08,1.0,DAB014074_H08,NB-jarvcass-5073893-0001,5.5,Histidine,0,0,0.0,7.0,0,,,,,,,,,,,0.0487,,,,,,,,,,,,35472.8,2359.2,797.7,492.2,152.8,101.8,0.0,0.0,,37967.2,3411.4,1222.0,644.9,186.7,135.8,17.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,DAB014074,DAB014074,Humanized,AB3068_F3'_VL-VH_scFv_Rehumanized_Sibro_BM1 _A49_M/I_NKG2D_FAb,8.41,125286.6265,,"FAP_H, NKG2D_H",BsAb,,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B02,1.3819,DNB_547B02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,99.5,0.1,0.1,63.11,99.81,-0.1,0.1,0.0404,,,,-16.65,11.17,5.48,16.65,11.17,5.48,62.8,,44637.4,6381.6,1544.5,780.7,271.6,135.8,0.0,0.0,,9538.2,1731.1,135.8,67.9,0.0,0.0,0.0,0.0,,,,,,,,82.34,13.44,4.22,-8.71,7.98,0.73,8.71,7.98,0.73,90.71,9.29,0.0,-0.03,0.03,0.0,0.03,0.03,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B03,1.3786,DNB_547B03,NB-munselle-5020702-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,99.5,0.0,0.0,63.41,99.92,0.0,0.0,0.0414,,,,-14.17,10.62,3.55,14.17,10.62,3.55,64.2,,11557.9,4412.7,1629.3,1001.3,373.4,135.8,0.0,0.0,,12151.9,1985.7,203.7,50.9,33.9,17.0,0.0,0.0,,,,,,,,82.59,13.16,4.26,-8.46,7.7,0.77,8.46,7.7,0.77,90.7,9.3,0.0,-0.04,0.04,0.0,0.04,0.04,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B04,1.3856,DNB_547B04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,88.5,-10.9,10.9,63.28,99.88,-0.1,0.1,0.0431,,,,-16.42,12.42,4.0,16.42,12.42,4.0,63.2,,13611.5,6313.6,1629.3,882.5,271.6,84.9,17.0,17.0,,96219.6,3768.0,220.6,101.8,17.0,0.0,0.0,0.0,,,,,,,,83.08,12.66,4.26,-7.97,7.2,0.77,7.97,7.2,0.77,90.64,9.36,0.0,-0.1,0.1,0.0,0.1,0.1,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B05,1.3739,DNB_547B05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,89.2,-10.2,10.2,63.45,99.93,0.0,0.0,0.0426,,,,-18.32,13.17,5.15,18.32,13.17,5.15,62.4,,30176.3,9657.1,1425.7,865.6,305.5,169.7,17.0,0.0,,25084.7,3615.1,288.5,33.9,0.0,0.0,0.0,0.0,,,,,,,,82.89,12.82,4.29,-8.16,7.36,0.8,8.16,7.36,0.8,90.65,9.35,0.0,-0.09,0.09,0.0,0.09,0.09,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B06,1.3812,DNB_547B06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,63.43,99.92,0.0,0.0,0.0415,,,,-19.53,15.98,3.55,19.53,15.98,3.55,60.0,,15546.4,4022.4,1272.9,729.8,254.6,135.8,0.0,0.0,,38849.2,4514.6,661.9,288.5,0.0,0.0,0.0,0.0,,,,,,,,82.21,13.32,4.47,-8.84,7.86,0.98,8.84,7.86,0.98,91.04,8.96,0.0,0.3,-0.3,0.0,0.3,0.3,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B07,1.3697,DNB_547B07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,63.42,99.93,0.0,0.0,0.0425,,,,-21.48,17.7,3.77,21.48,17.7,3.77,59.6,,17379.3,6347.5,1408.7,780.7,237.6,118.8,0.0,0.0,,38051.7,6687.1,1035.3,441.3,203.7,33.9,0.0,0.0,,,,,,,,80.53,14.88,4.59,-10.52,9.42,1.1,10.52,9.42,1.1,91.47,8.53,0.0,0.73,-0.73,0.0,0.73,0.73,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B08,1.3952,DNB_547B08,NB-munselle-5020702-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,99.4,0.0,0.0,63.29,99.81,-0.1,0.1,0.0435,,,,-13.43,9.13,4.29,13.43,9.13,4.29,62.2,,11931.3,5465.0,1340.8,831.6,373.4,169.7,0.0,0.0,,14782.6,2274.2,254.6,101.8,50.9,0.0,0.0,0.0,,,,,,,,82.96,13.05,3.99,-8.09,7.59,0.5,8.09,7.59,0.5,90.64,9.36,0.0,-0.1,0.1,0.0,0.1,0.1,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B09,1.3623,DNB_547B09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,99.4,0.0,0.0,63.34,99.81,-0.1,0.1,0.0432,,,,-12.78,9.39,3.39,12.78,9.39,3.39,63.6,,16547.6,8961.2,1934.8,899.5,237.6,67.9,0.0,0.0,,13339.9,1900.9,271.6,67.9,0.0,0.0,0.0,0.0,,,,,,,,83.87,12.37,3.76,-7.18,6.91,0.27,7.18,6.91,0.27,90.48,9.52,0.0,-0.26,0.26,0.0,0.26,0.26,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B10,1.3733,DNB_547B10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,99.4,-0.1,0.1,63.33,99.9,0.0,0.0,0.0433,,,,-14.82,11.13,3.69,14.82,11.13,3.69,64.8,,53445.3,17175.8,2647.7,1374.7,475.2,254.6,33.9,33.9,,40377.0,3598.1,390.4,186.7,101.8,50.9,0.0,0.0,,,,,,,,84.22,11.85,3.93,-6.83,6.39,0.44,6.83,6.39,0.44,90.73,9.27,0.0,-0.01,0.01,0.0,0.01,0.01,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B11,1.3339,DNB_547B11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,96.6,-2.8,2.8,63.4,99.93,0.0,0.0,0.0424,,,,-17.39,14.32,3.06,17.39,14.32,3.06,63.4,,30821.2,18126.1,2834.3,1340.8,407.3,169.7,17.0,0.0,,45502.3,5838.4,1001.4,543.1,135.8,50.9,33.9,0.0,,,,,,,,82.37,13.74,3.89,-8.68,8.28,0.4,8.68,8.28,0.4,90.69,9.31,0.0,-0.05,0.05,0.0,0.05,0.05,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C02,1.2963,DNB_547C02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,98.1,-1.4,1.4,62.99,99.88,-0.1,0.1,0.0406,,,,-18.42,13.53,4.89,18.42,13.53,4.89,,,5431.0,1035.3,101.8,67.9,0.0,0.0,0.0,0.0,,35913.1,6687.0,1561.4,933.5,288.5,118.8,33.9,33.9,,,,,,,,79.14,17.17,3.69,-11.91,11.71,0.2,11.91,11.71,0.2,90.18,9.82,0.0,-0.56,0.56,0.0,0.56,0.56,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C03,1.3525,DNB_547C03,NB-munselle-5020702-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,98.2,-1.2,1.2,63.38,99.87,-0.1,0.1,0.0428,,,,-17.83,13.02,4.81,17.83,13.02,4.81,59.0,,7552.5,1357.8,135.8,101.8,50.9,0.0,0.0,0.0,,12627.1,2104.5,271.6,135.8,33.9,17.0,0.0,0.0,,,,,,,,81.02,15.12,3.85,-10.03,9.66,0.36,10.03,9.66,0.36,90.39,9.61,0.0,-0.35,0.35,0.0,0.35,0.35,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C04,1.3989,DNB_547C04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,90.1,-9.4,9.4,63.49,99.89,0.0,0.0,0.0443,,,,-17.58,12.45,5.13,17.58,12.45,5.13,60.8,,6398.4,1476.6,169.7,84.9,17.0,17.0,0.0,0.0,,14884.4,2393.0,339.4,186.7,33.9,17.0,0.0,0.0,,,,,,,,82.24,14.08,3.68,-8.81,8.62,0.19,8.81,8.62,0.19,90.82,9.18,0.0,0.08,-0.08,0.0,0.08,0.08,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C05,1.3774,DNB_547C05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,90.9,-8.5,8.5,63.74,99.93,0.0,0.0,0.0448,,,,-17.2,12.77,4.44,17.2,12.77,4.44,60.2,,10539.5,4005.4,220.6,152.7,17.0,0.0,0.0,0.0,,13356.9,1816.0,356.4,169.7,50.9,50.9,50.9,33.9,,,,,,,,83.51,12.77,3.73,-7.54,7.31,0.24,7.54,7.31,0.24,91.02,8.98,0.0,0.28,-0.28,0.0,0.28,0.28,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C06,1.4014,DNB_547C06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,94.0,-5.5,5.5,63.64,99.91,0.0,0.0,0.0431,,,,-21.09,17.0,4.09,21.09,17.0,4.09,59.6,,12525.3,3699.9,322.5,220.6,67.9,17.0,0.0,0.0,,25899.6,5414.1,1103.2,543.1,84.9,17.0,0.0,0.0,,,,,,,,81.87,14.37,3.76,-9.18,8.91,0.27,9.18,8.91,0.27,91.48,8.52,0.0,0.74,-0.74,0.0,0.74,0.74,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C07,1.3925,DNB_547C07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,89.3,-10.1,10.1,63.82,99.93,0.0,0.0,0.0442,,,,-22.54,18.5,4.05,22.54,18.5,4.05,60.0,,14494.1,4226.0,628.0,322.5,101.8,67.9,0.0,0.0,,17583.0,3055.0,509.2,237.6,118.8,101.8,17.0,0.0,,,,,,,,82.26,13.7,4.04,-8.79,8.24,0.55,8.79,8.24,0.55,91.45,8.47,0.08,0.71,-0.79,0.08,0.71,0.79,0.08,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C08,1.3743,DNB_547C08,NB-munselle-5020702-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,99.4,-0.1,0.1,63.16,99.81,-0.1,0.1,0.0436,,,,-14.82,10.79,4.03,14.82,10.79,4.03,56.0,,7009.4,1799.0,356.4,220.6,67.9,17.0,0.0,0.0,,18805.0,3275.6,339.4,135.8,33.9,0.0,0.0,0.0,,,,,,,,80.73,15.97,3.3,-10.32,10.51,-0.19,10.32,10.51,0.19,90.44,9.56,0.0,-0.3,0.3,0.0,0.3,0.3,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C09,1.3743,DNB_547C09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,98.6,-0.9,0.9,63.46,99.81,-0.1,0.1,0.0433,,,,-12.85,9.37,3.48,12.85,9.37,3.48,59.0,,11829.5,3852.6,509.2,288.5,67.9,33.9,0.0,0.0,,16140.3,3139.8,577.0,271.6,67.9,33.9,0.0,0.0,,,,,,,,81.85,14.46,3.7,-9.2,9.0,0.21,9.2,9.0,0.21,90.88,9.12,0.0,0.14,-0.14,0.0,0.14,0.14,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C10,1.356,DNB_547C10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,99.3,-0.2,0.2,63.88,99.92,0.0,0.0,0.044,,,,-13.73,10.03,3.7,13.73,10.03,3.7,,,11812.4,5193.4,644.9,322.5,152.7,67.9,17.0,0.0,,14290.4,2376.1,220.6,67.9,33.9,17.0,17.0,17.0,,,,,,,,83.16,12.67,4.17,-7.89,7.21,0.68,7.89,7.21,0.68,90.97,8.92,0.11,0.23,-0.34,0.11,0.23,0.34,0.11,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C11,1.3295,DNB_547C11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,97.8,-1.7,1.7,63.82,99.93,0.0,0.0,0.0423,,,,-16.82,13.21,3.61,16.82,13.21,3.61,61.4,,13577.5,4107.2,882.5,526.1,152.7,101.8,17.0,17.0,,27376.1,7009.5,1748.1,950.4,203.7,33.9,0.0,0.0,,,,,,,,82.0,13.78,4.21,-9.05,8.32,0.72,9.05,8.32,0.72,90.92,8.64,0.44,0.18,-0.62,0.44,0.18,0.62,0.44,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D02,1.4113,DNB_547D02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,97.9,-1.5,1.5,62.49,99.44,-0.5,0.5,0.0427,,,,,,,,,,55.0,,345313.9,8776.3,899.7,288.6,17.0,17.0,17.0,17.0,,40597.4,4905.0,916.5,373.4,101.8,50.9,17.0,17.0,,,,,,,,76.79,19.61,3.6,-14.26,14.15,0.11,14.26,14.15,0.11,79.54,7.48,12.98,-11.2,-1.78,12.98,11.2,1.78,12.98,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D03,1.4213,DNB_547D03,NB-munselle-5020702-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,98.6,-0.9,0.9,63.63,99.87,-0.1,0.1,0.043,,,,,,,,,,56.6,,13730.3,1968.7,475.2,220.6,67.9,17.0,0.0,0.0,,17498.1,2681.6,458.2,220.6,33.9,17.0,0.0,0.0,,,,,,,,79.64,16.49,3.88,-11.41,11.03,0.39,11.41,11.03,0.39,90.84,8.7,0.46,0.1,-0.56,0.46,0.1,0.56,0.46,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D04,1.3951,DNB_547D04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,86.0,-13.4,13.4,64.12,99.87,-0.1,0.1,0.0432,,,,,,,,,,59.6,,8740.6,1849.9,475.2,288.5,101.8,33.9,0.0,0.0,,12389.5,1765.1,203.7,84.9,0.0,0.0,0.0,0.0,,,,,,,,81.03,14.14,4.83,-10.02,8.68,1.34,10.02,8.68,1.34,90.7,9.17,0.13,-0.04,-0.09,0.13,0.04,0.09,0.13,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D05,1.4015,DNB_547D05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,82.7,-16.8,16.8,64.26,99.93,0.0,0.0,0.0429,,,,,,,,,,61.2,,9707.9,2562.8,441.3,237.6,84.9,33.9,0.0,0.0,,17040.0,2749.5,577.1,288.5,33.9,0.0,0.0,0.0,,,,,,,,81.51,13.53,4.95,-9.54,8.07,1.46,9.54,8.07,1.46,91.23,8.57,0.2,0.49,-0.69,0.2,0.49,0.69,0.2,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D06,1.3895,DNB_547D06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,97.1,-2.3,2.3,64.11,100.0,0.1,0.1,0.0417,,,,,,,,,,59.4,,20705.8,4972.8,1018.3,644.9,169.7,50.9,0.0,0.0,,59149.2,9657.4,1340.8,729.8,220.6,84.9,17.0,0.0,,,,,,,,81.24,14.59,4.18,-9.81,9.13,0.69,9.81,9.13,0.69,90.91,8.93,0.16,0.17,-0.33,0.16,0.17,0.33,0.16,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D07,1.3902,DNB_547D07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,94.6,-4.8,4.8,64.37,100.0,0.1,0.1,0.0419,,,,,,,,,,61.8,,10318.9,2325.2,339.4,237.6,84.9,17.0,0.0,0.0,,24813.2,3649.0,678.9,441.3,169.7,101.8,17.0,0.0,,,,,,,,79.85,15.96,4.19,-11.2,10.5,0.7,11.2,10.5,0.7,91.03,8.76,0.2,0.29,-0.5,0.2,0.29,0.5,0.2,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D08,1.4019,DNB_547D08,NB-munselle-5020702-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,98.0,-1.4,1.4,63.27,99.83,-0.1,0.1,0.0435,,,,,,,,,,53.4,,18194.1,4192.1,1239.0,644.9,220.6,101.8,33.9,0.0,,30821.4,5227.4,984.4,526.1,135.8,33.9,17.0,0.0,,,,,,,,78.24,18.04,3.72,-12.81,12.58,0.23,12.81,12.58,0.23,88.92,8.24,2.85,-1.82,-1.02,2.85,1.82,1.02,2.85,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D09,1.3899,DNB_547D09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,98.4,-1.1,1.1,63.95,99.91,0.0,0.0,0.0433,,,,,,,,,,56.6,,15563.2,3411.4,882.5,424.3,169.7,118.8,17.0,17.0,,12134.9,2291.2,475.2,237.6,135.8,50.9,0.0,0.0,,,,,,,,80.8,15.27,3.93,-10.25,9.81,0.44,10.25,9.81,0.44,90.44,9.38,0.18,-0.3,0.12,0.18,0.3,0.12,0.18,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D10,1.4039,DNB_547D10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,98.4,-1.0,1.0,64.25,99.91,0.0,0.0,0.0445,,,,,,,,,,60.6,,17684.8,5804.4,1816.0,1052.3,441.3,237.6,67.9,33.9,,20553.2,3716.9,475.2,305.5,50.9,17.0,0.0,0.0,,,,,,,,83.23,12.38,4.39,-7.82,6.92,0.9,7.82,6.92,0.9,90.21,9.55,0.24,-0.53,0.29,0.24,0.53,0.29,0.24,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D11,1.3673,DNB_547D11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,98.0,-1.4,1.4,64.38,99.95,0.0,0.0,0.0427,,,,,,,,,,61.4,,16242.2,3632.0,1205.0,797.7,271.6,101.8,0.0,0.0,,16377.9,3122.8,611.0,254.6,50.9,33.9,0.0,0.0,,,,,,,,80.56,15.5,3.94,-10.49,10.04,0.45,10.49,10.04,0.45,90.01,9.89,0.1,-0.73,0.63,0.1,0.73,0.63,0.1,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB547,Fusion Protein,SINGLE CONTROL,,5.0,12.0,H02,1.3916,DNB_547H02,NB-munselle-5020702-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,99.5,0.0,0.0,64.08,99.93,0.0,0.0,0.0386,,,,0.0,0.0,0.0,0.0,0.0,0.0,66.0,,7858.0,2817.3,560.1,373.4,67.9,50.9,0.0,0.0,,11388.1,5431.0,322.5,169.7,0.0,0.0,0.0,0.0,,,,,,,,91.05,5.46,3.49,0.0,0.0,0.0,0.0,0.0,0.0,90.74,9.26,0.0,0.0,0.0,0.0,0.0,0.0,0.0,DNB000547_004,DNB000547,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S ZM856A / Fc ZM857B Genewiz CHO Opt),7.62,66400.5155,,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E02,1.4024,DNB_553E02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0405,,,,-16.26,11.19,5.08,16.26,11.19,5.08,63.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.62,15.93,1.45,-12.49,12.54,-0.05,12.49,12.54,0.05,90.94,9.06,0.0,-0.39,0.39,0.0,0.39,0.39,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E03,1.4073,DNB_553E03,NB-munselle-5020702-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0422,,,,-16.13,11.09,5.04,16.13,11.09,5.04,63.0,,,,,,,,,,,,,,,,,,,,,,,,,,84.57,14.17,1.27,-10.54,10.78,-0.23,10.54,10.78,0.23,90.55,9.45,0.0,-0.78,0.78,0.0,0.78,0.78,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E04,1.4024,DNB_553E04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0429,,,,-15.98,11.34,4.64,15.98,11.34,4.64,64.0,,,,,,,,,,,,,,,,,,,,,,,,,,84.65,13.93,1.42,-10.46,10.54,-0.08,10.46,10.54,0.08,90.96,9.04,0.0,-0.37,0.37,0.0,0.37,0.37,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E05,1.4042,DNB_553E05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0423,,,,-16.59,11.54,5.05,16.59,11.54,5.05,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,85.69,12.83,1.49,-9.42,9.44,-0.01,9.42,9.44,0.01,91.13,8.87,0.0,-0.2,0.2,0.0,0.2,0.2,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E06,1.4021,DNB_553E06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0412,,,,-18.14,15.18,2.96,18.14,15.18,2.96,60.0,,,,,,,,,,,,,,,,,,,,,,,,,,83.16,15.48,1.36,-11.95,12.09,-0.14,11.95,12.09,0.14,90.97,8.74,0.29,-0.36,0.07,0.29,0.36,0.07,0.29,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E07,1.3873,DNB_553E07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0429,,,,-20.49,16.75,3.74,20.49,16.75,3.74,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.82,14.74,1.44,-11.29,11.35,-0.06,11.29,11.35,0.06,91.14,8.62,0.24,-0.19,-0.05,0.24,0.19,0.05,0.24,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E08,1.4036,DNB_553E08,NB-munselle-5020702-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0431,,,,-11.24,7.23,4.02,11.24,7.23,4.02,62.6,,,,,,,,,,,,,,,,,,,,,,,,,,84.51,14.07,1.42,-10.6,10.68,-0.08,10.6,10.68,0.08,90.12,9.88,0.0,-1.21,1.21,0.0,1.21,1.21,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E09,1.397,DNB_553E09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.044,,,,-10.21,6.69,3.52,10.21,6.69,3.52,62.8,,,,,,,,,,,,,,,,,,,,,,,,,,84.52,14.29,1.19,-10.59,10.9,-0.31,10.59,10.9,0.31,89.78,10.22,0.0,-1.55,1.55,0.0,1.55,1.55,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E10,1.3954,DNB_553E10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0436,,,,-12.18,8.4,3.78,12.18,8.4,3.78,63.8,,,,,,,,,,,,,,,,,,,,,,,,,,86.45,12.4,1.14,-8.66,9.01,-0.36,8.66,9.01,0.36,89.65,10.35,0.0,-1.68,1.68,0.0,1.68,1.68,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E11,1.3726,DNB_553E11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0429,,,,-15.44,11.94,3.5,15.44,11.94,3.5,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.63,15.08,1.29,-11.48,11.69,-0.21,11.48,11.69,0.21,89.21,10.69,0.1,-2.12,2.02,0.1,2.12,2.02,0.1,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F02,1.3845,DNB_553F02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0412,,,,-16.88,12.5,4.39,16.88,12.5,4.39,54.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.59,17.04,1.36,-13.52,13.65,-0.14,13.52,13.65,0.14,89.86,10.14,0.0,-1.47,1.47,0.0,1.47,1.47,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F03,1.3852,DNB_553F03,NB-munselle-5020702-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0418,,,,-17.15,12.79,4.36,17.15,12.79,4.36,59.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.6,16.07,1.33,-12.51,12.68,-0.17,12.51,12.68,0.17,90.11,9.89,0.0,-1.22,1.22,0.0,1.22,1.22,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F04,1.3861,DNB_553F04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0431,,,,-15.65,11.61,4.04,15.65,11.61,4.04,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.88,14.78,1.35,-11.23,11.39,-0.15,11.23,11.39,0.15,90.68,9.32,0.0,-0.65,0.65,0.0,0.65,0.65,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F05,1.3812,DNB_553F05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0434,,,,-15.99,11.94,4.05,15.99,11.94,4.05,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,84.14,14.28,1.58,-10.97,10.89,0.08,10.97,10.89,0.08,90.7,9.3,0.0,-0.63,0.63,0.0,0.63,0.63,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F06,1.3868,DNB_553F06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,,,,,,,,0.0438,,,,-18.66,15.9,2.77,18.66,15.9,2.77,60.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.65,15.87,1.48,-12.46,12.48,-0.02,12.46,12.48,0.02,89.95,10.05,0.0,-1.38,1.38,0.0,1.38,1.38,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F07,1.3557,DNB_553F07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,,,,,,,,0.0447,,,,-19.83,16.42,3.41,19.83,16.42,3.41,62.0,,,,,,,,,,,,,,,,,,,,,,,,,,82.19,16.06,1.75,-12.92,12.67,0.25,12.92,12.67,0.25,90.58,9.42,0.0,-0.75,0.75,0.0,0.75,0.75,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F08,1.3896,DNB_553F08,NB-munselle-5020702-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0448,,,,-12.67,8.75,3.92,12.67,8.75,3.92,57.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.8,14.88,1.32,-11.31,11.49,-0.18,11.31,11.49,0.18,89.33,10.67,0.0,-2.0,2.0,0.0,2.0,2.0,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F09,1.3626,DNB_553F09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0433,,,,-10.06,6.54,3.52,10.06,6.54,3.52,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.31,15.33,1.36,-11.8,11.94,-0.14,11.8,11.94,0.14,89.35,10.65,0.0,-1.98,1.98,0.0,1.98,1.98,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F10,1.3398,DNB_553F10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.046,,,,-11.29,7.77,3.52,11.29,7.77,3.52,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,85.81,12.7,1.49,-9.3,9.31,-0.01,9.3,9.31,0.01,89.85,10.15,0.0,-1.48,1.48,0.0,1.48,1.48,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F11,1.3639,DNB_553F11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0401,,,,-16.59,12.87,3.72,16.59,12.87,3.72,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.8,15.73,1.47,-12.31,12.34,-0.03,12.31,12.34,0.03,90.09,9.66,0.25,-1.24,0.99,0.25,1.24,0.99,0.25,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G02,1.3572,DNB_553G02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.041,,,,,,,,,,51.2,,,,,,,,,,,,,,,,,,,,,,,,,,81.47,17.09,1.44,-13.64,13.7,-0.06,13.64,13.7,0.06,73.29,7.28,19.43,-18.04,-1.39,19.43,18.04,1.39,19.43,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G03,1.4033,DNB_553G03,NB-munselle-5020702-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0421,,,,,,,,,,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.8,15.81,1.39,-12.31,12.42,-0.11,12.31,12.42,0.11,90.25,9.2,0.54,-1.08,0.53,0.54,1.08,0.53,0.54,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G04,1.3967,DNB_553G04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0429,,,,,,,,,,59.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.97,14.65,1.38,-11.14,11.26,-0.12,11.14,11.26,0.12,90.8,9.2,0.0,-0.53,0.53,0.0,0.53,0.53,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G05,1.3835,DNB_553G05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0443,,,,,,,,,,61.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.75,14.86,1.39,-11.36,11.47,-0.11,11.36,11.47,0.11,90.59,9.41,0.0,-0.74,0.74,0.0,0.74,0.74,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G06,1.4021,DNB_553G06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0418,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.08,15.39,1.53,-12.03,12.0,0.03,12.03,12.0,0.03,90.41,9.59,0.0,-0.92,0.92,0.0,0.92,0.92,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G07,1.4081,DNB_553G07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0427,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,82.69,15.88,1.43,-12.42,12.49,-0.07,12.42,12.49,0.07,90.57,9.27,0.16,-0.76,0.6,0.16,0.76,0.6,0.16,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G08,1.4082,DNB_553G08,NB-munselle-5020702-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0444,,,,,,,,,,54.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.57,16.17,1.26,-12.54,12.78,-0.24,12.54,12.78,0.24,88.22,8.58,3.2,-3.11,-0.09,3.2,3.11,0.09,3.2,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G09,1.4007,DNB_553G09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0435,,,,,,,,,,57.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.72,14.87,1.41,-11.39,11.48,-0.09,11.39,11.48,0.09,89.5,10.36,0.14,-1.83,1.69,0.14,1.83,1.69,0.14,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G10,1.3998,DNB_553G10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0435,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.36,12.15,1.5,-8.75,8.76,0.0,8.75,8.76,0.0,89.97,10.03,0.0,-1.36,1.36,0.0,1.36,1.36,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G11,1.3356,DNB_553G11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0423,,,,,,,,,,62.0,,,,,,,,,,,,,,,,,,,,,,,,,,82.74,15.62,1.64,-12.37,12.23,0.14,12.37,12.23,0.14,89.15,10.85,0.0,-2.18,2.18,0.0,2.18,2.18,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB553,Fusion Protein,SINGLE CONTROL,,5.0,12.0,H07,1.4108,DNB_553H07,NB-munselle-5020702-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0414,,,,0.0,0.0,0.0,0.0,0.0,0.0,66.2,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,3.39,1.5,0.0,0.0,0.0,0.0,0.0,0.0,91.33,8.67,0.0,0.0,0.0,0.0,0.0,0.0,0.0,DNB000553_004,DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B02,1.4011,DNB_557B02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,63.63,99.69,-0.3,0.3,0.0413,,,,-16.04,11.44,4.61,16.04,11.44,4.61,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.81,15.12,1.07,-8.42,8.9,-0.48,8.42,8.9,0.48,89.57,10.43,0.0,-0.3,0.3,0.0,0.3,0.3,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B03,1.4385,DNB_557B03,NB-munselle-5020702-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.07,99.51,-0.5,0.5,0.0419,,,,-16.27,12.0,4.28,16.27,12.0,4.28,64.2,,,,,,,,,,,,,,,,,,,,,,,,,,84.38,14.39,1.23,-7.85,8.17,-0.32,7.85,8.17,0.32,90.07,9.93,0.0,0.2,-0.2,0.0,0.2,0.2,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B04,1.4419,DNB_557B04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.41,99.56,-0.4,0.4,0.0431,,,,-17.29,12.75,4.55,17.29,12.75,4.55,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,84.42,14.42,1.15,-7.81,8.2,-0.4,7.81,8.2,0.4,89.91,10.09,0.0,0.04,-0.04,0.0,0.04,0.04,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B08,1.449,DNB_557B08,NB-munselle-5020702-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.25,99.21,-0.8,0.8,0.0441,,,,-14.63,10.89,3.75,14.63,10.89,3.75,60.6,,,,,,,,,,,,,,,,,,,,,,,,,,84.79,14.12,1.1,-7.44,7.9,-0.45,7.44,7.9,0.45,89.14,10.86,0.0,-0.73,0.73,0.0,0.73,0.73,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B05,1.436,DNB_557B05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,98.9,-1.1,1.1,64.54,99.6,-0.4,0.4,0.0435,,,,-18.02,13.42,4.61,18.02,13.42,4.61,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,85.77,13.13,1.1,-6.46,6.91,-0.45,6.46,6.91,0.45,89.73,10.27,0.0,-0.14,0.14,0.0,0.14,0.14,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B06,1.4457,DNB_557B06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.52,99.5,-0.5,0.5,0.0423,,,,-19.67,16.78,2.9,19.67,16.78,2.9,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.68,15.07,1.25,-8.55,8.85,-0.3,8.55,8.85,0.3,89.67,10.33,0.0,-0.2,0.2,0.0,0.2,0.2,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B07,1.4392,DNB_557B07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,64.63,99.61,-0.4,0.4,0.0431,,,,-23.26,19.92,3.35,23.26,19.92,3.35,60.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.32,15.45,1.23,-8.91,9.23,-0.32,8.91,9.23,0.32,90.04,9.96,0.0,0.17,-0.17,0.0,0.17,0.17,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B09,1.4496,DNB_557B09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.21,99.34,-0.7,0.7,0.0432,,,,-13.63,10.22,3.42,13.63,10.22,3.42,63.8,,,,,,,,,,,,,,,,,,,,,,,,,,85.4,13.59,1.02,-6.83,7.37,-0.53,6.83,7.37,0.53,88.9,11.1,0.0,-0.97,0.97,0.0,0.97,0.97,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B10,1.419,DNB_557B10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.59,99.73,-0.3,0.3,0.0434,,,,-16.96,13.28,3.69,16.96,13.28,3.69,,,,,,,,,,,,,,,,,,,,,,,,,,,85.95,12.77,1.27,-6.28,6.55,-0.28,6.28,6.55,0.28,89.09,10.91,0.0,-0.78,0.78,0.0,0.78,0.78,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,B11,1.4032,DNB_557B11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,64.52,99.58,-0.4,0.4,0.0417,,,,-21.64,18.34,3.31,21.64,18.34,3.31,63.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.01,15.65,1.34,-9.22,9.43,-0.21,9.22,9.43,0.21,89.06,10.94,0.0,-0.81,0.81,0.0,0.81,0.81,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C02,1.415,DNB_557C02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,63.92,99.12,-0.9,0.9,0.041,,,,-18.71,14.04,4.68,18.71,14.04,4.68,54.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.47,17.31,1.22,-10.76,11.09,-0.33,10.76,11.09,0.33,89.05,10.95,0.0,-0.82,0.82,0.0,0.82,0.82,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C03,1.4324,DNB_557C03,NB-munselle-5020702-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,64.44,99.57,-0.4,0.4,0.0428,,,,-17.29,13.19,4.12,17.29,13.19,4.12,58.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.48,15.34,1.19,-8.75,9.12,-0.36,8.75,9.12,0.36,89.08,10.92,0.0,-0.79,0.79,0.0,0.79,0.79,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C04,1.4462,DNB_557C04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,64.95,99.75,-0.2,0.2,0.0442,,,,-17.27,12.94,4.34,17.27,12.94,4.34,58.4,,,,,,,,,,,,,,,,,,,,,,,,,,84.64,14.18,1.18,-7.59,7.96,-0.37,7.59,7.96,0.37,89.84,10.16,0.0,-0.03,0.03,0.0,0.03,0.03,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C05,1.4186,DNB_557C05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,65.28,99.76,-0.2,0.2,0.0441,,,,-17.7,13.65,4.05,17.7,13.65,4.05,60.0,,,,,,,,,,,,,,,,,,,,,,,,,,84.85,13.5,1.65,-7.38,7.28,0.1,7.38,7.28,0.1,89.49,10.51,0.0,-0.38,0.38,0.0,0.38,0.38,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C06,1.3988,DNB_557C06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,64.96,99.74,-0.3,0.3,0.0432,,,,-21.32,18.37,2.97,21.32,18.37,2.97,60.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.22,15.25,1.54,-9.01,9.03,-0.01,9.01,9.03,0.01,89.78,10.22,0.0,-0.09,0.09,0.0,0.09,0.09,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C07,1.4279,DNB_557C07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,65.34,99.75,-0.2,0.2,0.0449,,,,-22.03,18.47,3.57,22.03,18.47,3.57,59.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.31,14.97,1.73,-8.92,8.75,0.18,8.92,8.75,0.18,89.84,10.03,0.13,-0.03,-0.1,0.13,0.03,0.1,0.13,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C08,1.4484,DNB_557C08,NB-munselle-5020702-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,64.47,99.31,-0.7,0.7,0.044,,,,-14.59,10.07,4.53,14.59,10.07,4.53,,,,,,,,,,,,,,,,,,,,,,,,,,,83.61,15.01,1.38,-8.62,8.79,-0.17,8.62,8.79,0.17,89.11,10.89,0.0,-0.76,0.76,0.0,0.76,0.76,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C09,1.4349,DNB_557C09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,65.01,99.7,-0.3,0.3,0.0438,,,,-14.12,9.98,4.15,14.12,9.98,4.15,58.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.8,14.89,1.31,-8.43,8.67,-0.24,8.43,8.67,0.24,89.55,10.45,0.0,-0.32,0.32,0.0,0.32,0.32,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C10,1.4193,DNB_557C10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,65.14,99.39,-0.6,0.6,0.0426,,,,-14.87,11.32,3.56,14.87,11.32,3.56,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,85.21,13.27,1.53,-7.02,7.05,-0.02,7.02,7.05,0.02,89.4,10.6,0.0,-0.47,0.47,0.0,0.47,0.47,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,C11,1.4143,DNB_557C11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,0.0,65.36,99.75,-0.2,0.2,0.0429,,,,-19.21,15.6,3.61,19.21,15.6,3.61,60.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.7,15.5,1.8,-9.53,9.28,0.25,9.53,9.28,0.25,89.83,10.17,0.0,-0.04,0.04,0.0,0.04,0.04,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D02,1.3719,DNB_557D02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,64.66,99.7,-0.3,0.3,0.0421,,,,,,,,,,50.0,,,,,,,,,,,,,,,,,,,,,,,,,,78.45,20.11,1.44,-13.78,13.89,-0.11,13.78,13.89,0.11,67.94,8.1,23.96,-21.93,-2.03,23.96,21.93,2.03,23.96,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D03,1.4196,DNB_557D03,NB-munselle-5020702-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,65.48,99.75,-0.2,0.2,0.0421,,,,,,,,,,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.82,16.72,1.47,-10.41,10.5,-0.08,10.41,10.5,0.08,88.97,10.18,0.85,-0.9,0.05,0.85,0.9,0.05,0.85,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D04,1.4378,DNB_557D04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,65.98,99.76,-0.2,0.2,0.0436,,,,,,,,,,60.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.51,15.13,1.36,-8.72,8.91,-0.19,8.72,8.91,0.19,89.72,10.28,0.0,-0.15,0.15,0.0,0.15,0.15,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D05,1.4079,DNB_557D05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,65.21,98.28,-1.7,1.7,0.043,,,,,,,,,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,85.12,13.14,1.73,-7.11,6.92,0.18,7.11,6.92,0.18,89.84,10.16,0.0,-0.03,0.03,0.0,0.03,0.03,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D06,1.4209,DNB_557D06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,66.01,99.75,-0.2,0.2,0.0422,,,,,,,,,,58.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.24,15.44,1.33,-8.99,9.22,-0.22,8.99,9.22,0.22,89.69,10.31,0.0,-0.18,0.18,0.0,0.18,0.18,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D07,1.4257,DNB_557D07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,66.27,99.77,-0.2,0.2,0.0423,,,,,,,,,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.45,15.94,1.6,-9.78,9.72,0.05,9.78,9.72,0.05,89.35,10.65,0.0,-0.52,0.52,0.0,0.52,0.52,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D08,1.4138,DNB_557D08,NB-munselle-5020702-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,65.21,99.68,-0.3,0.3,0.0438,,,,,,,,,,53.8,,,,,,,,,,,,,,,,,,,,,,,,,,80.15,18.22,1.63,-12.08,12.0,0.08,12.08,12.0,0.08,85.28,10.06,4.66,-4.59,-0.07,4.66,4.59,0.07,4.66,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D09,1.4041,DNB_557D09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,65.88,99.71,-0.3,0.3,0.0444,,,,,,,,,,57.0,,,,,,,,,,,,,,,,,,,,,,,,,,82.46,15.83,1.71,-9.77,9.61,0.16,9.77,9.61,0.16,88.94,11.06,0.0,-0.93,0.93,0.0,0.93,0.93,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D10,1.429,DNB_557D10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,66.07,99.74,-0.3,0.3,0.0442,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.97,14.02,2.01,-8.26,7.8,0.46,8.26,7.8,0.46,88.55,11.45,0.0,-1.32,1.32,0.0,1.32,1.32,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,D11,1.4353,DNB_557D11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,0.0,66.23,99.76,-0.2,0.2,0.0435,,,,,,,,,,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.01,15.37,1.63,-9.22,9.15,0.08,9.22,9.15,0.08,89.27,10.73,0.0,-0.6,0.6,0.0,0.6,0.6,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB557,Fusion Protein,SINGLE CONTROL,,5.0,12.0,H02,1.4247,DNB_557H02,NB-munselle-5020702-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,69.47,100.0,0.0,0.0,0.0391,,,,0.0,0.0,0.0,0.0,0.0,0.0,64.4,,,,,,,,,,,,,,,,,,,,,,,,,,92.23,6.22,1.55,0.0,0.0,0.0,0.0,0.0,0.0,89.87,10.13,0.0,0.0,0.0,0.0,0.0,0.0,0.0,DNB000557_004,DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E02,1.4611,DNB_558E02,NB-munselle-5020702-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0408,,,,-13.16,9.24,3.92,13.16,9.24,3.92,63.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.74,14.33,2.93,-9.67,9.31,0.36,9.67,9.31,0.36,89.51,10.49,0.0,-0.66,0.66,0.0,0.66,0.66,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E03,1.4479,DNB_558E03,NB-munselle-5020702-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0433,,,,-13.19,9.27,3.92,13.19,9.27,3.92,63.8,,,,,,,,,,,,,,,,,,,,,,,,,,83.07,13.94,2.99,-9.34,8.92,0.42,9.34,8.92,0.42,89.74,10.26,0.0,-0.43,0.43,0.0,0.43,0.43,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E04,1.4579,DNB_558E04,NB-munselle-5020702-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0425,,,,-13.86,10.11,3.74,13.86,10.11,3.74,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.33,13.63,3.05,-9.08,8.61,0.48,9.08,8.61,0.48,89.62,10.38,0.0,-0.55,0.55,0.0,0.55,0.55,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E05,1.4371,DNB_558E05,NB-munselle-5020702-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0477,,,,-14.65,10.81,3.84,14.65,10.81,3.84,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,83.09,13.94,2.97,-9.32,8.92,0.4,9.32,8.92,0.4,89.91,10.09,0.0,-0.26,0.26,0.0,0.26,0.26,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E06,1.4275,DNB_558E06,NB-munselle-5020702-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0416,,,,-17.52,14.74,2.79,17.52,14.74,2.79,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.55,14.17,3.28,-9.86,9.15,0.71,9.86,9.15,0.71,89.77,10.23,0.0,-0.4,0.4,0.0,0.4,0.4,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E07,1.429,DNB_558E07,NB-munselle-5020702-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0437,,,,-18.59,15.85,2.74,18.59,15.85,2.74,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,80.83,16.04,3.12,-11.58,11.02,0.55,11.58,11.02,0.55,90.07,9.82,0.11,-0.1,-0.01,0.11,0.1,0.01,0.11,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E08,1.4505,DNB_558E08,NB-munselle-5020702-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.043,,,,-12.0,7.54,4.46,12.0,7.54,4.46,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,83.23,13.91,2.85,-9.18,8.89,0.28,9.18,8.89,0.28,88.94,11.06,0.0,-1.23,1.23,0.0,1.23,1.23,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E09,1.457,DNB_558E09,NB-munselle-5020702-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0434,,,,-12.33,8.57,3.76,12.33,8.57,3.76,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,82.66,14.11,3.23,-9.75,9.09,0.66,9.75,9.09,0.66,89.14,10.86,0.0,-1.03,1.03,0.0,1.03,1.03,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E10,1.4413,DNB_558E10,NB-munselle-5020702-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0444,,,,-13.18,9.78,3.39,13.18,9.78,3.39,64.6,,,,,,,,,,,,,,,,,,,,,,,,,,84.35,12.37,3.29,-8.06,7.35,0.72,8.06,7.35,0.72,89.32,10.68,0.0,-0.85,0.85,0.0,0.85,0.85,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,E11,1.4425,DNB_558E11,NB-munselle-5020702-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0433,,,,-17.59,14.42,3.17,17.59,14.42,3.17,63.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.51,15.38,3.11,-10.9,10.36,0.54,10.9,10.36,0.54,89.55,10.45,0.0,-0.62,0.62,0.0,0.62,0.62,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F02,1.4487,DNB_558F02,NB-munselle-5020702-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0415,,,,-15.02,9.68,5.34,15.02,9.68,5.34,56.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.55,15.32,3.13,-10.86,10.3,0.56,10.86,10.3,0.56,89.61,10.39,0.0,-0.56,0.56,0.0,0.56,0.56,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F03,1.4621,DNB_558F03,NB-munselle-5020702-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0423,,,,-14.5,10.59,3.9,14.5,10.59,3.9,59.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.29,15.59,3.12,-11.12,10.57,0.55,11.12,10.57,0.55,89.36,10.64,0.0,-0.81,0.81,0.0,0.81,0.81,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F04,1.44,DNB_558F04,NB-munselle-5020702-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0435,,,,-13.8,10.01,3.79,13.8,10.01,3.79,60.0,,,,,,,,,,,,,,,,,,,,,,,,,,82.83,13.97,3.2,-9.58,8.95,0.63,9.58,8.95,0.63,89.74,10.26,0.0,-0.43,0.43,0.0,0.43,0.43,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F05,1.4627,DNB_558F05,NB-munselle-5020702-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,,,,,,,,0.0435,,,,-14.41,10.61,3.8,14.41,10.61,3.8,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,82.92,13.68,3.4,-9.49,8.66,0.83,9.49,8.66,0.83,89.92,10.08,0.0,-0.25,0.25,0.0,0.25,0.25,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F06,1.4535,DNB_558F06,NB-munselle-5020702-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,,,,,,,,0.0442,,,,-16.2,13.99,2.2,16.2,13.99,2.2,59.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.78,14.73,3.48,-10.63,9.71,0.91,10.63,9.71,0.91,89.93,9.98,0.1,-0.24,0.15,0.1,0.24,0.15,0.1,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F07,1.4575,DNB_558F07,NB-munselle-5020702-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,,,,,,,,0.0444,,,,-17.54,14.38,3.16,17.54,14.38,3.16,61.6,,,,,,,,,,,,,,,,,,,,,,,,,,80.77,15.93,3.29,-11.64,10.91,0.72,11.64,10.91,0.72,90.27,9.58,0.15,0.1,-0.25,0.15,0.1,0.25,0.15,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F08,1.4558,DNB_558F08,NB-munselle-5020702-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0443,,,,-13.25,8.68,4.57,13.25,8.68,4.57,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.78,14.87,3.35,-10.63,9.85,0.78,10.63,9.85,0.78,89.08,10.92,0.0,-1.09,1.09,0.0,1.09,1.09,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F09,1.4481,DNB_558F09,NB-munselle-5020702-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0441,,,,-11.93,8.05,3.88,11.93,8.05,3.88,58.8,,,,,,,,,,,,,,,,,,,,,,,,,,82.45,14.41,3.15,-9.96,9.39,0.58,9.96,9.39,0.58,88.95,11.05,0.0,-1.22,1.22,0.0,1.22,1.22,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F10,1.4519,DNB_558F10,NB-munselle-5020702-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0445,,,,-11.98,8.16,3.82,11.98,8.16,3.82,61.2,,,,,,,,,,,,,,,,,,,,,,,,,,83.12,13.55,3.33,-9.29,8.53,0.76,9.29,8.53,0.76,89.57,10.43,0.0,-0.6,0.6,0.0,0.6,0.6,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,F11,1.4148,DNB_558F11,NB-munselle-5020702-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,,,,,,,,0.0434,,,,-15.56,11.99,3.57,15.56,11.99,3.57,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,80.97,15.91,3.12,-11.44,10.89,0.55,11.44,10.89,0.55,89.53,10.47,0.0,-0.64,0.64,0.0,0.64,0.64,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G02,1.4621,DNB_558G02,NB-munselle-5020702-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0413,,,,,,,,,,51.8,,,,,,,,,,,,,,,,,,,,,,,,,,81.52,15.04,3.44,-10.89,10.02,0.87,10.89,10.02,0.87,75.96,8.12,15.93,-14.21,-1.71,15.93,14.21,1.71,15.93,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G03,1.4431,DNB_558G03,NB-munselle-5020702-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0417,,,,,,,,,,56.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.14,14.39,3.47,-10.27,9.37,0.9,10.27,9.37,0.9,89.64,10.1,0.25,-0.53,0.27,0.25,0.53,0.27,0.25,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G04,1.4693,DNB_558G04,NB-munselle-5020702-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0426,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,82.88,13.99,3.13,-9.53,8.97,0.56,9.53,8.97,0.56,89.97,9.99,0.03,-0.2,0.16,0.03,0.2,0.16,0.03,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G05,1.4468,DNB_558G05,NB-munselle-5020702-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0434,,,,,,,,,,60.8,,,,,,,,,,,,,,,,,,,,,,,,,,82.48,14.0,3.52,-9.93,8.98,0.95,9.93,8.98,0.95,90.1,9.9,0.0,-0.07,0.07,0.0,0.07,0.07,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G06,1.4608,DNB_558G06,NB-munselle-5020702-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.042,,,,,,,,,,59.6,,,,,,,,,,,,,,,,,,,,,,,,,,81.93,14.64,3.43,-10.48,9.62,0.86,10.48,9.62,0.86,90.15,9.85,0.0,-0.02,0.02,0.0,0.02,0.02,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G07,1.4506,DNB_558G07,NB-munselle-5020702-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0429,,,,,,,,,,61.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.39,15.27,3.33,-11.02,10.25,0.76,11.02,10.25,0.76,90.02,9.98,0.0,-0.15,0.15,0.0,0.15,0.15,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G08,1.443,DNB_558G08,NB-munselle-5020702-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0438,,,,,,,,,,54.0,,,,,,,,,,,,,,,,,,,,,,,,,,81.94,14.87,3.2,-10.47,9.85,0.63,10.47,9.85,0.63,86.13,11.64,2.24,-4.04,1.81,2.24,4.04,1.81,2.24,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G09,1.4587,DNB_558G09,NB-munselle-5020702-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0435,,,,,,,,,,55.8,,,,,,,,,,,,,,,,,,,,,,,,,,82.84,14.42,2.74,-9.57,9.4,0.17,9.57,9.4,0.17,86.97,13.03,0.0,-3.2,3.2,0.0,3.2,3.2,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G10,1.4352,DNB_558G10,NB-munselle-5020702-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0435,,,,,,,,,,59.8,,,,,,,,,,,,,,,,,,,,,,,,,,85.66,11.46,2.88,-6.75,6.44,0.31,6.75,6.44,0.31,86.78,13.08,0.14,-3.39,3.25,0.14,3.39,3.25,0.14,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,Thermal Stress,40.0,12.0,G11,1.4426,DNB_558G11,NB-munselle-5020702-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,,,,,,,,0.0426,,,,,,,,,,62.4,,,,,,,,,,,,,,,,,,,,,,,,,,81.98,14.91,3.11,-10.43,9.89,0.54,10.43,9.89,0.54,86.84,13.02,0.14,-3.33,3.19,0.14,3.33,3.19,0.14,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
8/31/2022,munselle,IL-2Ra,DNB558,Fusion Protein,SINGLE CONTROL,,5.0,12.0,H07,1.4322,DNB_558H07,NB-munselle-5020702-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0388,,,,0.0,0.0,0.0,0.0,0.0,0.0,65.2,,,,,,,,,,,,,,,,,,,,,,,,,,92.41,5.02,2.57,0.0,0.0,0.0,0.0,0.0,0.0,90.17,9.83,0.0,0.0,0.0,0.0,0.0,0.0,0.0,DNB000558_004,DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.0,-0.5,,0.0537,60.1,30.9,9.0,-19.2,,,,,,53.6,55.6,5957.1,1493.5,288.5,152.7,84.9,33.9,0.0,0.0,,7552.5,2223.3,390.4,186.7,50.9,0.0,0.0,0.0,,,,,,,,91.6,5.55,2.83,-3.0,2.0,1.0,,,,87.6,9.41,3.0,-5.0,4.0,2.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.0,-0.3,,0.056,62.2,32.2,5.6,-17.1,,,,,,54.8,56.6,10658.4,1714.2,135.8,101.8,33.9,0.0,0.0,0.0,,8231.4,1951.8,288.5,186.7,67.9,17.0,17.0,17.0,,,,,,,,91.9,5.21,2.92,-3.0,2.0,1.0,,,,84.9,9.37,5.72,-8.0,4.0,4.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.3,,0.0586,59.8,35.1,5.1,-19.5,,,,,,56.0,54.6,22963.6,1425.7,135.8,33.9,17.0,0.0,0.0,0.0,,28615.7,2783.5,322.5,169.7,33.9,17.0,0.0,0.0,,,,,,,,92.1,4.84,3.11,-2.0,2.0,1.0,,,,85.4,8.03,6.54,-7.0,2.0,5.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B05,1.0,,NB-munselle-5020702-0007,6.2,Acetate,0,0,0.0,0.0,0,,,,96.0,-4.0,,,100.0,0.0,,0.0604,58.5,35.8,5.7,-20.8,,,,,,56.6,49.6,77672.0,2376.3,220.7,50.9,17.0,0.0,0.0,0.0,,137357.5,4854.7,882.7,271.6,50.9,33.9,0.0,0.0,,,,,,,,91.8,4.68,3.53,-3.0,2.0,1.0,,,,86.8,8.13,5.12,-6.0,3.0,4.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B06,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0.0,0.0,0,,,,97.0,-3.0,,,99.7,0.0,,0.0706,60.3,35.5,4.2,-19.0,,,,,,54.6,48.6,290078.2,3501.9,442.0,272.0,102.0,51.0,51.0,34.0,,4557712.9,41364.3,5170.5,2006.5,565.9,385.9,102.9,25.7,,,,,,,,91.3,5.45,3.29,-3.0,2.0,1.0,,,,79.9,8.13,11.95,-13.0,3.0,10.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B07,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0.0,0.0,0,,,,93.0,-7.0,,,99.8,0.1,,0.063,56.6,38.0,5.4,-22.7,,,,,,57.8,52.8,330599.4,3785.9,696.1,288.6,169.8,152.8,50.9,50.9,,1114791.7,26321.9,4907.8,2547.3,1001.9,713.2,50.9,17.0,,,,,,,,91.5,4.76,3.79,-3.0,2.0,1.0,,,,86.0,7.44,6.61,-7.0,2.0,5.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B08,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.4,-0.3,,0.0568,65.0,29.4,5.6,-14.3,,,,,,54.8,52.8,12983.6,3055.0,492.2,152.7,33.9,33.9,0.0,0.0,,14222.5,4158.1,678.9,356.4,84.9,67.9,0.0,0.0,,,,,,,,91.9,5.32,2.79,-3.0,2.0,0.0,,,,85.2,8.61,6.2,-8.0,3.0,5.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B09,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.4,-0.3,,0.0581,62.9,31.9,5.2,-16.4,,,,,,54.6,56.6,19518.1,2800.4,390.4,118.8,17.0,17.0,0.0,0.0,,21028.3,5159.5,865.6,373.4,152.7,33.9,0.0,0.0,,,,,,,,92.5,4.92,2.63,-2.0,2.0,0.0,,,,84.2,8.19,7.61,-9.0,3.0,6.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B10,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.6,-0.1,,0.0604,61.2,33.8,5.0,-18.1,,,,,,56.0,54.8,149515.5,2716.0,458.3,152.8,50.9,17.0,0.0,0.0,,109093.4,3870.1,645.0,288.6,50.9,33.9,17.0,17.0,,,,,,,,92.2,4.73,3.08,-2.0,2.0,1.0,,,,87.2,8.18,4.62,-6.0,3.0,3.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,B11,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,0,0.0,0.0,0,,,,97.0,-3.0,,,99.7,0.0,,0.0604,56.0,39.1,4.9,-23.3,,,,,,58.2,50.2,631835.1,1647.0,135.8,50.9,34.0,0.0,0.0,0.0,,747407.9,10969.1,1833.8,696.2,220.7,169.8,17.0,17.0,,,,,,,,92.0,4.75,3.21,-2.0,2.0,1.0,,,,88.0,8.06,3.91,-5.0,2.0,2.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,50,0.0,0.0,0,,,,97.0,-3.0,,,98.9,-0.8,,0.061,14.4,83.7,1.9,-64.9,,,,,,48.0,46.0,20332.5,1799.0,203.7,84.9,33.9,0.0,0.0,0.0,,54347.0,6398.8,1561.5,848.6,288.5,101.8,0.0,0.0,,,,,,,,81.3,13.62,5.13,-13.0,10.0,3.0,,,,42.1,5.77,52.17,-51.0,0.0,51.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,50,0.0,0.0,0,,,,98.0,-2.0,,,99.5,-0.3,,0.0602,45.1,50.3,4.6,-34.2,,,,,,50.0,44.2,42855.1,1816.0,203.7,33.9,17.0,17.0,0.0,0.0,,195031.1,5992.3,662.0,288.6,17.0,0.0,0.0,0.0,,,,,,,,89.1,7.55,3.33,-5.0,4.0,1.0,,,,72.2,6.74,21.08,-21.0,1.0,20.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.1,,0.0636,55.5,39.5,5.0,-23.8,,,,,,53.0,43.6,96646.9,3649.3,475.3,237.6,135.8,67.9,0.0,0.0,,992805.7,12277.6,1613.2,594.4,50.9,0.0,0.0,0.0,,,,,,,,91.1,5.41,3.48,-3.0,2.0,1.0,,,,79.6,5.76,14.67,-13.0,0.0,13.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C05,1.0,,NB-munselle-5020702-0007,6.2,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.8,0.1,,0.0637,54.8,39.5,5.7,-24.5,,,,,,54.2,46.0,191667.1,3617.0,1256.6,984.9,611.3,407.5,135.8,17.0,,1281924.0,25728.8,3787.1,1188.8,186.8,101.9,0.0,0.0,,,,,,,,91.5,4.93,3.57,-3.0,2.0,1.0,,,,79.9,5.78,14.36,-13.0,0.0,13.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C06,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,50,0.0,0.0,0,,,,91.0,-9.0,,,99.7,0.0,,0.0684,53.9,41.6,4.5,-25.4,,,,,,53.6,46.0,158386.0,10281.5,4622.4,3619.8,2566.1,2073.3,407.9,203.9,,3320574.5,50459.2,11259.5,4567.3,814.2,516.3,39.7,19.9,,,,,,,,90.5,5.8,3.69,-4.0,3.0,1.0,,,,76.0,5.7,18.29,-17.0,0.0,17.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C07,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,50,0.0,0.0,0,,,,90.0,-10.0,,,100.0,0.3,,0.0637,53.0,39.4,7.6,-26.3,,,,,,56.4,49.2,208019.4,17501.1,5845.1,3817.2,2044.9,1533.7,562.4,289.7,,729985.4,21479.1,3565.7,1307.4,356.6,288.7,17.0,0.0,,,,,,,,91.3,5.12,3.57,-3.0,2.0,1.0,,,,85.3,5.38,9.17,-8.0,0.0,8.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C08,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,50,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.7,,0.0612,29.6,67.3,3.1,-49.7,,,,,,48.0,49.4,39528.7,1900.9,271.6,186.7,135.8,118.8,0.0,0.0,,108599.3,5295.9,577.1,220.7,17.0,0.0,0.0,0.0,,,,,,,,86.2,10.79,3.03,-8.0,8.0,1.0,,,,49.9,6.96,43.17,-43.0,1.0,42.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C09,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.3,-0.4,,0.062,56.5,38.6,4.9,-22.8,,,,,,51.0,45.4,85919.0,2308.4,492.2,288.5,186.7,135.8,0.0,0.0,,504030.6,16010.4,3191.9,1426.2,322.6,169.8,0.0,0.0,,,,,,,,91.1,5.96,2.99,-3.0,3.0,1.0,,,,78.8,5.84,15.39,-14.0,0.0,14.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C10,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.7,0.0,,0.0641,57.5,37.4,5.1,-21.8,,,,,,54.0,45.4,248444.9,3327.3,1086.5,730.0,305.6,101.9,17.0,0.0,,1251707.8,14809.1,3243.7,1715.3,475.5,169.8,0.0,0.0,,,,,,,,92.1,5.08,2.85,-2.0,2.0,1.0,,,,80.7,5.48,13.79,-12.0,0.0,12.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,C11,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.7,0.0,,0.0624,57.3,37.5,5.2,-22.0,,,,,,55.4,49.6,407812.4,6912.6,2632.6,2004.2,1070.0,747.3,322.7,203.8,,986449.5,54473.5,10561.9,4448.9,832.0,322.6,34.0,0.0,,,,,,,,92.5,4.67,2.84,-2.0,2.0,1.0,,,,88.0,5.81,6.19,-5.0,0.0,5.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,150,0.0,0.0,0,,,,97.0,-3.0,,,98.7,-1.0,,0.0623,,,,,,,,,,42.8,40.4,62747.1,4616.5,1748.2,1256.0,848.6,594.0,0.0,0.0,,911993.2,94800.8,28645.7,15791.6,3973.4,1103.7,0.0,0.0,,,,,,,,79.2,16.27,4.55,-15.0,13.0,2.0,,,,4.5,2.48,92.98,-88.0,-3.0,91.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,150,0.0,0.0,0,,,,97.0,-3.0,,,99.2,-0.5,,0.0694,,,,,,,,,,45.8,47.0,109320.6,13917.9,7375.3,6559.6,4843.2,3806.6,475.8,85.0,,2751439.2,73198.4,18478.3,10157.9,2109.9,1003.9,119.1,85.1,,,,,,,,82.5,12.6,4.9,-12.0,9.0,3.0,,,,9.5,2.69,87.81,-83.0,-3.0,86.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,150,0.0,0.0,0,,,,98.0,-2.0,,,100.0,0.3,,0.0664,,,,,,,,,,51.0,45.4,118628.6,12424.7,6857.3,6110.5,4820.5,3937.9,254.6,84.9,,2456025.0,49813.8,11832.9,7412.6,4403.3,3502.3,170.0,51.0,,,,,,,,90.4,6.47,3.14,-4.0,3.0,1.0,,,,71.7,4.29,23.99,-21.0,-1.0,22.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D05,1.0,,NB-munselle-5020702-0007,6.2,Acetate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.3,,0.066,,,,,,,,,,53.8,47.6,154048.0,27195.0,14271.0,11849.8,8797.9,7024.7,613.8,153.5,,2132237.1,51046.4,13972.7,8567.2,5490.5,4470.6,238.0,102.0,,,,,,,,91.3,5.38,3.3,-3.0,2.0,1.0,,,,79.0,4.4,16.61,-14.0,-1.0,15.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D06,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,150,0.0,0.0,0,,,,80.0,-20.0,,,100.0,0.3,,0.0669,,,,,,,,,,51.4,52.0,111726.6,9849.2,5426.4,4831.1,3929.5,3334.1,442.3,187.1,,2907557.0,51397.9,12787.5,8324.3,5490.5,4516.4,194.8,124.0,,,,,,,,90.1,6.76,3.13,-4.0,4.0,1.0,,,,68.6,4.27,27.1,-24.0,-1.0,26.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D07,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.3,,0.0617,,,,,,,,,,55.0,49.0,118386.7,8809.0,1697.3,1035.4,543.1,407.4,50.9,33.9,,786741.3,39533.5,10019.5,6617.3,4048.6,3249.1,340.2,102.1,,,,,,,,91.9,4.94,3.15,-3.0,2.0,1.0,,,,83.2,4.12,12.7,-10.0,-2.0,11.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D08,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,150,0.0,0.0,0,,,,98.0,-2.0,,,97.0,-2.8,,0.0671,,,,,,,,,,45.2,44.2,99613.7,5295.5,1867.0,1425.7,984.4,814.7,101.8,50.9,,2158469.7,173778.9,37470.1,17359.2,3159.3,1053.1,51.0,17.0,,,,,,,,80.7,14.2,5.07,-14.0,11.0,3.0,,,,6.0,1.32,92.72,-87.0,-4.0,91.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D09,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,150,0.0,0.0,0,,,,98.0,-2.0,,,99.6,-0.1,,0.0677,,,,,,,,,,49.4,42.4,142817.6,10577.8,4829.7,4217.5,3656.3,3027.1,561.2,255.1,,2685153.5,65538.8,16919.8,11585.7,7083.9,5266.2,118.9,84.9,,,,,,,,89.0,8.05,3.0,-6.0,5.0,1.0,,,,55.2,4.27,40.5,-38.0,-1.0,39.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D10,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,150,0.0,0.0,0,,,,98.0,-2.0,,,100.0,0.3,,0.0666,,,,,,,,,,53.6,48.2,141561.3,14305.6,5216.0,4162.6,2990.3,2599.5,322.8,169.9,,1541421.7,39894.2,10139.1,6504.7,4636.5,3838.3,441.6,135.9,,,,,,,,92.2,4.85,2.93,-2.0,2.0,1.0,,,,80.5,4.18,15.34,-12.0,-1.0,14.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,40.0,12.0,D11,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,150,0.0,0.0,0,,,,98.0,-2.0,,,100.0,0.3,,0.0603,,,,,,,,,,55.0,47.0,107171.2,5805.0,1459.7,797.8,492.2,322.5,50.9,17.0,,300250.9,26659.1,5929.9,3279.3,1750.1,1138.4,186.9,85.0,,,,,,,,92.4,4.85,2.76,-2.0,2.0,0.0,,,,90.0,4.87,5.12,-3.0,-1.0,4.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,21BMT,Fusion Protein,Single Control,,5.0,0.0,H02,1.0,,NB-munselle-5020702-0007,5.2,Acetate,0,0,0.0,0.0,0,,,,100.0,,,,99.7,,,0.0527,79.3,16.7,4.0,0.0,,,,,,57.4,56.6,40410.5,20824.7,509.2,135.8,17.0,17.0,0.0,0.0,,31483.1,8638.7,1289.9,543.1,33.9,33.9,17.0,0.0,,,,,,,,94.5,3.17,2.31,0.0,0.0,0.0,,,,92.9,5.63,1.5,0.0,-6.33,0.0,,,,DNB000708_002,DNB000708,-,Fc-IL2 T3A D20N E68S Q74P C125S (-K),8.17,82277.83632,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,1.0,,,99.2,-0.5,,0.0532,54.4,38.3,7.3,-29.9,,,,,,54.2,51.6,28479.1,2749.5,526.1,373.4,50.9,0.0,0.0,0.0,,12168.9,3207.7,678.9,424.3,101.8,33.9,0.0,0.0,,,,,,,,90.3,6.24,3.42,-4.0,3.0,1.0,,,,86.9,6.71,6.44,-6.0,0.0,5.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,1.0,,,99.3,-0.5,,0.0555,54.2,39.8,6.0,-30.1,,,,,,54.2,49.6,92703.8,6093.1,526.1,203.7,101.8,67.9,0.0,0.0,,41157.4,7315.0,1714.2,916.5,203.7,101.8,0.0,0.0,,,,,,,,90.9,5.57,3.55,-4.0,3.0,1.0,,,,85.6,6.45,8.0,-7.0,0.0,7.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0.0,0.0,0,,,,97.0,-2.0,,,99.4,-0.3,,0.0566,54.5,40.0,5.5,-29.8,,,,,,54.4,51.4,104703.1,8112.8,746.8,356.4,152.8,33.9,0.0,0.0,,51714.4,8112.7,1476.6,678.9,84.9,0.0,0.0,0.0,,,,,,,,91.0,5.24,3.75,-4.0,2.0,1.0,,,,83.5,5.88,10.65,-9.0,0.0,9.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E05,1.0,,NB-munselle-5020702-0007,6.2,Acetate,0,0,0.0,0.0,0,,,,97.0,-2.0,,,100.0,0.3,,0.058,52.3,42.1,5.6,-32.0,,,,,,54.2,49.4,129317.8,8707.2,577.1,288.5,84.9,50.9,17.0,0.0,,80026.1,9776.3,2206.4,950.5,84.9,0.0,0.0,0.0,,,,,,,,91.2,4.91,3.91,-3.0,2.0,1.0,,,,78.5,5.89,15.56,-14.0,0.0,14.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E06,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0.0,0.0,0,,,,97.0,-2.0,,,99.3,-0.4,,0.0714,40.8,55.1,4.1,-43.5,,,,,,50.8,45.6,343996.5,30101.8,5730.4,3752.1,2438.8,2097.7,869.8,579.9,,4539343.5,120262.7,10729.6,3152.8,432.2,152.6,0.0,0.0,,,,,,,,90.1,6.57,3.31,-4.0,4.0,1.0,,,,62.2,5.63,32.17,-30.0,-1.0,31.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E07,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0.0,0.0,0,,,,96.0,-3.0,,,99.8,0.1,,0.0653,47.9,47.7,4.4,-36.4,,,,,,54.4,49.4,369594.0,33964.2,5388.7,3144.8,1716.9,1410.9,442.0,272.0,,2508716.8,68800.6,7374.5,1920.1,373.8,271.9,135.9,51.0,,,,,,,,90.4,5.49,4.1,-4.0,3.0,2.0,,,,71.6,5.53,22.88,-21.0,-1.0,22.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E08,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,1.0,,,99.2,-0.5,,0.0554,64.9,28.7,6.4,-19.4,,,,,,52.0,50.2,112578.7,7162.4,848.6,356.4,101.8,33.9,0.0,0.0,,34521.3,5566.9,1069.2,526.1,67.9,17.0,0.0,0.0,,,,,,,,91.4,5.66,2.96,-3.0,3.0,0.0,,,,86.3,6.89,6.78,-6.0,1.0,6.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E09,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,1.0,,,99.3,-0.4,,0.0564,63.0,31.1,5.9,-21.3,,,,,,54.6,53.4,117705.8,9267.1,882.6,322.5,118.8,33.9,0.0,0.0,,38441.7,6296.6,1306.8,560.1,135.8,17.0,0.0,0.0,,,,,,,,92.1,4.95,2.95,-3.0,2.0,0.0,,,,85.1,6.55,8.35,-7.0,0.0,7.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E10,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,1.0,,,99.7,0.0,,0.0584,55.8,39.3,4.9,-28.5,,,,,,54.2,55.8,181953.3,13748.3,1595.5,899.6,492.2,203.7,33.9,0.0,,73490.9,10760.6,2053.7,1086.2,407.3,186.7,17.0,0.0,,,,,,,,92.2,4.42,3.41,-2.0,2.0,1.0,,,,79.9,6.38,13.73,-13.0,0.0,12.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,E11,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,0,0.0,0.0,0,,,,98.0,-1.0,,,99.7,0.0,,0.0586,50.2,45.4,4.4,-34.1,,,,,,54.4,50.6,315913.5,10813.4,1035.5,560.2,203.7,101.9,0.0,0.0,,454341.5,33920.3,6926.7,3429.4,764.0,356.5,34.0,0.0,,,,,,,,91.9,4.7,3.37,-3.0,2.0,1.0,,,,80.2,4.01,15.82,-12.0,-2.0,15.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,50,0.0,0.0,0,,,,94.0,-5.0,,,98.0,-1.7,,0.0559,9.3,88.9,1.8,-75.0,,,,,,45.6,43.4,78787.0,2800.5,441.3,254.6,84.9,33.9,17.0,17.0,,65428.8,10998.2,1867.0,611.0,237.6,84.9,17.0,0.0,,,,,,,,74.5,20.34,5.16,-20.0,18.0,3.0,,,,19.5,3.32,77.23,-73.0,-3.0,76.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,50,0.0,0.0,0,,,,96.0,-3.0,,,98.9,-0.8,,0.0582,32.1,65.8,2.1,-52.2,,,,,,48.8,50.0,155355.6,8452.6,1459.7,831.7,390.4,288.5,17.0,0.0,,347115.4,40773.2,5805.3,1816.3,67.9,17.0,0.0,0.0,,,,,,,,82.8,12.35,4.9,-12.0,10.0,2.0,,,,53.8,5.04,41.19,-39.0,-1.0,40.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,50,0.0,0.0,0,,,,98.0,-2.0,,,99.3,-0.4,,0.0606,53.5,43.2,3.3,-30.8,,,,,,51.0,45.8,216908.8,15334.6,4432.3,2649.2,1154.8,679.3,169.8,50.9,,694463.7,88386.9,17962.6,7266.5,696.1,186.8,0.0,0.0,,,,,,,,90.0,6.84,3.17,-5.0,4.0,1.0,,,,76.8,4.91,18.32,-16.0,-1.0,17.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F05,1.0,,NB-munselle-5020702-0007,6.2,Acetate,0,50,0.0,0.0,0,,,,98.0,-1.0,,,99.7,0.0,,0.0608,51.9,46.0,2.1,-32.4,,,,,,51.8,45.2,211687.8,14742.0,5027.6,3544.9,2113.3,1448.6,460.2,153.4,,954814.3,55032.9,8880.7,3124.4,271.7,101.9,0.0,0.0,,,,,,,,91.8,5.1,3.08,-3.0,2.0,1.0,,,,77.6,3.23,19.19,-15.0,-3.0,18.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F06,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,50,0.0,0.0,0,,,,97.0,-2.0,,,99.2,-0.5,,0.0663,45.2,52.0,2.8,-39.1,,,,,,50.8,50.2,317552.8,33331.4,9279.6,6260.3,2644.0,1654.6,494.7,375.3,,2697652.6,118178.5,14082.2,3924.0,407.7,220.8,17.0,0.0,,,,,,,,88.7,7.85,3.48,-6.0,5.0,1.0,,,,62.3,4.6,33.13,-30.0,-2.0,32.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F07,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,50,0.0,0.0,0,,,,98.0,-1.0,,,100.0,0.3,,0.0635,48.8,47.1,4.1,-35.5,,,,,,54.0,48.4,344400.1,49599.6,15180.1,9551.5,4605.2,3121.3,716.4,443.5,,1690621.2,85462.6,13366.3,5112.1,900.1,628.4,118.9,34.0,,,,,,,,91.0,5.03,4.0,-4.0,2.0,1.0,,,,74.3,4.08,21.63,-18.0,-2.0,20.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F08,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,50,0.0,0.0,0,,,,96.0,-3.0,,,98.3,-1.4,,0.0593,18.6,78.2,3.2,-65.7,,,,,,46.2,39.8,186337.0,15062.5,2971.7,1952.9,815.1,492.5,84.9,0.0,,318457.4,36393.2,4549.1,1442.8,67.9,50.9,0.0,0.0,,,,,,,,78.1,17.36,4.52,-16.0,15.0,2.0,,,,31.4,2.78,65.83,-61.0,-4.0,65.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F09,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,50,0.0,0.0,0,,,,98.0,-2.0,,,99.0,-0.7,,0.06,59.6,35.4,5.0,-24.7,,,,,,49.6,54.0,193373.0,13026.3,3413.7,2089.0,1137.9,781.2,220.8,101.9,,548202.1,69722.1,12070.2,5126.9,458.4,220.7,34.0,0.0,,,,,,,,86.1,8.52,5.36,-8.0,6.0,3.0,,,,72.1,5.53,22.33,-20.0,-1.0,21.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F10,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,50,0.0,0.0,0,,,,96.0,-4.0,,,99.4,-0.3,,0.062,55.2,39.9,4.9,-29.1,,,,,,51.8,45.0,226353.9,19361.4,5150.6,3348.7,1546.9,917.9,374.0,221.0,,926110.1,56238.0,10188.0,4856.3,815.0,390.5,17.0,0.0,,,,,,,,91.6,4.94,3.46,-3.0,2.0,1.0,,,,76.2,5.1,18.74,-16.0,-1.0,17.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,F11,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.3,,0.0623,47.7,46.9,5.4,-36.6,,,,,,53.4,49.2,247743.5,9357.5,2751.2,1749.2,849.1,560.4,152.8,67.9,,1741782.7,50529.5,6861.8,2547.7,339.7,169.8,17.0,0.0,,,,,,,,92.3,4.06,3.68,-2.0,1.0,1.0,,,,73.6,3.56,22.83,-19.0,-3.0,22.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,150,0.0,0.0,0,,,,95.0,-4.0,,,98.0,-1.7,,0.0591,,,,,,,,,,40.6,39.2,139552.6,4367.9,1444.6,1002.8,509.9,322.9,68.0,34.0,,512246.5,40286.4,6366.4,2512.6,679.1,339.5,17.0,0.0,,,,,,,,73.2,20.21,6.55,-21.0,17.0,4.0,,,,4.5,1.46,94.03,-88.0,-5.0,93.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,150,0.0,0.0,0,,,,96.0,-3.0,,,98.6,-1.1,,0.0633,,,,,,,,,,45.2,48.8,234137.1,11852.0,3209.2,1901.8,764.1,492.4,118.9,50.9,,1837575.7,128130.3,17901.6,6556.0,1121.0,628.4,0.0,0.0,,,,,,,,76.2,17.41,6.44,-18.0,15.0,4.0,,,,7.6,1.49,91.14,-85.0,-5.0,90.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,150,0.0,0.0,0,,,,98.0,-1.0,,,99.5,-0.2,,0.0639,,,,,,,,,,49.6,50.8,297850.3,36042.3,9494.7,5146.5,1851.4,1104.0,271.8,101.9,,1979338.3,158071.9,24525.2,9052.6,1885.2,968.1,0.0,0.0,,,,,,,,85.0,9.5,5.53,-10.0,7.0,3.0,,,,56.4,2.68,40.89,-36.0,-4.0,40.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G05,1.0,,NB-munselle-5020702-0007,6.2,Acetate,0,150,0.0,0.0,0,,,,99.0,0.0,,,100.0,0.3,,0.0619,,,,,,,,,,51.0,52.6,172265.8,4299.0,645.7,407.8,305.9,237.9,102.0,68.0,,1503229.2,123328.8,19343.4,6674.2,815.2,577.4,34.0,0.0,,,,,,,,90.6,5.97,3.46,-4.0,3.0,1.0,,,,78.8,2.78,18.46,-14.0,-4.0,17.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G06,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,99.1,-0.6,,0.0655,,,,,,,,,,50.0,45.4,278588.0,23333.2,6135.0,4078.6,2022.3,1325.6,373.9,220.9,,2802579.8,168707.5,22727.6,7100.3,373.7,152.9,0.0,0.0,,,,,,,,84.2,10.01,5.77,-10.0,7.0,3.0,,,,48.3,2.82,48.88,-44.0,-4.0,48.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G07,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,150,0.0,0.0,0,,,,100.0,1.0,,,100.0,0.3,,0.0602,,,,,,,,,,53.0,48.4,316938.1,50812.8,15463.3,10189.8,4388.9,2721.8,578.4,221.1,,1159070.5,108709.0,18865.3,7980.8,2343.3,1664.1,0.0,0.0,,,,,,,,91.4,5.0,3.6,-3.0,2.0,1.0,,,,81.1,2.94,15.97,-11.0,-3.0,15.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G08,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,150,0.0,0.0,0,,,,97.0,-3.0,,,98.2,-1.5,,0.0637,,,,,,,,,,44.2,42.8,314256.7,46279.3,16418.9,10378.8,3556.0,1922.6,476.4,170.1,,1510100.0,126894.6,20345.3,7676.2,1511.5,815.2,0.0,0.0,,,,,,,,74.7,19.07,6.25,-20.0,16.0,4.0,,,,6.1,1.41,92.51,-86.0,-5.0,91.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G09,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,150,0.0,0.0,0,,,,98.0,-2.0,,,98.9,-0.9,,0.0665,,,,,,,,,,48.2,41.0,329321.4,38417.1,11068.8,6760.5,3627.2,2264.8,834.4,476.8,,2489197.8,176066.0,26584.0,9444.5,1274.0,611.5,101.9,17.0,,,,,,,,81.5,12.75,5.74,-13.0,10.0,3.0,,,,32.9,2.46,64.65,-60.0,-4.0,63.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G10,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.3,,0.0632,,,,,,,,,,51.4,45.8,285203.1,25689.8,5416.4,3446.8,1528.1,1188.6,322.6,118.9,,1361951.1,119995.8,20038.9,7506.1,1528.4,1188.8,84.9,17.0,,,,,,,,91.3,5.09,3.63,-3.0,2.0,1.0,,,,80.3,3.04,16.63,-12.0,-3.0,15.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,40.0,12.0,G11,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.3,,0.0595,,,,,,,,,,53.6,49.6,211631.4,13731.9,2359.4,1273.0,475.3,288.6,84.9,17.0,,1117470.2,84821.5,14383.1,5892.5,1528.3,1239.6,34.0,0.0,,,,,,,,91.8,4.96,3.25,-3.0,2.0,1.0,,,,78.8,2.96,18.27,-14.0,-3.0,17.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/19/2022,munselle,IL-2Ra,48BMP,Fusion Protein,Single Control,,5.0,0.0,H07,1.0,,NB-munselle-5020702-0007,5.2,Acetate,0,0,0.0,0.0,0,,,,99.0,,,,99.7,,,0.0538,84.3,13.8,1.9,0.0,,,,,,54.6,53.2,165063.0,10862.8,712.9,322.5,67.9,17.0,0.0,0.0,,125140.4,15360.4,2223.4,1018.4,339.5,169.7,17.0,0.0,,,,,,,,94.6,2.83,2.56,0.0,0.0,0.0,,,,92.4,6.33,1.26,0.0,-6.33,0.0,,,,DNB000707_002,DNB000707,-,Fc-IL2 T3A D20N E68S V69A Q74P C125S (-K),8.17,82221.72872,Results Template Bivalents.xlsx,IL-2_H,-,,-,-,0,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DAB015692_013,ADC,MULTIPLE CONTROL,Thermal Stress,40.0,14.0,,9.8,Anti-MMAE_Fab_2w40C,NB-ramapa-5085300-0002,6.0,Histidine,0,0,0.02,9.0,0,,,,99.3,0.2,0.2,47.95,77.3,-1.5,1.5,,8.427,14.037,18.621,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.65,0.0,2.35,-0.2,0.0,0.2,0.2,0.0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DAB015692_013,ADC,MULTIPLE CONTROL,Thermal Stress,5.0,0.0,,9.8,Anti-MMAE_Fab_T0,NB-ramapa-5085300-0002,6.0,Histidine,0,0,0.02,9.0,0,,,,99.1,0.0,0.0,48.02,78.82,0.0,0.0,,8.448,14.063,18.641,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.84,0.0,2.16,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000492_005,ADC,MULTIPLE CONTROL,Thermal Stress,25.0,14.0,,20.3,D64_2w25C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9.0,0,,,,97.2,,,64.9,98.32,,,,8.796,14.449,18.99,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.19,0.22,6.59,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000492_005,ADC,MULTIPLE CONTROL,Thermal Stress,40.0,14.0,,20.3,D64_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9.0,0,,,,96.3,,,62.93,97.47,,,,8.8,14.453,18.989,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84.73,0.67,14.61,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000674_005,ADC,MULTIPLE CONTROL,Thermal Stress,25.0,14.0,,21.1,D63_2w25C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9.0,0,,,,91.6,,,60.38,95.18,,,,8.587,14.149,18.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.59,0.07,3.34,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000674_005,ADC,MULTIPLE CONTROL,Thermal Stress,40.0,14.0,,21.1,D63_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9.0,0,,,,92.8,,,61.52,96.94,,,,8.569,14.156,18.894,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,0.58,3.78,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Thermal Stress,25.0,14.0,,21.6,D62_2w25C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9.0,0,,,,96.8,,,66.42,99.22,,,,8.785,14.419,18.966,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.11,0.95,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,DCC000706_005,ADC,MULTIPLE CONTROL,Thermal Stress,40.0,14.0,,21.6,D62_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.02,9.0,0,,,,96.5,,,65.38,98.75,,,,8.792,14.424,18.984,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.06,0.64,2.31,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Thermal Stress,40.0,14.0,,1.61,Trop2-Trabectedin_2w40C,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.0,9.0,0,,,,57.8,-32.4,32.4,54.85,87.98,-9.5,9.5,,10.1,5.85,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,73.93,0.94,25.13,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/19/2023,ramapa,Surfactant,Trab,ADC,MULTIPLE CONTROL,Thermal Stress,-80.0,0.0,,1.61,Trop2-Trabectedin_T0,NB-ramapa-5085300-0002,6.5,Histidine,0,0,0.0,9.0,0,,,,90.2,0.0,0.0,70.44,97.47,0.0,0.0,,8.869,14.533,19.067,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,77.4,1.09,21.51,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B02,1.03,,NB-ferguhei-5069961-0003,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.04,50.7,33.07,16.23,11.5,,,,,,74.0,72.2,34097.1,8129.7,2698.6,2002.7,1255.9,1001.4,560.1,339.4,,21520.6,2477.9,339.4,169.7,67.9,17.0,0.0,0.0,,,,,,,,91.2,6.06,2.77,-4.7,5.76,-1.1,,,,90.3,9.63,0.1,-3.0,3.0,0.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B03,1.01,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,97.0,-0.369,,0.041,41.9,38.01,20.13,2.7,,,,,,70.0,72.2,22895.4,1917.8,169.7,84.9,67.9,33.9,17.0,0.0,,25967.3,2528.8,169.7,135.8,67.9,0.0,0.0,0.0,,,,,,,,93.4,3.37,3.23,-2.4,3.08,-0.6,,,,91.4,8.41,0.23,-1.9,1.8,0.13,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B04,1.03,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,97.0,-0.439,,0.042,45.0,40.96,14.08,5.8,,,,,,71.4,73.4,21418.9,1850.0,305.5,169.7,33.9,17.0,0.0,0.0,,29701.5,3343.5,271.6,101.8,50.9,0.0,0.0,0.0,,,,,,,,94.0,2.52,3.46,-1.8,2.22,-0.4,,,,91.4,8.35,0.28,-1.9,1.7,0.18,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B05,1.04,,NB-ferguhei-5069961-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,97.0,-0.53,,0.043,10.5,48.59,40.94,-28.7,,,,,,68.6,76.6,21809.1,2376.1,577.0,407.3,203.7,67.9,0.0,0.0,,19857.3,2460.9,373.4,254.6,67.9,17.0,0.0,0.0,,,,,,,,95.2,1.8,3.03,-0.7,1.5,-0.8,,,,91.4,8.38,0.19,-1.8,1.7,0.09,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B06,1.03,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,97.2,-0.417,,0.042,9.3,51.1,39.61,-29.9,,,,,,70.6,76.8,22861.4,2240.3,322.5,203.7,152.7,67.9,17.0,0.0,,25085.1,2783.5,441.3,169.7,33.9,0.0,0.0,0.0,,,,,,,,95.4,1.44,3.2,-0.5,1.15,-0.7,,,,91.7,8.18,0.17,-1.6,1.5,0.07,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B07,1.04,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,97.1,-0.559,,0.042,9.3,52.17,38.51,-29.9,,,,,,69.0,70.8,19993.1,1850.0,288.5,152.7,67.9,33.9,0.0,0.0,,26544.4,2732.5,288.5,67.9,17.0,17.0,0.0,0.0,,,,,,,,95.5,1.17,3.31,-0.3,0.88,-0.5,,,,91.7,8.04,0.22,-1.5,1.4,0.12,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B08,1.04,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,96.3,-1.27,,0.044,10.4,50.82,38.76,-28.8,,,,,,64.2,61.2,25033.8,3852.7,1086.2,831.6,509.2,339.4,67.9,33.9,,30668.9,3122.9,84.9,50.9,33.9,0.0,0.0,0.0,,,,,,,,95.6,0.99,3.4,-0.2,0.7,-0.5,,,,91.7,7.93,0.37,-1.5,1.3,0.27,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B09,1.04,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.043,33.4,48.89,17.68,-5.8,,,,,,62.8,64.4,23608.2,2647.6,441.3,186.7,67.9,33.9,0.0,0.0,,27919.3,2189.4,220.6,169.7,67.9,17.0,0.0,0.0,,,,,,,,95.0,1.02,4.03,-0.9,0.73,0.2,,,,92.5,7.18,0.32,-0.7,0.5,0.22,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B10,1.03,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.042,34.0,51.86,14.13,-5.2,,,,,,60.6,,34691.3,7688.4,1391.7,611.0,186.7,101.8,0.0,0.0,,42346.3,6313.8,543.1,220.6,33.9,17.0,0.0,0.0,,,,,,,,95.1,0.95,3.91,-0.7,0.66,0.0,,,,92.6,7.06,0.38,-0.7,0.4,0.28,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,B11,1.02,,NB-ferguhei-5069961-0003,7.4,Phosphate,0,0,0.0,0.0,0,,,,99.8,-0.243,,,96.6,-1.053,,0.043,23.7,65.2,11.09,-15.5,,,,,,62.6,65.4,25033.9,2511.9,373.4,271.6,135.8,101.8,17.0,0.0,,70045.1,8520.1,746.8,424.3,203.7,84.9,0.0,0.0,,,,,,,,91.3,2.55,6.17,-4.6,2.26,2.3,,,,87.6,9.13,3.3,-5.7,2.5,3.2,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C02,1.03,,NB-ferguhei-5069961-0003,4.5,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.041,46.0,43.48,10.5,6.8,,,,,,65.6,63.8,28004.2,4972.9,1408.7,933.5,390.4,152.8,17.0,0.0,,29786.1,5974.2,1374.7,797.7,254.6,84.9,17.0,0.0,,,,,,,,95.1,1.64,3.31,-0.8,1.34,-0.6,,,,86.2,9.08,4.68,-7.0,2.4,4.58,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C03,1.03,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,97.7,0.111,,0.042,46.1,41.8,12.1,6.9,,,,,,64.4,59.2,23896.8,3055.0,763.7,526.1,169.7,50.9,17.0,0.0,,65242.0,12797.2,3479.3,1714.2,543.1,152.8,0.0,0.0,,,,,,,,95.9,0.73,3.4,0.0,0.44,-0.5,,,,91.5,8.24,0.31,-1.8,1.6,0.21,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C04,1.02,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,97.9,0.292,,0.043,47.6,48.84,3.61,8.4,,,,,,61.0,62.0,25033.8,3241.7,967.4,644.9,356.4,203.7,67.9,33.9,,33231.6,5736.6,1001.4,509.2,237.6,84.9,0.0,0.0,,,,,,,,95.7,0.7,3.6,-0.1,0.41,-0.3,,,,90.9,8.83,0.27,-2.3,2.2,0.17,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C05,1.03,,NB-ferguhei-5069961-0003,5.0,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,98.0,0.354,,0.044,0.0,65.24,34.76,-39.2,,,,,,55.0,60.6,22776.6,3088.9,729.8,356.4,169.7,101.8,17.0,0.0,,54718.6,10777.4,2393.1,1103.2,322.5,118.8,17.0,17.0,,,,,,,,95.4,1.27,3.32,-0.4,0.98,-0.5,,,,89.4,8.83,1.82,-3.9,2.2,1.72,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C06,1.03,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,98.1,0.435,,0.043,0.0,66.19,33.81,-39.2,,,,,,58.4,59.6,27206.3,3309.6,814.7,560.1,220.6,67.9,17.0,17.0,,62068.4,9759.2,1782.1,780.7,135.8,33.9,0.0,0.0,,,,,,,,96.3,0.54,3.19,0.4,0.25,-0.7,,,,91.3,8.37,0.38,-2.0,1.7,0.28,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C07,1.02,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,97.3,-0.281,,0.044,0.0,65.13,34.87,-39.2,,,,,,56.8,27.2,22980.2,2511.9,695.9,441.3,237.6,169.7,67.9,33.9,,49542.0,10539.8,1917.9,865.6,169.7,50.9,0.0,0.0,,,,,,,,96.0,0.6,3.37,0.2,0.3,-0.5,,,,91.1,8.69,0.24,-2.2,2.0,0.14,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C08,1.03,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,97.4,-0.193,,0.046,0.0,64.92,35.08,-39.2,,,,,,54.6,56.6,23845.7,2800.4,661.9,475.2,237.6,169.7,50.9,17.0,,58537.7,8282.5,1612.4,814.7,152.8,101.8,17.0,0.0,,,,,,,,96.1,0.65,3.28,0.2,0.36,-0.6,,,,91.4,8.34,0.24,-1.8,1.7,0.14,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C09,1.03,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0.0,0.0,0,,,,99.9,-0.063,,,97.6,-0.059,,0.043,41.1,9.25,49.65,1.9,,,,,,61.4,57.6,26374.7,3632.0,678.9,441.3,220.6,135.8,33.9,17.0,,41191.6,6738.0,1374.8,678.9,152.8,101.8,33.9,17.0,,,,,,,,94.2,1.53,4.28,-1.6,1.23,0.4,,,,92.9,6.81,0.27,-0.3,0.1,0.17,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C10,1.04,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0.0,0.0,0,,,,100.0,0.0,,,97.7,0.123,,0.043,39.8,53.46,6.73,0.6,,,,,,62.0,55.8,28139.6,4701.3,1171.1,712.8,220.6,118.8,17.0,0.0,,32043.3,4786.1,661.9,356.4,135.8,67.9,33.9,0.0,,,,,,,,94.6,1.51,3.94,-1.3,1.21,0.1,,,,92.4,7.28,0.31,-0.8,0.6,0.21,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,C11,1.02,,NB-ferguhei-5069961-0003,7.4,Phosphate,0,50,0.0,0.0,0,,,,99.9,-0.098,,,97.5,-0.114,,0.043,26.5,65.13,8.35,-12.7,,,,,,54.8,47.8,27019.6,3835.7,712.8,424.3,101.8,67.9,33.9,0.0,,94096.3,16819.9,2562.9,1239.0,237.6,67.9,0.0,0.0,,,,,,,,92.4,2.22,5.43,-3.5,1.92,1.6,,,,89.0,9.07,1.89,-4.2,2.4,1.79,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D02,1.05,,NB-ferguhei-5069961-0003,4.5,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,98.2,0.621,,0.04,,,,,,,,,,52.2,59.4,29904.9,3649.0,356.4,220.6,67.9,67.9,17.0,17.0,,106912.2,13374.6,2817.5,1544.5,526.2,135.8,0.0,0.0,,,,,,,,94.9,1.27,3.79,-0.9,0.98,-0.1,,,,44.8,7.76,47.46,-48.5,1.1,47.36,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D03,1.05,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,98.2,0.571,,0.045,,,,,,,,,,61.6,57.8,36252.7,5465.1,492.2,339.4,152.7,84.9,0.0,0.0,,85425.0,16769.3,3038.2,1595.5,441.3,186.7,17.0,0.0,,,,,,,,96.1,0.43,3.49,0.2,0.14,-0.4,,,,91.1,8.53,0.42,-2.2,1.9,0.32,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D04,1.02,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,98.2,0.618,,0.043,,,,,,,,,,61.4,53.6,24881.1,3088.9,831.6,543.1,254.6,135.8,33.9,0.0,,66856.4,14376.1,1985.8,1069.3,271.6,220.6,50.9,0.0,,,,,,,,95.8,0.61,3.57,0.0,0.32,-0.3,,,,91.2,8.52,0.25,-2.0,1.9,0.15,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D05,1.03,,NB-ferguhei-5069961-0003,5.0,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.044,,,,,,,,,,61.2,55.2,24728.5,3122.9,695.9,407.3,152.7,101.8,50.9,0.0,,69909.7,13326.7,2614.4,1137.4,169.8,34.0,0.0,0.0,,,,,,,,95.7,1.09,3.22,-0.2,0.8,-0.6,,,,83.1,8.75,8.13,-10.1,2.1,8.03,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D06,1.02,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.044,,,,,,,,,,60.2,58.4,25407.2,2851.3,424.3,271.6,152.7,84.9,0.0,0.0,,51952.1,9521.4,1816.0,899.5,288.5,101.8,17.0,0.0,,,,,,,,96.3,0.43,3.28,0.4,0.14,-0.6,,,,91.5,8.06,0.49,-1.8,1.4,0.39,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D07,1.03,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.042,,,,,,,,,,57.4,55.0,22029.8,2308.2,407.3,288.5,169.7,101.8,0.0,0.0,,56789.4,9810.0,1917.9,1137.1,288.5,101.8,50.9,33.9,,,,,,,,96.3,0.49,3.25,0.4,0.19,-0.6,,,,91.8,8.03,0.2,-1.5,1.4,0.1,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D08,1.03,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.042,,,,,,,,,,46.2,48.8,25373.3,2970.1,611.0,356.4,118.8,33.9,0.0,0.0,,58589.4,12220.3,2274.3,1188.1,407.3,271.6,0.0,0.0,,,,,,,,96.2,0.49,3.34,0.3,0.19,-0.5,,,,91.8,7.98,0.21,-1.4,1.3,0.11,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D09,1.01,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.045,,,,,,,,,,61.4,60.2,24507.8,2613.7,492.2,305.5,118.8,84.9,0.0,0.0,,66278.2,9351.9,1120.2,661.9,169.7,101.8,33.9,17.0,,,,,,,,94.7,1.75,3.58,-1.2,1.46,-0.3,,,,91.4,8.35,0.25,-1.8,1.7,0.15,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D10,1.04,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.383,,0.044,,,,,,,,,,61.2,56.2,34131.1,5566.9,865.6,492.2,118.8,50.9,0.0,0.0,,91007.1,16107.0,526.2,271.6,50.9,0.0,0.0,0.0,,,,,,,,94.9,1.16,3.95,-1.0,0.87,0.1,,,,91.8,7.94,0.24,-1.4,1.3,0.14,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,37.0,14.0,D11,1.02,,NB-ferguhei-5069961-0003,7.4,Phosphate,0,150,0.0,0.0,0,,,,100.0,0.0,,,100.0,2.368,,0.045,,,,,,,,,,51.0,46.8,26527.3,3920.5,424.3,203.7,33.9,33.9,0.0,0.0,,153563.8,26378.1,4365.2,2276.0,611.5,186.8,17.0,0.0,,,,,,,,93.5,1.83,4.69,-2.4,1.53,0.8,,,,90.6,8.53,0.91,-2.7,1.9,0.81,,,,SP10482,SP10482,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E02,0.97,,NB-ferguhei-5069961-0003,4.3,Acetate,0,0,0.0,0.0,0,,,,98.1,23.196,,,62.1,1.724,,0.039,18.8,18.48,62.74,-10.8,,,,,,56.4,49.8,77936.6,35862.4,5651.8,1646.3,322.5,101.8,17.0,0.0,,12847.7,4582.4,1374.7,780.7,271.6,118.8,17.0,17.0,,,,,,,,78.9,15.97,5.1,-16.9,15.68,1.2,,,,90.5,9.26,0.19,-1.97,2.02,-0.06,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E03,0.98,,NB-ferguhei-5069961-0003,4.7,Acetate,0,0,0.0,0.0,0,,,,98.2,23.336,,,61.8,1.42,,0.042,9.5,29.49,61.0,-20.0,,,,,,61.4,60.8,1189351.8,508616.2,188417.9,111814.8,31799.1,7775.8,84.9,0.0,,307798.2,46815.6,2987.5,950.6,237.6,84.9,0.0,0.0,,,,,,,,78.7,15.94,5.33,-17.1,15.65,1.5,,,,90.8,8.97,0.23,-1.71,1.73,-0.02,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E04,0.98,,NB-ferguhei-5069961-0003,4.85,Acetate,0,0,0.0,0.0,0,,,,98.1,23.229,,,62.2,1.818,,0.042,4.5,81.15,14.39,-25.1,,,,,,61.2,62.0,999216.1,304238.4,61424.9,25907.8,5483.8,2037.3,50.9,0.0,,525447.7,99154.8,8657.6,1765.5,101.9,34.0,0.0,0.0,,,,,,,,78.2,16.65,5.18,-17.7,16.36,1.3,,,,90.5,9.26,0.24,-2.01,2.02,-0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E05,0.98,,NB-ferguhei-5069961-0003,3.9,Histidine,0,0,0.0,0.0,0,,,,79.4,4.445,,,59.8,-0.58,,0.043,15.6,33.16,51.24,-13.9,,,,,,62.2,56.2,55397.1,13000.7,1306.9,644.9,203.7,50.9,0.0,0.0,,29803.1,4972.8,186.7,101.8,17.0,0.0,0.0,0.0,,,,,,,,79.4,16.33,4.32,-16.5,16.04,0.5,,,,90.8,9.06,0.13,-1.7,1.82,-0.12,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E06,0.97,,NB-ferguhei-5069961-0003,4.4,Histidine,0,0,0.0,0.0,0,,,,62.2,-12.725,,,59.8,-0.617,,0.041,2.7,28.76,68.58,-26.9,,,,,,55.6,60.4,259135.0,67147.3,13612.8,6534.8,865.7,186.7,0.0,0.0,,10352.9,2987.1,441.3,220.6,33.9,0.0,0.0,0.0,,,,,,,,77.6,18.06,4.33,-18.2,17.77,0.5,,,,91.3,8.48,0.21,-1.2,1.24,-0.04,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E07,0.96,,NB-ferguhei-5069961-0003,4.9,Histidine,0,0,0.0,0.0,0,,,,73.4,-1.491,,,58.9,-1.499,,0.041,1.4,28.68,69.9,-28.1,,,,,,58.4,59.6,1283423.1,520616.0,179300.3,102452.4,25978.2,6842.6,152.8,34.0,,670142.5,110332.3,6722.8,1392.1,203.7,84.9,34.0,0.0,,,,,,,,76.5,19.3,4.21,-19.4,19.01,0.3,,,,91.5,8.3,0.24,-1.06,1.06,-0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E08,0.98,,NB-ferguhei-5069961-0003,5.4,Histidine,0,0,0.0,0.0,0,,,,73.4,-1.464,,,63.3,2.837,,0.043,3.5,22.55,73.97,-26.1,,,,,,57.6,59.0,1483065.7,622797.2,210915.7,120535.4,32651.0,8846.2,186.8,17.0,,1286032.6,281969.7,13110.1,1800.1,237.7,67.9,0.0,0.0,,,,,,,,74.3,21.05,4.61,-21.5,20.76,0.7,,,,91.3,8.5,0.26,-1.26,1.26,0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E09,0.93,,NB-ferguhei-5069961-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,78.4,3.534,,,62.3,1.885,,0.051,25.8,41.86,32.37,-3.8,,,,,,55.2,44.6,510009.8,317364.3,131864.5,65448.5,15394.7,6432.8,220.7,33.9,,79904.5,30821.3,4616.4,1154.1,67.9,50.9,0.0,0.0,,,,,,,,75.7,18.61,5.68,-20.1,18.32,1.8,,,,78.1,21.71,0.2,-14.42,14.47,-0.05,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E10,0.94,,NB-ferguhei-5069961-0003,5.63,Citrate,0,0,0.0,0.0,0,,,,75.4,0.481,,,60.2,-0.223,,0.041,3.1,85.22,11.68,-26.4,,,,,,54.6,45.8,518534.5,332812.6,141167.0,69268.1,15123.2,5991.6,271.6,33.9,,53310.0,19263.6,3275.7,984.4,67.9,0.0,0.0,0.0,,,,,,,,75.9,0.0,24.06,-19.9,-0.29,20.2,,,,77.7,22.06,0.21,-14.78,14.82,-0.04,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,E11,1.07,,NB-ferguhei-5069961-0003,6.0,Phosphate,0,0,0.0,0.0,0,,,,80.8,5.94,,,64.5,4.041,,0.21,28.2,42.34,29.42,-1.3,,,,,,57.6,53.6,1704557.1,876610.0,477765.0,361150.8,160896.3,57475.1,2139.4,526.4,,3458767.8,3198934.5,407340.4,3737.9,1505.5,1107.5,34.6,17.3,,,,,,,,73.0,18.42,8.57,-22.8,18.13,4.7,,,,89.3,10.44,0.29,-3.24,3.2,0.04,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F02,0.99,,NB-ferguhei-5069961-0003,4.3,Acetate,0,50,0.0,0.0,0,,,,80.3,5.438,,,69.9,9.46,,0.04,5.1,76.52,18.42,-24.5,,,,,,57.2,59.0,34928.5,8740.6,1917.8,1188.0,441.3,203.7,17.0,0.0,,3816899.2,688218.4,1015.6,406.3,81.3,40.6,20.3,20.3,,,,,,,,78.1,15.9,6.02,-17.8,15.61,2.2,,,,85.2,14.57,0.23,-7.31,7.33,-0.02,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F03,0.98,,NB-ferguhei-5069961-0003,4.7,Acetate,0,50,0.0,0.0,0,,,,81.8,6.921,,,69.4,9.019,,0.042,6.2,81.37,12.46,-23.4,,,,,,55.2,56.6,1051858.7,305920.5,100649.2,58219.6,12700.0,2360.0,34.0,0.0,,2919489.6,66087.1,2005.2,492.8,51.0,0.0,0.0,0.0,,,,,,,,75.6,19.89,4.56,-20.3,19.6,0.7,,,,89.3,10.59,0.16,-3.26,3.35,-0.09,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F04,1.0,,NB-ferguhei-5069961-0003,4.85,Acetate,0,50,0.0,0.0,0,,,,82.7,7.747,,,69.0,8.579,,0.044,0.0,81.68,18.32,-29.5,,,,,,47.2,54.2,1254079.7,410097.0,136517.9,80484.4,17743.9,3599.7,50.9,0.0,,690470.3,43124.7,1969.5,458.4,67.9,34.0,0.0,0.0,,,,,,,,75.2,20.14,4.66,-20.6,19.85,0.8,,,,89.6,10.22,0.17,-2.9,2.98,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F05,0.98,,NB-ferguhei-5069961-0003,3.9,Histidine,0,50,0.0,0.0,0,,,,80.8,5.909,,,69.8,9.374,,0.043,0.0,42.37,57.63,-29.5,,,,,,48.8,56.6,31228.5,8316.3,2019.7,1188.0,373.4,152.7,0.0,0.0,,1017046.6,7370.5,1069.9,492.5,101.9,67.9,0.0,0.0,,,,,,,,81.8,14.03,4.16,-14.0,13.74,0.3,,,,79.5,20.26,0.24,-13.01,13.02,-0.01,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F06,0.98,,NB-ferguhei-5069961-0003,4.4,Histidine,0,50,0.0,0.0,0,,,,82.1,7.188,,,69.9,9.459,,0.043,0.0,43.7,56.3,-29.5,,,,,,49.2,42.6,47216.3,10386.9,2002.7,967.4,322.5,135.8,17.0,0.0,,710208.3,7624.6,984.9,492.5,118.9,50.9,17.0,0.0,,,,,,,,77.4,18.65,3.95,-18.4,18.36,0.1,,,,86.7,13.08,0.19,-5.78,5.84,-0.06,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F07,1.0,,NB-ferguhei-5069961-0003,4.9,Histidine,0,50,0.0,0.0,0,,,,82.1,7.175,,,69.1,8.646,,0.044,0.0,81.69,18.31,-29.5,,,,,,48.8,,1234955.7,370444.2,115320.3,67524.8,15722.4,4125.9,34.0,17.0,,1110585.8,91545.5,4601.9,934.0,84.9,50.9,0.0,0.0,,,,,,,,74.5,21.43,4.05,-21.3,21.14,0.2,,,,90.2,9.64,0.16,-2.3,2.4,-0.09,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F08,0.98,,NB-ferguhei-5069961-0003,5.4,Histidine,0,50,0.0,0.0,0,,,,73.0,-1.948,,,66.1,5.637,,0.047,0.0,44.97,55.03,-29.5,,,,,,45.6,39.2,1432110.5,496281.1,150483.9,89336.0,26184.4,7403.6,203.8,34.0,,1979828.5,330497.9,15454.9,3158.9,135.9,34.0,17.0,0.0,,,,,,,,73.9,21.9,4.18,-21.9,21.61,0.3,,,,91.0,8.79,0.19,-1.5,1.55,-0.06,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F09,0.96,,NB-ferguhei-5069961-0003,5.5,Citrate,0,50,0.0,0.0,0,,,,85.7,10.833,,,69.0,8.571,,0.055,1.8,85.94,12.24,-27.7,,,,,,48.6,40.4,669631.5,385338.1,146941.8,67012.4,13069.8,4175.5,50.9,0.0,,1121495.0,135610.5,5009.4,832.1,50.9,17.0,0.0,0.0,,,,,,,,76.4,18.55,5.06,-19.5,18.26,1.2,,,,78.2,21.61,0.17,-14.3,14.37,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F10,0.94,,NB-ferguhei-5069961-0003,5.63,Citrate,0,50,0.0,0.0,0,,,,84.1,9.155,,,70.4,9.994,,0.045,6.7,91.01,2.31,-22.9,,,,,,48.6,49.8,779124.6,342107.3,93569.0,38873.9,8759.4,3004.7,50.9,17.0,,121490.2,30533.8,3258.7,628.0,84.9,0.0,0.0,0.0,,,,,,,,75.6,18.87,5.5,-20.2,18.58,1.6,,,,79.3,20.51,0.2,-13.22,13.27,-0.05,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,F11,0.97,,NB-ferguhei-5069961-0003,6.0,Phosphate,0,50,0.0,0.0,0,,,,98.4,23.542,,,69.0,8.617,,0.071,4.3,90.9,4.77,-25.2,,,,,,42.8,44.6,1648463.5,816251.6,412930.9,293228.5,114065.4,42040.2,2428.0,475.4,,3344684.3,2377714.0,305826.4,24686.1,764.0,101.9,17.0,0.0,,,,,,,,78.0,16.51,5.49,-17.8,16.22,1.6,,,,90.7,9.09,0.25,-1.85,1.85,0.0,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G02,1.0,,NB-ferguhei-5069961-0003,4.3,Acetate,0,150,0.0,0.0,0,,,,96.2,21.261,,,97.7,37.236,,0.07,,,,,,,,,,34.6,45.6,1696816.4,671465.5,224235.0,134659.9,33435.7,7318.8,67.9,34.0,,7639647.6,2600399.7,14874.1,4750.4,2647.7,1907.9,0.0,0.0,,,,,,,,80.8,12.59,6.6,-15.0,12.3,2.7,,,,58.6,40.45,0.97,-33.93,33.21,0.72,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G03,1.13,,NB-ferguhei-5069961-0003,4.7,Acetate,0,150,0.0,0.0,0,,,,93.0,18.054,,,95.1,34.711,,0.281,,,,,,,,,,50.2,49.0,1660890.0,617296.0,186124.4,107521.2,27185.9,6673.4,135.8,17.0,,5215629.4,4436026.2,2589025.6,1316045.8,1567.9,52.3,0.0,0.0,,,,,,,,78.3,14.24,7.45,-17.5,13.95,3.6,,,,81.9,17.59,0.47,-10.57,10.35,0.22,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G04,1.13,,NB-ferguhei-5069961-0003,4.85,Acetate,0,150,0.0,0.0,0,,,,93.7,18.82,,,94.2,33.785,,0.299,,,,,,,,,,50.6,42.6,1665799.8,650568.5,209831.8,120920.3,31125.8,7131.9,50.9,0.0,,4611928.9,4007740.5,2595850.1,1585997.4,11573.3,231.0,23.1,0.0,,,,,,,,78.6,14.75,6.69,-17.3,14.46,2.8,,,,80.4,19.16,0.4,-12.07,11.92,0.15,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G05,1.0,,NB-ferguhei-5069961-0003,3.9,Histidine,0,150,0.0,0.0,0,,,,97.1,22.158,,,76.4,15.941,,0.05,,,,,,,,,,49.4,,1401474.6,414736.6,118445.2,65633.1,12413.4,1969.8,0.0,0.0,,4393396.7,38017.2,1467.9,298.6,99.5,24.9,24.9,0.0,,,,,,,,82.5,13.18,4.28,-13.3,12.89,0.4,,,,47.0,51.95,1.03,-45.49,44.71,0.78,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G06,1.02,,NB-ferguhei-5069961-0003,4.4,Histidine,0,150,0.0,0.0,0,,,,97.2,22.266,,,75.1,14.683,,0.07,,,,,,,,,,50.2,42.6,1594773.3,514467.7,123628.5,64429.5,14995.0,4143.6,84.9,0.0,,7673035.7,2307252.3,5726.0,2627.7,1529.5,1176.6,0.0,0.0,,,,,,,,83.2,12.89,3.93,-12.7,12.6,0.1,,,,66.5,32.62,0.87,-25.99,25.38,0.62,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G07,1.1,,NB-ferguhei-5069961-0003,4.9,Histidine,0,150,0.0,0.0,0,,,,98.5,23.588,,,83.4,22.983,,0.284,,,,,,,,,,49.8,,1552668.3,543559.6,161913.2,97419.6,31346.8,8982.9,152.8,0.0,,4243233.9,3407752.6,1806411.6,618217.4,149.2,0.0,0.0,0.0,,,,,,,,79.2,16.85,4.0,-16.7,16.56,0.1,,,,86.3,13.43,0.28,-6.22,6.19,0.03,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G08,0.97,,NB-ferguhei-5069961-0003,5.4,Histidine,0,150,0.0,0.0,0,,,,100.0,25.094,,,74.7,14.289,,0.057,,,,,,,,,,36.8,38.8,1079370.2,262719.3,44013.0,21904.6,9712.7,4907.3,237.7,50.9,,3146695.6,1489089.5,108455.8,15078.9,373.6,135.8,17.0,0.0,,,,,,,,75.6,20.45,3.98,-20.3,20.16,0.1,,,,91.6,8.19,0.17,-0.87,0.95,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G09,0.93,,NB-ferguhei-5069961-0003,5.5,Citrate,0,150,0.0,0.0,0,,,,99.1,24.204,,,99.7,39.299,,0.055,,,,,,,,,,44.6,43.0,1200514.3,291655.4,43826.4,18797.3,6537.5,2530.1,67.9,0.0,,2587820.6,706516.6,23133.3,5622.0,2598.7,1477.7,509.5,84.9,,,,,,,,75.3,20.3,4.42,-20.6,20.01,0.6,,,,76.4,23.47,0.16,-16.14,16.23,-0.09,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G10,0.96,,NB-ferguhei-5069961-0003,5.63,Citrate,0,150,0.0,0.0,0,,,,98.9,23.95,,,100.0,39.581,,0.045,,,,,,,,,,38.8,45.0,1219411.6,293734.7,44421.9,18237.4,5943.3,2869.8,84.9,34.0,,1323444.2,180283.6,8610.0,1613.3,560.4,169.8,84.9,0.0,,,,,,,,76.1,19.09,4.81,-19.7,18.8,0.9,,,,79.4,20.45,0.17,-13.13,13.21,-0.08,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP009849,polymer conjugate,Single Control,,37.0,14.0,G11,0.95,,NB-ferguhei-5069961-0003,6.0,Phosphate,0,150,0.0,0.0,0,,,,98.6,23.657,,,100.0,39.581,,0.042,,,,,,,,,,36.0,,564203.4,250155.4,128599.9,95414.5,50058.2,23391.1,1408.9,152.8,,1289321.8,188070.7,15352.7,6555.5,2870.1,1732.3,407.6,152.8,,,,,,,,78.5,16.19,5.29,-17.3,15.9,1.4,,,,92.1,7.7,0.23,-0.45,0.46,-0.02,,,,SP009849,SP009849,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B02,0.96,,NB-ferguhei-5069961-0003,4.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.515,,,99.0,1.291,,0.04,2.5,51.25,46.21,-16.6,,,,,,38.4,39.6,7705.3,1968.7,712.8,407.3,101.8,50.9,0.0,0.0,,41259.2,16259.3,5431.1,3428.4,1510.5,763.7,118.8,0.0,,,,,,,,76.2,19.58,4.25,-13.2,12.16,1.1,,,,88.7,10.99,0.32,0.3,0.7,-1.04,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B03,0.97,,NB-ferguhei-5069961-0003,5.1,Acetate,0,0,0.0,0.0,0,,,,92.3,-7.181,,,98.0,0.762,,0.041,11.2,57.49,31.34,-8.0,,,,,,46.2,,12067.1,2562.8,560.1,322.5,101.8,17.0,0.0,0.0,,551189.6,54242.9,17113.3,10373.2,3514.3,1443.1,322.6,50.9,,,,,,,,77.1,18.54,4.32,-12.3,11.12,1.1,,,,89.8,9.85,0.32,1.5,-0.4,-1.04,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B04,0.97,,NB-ferguhei-5069961-0003,5.2,Acetate,0,0,0.0,0.0,0,,,,98.8,-0.657,,,98.0,0.713,,0.042,9.3,54.18,36.54,-9.9,,,,,,49.8,,161460.3,6671.6,899.7,526.3,186.7,84.9,17.0,0.0,,339280.4,167951.4,76227.3,47780.0,20826.3,12390.6,1714.3,729.9,,,,,,,,75.0,20.36,4.66,-14.4,12.94,1.5,,,,89.6,10.04,0.36,1.3,-0.3,-1.0,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B05,0.99,,NB-ferguhei-5069961-0003,4.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.515,,,99.0,1.324,,0.044,0.0,28.77,71.23,-19.2,,,,,,48.6,,1783538.9,117449.1,2840.1,1462.6,391.2,136.1,0.0,0.0,,66633.0,20689.2,4972.9,2834.4,1306.9,780.7,101.8,17.0,,,,,,,,79.5,16.91,3.64,-10.0,9.49,0.5,,,,89.1,10.66,0.26,0.7,0.4,-1.1,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B06,0.98,,NB-ferguhei-5069961-0003,4.7,Histidine,0,0,0.0,0.0,0,,,,100.0,0.515,,,99.0,1.34,,0.042,0.0,28.81,71.19,-19.2,,,,,,50.2,,930205.3,33019.6,1664.6,730.4,220.8,101.9,17.0,0.0,,175672.8,44843.2,9929.3,5499.3,1748.2,814.7,135.8,33.9,,,,,,,,77.7,18.48,3.81,-11.7,11.06,0.6,,,,88.9,10.78,0.29,0.6,0.5,-1.07,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B07,0.98,,NB-ferguhei-5069961-0003,5.4,Histidine,0,0,0.0,0.0,0,,,,100.0,0.515,,,98.9,1.17,,0.045,0.0,33.28,66.72,-19.2,,,,,,50.4,57.0,2169366.2,818990.8,63016.3,7607.5,390.6,135.8,34.0,17.0,,2750265.7,1554034.4,438654.3,173485.5,38048.6,18031.1,831.9,169.8,,,,,,,,79.9,16.25,3.89,-9.5,8.83,0.7,,,,89.7,9.81,0.47,1.4,-0.5,-0.89,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B08,1.0,,NB-ferguhei-5069961-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,99.1,-0.383,,,98.8,1.128,,0.07,0.0,37.42,62.58,-19.2,,,,,,60.0,57.0,3098323.7,1836297.7,537513.9,171616.0,14312.6,1188.5,0.0,0.0,,2645642.9,2507215.0,1883186.3,1576883.1,740273.6,197407.4,2104.6,458.3,,,,,,,,78.7,17.26,4.06,-10.7,9.84,0.9,,,,90.4,8.8,0.76,2.1,-1.5,-0.6,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B09,0.93,,NB-ferguhei-5069961-0003,5.9,Citrate,0,0,0.0,0.0,0,,,,95.8,-3.64,,,98.1,0.419,,0.067,26.0,55.97,18.05,6.8,,,,,,61.6,60.4,1567895.4,906724.4,440356.1,204752.4,50479.2,20986.3,17.0,0.0,,2378153.1,2284259.9,2098527.1,1994840.7,1616772.8,1131114.6,419260.7,21114.1,,,,,,,,73.2,22.68,4.15,-16.2,15.26,1.0,,,,72.9,26.19,0.89,-15.4,15.9,-0.47,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B10,0.92,,NB-ferguhei-5069961-0003,6.1,Citrate,0,0,0.0,0.0,0,,,,94.7,-4.781,,,98.5,0.804,,0.056,28.1,54.11,17.8,8.9,,,,,,61.2,57.6,1975605.1,609378.5,304060.8,156845.8,43653.2,17563.2,34.0,17.0,,1842639.4,1661026.7,1414831.1,1316862.0,1026604.2,693692.7,232786.8,21589.8,,,,,,,,72.2,23.69,4.15,-17.2,16.27,1.0,,,,72.0,27.07,0.96,-16.4,16.8,-0.4,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,B11,0.84,,NB-ferguhei-5069961-0003,6.7,Phosphate,0,0,0.0,0.0,0,,,,92.8,-6.671,,,97.6,-0.055,,0.039,23.6,62.23,14.21,4.4,,,,,,51.0,53.4,331974.4,127999.8,40431.7,20012.2,6772.6,3513.6,50.9,17.0,,1044207.6,729556.8,520168.6,431032.3,263606.7,146020.0,39416.2,5211.4,,,,,,,,63.8,32.45,3.79,-25.6,25.03,0.6,,,,81.4,16.57,2.09,-7.0,6.3,0.73,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C05,0.99,,NB-ferguhei-5069961-0003,4.2,Histidine,0,50,0.0,0.0,0,,,,97.9,-1.595,,,96.1,-1.562,,0.047,0.0,59.49,40.51,-19.2,,,,,,41.2,50.4,1227151.1,9257.9,1494.8,815.4,271.8,84.9,17.0,0.0,,82842.8,18873.4,3122.9,1731.2,458.3,169.7,17.0,0.0,,,,,,,,79.0,16.6,4.37,-10.4,9.18,1.2,,,,67.9,31.15,1.0,-20.5,20.9,-0.36,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C02,0.99,,NB-ferguhei-5069961-0003,4.6,Acetate,0,50,0.0,0.0,0,,,,97.9,-1.634,,,96.7,-0.956,,0.044,22.4,62.86,14.74,3.3,,,,,,59.8,58.2,2331562.3,101895.4,12558.5,5743.9,951.7,254.9,0.0,0.0,,942749.5,214276.7,57763.0,31784.9,12021.2,5501.2,458.4,152.8,,,,,,,,70.3,24.99,4.76,-19.2,17.57,1.6,,,,79.0,20.32,0.7,-9.4,10.0,-0.66,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C03,0.98,,NB-ferguhei-5069961-0003,5.1,Acetate,0,50,0.0,0.0,0,,,,98.8,-0.708,,,98.3,0.65,,0.043,21.6,67.66,10.73,2.5,,,,,,61.8,56.2,1406435.3,13251.1,2106.6,883.4,186.9,68.0,17.0,0.0,,115805.5,26494.6,6432.7,3513.4,1120.2,577.1,33.9,17.0,,,,,,,,74.3,21.6,4.13,-15.1,14.18,0.9,,,,89.1,10.52,0.34,0.8,0.2,-1.02,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C04,0.97,,NB-ferguhei-5069961-0003,5.2,Acetate,0,50,0.0,0.0,0,,,,98.8,-0.649,,,98.9,1.225,,0.046,25.7,64.42,9.89,6.5,,,,,,60.4,55.4,1856159.0,25322.1,3110.0,1376.6,254.9,85.0,17.0,17.0,,1002960.1,303594.4,116201.6,78322.3,34449.6,18370.8,2886.4,1137.6,,,,,,,,73.2,22.62,4.17,-16.2,15.2,1.0,,,,,,,,,,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C06,1.01,,NB-ferguhei-5069961-0003,4.7,Histidine,0,50,0.0,0.0,0,,,,99.3,-0.158,,,98.3,0.576,,0.045,13.0,40.28,46.72,-6.2,,,,,,50.2,36.2,905685.8,9918.6,1851.2,1019.0,407.6,186.8,34.0,17.0,,92042.6,24457.6,6347.8,3309.7,831.7,390.4,0.0,0.0,,,,,,,,70.5,25.54,3.94,-18.9,18.12,0.8,,,,87.3,12.27,0.44,-1.1,2.0,-0.92,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C07,1.0,,NB-ferguhei-5069961-0003,5.4,Histidine,0,50,0.0,0.0,0,,,,100.0,0.515,,,98.8,1.132,,0.058,6.1,39.02,54.87,-13.0,,,,,,46.6,,1257179.4,580909.3,248861.7,92796.7,15485.9,6129.8,34.0,0.0,,2945070.1,1903889.0,956265.0,629384.0,175213.7,34105.6,899.8,339.5,,,,,,,,79.2,16.83,4.02,-10.3,9.41,0.8,,,,91.2,8.39,0.39,2.9,-1.9,-0.97,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C08,0.98,,NB-ferguhei-5069961-0003,6.0,Histidine,0,50,0.0,0.0,0,,,,98.1,-1.341,,,98.8,1.127,,0.059,4.5,43.68,51.8,-14.6,,,,,,43.8,42.0,1257103.8,234686.8,113768.0,48866.9,10038.4,3193.2,17.0,0.0,,2006027.1,1641085.0,1233741.8,1054343.1,711671.0,452239.6,39668.4,6127.6,,,,,,,,78.5,17.56,3.92,-10.9,10.14,0.7,,,,91.0,8.2,0.8,2.7,-2.1,-0.56,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C09,0.95,,NB-ferguhei-5069961-0003,5.9,Citrate,0,50,0.0,0.0,0,,,,97.3,-2.186,,,98.9,1.197,,0.062,25.7,64.56,9.74,6.6,,,,,,52.0,46.8,1498354.5,269058.7,133680.0,49667.1,10242.6,4314.5,17.0,17.0,,1711007.4,1504073.9,1245063.4,1108250.7,685913.7,333103.3,54911.8,7044.3,,,,,,,,74.6,20.99,4.37,-14.8,13.57,1.2,,,,76.4,22.84,0.78,-12.0,12.6,-0.58,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C10,0.96,,NB-ferguhei-5069961-0003,6.1,Citrate,0,50,0.0,0.0,0,,,,96.2,-3.247,,,98.7,1.032,,0.052,25.0,67.38,7.6,5.9,,,,,,54.6,47.8,142840.8,69129.1,16140.9,6059.2,967.4,305.5,50.9,50.9,,1393148.8,1195206.5,978288.2,856742.6,491970.1,213659.5,34897.0,5125.9,,,,,,,,74.2,21.07,4.7,-15.2,13.65,1.5,,,,76.7,22.39,0.93,-11.7,12.1,-0.43,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,C11,0.91,,NB-ferguhei-5069961-0003,6.7,Phosphate,0,50,0.0,0.0,0,,,,93.4,-6.127,,,97.8,0.069,,0.042,31.0,57.27,11.7,11.9,,,,,,35.8,38.0,1423646.4,246796.9,110770.7,40388.3,8118.4,3566.7,17.0,0.0,,759222.9,538240.5,365922.1,296668.8,155039.1,71459.9,13443.3,984.5,,,,,,,,72.2,24.47,3.29,-17.2,17.05,0.1,,,,87.1,11.35,1.52,-1.2,1.1,0.16,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D02,1.11,,NB-ferguhei-5069961-0003,4.6,Acetate,0,150,0.0,0.0,0,,,,95.2,-4.292,,,92.1,-5.603,,0.315,,,,,,,,,,45.8,38.4,6620635.3,5513472.2,913795.8,8453.4,331.5,33.2,0.0,0.0,,1615626.6,1599078.7,1568749.6,1549961.4,1465830.7,1195821.3,3479.3,271.6,,,,,,,,77.0,16.27,6.76,-12.4,8.85,3.6,,,,54.3,41.22,4.47,-34.0,30.9,3.11,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D03,0.96,,NB-ferguhei-5069961-0003,5.1,Acetate,0,150,0.0,0.0,0,,,,97.0,-2.483,,,96.1,-1.54,,0.24,,,,,,,,,,48.4,54.6,3806598.5,1949293.1,817760.9,361394.6,29111.8,1138.6,0.0,0.0,,1517855.3,1494315.2,1450934.8,1425205.2,1327701.2,1176684.5,773464.2,93261.0,,,,,,,,68.5,27.46,4.01,-20.9,20.04,0.8,,,,83.3,16.06,0.62,-5.0,5.8,-0.74,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D04,0.92,,NB-ferguhei-5069961-0003,5.2,Acetate,0,150,0.0,0.0,0,,,,98.0,-1.456,,,97.8,0.109,,0.136,,,,,,,,,,53.4,47.0,3009294.1,1972699.5,905053.0,383962.9,21799.1,424.4,0.0,0.0,,2543977.3,2432300.3,2240684.4,2123169.0,1700544.7,1141277.4,412559.8,28224.7,,,,,,,,72.0,24.25,3.77,-17.4,16.83,0.6,,,,84.8,14.65,0.52,-3.5,4.4,-0.84,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D05,1.07,,NB-ferguhei-5069961-0003,4.2,Histidine,0,150,0.0,0.0,0,,,,100.0,0.515,,,94.1,-3.615,,0.146,,,,,,,,,,52.8,51.6,2033641.5,1965836.0,1740914.9,1606542.7,865857.9,136086.4,33.9,0.0,,7086858.3,4406772.8,704200.0,214546.7,10420.4,2283.9,392.6,0.0,,,,,,,,79.6,15.33,5.1,-9.8,7.91,1.9,,,,70.8,23.75,5.51,-17.6,13.5,4.15,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D06,1.09,,NB-ferguhei-5069961-0003,4.7,Histidine,0,150,0.0,0.0,0,,,,97.2,-2.331,,,92.1,-5.567,,0.372,,,,,,,,,,51.8,35.6,3636390.9,578406.1,3929.4,742.9,117.3,58.6,0.0,0.0,,1364812.3,1356886.3,1339286.2,1329255.7,1286723.6,1182107.5,15410.7,84.9,,,,,,,,67.2,28.38,4.45,-22.2,20.96,1.3,,,,72.1,26.42,1.47,-16.2,16.1,0.11,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D07,0.96,,NB-ferguhei-5069961-0003,5.4,Histidine,0,150,0.0,0.0,0,,,,100.0,0.515,,,99.1,1.456,,0.053,,,,,,,,,,49.4,41.2,1910831.6,368527.2,217138.4,95490.6,19108.3,7524.4,34.0,17.0,,2685459.0,2080023.9,1353695.2,1041276.5,450931.8,181068.7,29366.2,1935.1,,,,,,,,80.8,15.41,3.75,-8.6,7.99,0.6,,,,93.1,6.34,0.55,4.8,-4.0,-0.81,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D08,0.97,,NB-ferguhei-5069961-0003,6.0,Histidine,0,150,0.0,0.0,0,,,,98.2,-1.264,,,98.5,0.806,,0.06,,,,,,,,,,,,2948272.1,456682.0,212696.5,85644.0,13222.4,3878.8,17.2,17.2,,1916417.6,1646717.4,1283490.4,1084724.6,600286.2,296841.6,37852.1,3768.2,,,,,,,,79.3,16.37,4.29,-10.1,8.95,1.1,,,,93.3,5.8,0.91,4.9,-4.5,-0.45,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D09,0.96,,NB-ferguhei-5069961-0003,5.9,Citrate,0,150,0.0,0.0,0,,,,96.9,-2.562,,,99.5,1.814,,0.051,,,,,,,,,,45.4,38.4,1978950.4,329629.7,193239.4,83396.8,18530.7,8220.8,17.0,0.0,,1604471.9,1269933.2,921560.1,744886.7,366349.4,159936.2,21863.5,2257.6,,,,,,,,73.3,21.98,4.68,-16.1,14.56,1.5,,,,76.2,23.14,0.68,-12.2,12.9,-0.68,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D10,0.96,,NB-ferguhei-5069961-0003,6.1,Citrate,0,150,0.0,0.0,0,,,,96.1,-3.353,,,98.9,1.227,,0.053,,,,,,,,,,47.2,41.6,2014433.7,324525.1,181873.3,81262.9,19092.7,7966.6,101.9,17.0,,1588485.0,1334649.3,1041212.1,866154.7,414227.3,158116.9,15752.3,2020.0,,,,,,,,73.8,21.72,4.48,-15.6,14.3,1.3,,,,76.5,22.67,0.84,-11.9,12.4,-0.52,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,Sutro IL-2,SP10478,polymer conjugate,Single Control,,37.0,14.0,D11,0.93,,NB-ferguhei-5069961-0003,6.7,Phosphate,0,150,0.0,0.0,0,,,,94.9,-4.615,,,98.8,1.072,,0.05,,,,,,,,,,,,82417.2,33061.9,8282.5,3411.4,865.6,339.4,0.0,0.0,,1071097.0,898849.7,727026.8,634826.6,377491.1,158991.0,22727.5,1578.5,,,,,,,,76.6,20.26,3.13,-12.8,12.84,-0.1,,,,89.0,9.65,1.36,0.6,-0.6,0.0,,,,SP10478,SP10478,,,,,Sutro IL2 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E02,1.0,,NB-ferguhei-5069961-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,94.8,-4.2,,,91.0,-8.3,,0.0533,,,,,,,,,,47.0,45.6,57414.0,9917.1,2428.3,1494.4,441.5,186.8,17.0,17.0,,769578.3,43179.8,8456.0,5077.0,2190.4,1171.6,322.6,135.8,,,,,,,,79.9,2.56,17.58,-16.0,2.0,14.0,,,,41.5,14.45,44.01,-45.0,1.0,44.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E03,1.0,,NB-ferguhei-5069961-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,93.9,-5.11,,,92.0,-6.6,,0.0544,,,,,,,,,,61.8,50.8,69240.6,10527.0,3175.1,2105.4,305.6,220.7,50.9,34.0,,1631024.5,15065.1,2836.4,1732.4,679.4,288.7,0.0,0.0,,,,,,,,85.5,2.13,12.42,-10.0,2.0,9.0,,,,54.6,13.32,32.07,-31.0,0.0,32.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E04,1.0,,NB-ferguhei-5069961-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,89.8,-9.17,,,90.0,-8.7,,0.0605,,,,,,,,,,59.4,50.0,91298.2,11580.0,3956.2,2546.9,305.6,169.8,34.0,0.0,,4030529.7,20853.8,2662.2,1517.9,700.6,280.2,23.4,23.4,,,,,,,,85.7,2.72,11.61,-10.0,2.0,8.0,,,,39.1,13.24,47.64,-47.0,0.0,47.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E05,1.0,,NB-ferguhei-5069961-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,98.3,-0.71,,,99.0,-0.2,,0.0484,,,,,,,,,,62.6,58.4,172344.4,11519.1,1817.9,1240.3,390.8,169.9,0.0,0.0,,58113.5,13442.2,3343.6,2036.7,797.7,356.4,84.9,33.9,,,,,,,,89.6,2.08,8.3,-6.0,2.0,4.0,,,,73.8,14.34,11.9,-12.0,1.0,11.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E06,1.0,,NB-ferguhei-5069961-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,98.7,-0.27,,,98.9,0.0,,0.0501,,,,,,,,,,62.6,58.6,163275.0,8153.6,1630.7,1036.2,322.7,135.9,51.0,17.0,,88037.8,15020.9,4124.4,2461.1,848.6,237.6,33.9,17.0,,,,,,,,90.8,1.86,7.31,-5.0,2.0,3.0,,,,69.8,12.86,17.36,-16.0,-1.0,17.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E07,1.0,,NB-ferguhei-5069961-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,96.0,-3.05,,,98.6,-0.3,,0.0556,,,,,,,,,,63.2,58.8,46263.6,4393.0,669.2,377.5,171.6,103.0,51.5,51.5,,795502.7,37357.9,6232.0,3328.2,1171.7,662.3,84.9,34.0,,,,,,,,89.0,2.48,8.54,-7.0,2.0,5.0,,,,58.6,18.48,22.88,-27.0,5.0,22.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E08,1.0,,NB-ferguhei-5069961-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,92.2,-6.83,,,93.0,-5.9,,0.0671,,,,,,,,,,61.0,53.8,101279.1,13631.8,2784.1,1426.0,271.6,118.8,34.0,17.0,,4352726.0,30700.8,7463.7,4453.4,1617.1,646.9,124.4,0.0,,,,,,,,87.5,3.28,9.18,-8.0,3.0,5.0,,,,29.3,11.76,58.93,-57.0,-2.0,59.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E09,1.0,,NB-ferguhei-5069961-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,85.2,-13.84,,,88.0,-10.9,,0.0666,,,,,,,,,,59.4,51.4,55116.8,4757.7,721.4,395.0,154.6,85.9,34.4,17.2,,5698114.5,60054.9,5211.4,3474.3,1116.7,527.3,93.1,31.0,,,,,,,,83.4,3.7,12.8,-12.0,3.0,9.0,,,,17.9,8.8,73.35,-68.0,-5.0,73.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
1/6/2023,ferguhei,Sutro IL-2,SP10482,polymer conjugate,Single Control,,50.0,10.0,E10,1.0,,NB-ferguhei-5069961-0004,6.8,Citrate,0,0,0.0,0.0,0,,,,79.4,-19.63,,,83.8,-15.1,,0.067,,,,,,,,,,58.2,51.6,250406.7,22962.7,3025.0,1839.1,515.6,309.4,34.4,17.2,,5348160.8,98127.6,9947.3,4534.8,1404.3,585.1,58.5,0.0,,,,,,,,82.1,3.28,14.61,-14.0,3.0,11.0,,,,12.7,8.42,78.85,-73.0,-5.0,78.0,,,,SP10482,SP10482,,,,,Sutro IL2 Results 50C Historical upload.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0732,0.0,0.0,100.0,0.0,,,,,,,,327408.3,73602.4,12204.8,5381.0,1001.5,322.5,17.0,0.0,,528696.7,118397.4,26416.2,14345.5,4295.2,1816.5,169.8,50.9,,,,,,,,43.2,50.55,6.22,-47.0,51.0,-3.0,,,,67.3,24.42,8.32,-21.0,16.0,5.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0803,0.0,0.0,100.0,0.0,,,,,,,,359801.9,80020.1,13478.1,6026.1,950.6,254.6,33.9,0.0,,459887.2,126112.1,31421.9,17332.1,4872.0,1952.2,135.8,34.0,,,,,,,,33.0,62.24,4.78,-58.0,62.0,-5.0,,,,64.5,31.24,4.25,-24.0,23.0,1.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0961,0.0,0.0,100.0,0.0,,,,,,,,354778.9,77813.7,14174.2,6433.6,1103.4,339.5,84.9,34.0,,300579.9,54914.8,6094.1,2733.0,492.3,203.7,17.0,17.0,,,,,,,,18.5,77.72,3.76,-72.0,78.0,-6.0,,,,51.2,45.16,3.64,-37.0,37.0,0.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B05,1.0,,NB-munselle-5020702-0007,4.5,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0782,0.0,0.0,100.0,0.0,,,,,,,,347481.9,78102.8,13987.5,6518.5,1256.2,288.6,50.9,0.0,,265682.6,42860.2,6637.0,3208.2,780.8,237.6,17.0,0.0,,,,,,,,48.1,44.94,6.99,-43.0,45.0,-2.0,,,,11.7,6.49,81.84,-77.0,-2.0,78.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B06,1.0,,NB-munselle-5020702-0007,5.0,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0862,0.0,0.0,100.0,0.0,,,,,,,,342519.1,76217.2,13749.7,6535.3,1171.3,509.2,67.9,50.9,,253527.2,39753.7,5279.0,2495.2,560.1,220.7,0.0,0.0,,,,,,,,33.0,62.02,4.96,-58.0,62.0,-4.0,,,,41.8,14.48,43.72,-47.0,6.0,40.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B07,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1047,0.0,0.0,100.0,0.0,,,,,,,,361175.6,80634.7,14157.8,5907.6,950.6,373.5,34.0,17.0,,311676.8,56187.0,6314.7,2495.3,492.3,135.8,0.0,0.0,,,,,,,,11.8,84.79,3.41,-79.0,85.0,-6.0,,,,45.5,32.64,21.89,-43.0,25.0,19.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B08,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1419,0.0,0.0,100.0,0.0,,,,,,,,370225.4,85554.2,15209.6,6993.7,1459.9,475.3,101.9,17.0,,714124.9,106570.3,9626.5,2920.2,322.6,84.9,17.0,0.0,,,,,,,,2.2,95.19,2.63,-88.0,95.0,-7.0,,,,22.8,74.17,3.08,-66.0,66.0,0.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B09,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.075,0.0,0.0,100.0,0.0,,,,,,,,378083.1,87866.3,15821.4,7520.2,1782.5,730.0,135.8,50.9,,246075.1,43267.3,5143.2,2206.6,475.3,135.8,0.0,0.0,,,,,,,,43.7,50.95,5.39,-47.0,51.0,-4.0,,,,65.1,24.97,9.88,-23.0,17.0,7.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B10,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0844,0.0,0.0,100.0,0.0,,,,,,,,378017.8,87947.8,16041.4,7621.8,1833.3,831.8,220.7,84.9,,254179.5,45526.2,6043.0,2580.2,594.1,254.6,33.9,0.0,,,,,,,,28.3,67.31,4.36,-62.0,67.0,-5.0,,,,60.7,34.51,4.81,-28.0,26.0,1.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,B11,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.115,0.0,0.0,100.0,0.0,,,,,,,,352581.3,79815.0,14683.1,6535.3,1680.5,611.1,101.8,17.0,,558681.8,107142.4,12868.6,5602.4,1578.9,662.1,17.0,17.0,,,,,,,,8.3,89.16,2.51,-82.0,89.0,-7.0,,,,33.1,64.09,2.8,-55.0,56.0,-1.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0828,0.0,0.0,100.0,0.0,,,,,,,,284222.5,69171.5,11950.1,5245.1,1052.4,475.3,67.9,33.9,,251132.8,55233.9,8928.4,4311.4,1188.2,356.5,50.9,0.0,,,,,,,,43.5,50.8,5.75,-47.0,51.0,-4.0,,,,71.5,19.82,8.67,-17.0,12.0,5.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0921,0.0,0.0,100.0,0.0,,,,,,,,289257.9,68321.3,12425.1,5618.5,1290.0,475.3,50.9,0.0,,273049.4,58086.2,7791.2,3377.9,594.1,169.7,0.0,0.0,,,,,,,,34.5,60.15,5.38,-56.0,60.0,-4.0,,,,67.1,28.11,4.76,-21.0,20.0,1.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1076,0.0,0.0,100.0,0.0,,,,,,,,294425.6,71361.5,13443.9,6297.6,1222.2,475.3,17.0,0.0,,262010.7,60410.5,7740.1,2936.5,628.0,169.7,0.0,0.0,,,,,,,,19.7,76.79,3.47,-71.0,77.0,-6.0,,,,53.4,42.61,4.05,-35.0,35.0,1.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C05,1.0,,NB-munselle-5020702-0007,4.5,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0862,0.0,0.0,100.0,0.0,,,,,,,,281723.9,68304.9,12764.7,5822.2,1222.2,356.5,33.9,0.0,,219504.7,50038.7,8300.2,3785.1,712.9,305.5,17.0,17.0,,,,,,,,49.4,43.54,7.04,-41.0,44.0,-2.0,,,,12.3,5.12,82.56,-76.0,-3.0,79.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C06,1.0,,NB-munselle-5020702-0007,5.0,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.095,0.0,0.0,100.0,0.0,,,,,,,,281091.2,70849.9,13138.0,6042.8,1459.8,662.0,84.9,33.9,,220915.0,48816.9,6925.3,3106.2,848.7,339.5,17.0,17.0,,,,,,,,33.8,60.75,5.47,-57.0,61.0,-4.0,,,,46.0,13.14,40.83,-43.0,5.0,37.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C07,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1185,0.0,0.0,100.0,0.0,,,,,,,,280848.9,69830.3,13222.6,6042.7,1001.5,339.5,84.9,33.9,,277256.2,65503.4,8164.6,3343.9,763.8,220.7,17.0,17.0,,,,,,,,12.4,84.15,3.42,-78.0,84.0,-6.0,,,,47.2,5.38,9.17,-41.0,-3.0,6.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C08,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1586,0.0,0.0,100.0,0.0,,,,,,,,285738.0,71001.7,14139.2,6925.3,1493.7,458.3,0.0,0.0,,540811.2,112487.9,16161.9,6026.7,1086.5,356.5,34.0,34.0,,,,,,,,2.0,95.82,2.21,-89.0,96.0,-7.0,,,,27.1,69.68,3.2,-61.0,62.0,0.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C09,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0846,0.0,0.0,100.0,0.0,,,,,,,,284249.0,70120.2,12526.9,5499.6,1171.2,441.3,17.0,0.0,,237465.3,51108.5,7723.1,3598.5,814.7,322.5,33.9,0.0,,,,,,,,43.9,50.31,5.84,-47.0,50.0,-4.0,,,,69.8,19.27,10.92,-19.0,11.0,8.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C10,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0957,0.0,0.0,100.0,0.0,,,,,,,,291599.8,71461.4,14343.2,7298.9,1901.1,611.1,67.9,17.0,,261863.1,56982.9,7502.7,2783.8,645.0,237.6,33.9,33.9,,,,,,,,27.9,67.32,4.78,-63.0,67.0,-5.0,,,,66.2,31.13,3.83,-22.0,23.0,0.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,C11,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1247,0.0,0.0,100.0,0.0,,,,,,,,305156.6,76454.7,15277.4,7587.8,1799.3,679.0,84.9,0.0,,403775.0,79818.0,9675.9,4328.7,1069.4,441.4,34.0,17.0,,,,,,,,8.0,89.38,2.65,-83.0,89.0,-7.0,,,,36.4,62.24,1.39,-52.0,54.0,-2.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D02,1.0,,NB-munselle-5020702-0007,4.5,Acetate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0744,,,,,,,,,,,,325465.2,78102.8,14768.4,7367.2,1782.4,679.0,101.9,17.0,,274436.6,53909.6,8605.8,3717.3,882.7,390.4,17.0,17.0,,,,,,,,50.3,43.34,6.36,-40.0,43.0,-3.0,,,,0.0,0.0,100.0,-89.0,-8.0,97.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D03,1.0,,NB-munselle-5020702-0007,5.0,Acetate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.085,,,,,,,,,,,,335001.6,78305.7,15294.5,7078.6,1850.3,696.0,84.9,50.9,,252964.6,44217.5,6416.2,2851.6,543.2,237.6,0.0,0.0,,,,,,,,36.2,58.23,5.62,-54.0,58.0,-4.0,,,,12.3,12.32,75.34,-76.0,4.0,72.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D04,1.0,,NB-munselle-5020702-0007,5.6,Acetate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0918,,,,,,,,,,,,348191.7,82142.2,15820.7,7316.2,2291.6,780.9,67.9,34.0,,291080.5,52162.9,6976.6,3055.4,645.0,237.6,0.0,0.0,,,,,,,,27.3,68.11,4.58,-63.0,68.0,-5.0,,,,45.2,19.69,35.13,-43.0,12.0,32.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D05,1.0,,NB-munselle-5020702-0007,4.5,Citrate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0702,,,,,,,,,,,,340177.3,79850.0,16211.0,7740.6,1833.3,746.9,50.9,17.0,,279431.1,54300.8,7977.9,3972.0,695.9,254.6,17.0,17.0,,,,,,,,61.3,30.64,8.04,-29.0,31.0,-1.0,,,,0.0,0.0,100.0,-89.0,-8.0,97.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D06,1.0,,NB-munselle-5020702-0007,5.0,Citrate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0813,,,,,,,,,,,,346169.1,82413.1,15905.5,7604.8,2087.9,797.8,135.8,17.0,,256835.2,46288.4,7400.7,3293.0,695.9,254.6,0.0,0.0,,,,,,,,41.2,52.15,6.66,-49.0,52.0,-3.0,,,,0.0,0.0,100.0,-89.0,-8.0,97.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D07,1.0,,NB-munselle-5020702-0007,5.6,Citrate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0892,,,,,,,,,,,,364027.1,88795.8,15022.8,7876.4,1731.4,577.1,118.8,33.9,,320333.9,56271.9,6263.7,2733.0,577.1,152.8,0.0,0.0,,,,,,,,27.0,68.68,4.33,-64.0,69.0,-5.0,,,,50.4,14.9,34.76,-38.0,7.0,31.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D08,1.0,,NB-munselle-5020702-0007,6.2,Citrate,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1112,,,,,,,,,,,,341161.9,82430.2,15820.6,7757.5,1969.1,696.0,118.8,33.9,,329267.4,64047.3,8368.8,3615.7,933.6,271.6,17.0,17.0,,,,,,,,9.8,87.18,3.04,-81.0,87.0,-6.0,,,,47.7,15.82,17.57,-41.0,8.0,14.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D09,1.0,,NB-munselle-5020702-0007,5.0,Histidine,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0809,,,,,,,,,,,,348649.7,83415.2,17025.9,9268.4,2410.5,746.9,50.9,0.0,,260893.5,46458.4,6653.9,3225.1,780.8,407.4,17.0,0.0,,,,,,,,42.4,52.03,5.58,-48.0,52.0,-4.0,,,,0.0,0.76,99.24,-89.0,-7.0,96.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D10,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.09,,,,,,,,,,,,352655.2,82804.0,15769.8,8063.1,1867.2,543.2,50.9,17.0,,267143.5,48445.0,7349.9,3921.1,1069.4,322.5,17.0,0.0,,,,,,,,29.9,65.76,4.39,-61.0,66.0,-5.0,,,,36.5,19.17,44.3,-52.0,11.0,41.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,D11,1.0,,NB-munselle-5020702-0007,6.2,Histidine,0,150,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1054,,,,,,,,,,,,352529.4,85263.6,15854.3,8283.6,2037.0,628.1,135.8,17.0,,361014.3,65066.4,8538.6,3768.5,899.7,390.4,0.0,0.0,,,,,,,,10.8,86.46,2.73,-80.0,86.0,-7.0,,,,47.6,40.65,11.8,-41.0,33.0,8.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,E02,1.0,,NB-munselle-5020702-0007,7.4,Phosphate,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.4228,0.0,0.0,100.0,,,,,,,,,420198.7,103212.1,22815.3,11509.5,2784.0,763.9,118.8,17.0,,6808646.1,5382295.2,2494894.3,1054793.4,9621.6,1671.8,136.5,102.4,,,,,,,,1.3,94.37,4.34,-89.0,94.0,-5.0,,,,0.0,100.0,0.0,-89.0,92.0,-3.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,E03,1.0,,NB-munselle-5020702-0007,6.8,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.1712,0.0,0.0,100.0,,,,,,,,,401298.4,98966.6,22254.7,11679.1,2750.0,899.7,152.8,50.9,,2106679.0,226832.4,22487.9,7150.6,1138.0,458.6,51.0,17.0,,,,,,,,1.6,95.52,2.86,-89.0,96.0,-7.0,,,,0.0,100.0,0.0,-89.0,92.0,-3.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,40.0,10.0,E04,1.0,,NB-munselle-5020702-0007,5.6,Histidine,0,0,0.0,0.0,0,,,,0.0,0.0,,,0.0,0.0,,0.0886,0.0,0.0,100.0,,,,,,,,,288455.1,72478.7,14122.3,7264.8,1527.7,492.2,0.0,0.0,,252827.1,51991.2,6891.4,2953.5,729.9,305.5,33.9,33.9,,,,,,,,31.7,63.49,4.78,-59.0,63.0,-5.0,,,,60.1,38.97,0.94,-28.0,31.0,-2.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,1,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,5.0,0.0,F09,1.0,,NB-munselle-5020702-0007,4.6,Acetate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0591,0.0,0.0,100.0,0.0,,,,,,,,419334.7,105550.9,23035.1,12086.2,3089.5,933.6,186.7,84.9,,350014.0,81417.8,15074.2,8045.3,2842.6,1877.8,447.9,292.9,,,,,,,,90.6,0.0,9.38,0.0,0.0,0.0,,,,88.6,8.09,3.36,0.0,0.0,0.0,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
12/19/2022,munselle,Sutro IL-2,SP10784,Fusion Protein,Single Control,,-80.0,0.0,F10,1.0,,NB-munselle-5020702-0007,4.5,Citrate,0,0,0.0,0.0,0,,,,0.0,,,,,,,0.0567,0.0,0.0,100.0,0.0,,,,,,,,,,,,,,,,,469455.6,223448.4,45270.2,19180.9,3666.4,1357.9,0.0,0.0,,,,,,,,90.7,0.0,9.31,0.0,0.0,0.0,,,,89.3,8.48,2.18,0.79,0.0,-1.18,,,,SEQ000636_005,SEQ000636,,,,,Results Template rPEG.xlsx,,,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,1,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,97.43,-0.55,0.55,,95.25,-1.8,1.8,0.0014,81.14,11.44,7.43,-6.4,0.6,5.8,6.36,0.64,5.83,68.34743591,84.32386876,,,,,,,,,,,,,,,,,,,,,,,,,96.905,1.584,0.234,,,,,,,98.262,0.11,1.628,0.461,0.1,-0.56,0.461,0.1,0.56,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,2,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,97.09,-0.89,0.89,,95.61,-1.43,1.43,0.0032,82.8,10.52,6.68,-4.7,-0.3,5.1,4.7,0.28,5.08,70.89762,84.80369688,,,,,,,,,,,,,,,,,,,,,,,,,97.28,2.538,0.183,,,,,,,98.644,0.06,1.296,0.843,0.05,-0.892,0.843,0.05,0.892,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,16,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,97.45,-0.53,0.53,,96.38,-0.66,0.66,0.0056,54.27,39.74,5.99,-33.2,28.9,4.4,33.23,28.94,4.39,67.50908,84.74658682,,,,,,,,,,,,,,,,,,,,,,,,,96.708,1.585,0.286,,,,,,,97.865,0.81,1.325,0.064,0.8,-0.863,0.064,0.8,0.863,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,6,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,97.75,-0.23,0.23,,90.76,-6.28,6.28,0.0035,69.37,18.19,12.45,-18.1,7.4,10.9,18.13,7.39,10.85,60.92531,78.82745438,,,,,,,,,,,,,,,,,,,,,,,,,96.761,1.304,0.177,,,,,,,97.96,0.39,1.65,0.159,0.38,-0.538,0.159,0.38,0.538,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,7,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,97.4,-0.58,0.58,,95.99,-1.05,1.05,0.0029,79.56,13.89,6.55,-7.9,3.1,5.0,7.94,3.09,4.95,67.35703,85.23141756,,,,,,,,,,,,,,,,,,,,,,,,,97.255,1.236,0.178,,,,,,,98.07,0.18,1.74,0.269,0.17,-0.448,0.269,0.17,0.448,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,18,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,96.64,-1.34,1.34,,96.57,-0.48,0.48,0.0069,37.23,59.31,3.47,-50.3,48.5,1.9,50.27,48.51,1.87,68.47509,86.0,,,,,,,,,,,,,,,,,,,,,,,,,97.381,1.307,0.149,,,,,,,98.15,0.39,1.47,0.349,0.38,-0.718,0.349,0.38,0.718,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,8,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,97.16,-0.82,0.82,,96.9,-0.14,0.14,0.004,75.12,16.77,8.11,-12.4,6.0,6.5,12.38,5.97,6.51,68.98753,86.0,,,,,,,,,,,,,,,,,,,,,,,,,97.267,1.272,0.153,,,,,,,97.75,0.18,2.07,-0.051,0.17,-0.118,0.051,0.17,0.118,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,3,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.6,-0.38,0.38,,93.7,-3.35,3.35,0.0038,74.1,15.39,10.51,-13.4,4.6,8.9,13.4,4.59,8.91,67.72348,81.75832395,,,,,,,,,,,,,,,,,,,,,,,,,97.105,1.321,0.16,,,,,,,98.994,0.12,0.886,1.193,0.11,-1.302,1.193,0.11,1.302,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,4,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,97.28,-0.7,0.7,,94.62,-2.43,2.43,0.0036,69.98,19.01,11.02,-17.5,8.2,9.4,17.52,8.21,9.42,69.87636,87.0,,,,,,,,,,,,,,,,,,,,,,,,,97.212,2.586,0.202,,,,,,,98.549,0.159,1.292,0.748,0.149,-0.896,0.748,0.149,0.896,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,5,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.29,-0.69,0.69,,95.22,-1.83,1.83,0.0037,74.86,15.7,9.43,-12.6,4.9,7.8,12.64,4.9,7.83,70.77851,87.0,,,,,,,,,,,,,,,,,,,,,,,,,97.324,2.492,0.183,,,,,,,98.206,0.146,1.648,0.405,0.136,-0.54,0.405,0.136,0.54,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,17,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,96.94,-1.04,1.04,,95.73,-1.32,1.32,0.0067,37.43,57.74,4.84,-50.1,46.9,3.2,50.07,46.94,3.24,65.79023,83.3494074,,,,,,,,,,,,,,,,,,,,,,,,,97.421,1.131,0.101,,,,,,,97.012,0.558,2.431,-0.789,0.548,0.243,0.789,0.548,0.243,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,12,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,96.93,-1.05,1.05,,96.63,-0.42,0.42,0.0055,79.32,12.28,8.39,-8.2,1.5,6.8,8.18,1.48,6.79,69.92788,85.47466342,,,,,,,,,,,,,,,,,,,,,,,,,97.462,1.197,0.173,,,,,,,98.321,0.271,1.408,0.52,0.261,-0.78,0.52,0.261,0.78,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,13,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,96.63,-1.35,1.35,,96.49,-0.55,0.55,0.0076,78.58,13.74,7.68,-8.9,2.9,6.1,8.92,2.94,6.08,71.40955,90.0,,,,,,,,,,,,,,,,,,,,,,,,,97.279,1.242,0.171,,,,,,,98.115,0.333,1.551,0.314,0.323,-0.637,0.314,0.323,0.637,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,14,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,97.25,-0.73,0.73,,96.3,-0.74,0.74,0.0078,76.67,15.9,7.44,-10.8,5.1,5.8,10.83,5.1,5.84,70.58512,87.0,,,,,,,,,,,,,,,,,,,,,,,,,97.105,1.415,0.186,,,,,,,97.664,0.35,1.986,-0.137,0.34,-0.202,0.137,0.34,0.202,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,15,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,96.96,-1.02,1.02,,95.57,-1.47,1.47,0.0069,72.31,19.48,8.21,-15.2,8.7,6.6,15.19,8.68,6.61,70.64557,87.0,,,,,,,,,,,,,,,,,,,,,,,,,96.077,1.877,0.206,,,,,,,96.78,0.508,2.713,-1.021,0.498,0.525,1.021,0.498,0.525,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,19,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,96.58,-1.4,1.4,,96.75,-0.29,0.29,0.0044,40.96,57.13,1.91,-46.5,46.3,0.3,46.54,46.33,0.31,68.75246,86.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.676,0.033,1.838,-0.125,0.023,-0.35,0.125,0.023,0.35,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,9,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,97.74,-0.24,0.24,,93.44,-3.61,3.61,0.0027,73.52,15.6,10.89,-14.0,4.8,9.3,13.98,4.8,9.29,66.99309,82.25193954,,,,,,,,,,,,,,,,,,,,,,,,,97.157,2.677,0.167,,,,,,,98.687,0.249,1.063,0.886,0.239,-1.125,0.886,0.239,1.125,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,10,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,97.37,-0.61,0.61,,96.19,-0.86,0.86,0.0017,76.57,14.46,8.96,-10.9,3.7,7.4,10.93,3.66,7.36,69.52102,87.0,,,,,,,,,,,,,,,,,,,,,,,,,97.409,1.241,0.147,,,,,,,97.803,0.24,1.957,0.002,0.23,-0.231,0.002,0.23,0.231,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,25.0,30.0,11,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,97.37,-0.61,0.61,,96.64,-0.4,0.4,0.004,84.14,13.9,1.96,-3.4,3.1,0.4,3.36,3.1,0.36,69.93926,87.0,,,,,,,,,,,,,,,,,,,,,,,,,96.933,1.606,0.224,,,,,,,98.009,0.249,1.741,0.208,0.239,-0.447,0.208,0.239,0.447,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,1,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,97.71,-0.71,0.71,,,,,0.0038,75.9,19.81,4.29,-8.9,7.0,1.9,8.9,7.01,1.89,69.33366,86.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.03,0.76,3.22,-0.284,0.755,-0.461,0.284,0.755,0.461,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,2,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,97.68,-0.74,0.74,,,,,0.0061,78.81,17.81,3.37,-6.0,5.0,1.0,5.99,5.01,0.97,71.21933,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.24,0.53,3.22,-0.074,0.525,-0.461,0.074,0.525,0.461,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,3,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.58,-0.84,0.84,,,,,0.0063,73.52,20.77,5.71,-11.3,8.0,3.3,11.28,7.97,3.31,67.70273,81.81545696,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.34,0.92,2.75,0.026,0.915,-0.931,0.026,0.915,0.931,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,4,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,97.73,-0.69,0.69,,,,,0.0069,76.2,19.37,4.43,-8.6,6.6,2.0,8.6,6.57,2.03,69.56688,85.40042975,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.12,0.77,3.12,-0.194,0.765,-0.561,0.194,0.765,0.561,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,5,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.71,-0.71,0.71,,,,,0.0057,78.1,18.34,3.56,-6.7,5.5,1.2,6.7,5.54,1.16,70.50187,88.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.95,0.57,3.48,-0.364,0.565,-0.201,0.364,0.565,0.201,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,6,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,97.27,-1.15,1.15,,,,,0.0065,70.16,22.86,6.99,-14.6,10.1,4.6,14.64,10.06,4.59,61.10062,78.94443132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.36,1.2,3.45,-0.954,1.195,-0.231,0.954,1.195,0.231,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,7,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,97.81,-0.61,0.61,,,,,0.0075,75.01,20.83,4.15,-9.8,8.0,1.8,9.79,8.03,1.75,67.43836,86.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,0.6,3.8,-0.714,0.595,0.119,0.714,0.595,0.119,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,8,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,97.51,-0.91,0.91,,,,,0.0039,73.7,22.83,3.47,-11.1,10.0,1.1,11.1,10.03,1.07,68.74003,87.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.11,0.39,3.5,-0.204,0.385,-0.181,0.204,0.385,0.181,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,9,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,97.41,-1.01,1.01,,,,,0.0055,73.89,20.62,5.48,-10.9,7.8,3.1,10.91,7.82,3.08,66.99896,82.32103161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.36,0.76,2.88,0.046,0.755,-0.801,0.046,0.755,0.801,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,10,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,97.78,-0.64,0.64,,,,,0.0047,74.72,21.5,3.77,-10.1,8.7,1.4,10.08,8.7,1.37,69.40223,88.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.94,0.45,3.61,-0.374,0.445,-0.071,0.374,0.445,0.071,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,11,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,97.59,-0.83,0.83,,,,,0.0054,76.61,20.38,3.0,-8.2,7.6,0.6,8.19,7.58,0.6,70.28021,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.18,0.38,3.43,-0.134,0.375,-0.251,0.134,0.375,0.251,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,12,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,97.43,-0.99,0.99,,,,,0.0066,77.28,19.37,3.35,-7.5,6.6,1.0,7.52,6.57,0.95,69.85283,86.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.33,0.48,3.19,0.016,0.475,-0.491,0.016,0.475,0.491,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,13,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,97.46,-0.96,0.96,,,,,0.0083,77.84,18.6,3.56,-7.0,5.8,1.2,6.96,5.8,1.16,71.07001,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.26,0.26,3.49,-0.054,0.255,-0.191,0.054,0.255,0.191,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,14,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,97.61,-0.81,0.81,,,,,0.0076,76.68,20.19,3.13,-8.1,7.4,0.7,8.12,7.39,0.73,70.33449,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.82,0.42,3.76,-0.494,0.415,0.079,0.494,0.415,0.079,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,15,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,97.54,-0.88,0.88,,,,,0.0064,68.39,25.93,5.67,-16.4,13.1,3.3,16.41,13.13,3.27,70.0695,87.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,0.4,3.98,-0.684,0.395,0.299,0.684,0.395,0.299,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,16,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,97.57,-0.85,0.85,,,,,0.0055,36.59,61.72,1.69,-48.2,48.9,-0.7,48.21,48.92,0.71,66.48062,84.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.73,0.64,3.63,-0.584,0.635,-0.051,0.584,0.635,0.051,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,17,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,97.55,-0.87,0.87,,,,,0.0065,35.17,63.1,1.73,-49.6,50.3,-0.7,49.63,50.3,0.67,65.64906,83.44973716,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.94,0.77,4.3,-1.374,0.765,0.619,1.374,0.765,0.619,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,18,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,97.41,-1.01,1.01,,,,,0.0069,31.44,67.34,1.22,-53.4,54.5,-1.2,53.36,54.54,1.18,68.09826,87.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.21,0.62,3.17,-0.104,0.615,-0.511,0.104,0.615,0.511,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,25.0,30.0,19,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,97.45,-0.97,0.97,,,,,0.0058,31.69,66.47,1.84,-53.1,53.7,-0.6,53.11,53.67,0.56,68.51927,86.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,1.17,3.23,-0.714,1.165,-0.451,0.714,1.165,0.451,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,1,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,97.34,1.46,1.46,,,,,0.0041,71.44,24.47,4.09,-1.7,0.2,1.5,1.66,0.17,1.49,69.14442678,88.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.9,2.37,3.73,-0.043,2.33,-2.287,0.043,2.33,2.287,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,2,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,97.02,1.14,1.14,,,,,0.005,71.68,24.54,3.78,-1.4,0.2,1.2,1.42,0.24,1.18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.2,0.65,4.14,1.257,0.61,-1.877,1.257,0.61,1.877,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,3,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.36,1.48,1.48,,,,,0.0048,70.04,24.52,5.43,-3.1,0.2,2.8,3.06,0.22,2.83,67.54287147,83.55866571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.47,3.68,2.86,-0.473,3.64,-3.157,0.473,3.64,3.157,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,4,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,97.12,1.24,1.24,,,,,0.0055,70.45,25.19,4.36,-2.6,0.9,1.8,2.65,0.89,1.76,69.35562335,87.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.44,0.87,3.7,1.497,0.83,-2.317,1.497,0.83,2.317,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,5,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.21,1.33,1.33,,,,,0.0035,70.61,25.68,3.72,-2.5,1.4,1.1,2.49,1.38,1.12,70.38845686,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.75,1.0,4.25,0.807,0.96,-1.767,0.807,0.96,1.767,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,6,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,97.68,1.8,1.8,,,,,0.0036,69.52,24.63,5.85,-3.6,0.3,3.3,3.58,0.33,3.25,60.79894114,81.16082577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.98,1.78,4.24,0.037,1.74,-1.777,0.037,1.74,1.777,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,7,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,97.4,1.52,1.52,,,,,0.0053,71.05,25.19,3.77,-2.1,0.9,1.2,2.05,0.89,1.17,67.30275451,88.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.67,1.72,4.61,-0.273,1.68,-1.407,0.273,1.68,1.407,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,8,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,96.85,0.97,0.97,,,,,0.0064,69.8,26.82,3.38,-3.3,2.5,0.8,3.3,2.52,0.78,68.74277443,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.32,1.42,5.26,-0.623,1.38,-0.757,0.623,1.38,0.757,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,9,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,97.56,1.68,1.68,,,,,0.0051,67.51,27.28,5.21,-5.6,3.0,2.6,5.59,2.98,2.61,67.06594589,84.43055977,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.55,1.81,3.64,0.607,1.77,-2.377,0.607,1.77,2.377,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,10,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,97.21,1.33,1.33,,,,,0.0045,69.1,27.16,3.72,-4.0,2.9,1.1,4.0,2.86,1.12,69.15403139,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.68,1.51,4.81,-0.263,1.47,-1.207,0.263,1.47,1.207,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,11,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,96.8,0.92,0.92,,,,,0.0049,68.98,27.73,3.29,-4.1,3.4,0.7,4.12,3.43,0.69,69.72865739,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.52,3.62,3.86,-1.423,3.58,-2.157,1.423,3.58,2.157,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,12,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,96.6,0.72,0.72,,,,,0.0056,75.89,21.13,2.98,2.8,-3.2,0.4,2.79,3.17,0.38,69.57070583,88.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.62,0.93,3.45,1.677,0.89,-2.567,1.677,0.89,2.567,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,13,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,96.27,0.39,0.39,,,,,0.0074,71.67,24.33,4.01,-1.4,0.0,1.4,1.43,0.03,1.41,70.73565377,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.97,0.7,4.33,1.027,0.66,-1.687,1.027,0.66,1.687,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,14,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,96.95,1.07,1.07,,,,,0.0072,71.62,25.03,3.35,-1.5,0.7,0.8,1.48,0.73,0.75,70.22723835,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.64,1.09,5.27,-0.303,1.05,-0.747,0.303,1.05,0.747,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,15,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,96.91,1.03,1.03,,,,,0.0058,66.96,27.07,5.96,-6.1,2.8,3.4,6.14,2.77,3.36,70.34676147,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.5,2.8,4.7,-1.443,2.76,-1.317,1.443,2.76,1.317,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,16,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,97.02,1.14,1.14,,,,,0.0066,32.57,66.25,1.19,-40.5,42.0,-1.4,40.53,41.95,1.41,66.46567468,86.11640609,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.34,1.98,4.68,-0.603,1.94,-1.337,0.603,1.94,1.337,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,17,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,97.3,1.42,1.42,,,,,0.0068,29.91,68.88,1.21,-43.2,44.6,-1.4,43.19,44.58,1.39,65.54175193,85.08930582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.04,1.57,5.39,-0.903,1.53,-0.627,0.903,1.53,0.627,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,18,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,96.69,0.81,0.81,,,,,0.0082,29.77,69.21,1.02,-43.3,44.9,-1.6,43.33,44.91,1.58,68.21492229,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.36,1.72,4.92,-0.583,1.68,-1.097,0.583,1.68,1.097,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,25.0,30.0,19,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,96.59,0.71,0.71,,,,,0.0056,27.42,70.9,1.68,-46.7,48.8,-2.1,46.68,48.8,2.12,68.4921336,90.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.13,1.64,5.23,-0.813,1.6,-0.787,0.813,1.6,0.787,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,1,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,98.19,0.65,0.65,,,,,0.003,77.54,18.84,3.62,3.4,-3.3,-0.2,3.44,3.26,0.18,69.2545527,82.10241214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.57,0.0,2.43,1.185,-0.015,-1.17,1.185,0.015,1.17,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,2,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,98.07,0.53,0.53,,,,,0.0047,74.45,21.84,3.72,0.4,-0.3,-0.1,0.35,0.26,0.08,70.79934909,83.28610996,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.5,0.05,1.45,2.115,0.035,-2.15,2.115,0.035,2.15,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,3,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,98.02,0.48,0.48,,,,,0.0053,70.16,23.33,6.51,-3.9,1.2,2.7,3.94,1.23,2.71,67.92585223,79.86924857,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.71,1.25,2.03,0.325,1.235,-1.57,0.325,1.235,1.57,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,4,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,98.12,0.58,0.58,,,,,0.0058,72.12,23.03,4.86,-2.0,0.9,1.1,1.98,0.93,1.06,69.70809066,82.07925348,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.62,1.8,1.57,0.235,1.785,-2.03,0.235,1.785,2.03,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,5,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,98.34,0.8,0.8,,,,,0.005,77.72,19.23,3.06,3.6,-2.9,-0.7,3.62,2.87,0.74,70.46986227,82.75395634,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.71,1.28,2.01,0.325,1.265,-1.59,0.325,1.265,1.59,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,6,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,97.61,0.07,0.07,,,,,0.0049,69.82,23.44,6.74,-4.3,1.3,2.9,4.28,1.34,2.94,60.90048361,77.17585325,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.56,1.2,2.23,0.175,1.185,-1.37,0.175,1.185,1.37,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,7,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,98.38,0.84,0.84,,,,,0.0052,76.42,19.73,3.85,2.3,-2.4,0.0,2.32,2.37,0.05,67.3923395,81.74312684,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.81,1.69,2.5,-0.575,1.675,-1.1,0.575,1.675,1.1,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,8,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,98.43,0.89,0.89,,,,,0.006,69.18,27.16,3.66,-4.9,5.1,-0.1,4.92,5.06,0.14,68.76021275,82.85631598,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.7,1.49,2.81,-0.685,1.475,-0.79,0.685,1.475,0.79,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,9,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,97.78,0.24,0.24,,,,,0.0046,70.08,24.19,5.73,-4.0,2.1,1.9,4.02,2.09,1.93,66.88536993,80.11943129,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.27,1.68,2.05,-0.115,1.665,-1.55,0.115,1.665,1.55,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,10,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,98.4,0.86,0.86,,,,,0.0026,73.01,23.2,3.79,-1.1,1.1,0.0,1.09,1.1,0.01,69.48036562,82.57865167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.86,1.49,2.64,-0.525,1.475,-0.96,0.525,1.475,0.96,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,11,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,98.37,0.83,0.83,,,,,0.0012,65.28,31.0,3.72,-8.8,8.9,-0.1,8.82,8.9,0.08,70.0486006,83.14555131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.72,3.44,1.85,-1.665,3.425,-1.75,1.665,3.425,1.75,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,12,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,98.02,0.48,0.48,,,,,0.0031,75.44,21.21,3.36,1.3,-0.9,-0.4,1.34,0.89,0.44,69.89132675,82.08181823,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.74,0.58,1.68,1.355,0.565,-1.92,1.355,0.565,1.92,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,13,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,98.29,0.75,0.75,,,,,0.0042,72.55,23.44,4.0,-1.6,1.3,0.2,1.55,1.34,0.2,71.14691673,83.65004188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.45,1.69,1.86,0.065,1.675,-1.74,0.065,1.675,1.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,14,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,98.6,1.06,1.06,,,,,0.0028,75.13,21.66,3.21,1.0,-0.4,-0.6,1.03,0.44,0.59,70.76990889,84.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.24,0.63,2.14,0.855,0.615,-1.46,0.855,0.615,1.46,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,15,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,98.31,0.77,0.77,,,,,0.0033,63.44,31.5,5.04,-10.7,9.4,1.2,10.66,9.4,1.24,70.33157163,83.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.72,0.67,3.61,-0.665,0.655,0.01,0.665,0.655,0.01,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,16,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,98.23,0.69,0.69,,,,,0.0024,1.01,98.73,0.26,-73.1,76.6,-3.5,73.09,76.63,3.54,66.58332198,80.79622403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.32,2.47,2.21,-1.065,2.455,-1.39,1.065,2.455,1.39,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,17,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,98.29,0.75,0.75,,,,,0.0035,27.22,71.15,1.63,-46.9,49.1,-2.2,46.88,49.05,2.17,65.80467254,80.25492094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.01,0.74,3.24,-0.375,0.725,-0.36,0.375,0.725,0.36,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,18,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,98.34,0.8,0.8,,,,,0.0033,27.97,70.83,1.19,-46.1,48.7,-2.6,46.13,48.73,2.61,68.49099698,82.60103997,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.14,1.28,2.57,-0.245,1.265,-1.03,0.245,1.265,1.03,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,25.0,30.0,19,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,98.37,0.83,0.83,,,,,-0.0004,26.6,71.86,1.55,-47.5,49.8,-2.3,47.5,49.76,2.25,68.94709907,82.64533277,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.71,1.42,2.86,-0.675,1.405,-0.74,0.675,1.405,0.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,24,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0042,78.55,14.46,7.0,-9.0,3.7,5.4,8.95,3.66,5.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.61,0.36,9.03,-7.191,0.35,6.842,7.191,0.35,6.842,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,21,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0024,81.15,12.39,6.46,-6.3,1.6,4.9,6.35,1.59,4.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.64,0.27,11.09,-9.161,0.26,8.902,9.161,0.26,8.902,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,22,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0044,81.07,11.2,7.73,-6.4,0.4,6.1,6.43,0.4,6.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.53,0.19,8.28,-6.271,0.18,6.092,6.271,0.18,6.092,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,23,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.004,71.0,16.88,12.12,-16.5,6.1,10.5,16.5,6.08,10.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.57,0.66,4.76,-3.231,0.65,2.572,3.231,0.65,2.572,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,25,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0054,78.08,13.51,8.41,-9.4,2.7,6.8,9.42,2.71,6.81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.73,0.26,12.01,-10.071,0.25,9.822,10.071,0.25,9.822,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,26,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0121,24.61,69.35,6.04,-62.9,58.6,4.4,62.89,58.55,4.44,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.13,2.49,65.38,-65.671,2.48,63.192,65.671,2.48,63.192,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,27,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0327,51.25,36.47,12.28,-36.3,25.7,10.7,36.25,25.67,10.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,43.39,0.54,56.07,-54.411,0.53,53.882,54.411,0.53,53.882,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,28,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0401,48.43,36.39,15.18,-39.1,25.6,13.6,39.07,25.59,13.58,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41.98,0.25,57.77,-55.821,0.24,55.582,55.821,0.24,55.582,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,29,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0067,64.2,20.6,15.2,-23.3,9.8,13.6,23.3,9.8,13.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.54,0.9,11.54,-10.261,0.89,9.352,10.261,0.89,9.352,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,30,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0076,56.18,36.89,6.92,-31.3,26.1,5.3,31.32,26.09,5.32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,73.52,0.33,26.15,-24.281,0.32,23.962,24.281,0.32,23.962,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,31,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0109,74.35,18.91,6.73,-13.2,8.1,5.1,13.15,8.11,5.13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.15,0.25,24.6,-22.651,0.24,22.412,22.651,0.24,22.412,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,32,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0131,77.09,13.63,9.28,-10.4,2.8,7.7,10.41,2.83,7.68,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.41,0.27,7.32,-5.391,0.26,5.132,5.391,0.26,5.132,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,33,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0063,81.5,12.5,6.0,-6.0,1.7,4.4,6.0,1.7,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.53,0.28,9.19,-7.271,0.27,7.002,7.271,0.27,7.002,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,34,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0091,62.36,30.01,7.63,-25.1,19.2,6.0,25.14,19.21,6.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.2,0.29,24.5,-22.601,0.28,22.312,22.601,0.28,22.312,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,35,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0142,42.38,44.23,13.4,-45.1,33.4,11.8,45.12,33.43,11.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,61.04,1.02,37.95,-36.761,1.01,35.762,36.761,1.01,35.762,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,36,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0278,57.29,37.26,5.45,-30.2,26.5,3.9,30.21,26.46,3.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70.31,0.61,29.08,-27.491,0.6,26.892,27.491,0.6,26.892,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,37,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,,,,,,,,0.0114,18.16,73.19,8.64,-69.3,62.4,7.0,69.34,62.39,7.04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30.9,0.92,68.18,-66.901,0.91,65.992,66.901,0.91,65.992,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,38,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0483,29.98,68.64,1.37,-57.5,57.8,-0.2,57.52,57.84,0.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.88,0.34,38.79,-36.921,0.33,36.602,36.921,0.33,36.602,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014234,Trispecific,MULTIPLE CONTROL,,35.0,30.0,39,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,,,,,,,,0.0214,23.22,73.32,3.46,-64.3,62.5,1.9,64.28,62.52,1.86,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64.88,0.46,34.66,-32.921,0.45,32.472,32.921,0.45,32.472,DAB014234,DAB014234,Humanized,JXA3188-(VH)-JXP1956 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,24,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0081,68.76,22.61,8.64,-16.0,9.8,6.2,16.04,9.81,6.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.04,1.3,10.66,-8.274,1.295,6.979,8.274,1.295,6.979,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,21,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0049,70.4,23.11,6.49,-14.4,10.3,4.1,14.4,10.31,4.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.79,1.08,13.12,-10.524,1.075,9.439,10.524,1.075,9.439,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,22,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0059,77.41,17.91,4.68,-7.4,5.1,2.3,7.39,5.11,2.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.95,0.61,9.45,-6.364,0.605,5.769,6.364,0.605,5.769,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,23,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0072,62.65,25.25,12.1,-22.2,12.5,9.7,22.15,12.45,9.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.19,2.24,6.57,-5.124,2.235,2.889,5.124,2.235,2.889,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,25,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0073,70.78,23.54,5.67,-14.0,10.7,3.3,14.02,10.74,3.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84.56,0.87,14.56,-11.754,0.865,10.879,11.754,0.865,10.879,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,26,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0175,17.06,79.85,3.1,-67.7,67.1,0.7,67.74,67.05,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30.25,3.04,66.72,-66.064,3.035,63.039,66.064,3.035,63.039,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,27,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0495,40.04,47.56,12.4,-44.8,34.8,10.0,44.76,34.76,10.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38.67,0.86,60.48,-57.644,0.855,56.799,57.644,0.855,56.799,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,28,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0521,52.53,32.86,14.61,-32.3,20.1,12.2,32.27,20.06,12.21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,35.46,0.41,64.12,-60.854,0.405,60.439,60.854,0.405,60.439,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,29,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0064,64.2,20.6,15.2,-20.6,7.8,12.8,20.6,7.8,12.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.71,2.31,10.97,-9.604,2.305,7.289,9.604,2.305,7.289,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,30,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0121,56.18,36.89,6.92,-28.6,24.1,4.5,28.62,24.09,4.52,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65.39,0.81,33.8,-30.924,0.805,30.119,30.924,0.805,30.119,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,31,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0159,74.35,18.91,6.73,-10.5,6.1,4.3,10.45,6.11,4.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,67.72,0.36,31.92,-28.594,0.355,28.239,28.594,0.355,28.239,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,32,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0074,78.55,16.95,4.49,-6.3,4.2,2.1,6.25,4.15,2.09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.35,0.64,10.01,-6.964,0.635,6.329,6.964,0.635,6.329,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,33,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0115,81.5,12.5,6.0,-3.3,-0.3,3.6,3.3,0.3,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.54,0.35,13.11,-9.774,0.345,9.429,9.774,0.345,9.429,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,34,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0172,62.36,30.01,7.63,-22.4,17.2,5.2,22.44,17.21,5.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,66.58,0.35,33.06,-29.734,0.345,29.379,29.734,0.345,29.379,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,35,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0338,42.38,44.23,13.4,-42.4,31.4,11.0,42.42,31.43,11.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,52.67,1.0,46.33,-43.644,0.995,42.649,43.644,0.995,42.649,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,36,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.052,22.78,44.46,32.76,-62.0,31.7,30.4,62.02,31.66,30.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34.29,1.18,64.54,-62.024,1.175,60.859,62.024,1.175,60.859,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,37,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,,,,,,,,0.0629,17.58,76.91,5.51,-67.2,64.1,3.1,67.22,64.11,3.11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.97,1.58,69.45,-67.344,1.575,65.769,67.344,1.575,65.769,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,38,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0281,29.98,68.64,1.37,-54.8,55.8,-1.0,54.82,55.84,1.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50.88,0.42,48.7,-45.434,0.415,45.019,45.434,0.415,45.019,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014235,Trispecific,MULTIPLE CONTROL,,35.0,30.0,39,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,,,,,,,,0.0258,23.22,73.32,3.46,-61.6,60.5,1.1,61.58,60.52,1.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57.25,0.52,42.24,-39.064,0.515,38.559,39.064,0.515,38.559,DAB014235,DAB014235,Humanized,JXA3189-(VL)-JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_LC(G57T) / JXP1956 + CM + DAB012135_HC (huHYB023164),8.22,94631.21036,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,21,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0041,67.98,24.62,7.4,-5.1,0.3,4.8,5.12,0.32,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.52,0.4,10.09,-4.423,0.36,4.073,4.423,0.36,4.073,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,22,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0057,70.71,24.04,5.25,-2.4,-0.3,2.7,2.39,0.26,2.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,0.31,8.39,-2.643,0.27,2.373,2.643,0.27,2.373,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,23,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0063,59.61,27.13,13.25,-13.5,2.8,10.7,13.49,2.83,10.65,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.27,0.98,7.75,-2.673,0.94,1.733,2.673,0.94,1.733,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,24,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0075,66.33,25.1,8.56,-6.8,0.8,6.0,6.77,0.8,5.96,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.98,0.47,9.55,-3.963,0.43,3.533,3.963,0.43,3.533,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,25,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0058,71.01,23.15,5.84,-2.1,-1.2,3.2,2.09,1.15,3.24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.11,0.36,11.53,-5.833,0.32,5.513,5.833,0.32,5.513,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,26,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0115,16.76,80.25,2.99,-56.3,56.0,0.4,56.34,55.95,0.39,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33.76,2.37,63.88,-60.183,2.33,57.863,60.183,2.33,57.863,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,27,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0301,45.34,45.88,8.77,-27.8,21.6,6.2,27.76,21.58,6.17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,42.28,0.61,57.1,-51.663,0.57,51.083,51.663,0.57,51.083,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,28,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0336,51.52,36.52,11.96,-21.6,12.2,9.4,21.58,12.22,9.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,39.89,0.34,59.78,-54.053,0.3,53.763,54.053,0.3,53.763,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,29,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0052,56.87,31.36,11.76,-16.2,7.1,9.2,16.23,7.06,9.16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.21,1.02,11.76,-6.733,0.98,5.743,6.733,0.98,5.743,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,30,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0073,71.39,23.89,4.72,-1.7,-0.4,2.1,1.71,0.41,2.12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.32,0.34,24.35,-18.623,0.3,18.333,18.623,0.3,18.333,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,31,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0091,55.39,40.95,3.66,-17.7,16.7,1.1,17.71,16.65,1.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,74.5,0.09,25.42,-19.443,0.05,19.403,19.443,0.05,19.403,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,32,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0066,73.76,21.62,4.63,0.7,-2.7,2.0,0.66,2.68,2.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.48,0.36,8.16,-2.463,0.32,2.143,2.463,0.32,2.143,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,33,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0095,73.27,19.46,7.27,0.2,-4.8,4.7,0.17,4.84,4.67,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.64,0.47,9.89,-4.303,0.43,3.873,4.303,0.43,3.873,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,34,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0248,61.42,33.71,4.87,-11.7,9.4,2.3,11.68,9.41,2.27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,75.4,0.49,24.11,-18.543,0.45,18.093,18.543,0.45,18.093,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,35,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0184,58.96,28.69,12.35,-14.1,4.4,9.8,14.14,4.39,9.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.71,1.44,26.85,-22.233,1.4,20.833,22.233,1.4,20.833,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,36,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.0305,21.34,72.33,6.34,-51.8,48.0,3.7,51.76,48.03,3.74,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41.22,0.79,57.98,-52.723,0.75,51.963,52.723,0.75,51.963,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,37,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,,,,,,,,0.0546,14.42,83.91,1.67,-58.7,59.6,-0.9,58.68,59.61,0.93,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,31.92,1.11,66.98,-62.023,1.07,60.963,62.023,1.07,60.963,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,38,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0187,31.93,67.8,0.26,-41.2,43.5,-2.3,41.17,43.5,2.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58.96,0.64,40.41,-34.983,0.6,34.393,34.983,0.6,34.393,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014236,Trispecific,MULTIPLE CONTROL,,35.0,30.0,39,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,,,,,,,,0.0163,23.26,73.88,2.85,-49.8,49.6,0.3,49.84,49.58,0.25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,60.31,0.68,39.0,-33.633,0.64,32.983,33.633,0.64,32.983,DAB014236,DAB014236,Humanized,JXA3190-(VH)-JXP1957 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC (huHYB023164),8.32,94557.13096,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,21,1.0,Acetate pH 4.5,NB-walpeter-5075040-0039,4.5,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0045,74.04,18.81,7.15,-0.1,-3.3,3.4,0.06,3.29,3.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.99,0.67,11.34,-8.395,0.655,7.74,8.395,0.655,7.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,22,1.0,Acetate pH 5.0,NB-walpeter-5075040-0039,5.0,Acetate,0,0,0.0,0.0,0,,,,,,,,,,,0.0059,73.35,20.94,5.72,-0.8,-1.2,1.9,0.75,1.16,1.92,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.59,0.49,8.91,-5.795,0.475,5.31,5.795,0.475,5.31,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,23,1.0,Glutamate pH 4.0,NB-walpeter-5075040-0039,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0067,57.38,27.18,15.43,-16.7,5.1,11.6,16.72,5.08,11.63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.88,0.87,7.24,-4.505,0.855,3.64,4.505,0.855,3.64,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,24,1.0,Glutamate pH 4.5,NB-walpeter-5075040-0039,4.5,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0078,64.93,25.16,9.9,-9.2,3.1,6.1,9.17,3.06,6.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.6,0.68,10.72,-7.785,0.665,7.12,7.785,0.665,7.12,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,25,1.0,Glutamate pH 5.0,NB-walpeter-5075040-0039,5.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,0.0072,70.91,22.25,6.83,-3.2,0.2,3.0,3.19,0.15,3.03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.11,0.59,13.29,-10.275,0.575,9.69,10.275,0.575,9.69,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,26,1.0,Citrate pH 4.0,NB-walpeter-5075040-0039,4.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0135,18.1,77.81,4.08,-56.0,55.7,0.3,56.0,55.71,0.28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32.6,2.59,64.82,-63.785,2.575,61.22,63.785,2.575,61.22,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,27,1.0,Citrate pH 5.0,NB-walpeter-5075040-0039,5.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0427,59.27,26.02,14.71,-14.8,3.9,10.9,14.83,3.92,10.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,38.27,0.83,60.9,-58.115,0.815,57.3,58.115,0.815,57.3,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,28,1.0,Citrate pH 6.5,NB-walpeter-5075040-0039,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,0.0511,43.58,43.55,12.87,-30.5,21.5,9.1,30.52,21.45,9.07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,36.48,0.61,62.9,-59.905,0.595,59.3,59.905,0.595,59.3,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,29,1.0,Succinate pH 4.0,NB-walpeter-5075040-0039,4.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0051,57.21,29.27,13.53,-16.9,7.2,9.7,16.89,7.17,9.73,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.63,1.0,11.37,-8.755,0.985,7.77,8.755,0.985,7.77,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,30,1.0,Succinate pH 5.0,NB-walpeter-5075040-0039,5.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0086,57.09,38.76,4.15,-17.0,16.7,0.4,17.01,16.66,0.35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.16,0.62,28.22,-25.225,0.605,24.62,25.225,0.605,24.62,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,31,1.0,Succinate pH 6.0,NB-walpeter-5075040-0039,6.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,0.0118,62.75,33.12,4.13,-11.4,11.0,0.3,11.35,11.02,0.33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70.59,0.54,28.87,-25.795,0.525,25.27,25.795,0.525,25.27,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,32,1.0,Histidine pH 5.5,NB-walpeter-5075040-0039,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.005,76.76,18.1,5.14,2.7,-4.0,1.3,2.66,4.0,1.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.22,0.44,8.34,-5.165,0.425,4.74,5.165,0.425,4.74,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,33,1.0,Histidine pH 6.5,NB-walpeter-5075040-0039,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,0.0069,74.36,17.93,7.71,0.3,-4.2,3.9,0.26,4.17,3.91,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.36,0.51,11.12,-8.025,0.495,7.52,8.025,0.495,7.52,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,0,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,34,1.0,Phosphate pH 6.0,NB-walpeter-5075040-0039,6.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0121,66.33,28.17,5.49,-7.8,6.1,1.7,7.77,6.07,1.69,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,71.39,0.54,28.08,-24.995,0.525,24.48,24.995,0.525,24.48,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,35,1.0,Phosphate pH 7.0,NB-walpeter-5075040-0039,7.0,Phosphate,0,0,0.0,0.0,0,,,,,,,,,,,0.0303,41.72,39.43,18.86,-32.4,17.3,15.1,32.38,17.33,15.06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,55.98,1.14,42.88,-40.405,1.125,39.28,40.405,1.125,39.28,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,,-,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,36,1.0,Acetate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Acetate,0,150,0.0,0.0,0,,,,,,,,,,,0.039,20.76,69.11,10.14,-53.3,47.0,6.3,53.34,47.01,6.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37.2,0.76,62.04,-59.185,0.745,58.44,59.185,0.745,58.44,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,37,1.0,Glutamate pH 5.0 NaCl,NB-walpeter-5075040-0039,5.0,Glutamate,0,150,0.0,0.0,0,,,,,,,,,,,0.0505,24.42,60.28,15.29,-49.7,38.2,11.5,49.68,38.18,11.49,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.93,0.96,70.11,-67.455,0.945,66.51,67.455,0.945,66.51,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,38,1.0,Citrate pH 6.0 NaCl,NB-walpeter-5075040-0039,6.0,Citrate,0,150,0.0,0.0,0,,,,,,,,,,,0.0238,25.36,61.23,13.41,-48.7,39.1,9.6,48.74,39.13,9.61,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,53.89,0.52,45.59,-42.495,0.505,41.99,42.495,0.505,41.99,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
10/18/2023,walpeter,TRACTr Nectin-4,DAB014238,Trispecific,MULTIPLE CONTROL,,35.0,30.0,39,1.0,Phosphate pH 7.0 NaCl,NB-walpeter-5075040-0039,7.0,Phosphate,0,150,0.0,0.0,0,,,,,,,,,,,0.0191,21.34,66.12,12.55,-52.8,44.0,8.8,52.76,44.02,8.75,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,58.83,0.67,40.5,-37.555,0.655,36.9,37.555,0.655,36.9,DAB014238,DAB014238,Humanized,JXA3192-(VH)-JXP1963 + CM + DAB012135_LC(G57T) / JXA2198 + JXA1443 + CM + SP34.185 scFv + DAB012135_HC,8.32,94583.21216,,"ALB_H, NECTIN-4_H",TsAb,NaCl 150 mM,NaCl 150 mM,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_5.5S_2w25C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,9.0,0,,,,91.2,-4.0,4.0,65.98,99.56,-0.4,0.4,,55.4,35.6,9.0,-8.6,8.9,-0.2,8.6,8.9,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.5,3.44,5.06,0.8,-0.8,0.0,0.8,0.8,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_5.5S_2w40C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,9.0,0,,,,88.6,-6.6,6.6,63.84,98.78,-1.2,1.2,,29.5,62.8,7.7,-34.5,36.1,-1.5,34.5,36.1,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.52,9.13,4.36,-4.2,4.9,-0.7,4.2,4.9,0.7,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Cit_5.5S_4w5C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,9.0,0,,,,88.7,-6.5,6.5,66.23,99.98,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.18,3.16,5.66,0.5,-1.0,0.6,0.5,1.0,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_5.5S_T0,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,9.0,0,,,,95.2,0.0,0.0,66.43,100.0,0.0,0.0,,64.03,26.73,9.24,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.7,4.2,5.1,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_5.5_2w25C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,0.0,0,,,,91.2,-4.0,4.0,66.06,99.59,-0.4,0.4,,46.23,46.55,7.22,-6.8,6.8,-0.1,6.8,6.8,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.6,3.17,5.23,0.9,-1.1,0.1,0.9,1.1,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_5.5_2w40C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,0.0,0,,,,88.7,-6.5,6.5,63.62,98.67,-1.3,1.3,,27.05,66.89,6.06,-25.9,27.2,-1.2,25.9,27.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.67,9.45,4.88,-5.0,5.2,-0.2,5.0,5.2,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Cit_5.5_4w5C,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,0.0,0,,,,89.2,-6.0,6.0,66.27,99.96,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,2.97,5.74,0.6,-1.3,0.7,0.6,1.3,0.7,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_5.5_T0,NB-penglei5-5060234-0005,5.5,Citrate,0,0,0.0,0.0,0,,,,95.2,0.0,0.0,66.72,100.0,0.0,0.0,,52.98,39.74,7.28,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.65,4.27,5.09,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_5S_2w25C,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,9.0,0,,,,91.6,-3.7,3.7,65.8,99.32,0.4,0.4,,54.94,37.07,7.99,-11.9,13.5,-1.7,11.9,13.5,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.99,2.87,5.14,1.2,-1.2,0.0,1.2,1.2,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_5S_2w40C,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,9.0,0,,,,88.3,-7.0,7.0,63.46,98.49,-0.4,0.4,,30.7,60.0,9.2,-36.1,36.5,-0.5,36.1,36.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.27,9.9,4.83,-5.5,5.8,-0.3,5.5,5.8,0.3,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Cit_5S_4w5C,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,9.0,0,,,,89.1,-6.2,6.2,66.39,99.94,1.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,2.69,6.01,0.5,-1.4,0.9,0.5,1.4,0.9,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_5S_T0,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,9.0,0,,,,95.3,0.0,0.0,65.92,98.9,0.0,0.0,,66.8,23.54,9.66,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.79,4.1,5.11,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_5_2w25C,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,0.0,0,,,,91.6,-3.6,3.6,65.71,99.26,-0.7,0.7,,43.4,49.81,6.79,-13.6,15.2,-1.6,13.6,15.2,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.78,2.82,5.4,0.9,-1.3,0.4,0.9,1.3,0.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_5_2w40C,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,0.0,0,,,,88.6,-6.6,6.6,63.25,98.64,-1.4,1.4,,32.05,62.45,5.51,-25.0,27.8,-2.9,25.0,27.8,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.12,11.26,5.62,-7.7,7.2,0.6,7.7,7.2,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Cit_5_4w5C,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,0.0,0,,,,89.1,-6.1,6.1,66.29,99.94,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.39,2.51,6.1,0.5,-1.6,1.0,0.5,1.6,1.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_5_T0,NB-penglei5-5060234-0005,5.0,Citrate,0,0,0.0,0.0,0,,,,95.2,0.0,0.0,66.85,100.0,0.0,0.0,,57.0,34.62,8.38,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.85,4.1,5.05,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_6S_2w25C,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,9.0,0,,,,90.8,-4.3,4.3,66.01,99.58,-0.4,0.4,,61.89,29.61,8.5,-1.0,1.8,-0.8,1.0,1.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.05,4.04,4.91,0.2,-0.1,-0.2,0.2,0.1,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_6S_2w40C,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,9.0,0,,,,89.0,-6.1,6.1,63.96,98.94,-1.1,1.1,,30.7,60.8,8.5,-32.1,32.9,-0.8,32.1,32.9,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.32,8.45,4.23,-3.5,4.3,-0.8,3.5,4.3,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Cit_6S_4w5C,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,9.0,0,,,,89.3,-5.8,5.8,66.29,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.79,3.82,5.39,0.0,-0.3,0.3,0.0,0.3,0.3,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_6S_T0,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,9.0,0,,,,95.1,0.0,0.0,66.8,100.0,0.0,0.0,,62.84,27.86,9.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.8,4.12,5.08,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_6_2w25C,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,0.0,0,,,,90.8,-4.2,4.2,66.04,99.65,-0.3,0.3,,44.8,48.45,6.74,-5.8,5.9,-0.1,5.8,5.9,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.24,3.67,5.09,0.3,-0.4,0.1,0.3,0.4,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_6_2w40C,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,0.0,0,,,,89.2,-5.8,5.8,63.92,98.88,-1.1,1.1,,26.51,67.9,5.59,-24.1,25.3,-1.2,24.1,25.3,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.38,8.99,4.63,-4.6,5.0,-0.4,4.6,5.0,0.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Cit_6_4w5C,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,0.0,0,,,,89.4,-5.6,5.6,66.49,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.34,3.42,5.24,0.4,-0.6,0.2,0.4,0.6,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_6_T0,NB-penglei5-5060234-0005,6.0,Citrate,0,0,0.0,0.0,0,,,,95.0,0.0,0.0,66.93,100.0,0.0,0.0,,50.63,42.56,6.82,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.96,4.04,5.0,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Glu_4_2w25C,NB-penglei5-5060234-0005,4.0,Glutamate,0,0,0.0,0.0,0,,,,91.4,-3.7,3.7,66.39,99.6,-0.4,0.4,,55.85,36.45,7.71,-7.6,9.3,-1.7,7.6,9.3,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.88,4.22,3.9,1.5,-0.5,-1.0,1.5,0.5,1.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Glu_4_2w40C,NB-penglei5-5060234-0005,4.0,Glutamate,0,0,0.0,0.0,0,,,,85.4,-9.7,9.7,57.99,94.68,-5.3,5.3,,34.26,59.08,6.66,-29.2,31.9,-2.8,29.2,31.9,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.84,17.8,2.36,-10.6,13.1,-2.5,10.6,13.1,2.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Glu_4_4w5C,NB-penglei5-5060234-0005,4.0,Glutamate,0,0,0.0,0.0,0,,,,89.5,-5.6,5.6,66.47,99.96,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Glu_4_T0,NB-penglei5-5060234-0005,4.0,Glutamate,0,0,0.0,0.0,0,,,,95.1,0.0,0.0,68.31,100.0,0.0,0.0,,63.43,27.15,9.42,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.41,4.71,4.88,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Glu_5S_2w25C,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,9.0,0,,,,91.4,-3.8,3.8,66.45,99.63,-0.4,0.4,,65.45,25.23,9.32,-2.2,2.6,-0.4,2.2,2.6,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.59,4.15,4.25,0.7,0.0,-0.7,0.7,0.0,0.7,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Glu_5S_2w40C,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,9.0,0,,,,89.0,-6.2,6.2,65.05,99.04,-1.0,1.0,,41.27,45.43,13.3,-26.4,22.8,3.6,26.4,22.8,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.23,9.21,3.56,-3.6,5.0,-1.4,3.6,5.0,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Glu_5S_4w5C,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,9.0,0,,,,89.3,-5.9,5.9,66.57,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.87,3.16,4.98,1.0,-1.0,0.0,1.0,1.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Glu_5S_T0,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,9.0,0,,,,95.2,0.0,0.0,67.02,100.0,0.0,0.0,,67.65,22.66,9.69,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.87,4.19,4.94,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Glu_5_2w25C,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,0.0,0,,,,91.4,-3.6,3.6,66.41,99.65,-0.3,0.3,,60.24,31.53,8.24,-3.4,4.1,-0.6,3.4,4.1,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.24,4.36,4.4,0.4,0.2,-0.6,0.4,0.2,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Glu_5_2w40C,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,0.0,0,,,,89.0,-6.0,6.0,64.39,99.1,-0.9,0.9,,42.3,48.16,9.54,-21.4,20.7,0.7,21.4,20.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.9,10.53,3.57,-4.9,6.4,-1.5,4.9,6.4,1.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Glu_5_4w5C,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,0.0,0,,,,89.2,-5.8,5.8,66.54,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.3,3.54,5.16,0.5,-0.6,0.1,0.5,0.6,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Glu_5_T0,NB-penglei5-5060234-0005,5.0,Glutamate,0,0,0.0,0.0,0,,,,95.0,0.0,0.0,67.13,100.0,0.0,0.0,,63.69,27.47,8.84,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.83,4.13,5.04,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_5.5S_2w25C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,9.0,0,,,,91.3,-3.8,3.8,65.87,99.29,-0.7,0.7,,64.63,27.37,7.99,-3.1,4.4,-1.2,3.1,4.4,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.41,4.38,4.21,0.7,0.1,-0.8,0.7,0.1,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_5.5S_2w40C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,9.0,0,,,,88.8,-6.3,6.3,64.45,98.75,-1.2,1.2,,41.2,43.7,15.1,-26.6,20.7,5.9,26.6,20.7,5.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.62,8.79,3.59,-3.1,4.5,-1.4,3.1,4.5,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_His_5.5S_4w5C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,9.0,0,,,,89.0,-6.1,6.1,66.4,99.93,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.93,4.19,4.88,0.2,-0.1,-0.1,0.2,0.1,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_5.5S_T0,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,9.0,0,,,,95.1,0.0,0.0,68.46,100.0,0.0,0.0,,67.75,23.01,9.24,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.73,4.26,5.01,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_5.5_2w25C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,0.0,0,,,,91.5,-3.5,3.5,66.12,99.35,-0.6,0.6,,61.33,30.36,8.3,-3.3,4.3,-1.0,3.3,4.3,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.12,4.43,4.45,0.7,-0.1,-0.6,0.7,0.1,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_5.5_2w40C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,0.0,0,,,,88.6,-6.4,6.4,64.66,98.75,-1.2,1.2,,45.62,44.72,9.66,-19.0,18.6,0.4,19.0,18.6,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.71,9.6,3.69,-3.7,5.1,-1.4,3.7,5.1,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_His_5.5_4w5C,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,0.0,0,,,,89.2,-5.8,5.8,66.6,99.94,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.18,3.74,5.08,0.7,-0.8,0.0,0.7,0.8,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_5.5_T0,NB-penglei5-5060234-0005,5.5,Histidine,0,0,0.0,0.0,0,,,,95.0,0.0,0.0,67.21,100.0,0.0,0.0,,64.64,26.08,9.28,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.44,4.51,5.05,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_6S_2w25C,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,9.0,0,,,,91.1,-3.9,3.9,66.44,99.59,-0.4,0.4,,59.19,32.48,8.32,-9.2,10.3,-1.1,9.2,10.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.58,4.18,4.23,0.5,0.3,-0.8,0.5,0.3,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_6S_2w40C,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,9.0,0,,,,88.8,-6.2,6.2,64.68,99.11,-0.9,0.9,,39.2,49.5,11.3,-29.2,27.3,1.8,29.2,27.3,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.08,8.35,3.57,-3.0,4.5,-1.5,3.0,4.5,1.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_His_6S_4w5C,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,9.0,0,,,,88.9,-6.1,6.1,66.59,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.03,4.11,4.86,0.0,0.3,-0.2,0.0,0.3,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_6S_T0,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,9.0,0,,,,95.0,0.0,0.0,66.86,100.0,0.0,0.0,,68.38,22.16,9.46,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.08,3.84,5.08,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_6_2w25C,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,0.0,0,,,,91.1,-3.8,3.8,66.49,99.63,-0.4,0.4,,59.49,33.11,7.39,-5.1,6.2,-1.1,5.1,6.2,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.48,4.28,4.24,1.0,-0.2,-0.8,1.0,0.2,0.8,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_6_2w40C,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,0.0,0,,,,88.9,-6.0,6.0,64.57,98.96,-1.0,1.0,,41.01,49.53,9.46,-23.5,22.6,1.0,23.5,22.6,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.6,9.74,3.66,-3.9,5.3,-1.4,3.9,5.3,1.4,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_His_6_4w5C,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,0.0,0,,,,89.4,-5.5,5.5,66.64,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.71,4.29,5.01,0.2,-0.2,0.0,0.2,0.2,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_6_T0,NB-penglei5-5060234-0005,6.0,Histidine,0,0,0.0,0.0,0,,,,94.9,0.0,0.0,67.12,100.0,0.0,0.0,,64.55,26.94,8.51,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.52,4.44,5.04,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_7_2w25C,NB-penglei5-5060234-0005,7.0,Histidine,0,0,0.0,0.0,0,,,,90.8,-4.0,4.0,65.88,99.45,-0.5,0.5,,62.61,22.06,15.33,0.7,5.2,-5.8,0.7,5.2,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.3,3.75,0.94,4.7,-0.8,-4.0,4.7,0.8,4.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_7_2w40C,NB-penglei5-5060234-0005,7.0,Histidine,0,0,0.0,0.0,0,,,,89.7,-5.1,5.1,63.96,98.63,-1.4,1.4,,57.18,29.84,12.98,-4.8,12.9,-8.2,4.8,12.9,8.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.36,3.71,3.93,1.8,-0.8,-1.0,1.8,0.8,1.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_His_7_4w5C,NB-penglei5-5060234-0005,7.0,Histidine,0,0,0.0,0.0,0,,,,89.7,-5.1,5.1,66.43,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.59,3.5,1.91,4.0,-1.0,-3.0,4.0,1.0,3.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_7_T0,NB-penglei5-5060234-0005,7.0,Histidine,0,0,0.0,0.0,0,,,,94.8,0.0,0.0,67.5,100.0,0.0,0.0,,61.93,16.9,21.17,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.58,4.53,4.89,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,,-,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Succ_5.5S_2w25C,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0.0,9.0,0,,,,91.3,-3.9,3.9,65.67,99.5,-0.5,0.5,,59.1,31.5,9.5,-2.6,2.5,0.2,2.6,2.5,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.71,4.27,5.01,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Succ_5.5S_2w40C,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0.0,9.0,0,,,,88.9,-6.3,6.3,63.41,98.66,-1.3,1.3,,32.6,58.2,9.2,-29.1,29.2,-0.1,29.1,29.2,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.09,9.43,4.48,-4.8,5.4,-0.6,4.8,5.4,0.6,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Succ_5.5S_4w5C,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0.0,9.0,0,,,,88.5,-6.7,6.7,66.27,99.95,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.11,3.3,5.58,0.2,-0.7,0.5,0.2,0.7,0.5,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Succ_5.5S_T0,NB-penglei5-5060234-0005,5.5,Succinate,0,0,0.0,9.0,0,,,,95.2,0.0,0.0,66.45,100.0,0.0,0.0,,61.7,29.04,9.26,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.88,4.01,5.11,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Succ_6S_2w25C,NB-penglei5-5060234-0005,6.0,Succinate,0,0,0.0,9.0,0,,,,90.8,-4.2,4.2,66.27,99.72,-0.3,0.3,,57.94,33.33,8.73,-8.6,9.3,-0.7,8.6,9.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.69,3.53,4.78,0.7,-0.5,-0.2,0.7,0.5,0.2,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Succ_6S_2w40C,NB-penglei5-5060234-0005,6.0,Succinate,0,0,0.0,9.0,0,,,,89.1,-5.9,5.9,63.84,98.87,-1.1,1.1,,33.8,57.6,8.5,-32.8,33.6,-1.0,32.8,33.6,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.43,8.39,4.18,-3.5,4.4,-0.9,3.5,4.4,0.9,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,28.0,,1.0,Trop2_PNU_Succ_6S_4w5C,NB-penglei5-5060234-0005,6.0,Succinate,0,0,0.0,9.0,0,,,,89.0,-6.0,6.0,66.36,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.9,4.02,5.08,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/1/2022,penglei5,Trop2,DCC000770_007,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Succ_6S_T0,NB-penglei5-5060234-0005,6.0,Succinate,0,0,0.0,9.0,0,,,,95.0,0.0,0.0,66.85,100.0,0.0,0.0,,66.55,23.99,9.46,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.95,4.02,5.03,0.0,0.0,0.0,0.0,0.0,0.0,DCC000770_007,DCC000770,,,8.32,145719.586,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_012,Fab,MULTIPLE CONTROL,,-80.0,0.0,,9.8,Anti_MMAE_Fab_ST,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.0,9.0,0,,,,99.2,,,52.22,99.59,,,,87.61,8.53,3.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.0,2.18,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25.0,2.0,,10.5,Anti_MMAE_Fab_48hRT,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.02,9.0,0,,,,98.9,,,52.06,99.58,,,,87.1,9.54,3.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.73,0.0,2.27,-0.1,0.0,0.1,0.1,0.0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25.0,0.25,,10.5,Anti_MMAE_Fab_6hRT,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.02,9.0,0,,,,99.0,,,51.87,99.31,,,,87.48,9.15,3.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.76,0.0,2.24,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/17/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,-80.0,0.0,,10.5,Anti_MMAE_Fab_CT,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.02,9.0,0,,,,99.1,,,52.12,99.57,,,,87.68,9.09,3.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.81,0.0,2.19,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-ramapa-5085740-0001,5.5,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.94,3.96,6.1,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-ramapa-5085740-0001,6.0,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.06,7.02,4.91,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,51.8,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-ramapa-5085740-0001,5.0,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.92,8.46,5.62,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,51.6,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-ramapa-5085740-0001,5.5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.18,4.82,3.01,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,53.0,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-ramapa-5085740-0001,6.0,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.06,4.28,2.66,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.7,Trop2_PNU_Cit_5.5_5S_1M40C,NB-ramapa-5085740-0001,5.5,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.18,5.9,5.92,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.8,Trop2_PNU_Cit_6.0_5S_1M40C,NB-ramapa-5085740-0001,6.0,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.03,5.04,5.93,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.2,Trop2_PNU_Cit_6.5_5S_1M40C,NB-ramapa-5085740-0001,6.5,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.4,2.88,4.73,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.9,Trop2_PNU_His_5.5_5S_1M40C,NB-ramapa-5085740-0001,5.5,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.89,4.39,2.72,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.6,Trop2_PNU_His_6.0_5S_1M40C,NB-ramapa-5085740-0001,6.0,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.21,7.92,4.86,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/29/2023,ramapa,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.7,Trop2_PNU_His_6.5_5S_1M40C,NB-ramapa-5085740-0001,6.5,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.13,6.44,4.44,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Glu_4_2w25C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.8,1.6,1.6,75.34,99.22,-0.1,0.1,,58.58,23.83,17.59,-2.5,2.7,-0.1,2.5,2.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0.0,0.84,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Glu_4_2w40C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.4,1.2,1.2,73.01,98.99,-0.3,0.3,,54.6,25.08,20.32,-6.5,3.9,2.6,6.5,3.9,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.57,0.78,0.65,-0.6,0.8,-0.2,0.6,0.8,0.2,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Glu_4_T0,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,96.2,0.0,0.0,75.18,99.27,0.0,0.0,,61.11,21.16,17.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0.0,0.86,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Glu_5_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.9,1.6,1.6,76.17,100.0,0.3,0.3,,57.68,28.92,13.41,-2.2,5.6,-3.4,2.2,5.6,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,-0.1,0.0,0.1,0.1,0.0,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Glu_5_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,98.4,2.1,2.1,73.91,99.63,-0.1,0.1,,53.89,32.92,13.2,-6.0,9.6,-3.6,6.0,9.6,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.01,0.24,0.75,-0.2,0.2,0.0,0.2,0.2,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,97.9,1.4,1.4,76.18,100.0,0.3,0.3,,63.18,26.53,10.3,3.4,3.3,-6.7,3.4,3.3,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0.0,0.86,-0.1,0.0,0.1,0.1,0.0,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,98.1,1.6,1.6,74.02,99.82,0.1,0.1,,52.23,34.1,13.67,-7.6,10.9,-3.3,7.6,10.9,3.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.62,0.61,0.76,-0.6,0.6,0.0,0.6,0.6,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Glu_5_S_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,96.5,0.0,0.0,75.64,99.71,0.0,0.0,,59.81,23.21,16.98,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.2,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Glu_5_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,96.3,0.0,0.0,75.71,99.71,0.0,0.0,,59.86,23.37,16.77,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.21,0.0,0.79,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,97.9,1.6,1.6,75.56,99.74,0.3,0.3,,58.24,26.25,15.5,-2.4,3.9,-1.5,2.4,3.9,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0.0,0.75,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,98.3,2.0,2.0,73.33,99.24,-0.2,0.2,,53.11,32.19,14.7,-7.6,9.9,-2.3,7.6,9.9,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0.3,0.75,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,97.8,1.5,1.5,75.6,99.69,0.4,0.4,,58.87,25.63,15.5,-0.9,1.5,-0.6,0.9,1.5,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.2,0.0,0.8,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,98.3,2.0,2.0,73.49,99.28,0.0,0.0,,51.51,34.43,14.06,-8.2,10.3,-2.0,8.2,10.3,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.18,0.19,0.63,0.0,0.2,-0.2,0.0,0.2,0.2,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,96.3,0.0,0.0,74.86,99.29,0.0,0.0,,59.76,24.14,16.1,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,96.3,0.0,0.0,75.23,99.4,0.0,0.0,,60.68,22.31,17.01,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0.0,0.87,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,97.9,1.5,1.5,75.47,99.69,0.3,0.3,,58.11,26.79,15.1,-0.2,2.6,-2.4,0.2,2.6,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,98.3,1.9,1.9,73.5,99.29,-0.1,0.1,,51.53,32.93,15.55,-6.8,8.8,-1.9,6.8,8.8,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.11,0.12,0.77,0.0,0.1,-0.1,0.0,0.1,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,96.4,0.0,0.0,75.44,99.38,0.0,0.0,,58.35,24.15,17.49,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0.0,0.87,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_His_6_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,98.0,1.6,1.6,75.81,99.86,0.4,0.4,,51.36,37.39,11.25,-4.6,9.0,-4.5,4.6,9.0,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_His_6_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,97.3,0.9,0.9,73.56,99.43,-0.1,0.1,,42.82,45.89,11.28,-13.1,17.5,-4.4,13.1,17.5,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.97,0.23,0.8,-0.2,0.2,-0.1,0.2,0.2,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_His_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,97.9,1.5,1.5,75.78,99.7,0.1,0.1,,50.61,35.96,13.43,-2.9,5.1,-2.2,2.9,5.1,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_His_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,97.4,1.0,1.0,73.86,99.54,-0.1,0.1,,40.11,48.7,11.2,-13.4,17.8,-4.5,13.4,17.8,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0.33,0.76,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_His_6_S_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,96.4,0.0,0.0,75.42,99.58,0.0,0.0,,53.48,30.87,15.65,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_His_6_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,96.4,0.0,0.0,75.47,99.49,0.0,0.0,,55.92,28.37,15.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0.0,0.87,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_His_7_2w25C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,98.0,1.4,1.4,76.28,100.0,0.3,0.3,,52.37,32.12,15.51,-6.4,8.6,-2.2,6.4,8.6,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.18,0.0,0.82,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_His_7_2w40C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,97.7,1.1,1.1,73.53,99.8,0.1,0.1,,46.16,39.09,14.76,-12.6,15.6,-2.9,12.6,15.6,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.32,0.91,0.77,-0.8,0.9,-0.1,0.8,0.9,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_His_7_T0,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,96.6,0.0,0.0,75.81,99.74,0.0,0.0,,58.8,23.54,17.66,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0.0,0.86,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Succ_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,98.0,1.6,1.6,75.76,100.0,0.5,0.5,,53.63,31.73,14.64,-2.5,2.4,0.1,2.5,2.4,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0.0,0.87,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Succ_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,97.8,1.4,1.4,73.42,99.42,-0.1,0.1,,47.35,40.37,12.28,-8.8,11.1,-2.3,8.8,11.1,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.41,0.81,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Succ_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,98.0,1.8,1.8,76.01,100.0,0.6,0.6,,55.67,28.81,15.51,-2.0,4.6,-2.6,2.0,4.6,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0.0,0.86,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Succ_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,97.7,1.5,1.5,73.58,99.59,0.2,0.2,,45.78,40.05,14.17,-11.9,15.8,-3.9,11.9,15.8,3.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.62,0.59,0.78,-0.6,0.6,0.0,0.6,0.6,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Succ_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,96.2,0.0,0.0,75.23,99.41,0.0,0.0,,57.68,24.22,18.1,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.19,0.0,0.81,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Succ_5.5_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,96.4,0.0,0.0,75.26,99.45,0.0,0.0,,56.15,29.31,14.54,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0.0,0.88,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Succ_5_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,97.9,1.6,1.6,75.19,99.66,0.4,0.4,,60.57,29.38,10.06,1.2,4.6,-5.8,1.2,4.6,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0.0,0.86,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Succ_5_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,98.3,2.0,2.0,73.2,99.1,-0.2,0.2,,50.66,35.73,13.61,-8.7,10.9,-2.2,8.7,10.9,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.49,0.75,0.76,-0.7,0.8,-0.1,0.7,0.8,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Succ_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,97.9,1.6,1.6,75.35,99.67,0.3,0.3,,63.18,26.2,10.62,3.3,3.5,-6.8,3.3,3.5,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.14,0.0,0.86,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Succ_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,98.2,1.9,1.9,73.19,99.12,-0.3,0.3,,50.16,35.04,14.8,-9.7,12.3,-2.6,9.7,12.3,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.57,0.66,0.77,-0.6,0.7,-0.1,0.6,0.7,0.1,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Succ_5_S_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,96.3,0.0,0.0,75.12,99.4,0.0,0.0,,59.88,22.71,17.41,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.15,0.0,0.85,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Succ_5_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,96.3,0.0,0.0,75.27,99.34,0.0,0.0,,59.33,24.8,15.86,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0.0,0.84,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Succ_6_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,98.0,1.5,1.5,76.16,100.0,0.3,0.3,,56.81,35.84,7.35,3.2,3.7,-6.8,3.2,3.7,6.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Succ_6_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,97.9,1.4,1.4,73.93,99.65,0.0,0.0,,37.05,53.06,9.89,-16.6,20.9,-4.3,16.6,20.9,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.35,0.87,-0.3,0.4,0.0,0.3,0.4,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D238_Succ_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,98.0,1.6,1.6,76.17,100.0,0.3,0.3,,52.36,33.91,13.73,-3.7,5.4,-1.7,3.7,5.4,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0.0,0.87,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D238_Succ_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,97.7,1.3,1.3,73.74,99.64,-0.1,0.1,,38.97,50.82,10.21,-17.1,22.3,-5.2,17.1,22.3,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.51,0.68,0.8,-0.7,0.7,0.0,0.7,0.7,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Succ_6_S_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,96.4,0.0,0.0,75.75,99.7,0.0,0.0,,56.07,28.49,15.44,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.17,0.0,0.83,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000238_004,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D238_Succ_6_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,96.5,0.0,0.0,75.79,99.73,0.0,0.0,,53.62,32.18,14.19,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,DCC000238_004,DCC000238,,mal-AA-PAB-MMAE,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Glu_4_2w25C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.6,1.5,1.5,76.26,99.02,-0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.94,0.0,1.06,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Glu_4_2w40C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,96.6,0.5,0.5,73.09,98.57,-0.7,0.7,,51.7,23.74,24.56,-11.1,7.5,3.6,11.1,7.5,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.73,0.56,0.72,-0.2,0.6,-0.4,0.2,0.6,0.4,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Glu_4_T0,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,96.1,0.0,0.0,76.15,99.31,0.0,0.0,,62.77,16.27,20.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0.0,1.08,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Glu_5_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,98.1,1.9,1.9,76.5,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0.0,1.09,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Glu_5_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.7,1.5,1.5,74.34,99.45,-0.2,0.2,,58.99,21.12,19.88,-0.8,0.5,0.3,0.8,0.5,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.41,0.6,0.99,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,97.0,0.8,0.8,77.32,100.0,2.1,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.9,0.0,1.1,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,97.7,1.5,1.5,74.43,99.54,1.6,1.6,,50.24,30.16,19.6,-5.9,7.3,-1.4,5.9,7.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.46,0.56,0.98,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Glu_5_S_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,96.2,0.0,0.0,74.21,97.89,0.0,0.0,,56.17,22.85,20.98,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0.0,1.18,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Glu_5_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,96.2,0.0,0.0,76.37,99.7,0.0,0.0,,59.81,20.66,19.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.79,0.0,1.21,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,98.0,1.9,1.9,76.35,99.15,0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0.0,1.08,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,97.4,1.3,1.3,74.14,99.17,0.2,0.2,,58.81,22.52,18.67,-8.5,8.0,0.5,8.5,8.0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.44,0.6,0.96,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,98.1,2.1,2.1,76.87,99.31,0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.0,1.07,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,97.7,1.7,1.7,73.9,99.1,0.0,0.0,,56.63,22.77,20.61,1.8,-2.2,0.4,1.8,-2.2,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.5,0.53,0.97,-0.3,0.5,-0.2,0.3,0.5,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,96.0,0.0,0.0,75.8,99.05,0.0,0.0,,54.87,24.96,20.17,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.83,0.0,1.17,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,96.1,0.0,0.0,75.74,99.02,0.0,0.0,,67.26,14.53,18.21,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.8,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,98.1,2.0,2.0,76.6,99.27,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0.0,1.08,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,96.6,0.5,0.5,74.09,99.18,-0.1,0.1,,54.42,24.51,21.07,-2.0,2.0,0.1,2.0,2.0,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.4,0.6,0.99,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,96.1,0.0,0.0,75.95,99.26,0.0,0.0,,56.43,22.56,21.02,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.0,1.22,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_His_6_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,98.1,1.9,1.9,76.55,100.0,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0.0,1.09,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_His_6_S_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,96.2,0.0,0.0,76.02,99.3,0.0,0.0,,69.93,7.93,22.14,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0.0,1.18,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_His_6_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,98.0,1.8,1.8,74.18,99.4,0.1,0.1,,57.43,22.53,20.04,-6.1,6.3,-0.2,6.1,6.3,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.87,0.15,0.98,0.1,0.2,-0.2,0.1,0.2,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_His_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,98.1,1.9,1.9,75.78,99.68,0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.92,0.0,1.08,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_His_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,97.8,1.6,1.6,74.22,99.35,0.1,0.1,,51.37,30.81,17.83,-18.6,22.9,-4.3,18.6,22.9,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.75,0.29,0.96,-0.1,0.3,-0.2,0.1,0.3,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_His_6_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,96.2,0.0,0.0,76.02,99.34,0.0,0.0,,63.49,16.22,20.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.8,0.0,1.2,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_His_7_2w25C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,98.2,1.8,1.8,76.01,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0.0,1.09,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_His_7_2w40C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,97.7,1.3,1.3,74.34,99.74,0.0,0.0,,61.93,23.66,14.41,-5.0,3.2,1.8,5.0,3.2,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.25,0.62,1.13,-0.6,0.6,0.0,0.6,0.6,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_His_7_T0,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,96.4,0.0,0.0,76.3,99.71,0.0,0.0,,66.89,20.5,12.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.83,0.0,1.17,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Succ_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,98.2,2.0,2.0,77.0,100.0,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.86,0.0,1.14,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Succ_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,97.6,1.4,1.4,74.11,99.35,0.1,0.1,,55.43,27.69,16.88,-2.7,4.6,-1.9,2.7,4.6,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.34,0.58,1.08,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Succ_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,98.1,1.9,1.9,77.22,100.0,0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.9,0.0,1.1,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Succ_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,97.4,1.2,1.2,74.13,99.4,-0.1,0.1,,48.95,32.36,18.69,-7.3,9.3,-2.0,7.3,9.3,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.49,0.5,1.01,-0.3,0.5,-0.2,0.3,0.5,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Succ_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,96.2,0.0,0.0,76.05,99.45,0.0,0.0,,56.25,23.03,20.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.81,0.0,1.19,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Succ_5.5_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,96.2,0.0,0.0,75.92,99.27,0.0,0.0,,58.12,23.1,18.78,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.0,1.24,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Succ_5_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,98.2,2.1,2.1,76.42,98.92,-0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.9,0.0,1.1,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Succ_5_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,97.1,1.0,1.0,73.77,98.92,-0.4,0.4,,56.2,26.86,16.94,-3.2,5.3,-2.1,3.2,5.3,2.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.43,0.67,0.9,-0.4,0.7,-0.3,0.4,0.7,0.3,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Succ_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,98.2,2.1,2.1,76.55,98.98,0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.91,0.0,1.09,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Succ_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,97.4,1.3,1.3,73.8,99.04,0.1,0.1,,52.05,32.16,15.79,-0.4,5.6,-5.2,0.4,5.6,5.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.41,0.6,0.99,-0.4,0.6,-0.2,0.4,0.6,0.2,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Succ_5_S_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,96.1,0.0,0.0,75.42,98.93,0.0,0.0,,52.47,26.58,20.95,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0.0,1.18,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Succ_5_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,96.1,0.0,0.0,76.06,99.33,0.0,0.0,,59.42,21.57,19.02,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.79,0.0,1.21,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Succ_6_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,98.2,2.0,2.0,77.58,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.83,0.0,1.17,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Succ_6_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,97.8,1.6,1.6,74.27,99.59,-0.1,0.1,,58.87,23.82,17.31,1.8,-0.4,-1.3,1.8,-0.4,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.54,0.26,1.2,-0.2,0.3,-0.1,0.2,0.3,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D250_Succ_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,98.1,1.8,1.8,74.98,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.0,1.07,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D250_Succ_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,97.8,1.5,1.5,74.1,99.45,-0.2,0.2,,48.36,32.2,19.43,-9.1,9.7,-0.6,9.1,9.7,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.46,0.5,1.04,-0.4,0.5,-0.1,0.4,0.5,0.1,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Succ_6_S_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,96.3,0.0,0.0,76.14,99.69,0.0,0.0,,57.45,22.51,20.04,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0.0,1.18,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000250_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D250_Succ_6_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,96.2,0.0,0.0,76.37,99.73,0.0,0.0,,57.09,24.27,18.64,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.75,0.0,1.25,0.0,0.0,0.0,0.0,0.0,0.0,DCC000250_003,DCC000250,,Pyr-Ala-Ala-PAB-MMAE conjugate,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Glu_4_2w25C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100.0,0.0,0.0,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Glu_4_2w40C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.4,-1.5,1.5,71.82,99.31,-0.3,0.3,,51.44,28.02,20.53,-6.2,3.3,2.9,6.2,3.3,2.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.28,0.0,0.72,0.3,0.0,-0.3,0.3,0.0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Glu_4_T0,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,98.9,0.0,0.0,74.42,99.55,0.0,0.0,,57.62,24.73,17.65,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.98,0.0,1.02,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Glu_5_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.97,0.0,0.03,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Glu_5_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,98.9,-0.3,0.3,73.15,99.78,0.1,0.1,,56.99,25.22,17.79,-4.1,2.4,1.6,4.1,2.4,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0.0,0.84,0.2,0.0,-0.2,0.2,0.0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,98.5,-0.8,0.8,73.01,99.74,0.0,0.0,,,,,-4.3,6.1,-1.8,4.3,39.3,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Glu_5_S_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,99.3,0.0,0.0,74.69,99.64,-0.1,0.1,,,,,-2.1,1.7,0.4,2.1,34.9,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Glu_5_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,99.2,0.0,0.0,74.76,99.77,0.1,0.1,,61.06,22.78,16.16,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.98,0.0,1.02,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.94,0.0,0.06,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,98.4,-0.6,0.6,72.95,99.74,0.1,0.1,,57.18,24.84,17.97,-3.9,4.0,-0.1,3.9,4.0,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.21,0.0,0.79,0.3,0.0,-0.3,0.3,0.0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.92,0.0,0.08,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,98.6,-0.4,0.4,72.92,99.69,0.2,0.2,,54.86,26.96,18.19,0.3,-0.9,0.6,0.3,-0.9,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0.0,0.75,0.3,0.0,-0.3,0.3,0.0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,99.0,0.0,0.0,74.57,99.53,0.0,0.0,,54.57,27.82,17.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.0,1.07,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,99.0,0.0,0.0,74.65,99.56,0.0,0.0,,61.09,20.86,18.04,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0.0,1.05,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.9,0.0,0.1,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,98.8,-0.2,0.2,72.88,99.64,0.0,0.0,,58.74,26.13,15.14,0.2,1.8,-2.0,0.2,1.8,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.19,0.0,0.81,0.2,0.0,-0.2,0.2,0.0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,99.0,0.0,0.0,74.48,99.56,0.0,0.0,,58.52,24.34,17.14,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0.0,1.05,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_6_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.98,0.0,0.02,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_6_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,98.8,-0.4,0.4,73.09,99.65,0.1,0.1,,56.83,26.96,16.21,-7.4,7.9,-0.4,7.4,7.9,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.49,0.0,0.51,0.5,0.0,-0.5,0.5,0.0,0.5,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,98.5,-0.7,0.7,73.03,99.69,0.1,0.1,,,,,-3.8,3.8,0.0,3.8,35.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_6_S_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,99.2,0.0,0.0,74.71,99.62,0.0,0.0,,,,,-2.7,2.7,0.0,2.7,33.9,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_6_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,99.1,-0.1,0.1,74.62,99.59,0.0,0.0,,64.27,19.1,16.64,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.97,0.0,1.03,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_7_2w25C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.94,0.0,0.06,0.9,0.0,-0.9,0.9,0.0,0.9,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_7_2w40C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,98.5,-0.7,0.7,73.04,99.7,0.0,0.0,,51.8,35.59,12.61,-8.3,12.7,-4.4,8.3,12.7,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100.0,0.0,0.0,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_7_T0,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,99.2,0.0,0.0,74.63,99.68,0.0,0.0,,60.08,22.91,17.01,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.03,0.0,0.97,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Succinate_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.91,0.0,0.09,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Succinate_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,98.3,-0.7,0.7,72.75,99.67,0.0,0.0,,47.08,34.84,18.08,-8.2,9.4,-1.2,8.2,9.4,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0.0,0.84,0.2,0.0,-0.2,0.2,0.0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Succinate_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,99.0,0.0,0.0,74.61,99.71,0.0,0.0,,55.3,25.46,19.24,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.0,1.07,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Succinate_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100.0,0.0,0.0,1.0,0.0,-1.0,1.0,0.0,1.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Succinate_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,98.6,-0.2,0.2,72.49,99.59,0.1,0.1,,47.03,36.23,16.75,-5.5,7.8,-2.3,5.5,7.8,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.31,0.0,0.69,0.3,0.0,-0.3,0.3,0.0,0.3,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Succinate_5_S_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,98.8,0.0,0.0,74.34,99.53,0.0,0.0,,52.5,28.43,19.08,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.97,0.0,1.03,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Succinate_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.63,0.0,0.37,0.7,0.0,-0.7,0.7,0.0,0.7,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Succinate_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,98.4,-0.7,0.7,72.8,99.7,0.0,0.0,,48.21,35.44,16.35,-6.7,9.0,-2.3,6.7,9.0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.13,0.0,0.87,0.2,0.0,-0.2,0.2,0.0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Succinate_6_S_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,99.1,0.0,0.0,74.6,99.69,0.0,0.0,,54.89,26.42,18.69,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.0,1.07,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.77,0.0,0.23,0.8,0.0,-0.8,0.8,0.0,0.8,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,98.5,-0.8,0.8,73.01,99.74,0.0,0.0,,50.21,34.59,15.2,-3.8,7.8,-4.0,3.8,7.8,4.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.17,0.0,0.83,0.2,0.0,-0.2,0.2,0.0,0.2,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_Glu_5_S_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,99.3,0.0,0.0,74.69,99.64,-0.1,0.1,,53.99,26.84,19.17,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.93,0.0,1.07,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,L133_His_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.94,0.0,0.06,0.8,0.0,-0.8,0.8,0.0,0.8,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,L133_His_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,98.5,-0.7,0.7,73.03,99.69,0.1,0.1,,52.0,29.7,18.4,-2.0,1.8,0.3,2.0,1.8,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100.0,0.0,0.0,0.8,0.0,-0.8,0.8,0.0,0.8,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000712_002,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,L133_His_6_S_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,99.2,0.0,0.0,74.71,99.62,0.0,0.0,,53.95,27.92,18.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.16,0.0,0.84,0.0,0.0,0.0,0.0,0.0,0.0,DCC000712_002,DCC000712,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Glu_5_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.6,1.7,1.7,76.22,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Glu_4_2w25C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.6,1.7,1.7,75.32,99.3,-0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0.0,0.91,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Glu_4_2w40C,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,97.2,1.3,1.3,72.98,98.71,-0.7,0.7,,53.71,21.6,24.69,-7.5,3.1,4.4,7.5,3.1,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.27,0.84,0.89,-0.8,0.8,0.0,0.8,0.8,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Glu_4_T0,NB-penglei5-5060234-0003,4.0,Glutamate,0,0,0.0,0.0,0,,,,95.9,0.0,0.0,75.47,99.37,0.0,0.0,,61.23,18.5,20.26,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.06,0.0,0.94,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Glu_5_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,98.2,2.3,2.3,73.89,99.37,-0.3,0.3,,54.32,24.28,21.4,-9.1,6.5,2.6,9.1,6.5,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.77,0.42,0.8,-0.3,0.4,-0.2,0.3,0.4,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Glu_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,97.6,1.5,1.5,76.27,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0.0,0.91,-0.1,0.0,0.2,0.1,0.0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Glu_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,97.9,1.8,1.8,73.85,99.25,-0.4,0.4,,53.13,25.53,21.34,-4.5,2.1,2.4,4.5,2.1,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.79,0.46,0.75,-0.4,0.5,0.0,0.4,0.5,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Glu_5_S_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,7.0,0,,,,96.1,0.0,0.0,75.73,99.71,0.0,0.0,,57.6,23.48,18.93,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.24,0.0,0.76,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Glu_5_T0,NB-penglei5-5060234-0003,5.0,Glutamate,0,0,0.0,0.0,0,,,,95.9,0.0,0.0,75.72,99.68,0.0,0.0,,63.47,17.77,18.76,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.04,0.0,0.96,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_His_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,97.1,1.3,1.3,75.41,99.84,0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0.0,0.91,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_His_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,98.1,2.3,2.3,73.66,99.12,-0.3,0.3,,57.95,19.91,22.14,-6.8,6.4,0.3,6.8,6.4,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.43,0.82,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_His_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,97.4,1.6,1.6,75.52,99.79,0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_His_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,97.9,2.1,2.1,73.66,99.27,0.4,0.4,,54.44,25.56,20.0,-0.9,2.2,-1.3,0.9,2.2,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.74,0.44,0.81,-0.4,0.4,-0.1,0.4,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_His_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,7.0,0,,,,95.8,0.0,0.0,74.02,98.93,0.0,0.0,,55.33,23.37,21.3,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0.0,0.88,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_His_5.5_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,95.8,0.0,0.0,75.46,99.42,0.0,0.0,,64.73,13.46,21.82,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.05,0.0,0.95,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_His_5.5_T_2w25C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,97.5,1.7,1.7,75.63,100.0,0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_His_5.5_T_2w40C,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,98.2,2.4,2.4,73.67,99.1,-0.4,0.4,,58.49,23.34,18.17,0.8,0.3,-1.1,0.8,0.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.82,0.39,0.8,-0.2,0.4,-0.1,0.2,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_His_5.5_T_T0,NB-penglei5-5060234-0003,5.5,Histidine,0,0,0.0,0.0,7,,,,95.8,0.0,0.0,75.17,99.51,0.0,0.0,,57.67,23.03,19.3,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0.0,0.93,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_His_6_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,97.5,1.6,1.6,76.13,100.0,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.08,0.0,0.92,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_His_6_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,98.1,2.2,2.2,74.18,99.51,0.1,0.1,,55.95,23.02,21.03,-2.2,3.6,-1.4,2.2,3.6,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.78,0.38,0.84,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_His_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,97.4,1.5,1.5,76.06,100.0,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_His_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,97.9,2.0,2.0,74.04,99.45,0.2,0.2,,49.76,30.52,19.72,-8.7,7.3,1.4,8.7,7.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.44,0.79,-0.3,0.4,-0.1,0.3,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_His_6_S_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,7.0,0,,,,95.9,0.0,0.0,75.44,99.34,0.0,0.0,,58.47,23.22,18.31,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.09,0.0,0.91,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_His_6_T0,NB-penglei5-5060234-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,95.9,0.0,0.0,75.63,99.44,0.0,0.0,,58.14,19.45,22.42,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.05,0.0,0.95,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_His_7_2w25C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,97.5,1.5,1.5,76.36,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.11,0.0,0.89,0.1,0.0,-0.1,0.1,0.0,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_His_7_2w40C,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,98.0,2.0,2.0,73.97,99.81,0.1,0.1,,47.34,24.29,28.37,-11.0,2.3,8.7,11.0,2.3,8.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.76,0.45,0.79,-0.2,0.4,-0.2,0.2,0.4,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_His_7_T0,NB-penglei5-5060234-0003,7.0,Histidine,0,0,0.0,0.0,0,,,,96.0,0.0,0.0,76.11,99.71,0.0,0.0,,58.37,22.0,19.64,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.98,0.0,1.02,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Succ_5.5_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,97.6,1.8,1.8,75.44,100.0,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0.0,0.93,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Succ_5.5_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,98.2,2.4,2.4,73.77,99.18,-0.2,0.2,,53.64,27.0,19.36,-7.9,7.9,0.0,7.9,7.9,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.68,0.43,0.89,-0.4,0.4,0.0,0.4,0.4,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Succ_5.5_S_2w25C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,97.6,1.8,1.8,76.26,100.0,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.08,0.0,0.92,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Succ_5.5_S_2w40C,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,97.9,2.1,2.1,73.7,99.35,0.1,0.1,,49.62,29.97,20.41,-6.1,8.1,-2.0,6.1,8.1,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.7,0.45,0.85,-0.4,0.4,0.0,0.4,0.4,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Succ_5.5_S_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,7.0,0,,,,95.8,0.0,0.0,75.31,99.32,0.0,0.0,,55.71,21.88,22.41,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0.0,0.88,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Succ_5.5_T0,NB-penglei5-5060234-0003,5.5,Succinate,0,0,0.0,0.0,0,,,,95.8,0.0,0.0,75.48,99.41,0.0,0.0,,61.55,19.11,19.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0.0,0.93,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Succ_5_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,97.5,1.8,1.8,75.36,99.27,0.1,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.08,0.0,0.92,-0.2,0.0,0.2,0.2,0.0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Succ_5_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,97.8,2.1,2.1,73.52,99.09,-0.1,0.1,,57.49,22.67,19.84,-2.8,2.7,0.1,2.8,2.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.65,0.52,0.83,-0.6,0.5,0.1,0.6,0.5,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Succ_5_S_2w25C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,97.5,1.7,1.7,75.43,99.84,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.1,0.0,0.9,-0.2,0.0,0.2,0.2,0.0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Succ_5_S_2w40C,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,98.1,2.3,2.3,73.24,98.9,-0.3,0.3,,45.16,33.54,21.29,-11.7,11.9,-0.2,11.7,11.9,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.59,0.56,0.85,-0.7,0.6,0.1,0.7,0.6,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Succ_5_S_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,7.0,0,,,,95.8,0.0,0.0,75.16,99.19,0.0,0.0,,56.81,21.67,21.52,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0.0,0.75,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Succ_5_T0,NB-penglei5-5060234-0003,5.0,Succinate,0,0,0.0,0.0,0,,,,95.7,0.0,0.0,75.26,99.24,0.0,0.0,,60.25,19.98,19.77,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0.0,0.75,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Succ_6_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,97.7,2.0,2.0,77.6,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.05,0.0,0.95,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Succ_6_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,98.2,2.5,2.5,73.95,99.63,-0.1,0.1,,57.42,24.61,17.97,0.3,1.1,-1.4,0.3,1.1,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.64,0.4,0.96,-0.4,0.4,0.0,0.4,0.4,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,D159_Succ_6_S_2w25C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,97.6,1.6,1.6,76.43,100.0,0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.07,0.0,0.93,-0.2,0.0,0.2,0.2,0.0,0.2,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,D159_Succ_6_S_2w40C,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,97.9,1.9,1.9,73.82,99.62,-0.1,0.1,,47.43,33.47,19.1,-6.0,9.2,-3.1,6.0,9.2,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.7,0.44,0.87,-0.5,0.4,0.1,0.5,0.4,0.1,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Succ_6_S_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,7.0,0,,,,96.0,0.0,0.0,75.83,99.68,0.0,0.0,,53.47,24.28,22.24,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.23,0.0,0.77,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
11/13/2022,penglei5,Trop2,DCC000159_003,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,D159_Succ_6_T0,NB-penglei5-5060234-0003,6.0,Succinate,0,0,0.0,0.0,0,,,,95.7,0.0,0.0,75.84,99.7,0.0,0.0,,57.11,23.56,19.33,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.01,0.0,0.99,0.0,0.0,0.0,0.0,0.0,0.0,DCC000159_003,DCC000159,,,8.42,145439.425,,,,,-,-,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,-80.0,0.0,,53.0,Trop2_MMAE_53_Start,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.0,7.5,0,,,,94.8,0.0,0.0,68.72,98.77,0.0,0.0,,58.69,14.89,26.42,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.91,3.07,1.02,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,-,Sucrose,0,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,67.89,99.71,1.0,1.0,,59.98,14.18,25.85,-0.2,1.1,-0.9,0.2,1.1,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.93,3.98,1.09,-1.3,1.1,0.2,1.3,1.1,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,91.5,-2.7,2.7,65.05,97.18,-1.5,1.5,,42.26,37.66,20.08,-17.9,24.6,-6.7,17.9,24.6,6.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.94,3.96,6.1,-6.3,1.1,5.2,6.3,1.1,5.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_1M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.8,0.6,0.6,67.74,99.71,1.0,1.0,,58.61,13.98,27.41,-1.5,0.9,0.6,1.5,0.9,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.23,3.85,0.92,-1.0,1.0,0.0,1.0,1.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,95.7,1.5,1.5,70.04,98.94,0.2,0.2,,56.19,17.35,26.46,-3.9,4.3,-0.3,3.9,4.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.62,4.08,1.29,-1.6,1.2,0.4,1.6,1.2,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.9,0.7,0.7,70.32,99.19,0.5,0.5,,57.97,14.58,27.45,-2.2,1.5,0.7,2.2,1.5,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.08,3.9,1.01,-1.1,1.0,0.1,1.1,1.0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2w25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,71.08,98.61,-0.1,0.1,,58.95,14.01,27.04,-1.2,0.9,0.2,1.2,0.9,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.61,3.31,1.08,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_2w40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,92.5,-1.7,1.7,69.04,96.49,-2.2,2.2,,45.6,31.02,23.38,-14.5,17.9,-3.4,14.5,17.9,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.14,2.8,7.06,-6.1,-0.1,6.2,6.1,0.1,6.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_T0,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,94.2,0.0,0.0,69.46,98.72,0.0,0.0,,60.13,13.09,26.79,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.22,2.9,0.89,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_T0_25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,52.2,Trop2_MMAE_Cit_5.5_7.5S_T0_40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,94.4,0.1,0.1,67.86,99.7,0.6,0.6,,58.15,16.48,25.38,-1.5,3.0,-1.5,1.5,3.0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.72,3.93,1.36,-1.0,0.6,0.4,1.0,0.6,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,91.7,-2.6,2.6,65.19,97.28,-1.8,1.8,,33.46,51.15,15.39,-26.2,37.7,-11.5,26.2,37.7,11.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.77,4.02,4.21,-4.0,0.7,3.2,4.0,0.7,3.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_1M5C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,94.5,0.2,0.2,66.22,99.72,0.6,0.6,,59.84,14.22,25.94,0.2,0.8,-0.9,0.2,0.8,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.73,4.2,1.07,-1.0,0.9,0.1,1.0,0.9,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2M25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,95.4,1.1,1.1,70.0,99.13,0.0,0.0,,52.7,22.39,24.91,-7.0,8.9,-2.0,7.0,8.9,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.07,4.37,1.56,-1.7,1.1,0.6,1.7,1.1,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2M5C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,95.3,1.0,1.0,70.34,99.24,0.1,0.1,,58.05,15.15,26.8,-1.6,1.7,-0.1,1.6,1.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.06,3.74,1.2,-0.7,0.4,0.2,0.7,0.4,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2w25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,94.4,0.1,0.1,70.68,98.8,-0.3,0.3,,58.56,15.15,26.29,-1.1,1.7,-0.6,1.1,1.7,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.85,2.84,1.3,0.1,-0.5,0.3,0.1,0.5,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_2w40C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,91.5,-2.8,2.8,68.85,96.44,-2.7,2.7,,36.9,45.28,17.82,-22.8,31.8,-9.0,22.8,31.8,9.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.52,2.93,4.55,-3.2,-0.4,3.6,3.2,0.4,3.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_T0,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,94.3,0.0,0.0,68.76,99.09,0.0,0.0,,59.67,13.46,26.87,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,3.3,0.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_T0_25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,51.3,Trop2_MMAE_Cit_6.0_7.5S_T0_40C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,51.8,Trop2_MMAE_His_5.0_7.5S_1M25C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,67.77,99.58,1.1,1.1,,60.13,13.44,26.42,0.1,0.7,-0.8,0.1,0.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.58,4.53,0.88,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,51.8,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,91.2,-3.0,3.0,63.33,96.46,-2.0,2.0,,46.55,29.68,23.77,-13.5,16.9,-3.4,13.5,16.9,3.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.1,5.03,4.87,-5.8,1.7,4.1,5.8,1.7,4.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,51.8,Trop2_MMAE_His_5.0_7.5S_1M5C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,94.7,0.5,0.5,67.07,99.55,1.1,1.1,,59.1,13.45,27.45,-0.9,0.7,0.2,0.9,0.7,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.84,4.38,0.78,-1.0,1.0,0.0,1.0,1.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,51.8,Trop2_MMAE_His_5.0_7.5S_2M5C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,94.9,0.7,0.7,68.65,97.99,-0.5,0.5,,58.82,13.81,27.37,-1.2,1.0,0.2,1.2,1.0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.5,3.64,0.86,-0.4,0.3,0.1,0.4,0.3,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,51.8,Trop2_MMAE_His_5.0_7.5S_2w25C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,94.4,0.2,0.2,70.31,98.46,0.0,0.0,,59.65,13.26,27.09,-0.4,0.5,-0.1,0.4,0.5,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.7,3.4,0.9,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,51.8,Trop2_MMAE_His_5.0_7.5S_2w40C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,92.2,-2.0,2.0,66.91,96.86,-1.6,1.6,,50.4,24.05,25.55,-9.6,11.3,-1.6,9.6,11.3,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.45,2.69,4.85,-3.4,-0.6,4.1,3.4,0.6,4.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,51.8,Trop2_MMAE_His_5.0_7.5S_T0,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,94.2,0.0,0.0,68.83,98.46,0.0,0.0,,60.03,12.77,27.2,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.89,3.33,0.78,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,51.8,Trop2_MMAE_His_5.0_7.5S_T0_25C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,51.8,Trop2_MMAE_His_5.0_7.5S_T0_40C,NB-aujer-5078398-0002,5.0,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,51.6,Trop2_MMAE_His_5.5_7.5S_1M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.3,0.2,0.2,67.71,99.67,1.1,1.1,,57.35,16.1,26.55,-1.2,2.0,-0.7,1.2,2.0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.59,4.39,1.02,-1.0,0.9,0.2,1.0,0.9,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,51.6,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,91.3,-2.8,2.8,64.97,97.14,-1.5,1.5,,40.06,40.05,19.89,-18.5,25.9,-7.4,18.5,25.9,7.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.18,4.82,3.01,-3.4,1.3,2.2,3.4,1.3,2.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,51.6,Trop2_MMAE_His_5.5_7.5S_1M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.6,0.5,0.5,67.61,99.56,1.0,1.0,,60.23,13.39,26.38,1.6,-0.7,-0.9,1.6,-0.7,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.1,4.0,0.89,-0.5,0.5,0.0,0.5,0.5,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,51.6,Trop2_MMAE_His_5.5_7.5S_2M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.9,0.8,0.8,69.82,98.62,0.0,0.0,,55.65,18.46,25.89,-3.0,4.3,-1.4,3.0,4.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.85,3.96,1.19,-0.8,0.4,0.3,0.8,0.4,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,51.6,Trop2_MMAE_His_5.5_7.5S_2M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.9,0.8,0.8,69.4,98.58,0.0,0.0,,57.83,14.84,27.34,-0.8,0.7,0.1,0.8,0.7,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.52,3.47,1.01,-0.1,0.0,0.2,0.1,0.0,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,51.6,Trop2_MMAE_His_5.5_7.5S_2w25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.4,0.3,0.3,70.83,98.66,0.1,0.1,,59.16,14.44,26.39,0.6,0.3,-0.9,0.6,0.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.59,3.38,1.03,0.0,-0.1,0.2,0.0,0.1,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,51.6,Trop2_MMAE_His_5.5_7.5S_2w40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,92.2,-1.9,1.9,68.85,97.49,-1.1,1.1,,46.94,31.14,21.92,-11.7,17.0,-5.4,11.7,17.0,5.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.11,3.51,3.37,-2.5,0.0,2.5,2.5,0.0,2.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,51.6,Trop2_MMAE_His_5.5_7.5S_T0,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,94.1,0.0,0.0,69.94,98.61,0.0,0.0,,58.6,14.12,27.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,3.52,0.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,51.6,Trop2_MMAE_His_5.5_7.5S_T0_25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,51.6,Trop2_MMAE_His_5.5_7.5S_T0_40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,53.0,Trop2_MMAE_His_6.0_7.5S_1M25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,94.5,0.5,0.5,68.74,99.67,1.0,1.0,,55.66,20.49,23.86,-2.9,6.0,-3.1,2.9,6.0,3.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.55,3.25,1.2,-0.7,0.4,0.3,0.7,0.4,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,53.0,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,91.2,-2.8,2.8,65.47,97.62,-1.1,1.1,,33.9,50.4,15.7,-24.6,35.9,-11.2,24.6,35.9,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.06,4.28,2.66,-3.2,1.4,1.8,3.2,1.4,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,53.0,Trop2_MMAE_His_6.0_7.5S_1M5C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,94.3,0.3,0.3,67.24,99.6,0.9,0.9,,58.19,15.87,25.93,-0.4,1.4,-1.0,0.4,1.4,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.81,4.19,0.99,-1.4,1.3,0.1,1.4,1.3,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,53.0,Trop2_MMAE_His_6.0_7.5S_2M25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,95.8,1.8,1.8,70.14,98.84,0.1,0.1,,47.47,29.76,22.77,-11.1,15.3,-4.2,11.1,15.3,4.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.06,4.61,1.34,-2.2,1.8,0.4,2.2,1.8,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,53.0,Trop2_MMAE_His_6.0_7.5S_2M5C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,94.8,0.8,0.8,69.99,98.93,0.2,0.2,,57.79,17.15,25.06,-0.8,2.6,-1.9,0.8,2.6,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.89,4.0,1.12,-1.4,1.2,0.2,1.4,1.2,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,53.0,Trop2_MMAE_His_6.0_7.5S_2w25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,94.4,0.4,0.4,71.19,98.72,0.0,0.0,,57.22,18.08,24.7,-1.3,3.6,-2.2,1.3,3.6,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.67,3.2,1.13,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,53.0,Trop2_MMAE_His_6.0_7.5S_2w40C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,92.2,-1.8,1.8,69.69,96.98,-1.7,1.7,,40.88,40.81,18.3,-17.7,26.3,-8.6,17.7,26.3,8.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.57,3.41,3.02,-2.7,0.6,2.1,2.7,0.6,2.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,53.0,Trop2_MMAE_His_6.0_7.5S_T0,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,94.0,0.0,0.0,70.34,98.68,0.0,0.0,,58.55,14.51,26.94,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.25,2.85,0.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,53.0,Trop2_MMAE_His_6.0_7.5S_T0_25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,53.0,Trop2_MMAE_His_6.0_7.5S_T0_40C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,7.5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,-80.0,0.0,,17.5,Trop2_PNU_17.5_Start,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.0,7.5,0,,,,94.4,0.0,0.0,66.09,98.75,0.0,0.0,,55.7,19.87,24.43,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.19,3.04,1.77,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,-,Sucrose,0,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,10.7,Trop2_PNU_Cit_5.5_5S_1M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,95.4,0.8,0.8,63.97,99.7,1.0,1.0,,42.9,36.52,20.58,-13.7,18.1,-4.3,13.7,18.1,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.83,1.86,3.32,-0.5,-1.0,1.5,0.5,1.0,1.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.7,Trop2_PNU_Cit_5.5_5S_1M40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,92.4,-2.2,2.2,59.53,97.25,-1.4,1.4,,10.47,82.32,7.21,-46.2,63.9,-17.7,46.2,63.9,17.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.55,3.77,4.68,-3.8,0.9,2.9,3.8,0.9,2.9,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,10.7,Trop2_PNU_Cit_5.5_5S_1M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,95.2,0.6,0.6,63.68,99.7,1.0,1.0,,54.04,21.68,24.27,-2.6,3.2,-0.6,2.6,3.2,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,1.85,2.55,0.2,-1.0,0.7,0.2,1.0,0.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,10.7,Trop2_PNU_Cit_5.5_5S_2M25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,95.7,1.1,1.1,64.99,98.78,0.1,0.1,,33.79,49.3,16.91,-22.8,30.8,-8.0,22.8,30.8,8.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.45,1.97,3.58,-0.9,-0.9,1.8,0.9,0.9,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,10.7,Trop2_PNU_Cit_5.5_5S_2M5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,95.7,1.1,1.1,65.74,98.95,0.3,0.3,,50.53,26.73,22.74,-6.1,8.3,-2.2,6.1,8.3,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.0,2.19,2.81,-0.4,-0.6,1.0,0.4,0.6,1.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,10.7,Trop2_PNU_Cit_5.5_5S_2w25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,94.7,0.1,0.1,67.11,98.33,-0.4,0.4,,46.54,30.51,22.95,-10.1,12.1,-1.9,10.1,12.1,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.79,2.24,2.97,-0.6,-0.6,1.2,0.6,0.6,1.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,10.7,Trop2_PNU_Cit_5.5_5S_2w40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,92.9,-1.7,1.7,63.2,96.5,-2.2,2.2,,16.45,76.95,6.6,-40.2,58.5,-18.3,40.2,58.5,18.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.97,3.05,4.99,-3.4,0.2,3.2,3.4,0.2,3.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,10.7,Trop2_PNU_Cit_5.5_5S_3w5C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,94.7,0.1,0.1,65.96,98.82,0.1,0.1,,55.53,19.82,24.65,-1.1,1.4,-0.2,1.1,1.4,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.01,2.5,2.49,-0.3,-0.3,0.7,0.3,0.3,0.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,10.7,Trop2_PNU_Cit_5.5_5S_T0,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,94.6,0.0,0.0,66.18,98.72,0.0,0.0,,56.64,18.45,24.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.36,2.83,1.81,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,10.7,Trop2_PNU_Cit_5.5_5S_T0_25C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,10.7,Trop2_PNU_Cit_5.5_5S_T0_40C,NB-aujer-5078398-0002,5.5,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,10.8,Trop2_PNU_Cit_6.0_5S_1M25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,95.2,0.5,0.5,63.86,99.7,0.8,0.8,,44.67,34.24,21.09,-12.3,16.4,-4.0,12.3,16.4,4.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.68,1.38,2.94,0.5,-1.6,1.1,0.5,1.6,1.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.8,Trop2_PNU_Cit_6.0_5S_1M40C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,92.4,-2.3,2.3,59.92,97.36,-1.5,1.5,,14.99,74.24,10.77,-42.0,56.4,-14.4,42.0,56.4,14.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.21,3.19,4.6,-1.8,0.0,1.8,1.8,0.0,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,10.8,Trop2_PNU_Cit_6.0_5S_1M5C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,95.3,0.6,0.6,63.6,99.74,0.8,0.8,,57.3,20.29,22.41,0.3,2.4,-2.7,0.3,2.4,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.9,1.79,2.3,0.8,-1.2,0.4,0.8,1.2,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,10.8,Trop2_PNU_Cit_6.0_5S_2M25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,95.7,1.0,1.0,65.03,98.79,-0.1,0.1,,35.98,46.54,17.47,-21.0,28.6,-7.7,21.0,28.6,7.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.6,1.95,3.45,-0.6,-1.0,1.6,0.6,1.0,1.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,10.8,Trop2_PNU_Cit_6.0_5S_2M5C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,95.5,0.8,0.8,65.69,99.19,0.3,0.3,,49.72,26.24,24.04,-7.2,8.3,-1.1,7.2,8.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.87,2.47,2.66,-0.3,-0.5,0.8,0.3,0.5,0.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,10.8,Trop2_PNU_Cit_6.0_5S_2w25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,94.7,0.0,0.0,67.11,98.56,-0.3,0.3,,49.02,28.05,22.93,-7.9,10.2,-2.2,7.9,10.2,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.44,2.65,2.9,-0.7,-0.4,1.0,0.7,0.4,1.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,10.8,Trop2_PNU_Cit_6.0_5S_2w40C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,93.1,-1.6,1.6,62.45,96.0,-2.9,2.9,,15.83,69.87,14.3,-41.1,52.0,-10.8,41.1,52.0,10.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.25,3.19,4.56,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,10.8,Trop2_PNU_Cit_6.0_5S_3w5C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,94.6,-0.1,0.1,66.28,98.77,-0.1,0.1,,56.67,18.56,24.78,-0.3,0.7,-0.3,0.3,0.7,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.77,2.77,2.46,-0.4,-0.2,0.6,0.4,0.2,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,10.8,Trop2_PNU_Cit_6.0_5S_T0,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,94.7,0.0,0.0,64.56,98.91,0.0,0.0,,56.97,17.89,25.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.15,3.0,1.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,10.8,Trop2_PNU_Cit_6.0_5S_T0_25C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,10.8,Trop2_PNU_Cit_6.0_5S_T0_40C,NB-aujer-5078398-0002,6.0,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,10.2,Trop2_PNU_Cit_6.5_5S_1M25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,95.5,0.9,0.9,63.43,99.67,0.6,0.6,,40.12,42.31,17.57,-16.1,23.3,-7.1,16.1,23.3,7.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.32,1.84,2.85,0.4,-1.2,0.8,0.4,1.2,0.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.2,Trop2_PNU_Cit_6.5_5S_1M40C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,91.9,-2.7,2.7,59.39,97.41,-1.7,1.7,,13.21,81.71,5.07,-43.0,62.7,-19.6,43.0,62.7,19.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.4,2.88,4.73,-1.5,-0.3,1.8,1.5,0.3,1.8,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,10.2,Trop2_PNU_Cit_6.5_5S_1M5C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,95.3,0.7,0.7,63.47,99.71,0.6,0.6,,54.34,22.12,23.54,-1.9,3.1,-1.2,1.9,3.1,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.32,2.16,2.53,0.4,-0.8,0.5,0.4,0.8,0.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,10.2,Trop2_PNU_Cit_6.5_5S_2M25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,95.7,1.1,1.1,64.74,98.88,-0.2,0.2,,30.59,54.77,14.64,-25.7,35.7,-10.1,25.7,35.7,10.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.32,2.35,3.33,-0.6,-0.6,1.3,0.6,0.6,1.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,10.2,Trop2_PNU_Cit_6.5_5S_2M5C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,95.4,0.8,0.8,65.33,99.06,0.0,0.0,,46.43,30.31,23.25,-9.8,11.3,-1.5,9.8,11.3,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.77,2.59,2.65,-0.2,-0.4,0.6,0.2,0.4,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,10.2,Trop2_PNU_Cit_6.5_5S_2w25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,94.7,0.1,0.1,65.71,99.02,-0.1,0.1,,43.95,33.82,22.23,-12.3,14.8,-2.5,12.3,14.8,2.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.04,2.98,2.98,-0.9,0.0,0.9,0.9,0.0,0.9,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,10.2,Trop2_PNU_Cit_6.5_5S_2w40C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,92.9,-1.7,1.7,61.66,95.48,-3.6,3.6,,16.43,77.42,6.15,-39.8,58.4,-18.6,39.8,58.4,18.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.62,1.65,4.75,-1.3,-1.4,2.7,1.3,1.4,2.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,10.2,Trop2_PNU_Cit_6.5_5S_3w5C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,93.9,-0.7,0.7,65.41,99.17,0.1,0.1,,54.6,20.6,24.8,-1.6,1.6,0.1,1.6,1.6,0.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.6,2.93,2.47,-0.4,-0.1,0.4,0.4,0.1,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,10.2,Trop2_PNU_Cit_6.5_5S_T0,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,94.6,0.0,0.0,66.56,99.09,0.0,0.0,,56.25,19.03,24.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.95,3.0,2.05,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,10.2,Trop2_PNU_Cit_6.5_5S_T0_25C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,10.2,Trop2_PNU_Cit_6.5_5S_T0_40C,NB-aujer-5078398-0002,6.5,Citrate,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,10.9,Trop2_PNU_His_5.5_5S_1M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,95.2,1.0,1.0,63.63,99.71,0.9,0.9,,52.07,26.87,21.06,-5.3,9.7,-4.3,5.3,9.7,4.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.74,1.7,1.56,1.6,-1.8,0.2,1.6,1.8,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.9,Trop2_PNU_His_5.5_5S_1M40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,91.6,-2.6,2.6,60.93,97.87,-0.9,0.9,,18.71,71.4,9.9,-38.7,54.2,-15.5,38.7,54.2,15.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.89,4.39,2.72,-2.2,0.8,1.4,2.2,0.8,1.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,10.9,Trop2_PNU_His_5.5_5S_1M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,95.3,1.1,1.1,63.67,99.68,0.9,0.9,,57.86,18.56,23.59,0.5,1.4,-1.8,0.5,1.4,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.87,1.78,1.35,1.8,-1.8,0.0,1.8,1.8,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,10.9,Trop2_PNU_His_5.5_5S_2w40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,92.3,-1.9,1.9,64.05,96.69,-2.1,2.1,,27.48,60.2,12.32,-29.9,43.0,-13.1,29.9,43.0,13.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.06,4.58,2.37,-2.1,1.0,1.0,2.1,1.0,1.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,10.9,Trop2_PNU_His_5.5_5S_2M25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,95.4,1.2,1.2,65.47,98.91,0.1,0.1,,45.2,33.92,20.88,-12.2,16.7,-4.5,12.2,16.7,4.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,2.53,1.73,0.6,-1.0,0.4,0.6,1.0,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,10.9,Trop2_PNU_His_5.5_5S_2M5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,95.4,1.2,1.2,65.61,98.97,0.2,0.2,,54.83,20.22,24.96,-2.6,3.0,-0.4,2.6,3.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.81,1.43,0.6,-0.7,0.1,0.6,0.7,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,10.9,Trop2_PNU_His_5.5_5S_2w25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,94.7,0.5,0.5,65.5,96.91,-1.9,1.9,,55.43,20.28,24.29,-2.0,3.1,-1.1,2.0,3.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.04,3.47,1.48,-0.1,-0.1,0.1,0.1,0.1,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,10.9,Trop2_PNU_His_5.5_5S_3w5C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,94.6,0.4,0.4,65.87,98.78,0.0,0.0,,57.09,18.15,24.76,-0.3,0.9,-0.6,0.3,0.9,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.42,3.12,1.46,0.3,-0.4,0.1,0.3,0.4,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,10.9,Trop2_PNU_His_5.5_5S_T0,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,94.2,0.0,0.0,66.0,98.81,0.0,0.0,,57.4,17.2,25.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.12,3.54,1.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,10.9,Trop2_PNU_His_5.5_5S_T0_25C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,10.9,Trop2_PNU_His_5.5_5S_T0_40C,NB-aujer-5078398-0002,5.5,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,10.6,Trop2_PNU_His_6.0_5S_1M25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,95.1,0.2,0.2,63.71,99.69,0.8,0.8,,44.88,34.88,20.23,-10.5,14.9,-4.4,10.5,14.9,4.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,2.39,1.87,0.8,-1.2,0.3,0.8,1.2,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.6,Trop2_PNU_His_6.0_5S_1M40C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,91.7,-3.2,3.2,60.65,98.02,-0.9,0.9,,15.01,78.16,6.82,-40.4,58.2,-17.8,40.4,58.2,17.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.33,4.11,3.56,-2.2,0.5,1.7,2.2,0.5,1.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,10.6,Trop2_PNU_His_6.0_5S_1M5C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,95.6,0.7,0.7,63.63,99.71,0.8,0.8,,50.92,26.35,22.74,-4.5,6.4,-1.9,4.5,6.4,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.72,1.66,1.62,1.8,-1.9,0.1,1.8,1.9,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,10.6,Trop2_PNU_His_6.0_5S_2M25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,95.3,0.4,0.4,65.2,98.88,0.0,0.0,,34.67,48.03,17.29,-20.8,28.1,-7.3,20.8,28.1,7.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,2.83,2.07,0.2,-0.8,0.5,0.2,0.8,0.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,10.6,Trop2_PNU_His_6.0_5S_2M5C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,95.6,0.7,0.7,65.57,98.87,0.0,0.0,,48.16,29.93,21.91,-7.3,10.0,-2.7,7.3,10.0,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.55,1.68,0.9,-1.0,0.1,0.9,1.0,0.1,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,10.6,Trop2_PNU_His_6.0_5S_2w25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,94.5,-0.4,0.4,67.42,98.51,-0.4,0.4,,47.48,30.23,22.29,-7.9,10.3,-2.3,7.9,10.3,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.54,3.67,1.79,-0.3,0.1,0.3,0.3,0.1,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,10.6,Trop2_PNU_His_6.0_5S_2w40C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,92.0,-2.9,2.9,63.21,96.52,-2.4,2.4,,20.9,69.59,9.52,-34.5,49.6,-15.1,34.5,49.6,15.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.56,4.24,3.2,-2.3,0.7,1.7,2.3,0.7,1.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,10.6,Trop2_PNU_His_6.0_5S_3w5C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,94.5,-0.4,0.4,66.85,98.74,-0.2,0.2,,54.32,22.2,23.48,-1.1,2.2,-1.1,1.1,2.2,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.72,3.51,1.78,-0.2,-0.1,0.2,0.2,0.1,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,10.6,Trop2_PNU_His_6.0_5S_T0,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,94.9,0.0,0.0,65.05,98.93,0.0,0.0,,55.42,19.97,24.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.89,3.58,1.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,10.6,Trop2_PNU_His_6.0_5S_T0_25C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,10.6,Trop2_PNU_His_6.0_5S_T0_40C,NB-aujer-5078398-0002,6.0,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,10.7,Trop2_PNU_His_6.5_5S_1M25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,95.2,0.6,0.6,63.64,99.71,0.8,0.8,,32.04,53.12,14.84,-23.1,31.9,-8.9,23.1,31.9,8.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.62,3.29,2.09,-0.3,-0.2,0.5,0.3,0.2,0.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,10.7,Trop2_PNU_His_6.5_5S_1M40C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,91.9,-2.7,2.7,59.93,97.6,-1.3,1.3,,12.7,81.68,5.62,-42.4,60.5,-18.1,42.4,60.5,18.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.78,2.95,3.26,-1.1,-0.5,1.7,1.1,0.5,1.7,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,10.7,Trop2_PNU_His_6.5_5S_1M5C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,95.4,0.8,0.8,63.67,99.71,0.8,0.8,,45.26,33.84,20.9,-9.9,12.7,-2.8,9.9,12.7,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.02,2.17,1.81,1.1,-1.3,0.2,1.1,1.3,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,10.7,Trop2_PNU_His_6.5_5S_2M25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,95.4,0.8,0.8,65.19,98.93,0.0,0.0,,25.14,63.18,11.68,-30.0,42.0,-12.0,30.0,42.0,12.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.18,2.6,2.23,0.3,-0.9,0.6,0.3,0.9,0.6,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,10.7,Trop2_PNU_His_6.5_5S_2M5C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,95.6,1.0,1.0,65.52,98.89,0.0,0.0,,38.79,42.31,18.9,-16.3,21.1,-4.8,16.3,21.1,4.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.89,2.29,1.82,1.0,-1.2,0.2,1.0,1.2,0.2,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,10.7,Trop2_PNU_His_6.5_5S_2w25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,94.6,0.0,0.0,67.46,98.43,-0.5,0.5,,38.29,43.84,17.88,-16.8,22.7,-5.8,16.8,22.7,5.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.42,3.58,2.0,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,10.7,Trop2_PNU_His_6.5_5S_2w40C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,91.6,-3.0,3.0,63.42,96.45,-2.4,2.4,,14.21,76.7,9.1,-40.9,55.5,-14.6,40.9,55.5,14.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.83,3.08,3.09,-1.1,-0.4,1.5,1.1,0.4,1.5,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,10.7,Trop2_PNU_His_6.5_5S_3w5C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,94.3,-0.3,0.3,66.22,99.0,0.1,0.1,,45.43,32.82,21.75,-9.7,11.6,-1.9,9.7,11.6,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,3.0,1.89,0.2,-0.5,0.3,0.2,0.5,0.3,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,10.7,Trop2_PNU_His_6.5_5S_T0,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,94.6,0.0,0.0,65.17,98.93,0.0,0.0,,55.13,21.17,23.7,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.92,3.49,1.6,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,10.7,Trop2_PNU_His_6.5_5S_T0_25C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
4/12/2023,aujer,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,10.7,Trop2_PNU_His_6.5_5S_T0_40C,NB-aujer-5078398-0002,6.5,Histidine,0,0,0.02,5.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PS80 Sucrose,PS80,Sucrose,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60.0,5.0,,5.0,Trop2_PNU_ctrl_60C_t5,NB-knoxbrow-5090913-0001,6.0,Histidine,0,0,0.0,9.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,65.46,0.88,33.66,-32.1,0.1,32.1,32.1,0.1,32.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
10/30/2023,knoxbrow,Trop2,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,25.0,0.0,,5.0,Trop2_PNU_ctrl_t0,NB-knoxbrow-5090913-0001,6.0,Histidine,0,0,0.0,9.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.58,0.83,1.58,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,-80.0,0.0,,1.0,Trop2_MMAE_53_Start,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.8,0.0,0.0,68.72,98.77,0.0,0.0,,58.69,14.89,26.42,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,207063.5,24980.0,198.0,207024.0,0.0,4.1,,,,,,,,,,95.91,3.07,1.02,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,67.89,99.71,1.0,1.0,,59.98,14.18,25.85,-0.2,1.1,-0.9,0.2,1.1,0.9,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0.0,15079.3,0.0,2.0,,,,,,,,,,94.93,3.98,1.09,-1.3,1.1,0.2,1.3,1.1,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,91.5,-2.7,2.7,65.05,97.18,-1.5,1.5,,42.26,37.66,20.08,-17.9,24.6,-6.7,17.9,24.6,6.7,,,,,,,,,,,,,,,,,,,,,12156.0,2116.3,13.3,12156.0,0.0,2.3,,,,,,,,,,89.94,3.96,6.1,-6.3,1.1,5.2,6.3,1.1,5.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.8,0.6,0.6,67.74,99.71,1.0,1.0,,58.61,13.98,27.41,-1.5,0.9,0.6,1.5,0.9,0.6,,,,,,,,,,,,,,,,,,,,,2817.3,635.0,0.0,2817.3,0.0,2.3,,,,,,,,,,95.23,3.85,0.92,-1.0,1.0,0.0,1.0,1.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,95.7,1.5,1.5,70.04,98.94,0.2,0.2,,56.19,17.35,26.46,-3.9,4.3,-0.3,3.9,4.3,0.3,,,,,,,,,,,,,,,,,,,,,6124.3,1362.3,185.0,6071.3,0.0,3.7,,,,,,,,,,94.62,4.08,1.29,-1.6,1.2,0.4,1.6,1.2,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.9,0.7,0.7,70.32,99.19,0.5,0.5,,57.97,14.58,27.45,-2.2,1.5,0.7,2.2,1.5,0.7,,,,,,,,,,,,,,,,,,,,,3148.3,569.0,0.0,3148.3,0.0,2.7,,,,,,,,,,95.08,3.9,1.01,-1.1,1.0,0.1,1.1,1.0,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,71.08,98.61,-0.1,0.1,,58.95,14.01,27.04,-1.2,0.9,0.2,1.2,0.9,0.2,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1.0,,,,,,,,,,95.61,3.31,1.08,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,92.5,-1.7,1.7,69.04,96.49,-2.2,2.2,,45.6,31.02,23.38,-14.5,17.9,-3.4,14.5,17.9,3.4,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0.0,2182.7,0.0,1.4,,,,,,,,,,90.14,2.8,7.06,-6.1,-0.1,6.2,6.1,0.1,6.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,69.46,98.72,0.0,0.0,,60.13,13.09,26.79,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,4391.7,820.0,0.0,4391.7,0.0,1.2,,,,,,,,,,96.22,2.9,0.89,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.4,0.1,0.1,67.86,99.7,0.6,0.6,,58.15,16.48,25.38,-1.5,3.0,-1.5,1.5,3.0,1.5,,,,,,,,,,,,,,,,,,,,,3558.0,621.7,39.7,3544.7,0.0,1.4,,,,,,,,,,94.72,3.93,1.36,-1.0,0.6,0.4,1.0,0.6,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,91.7,-2.6,2.6,65.19,97.28,-1.8,1.8,,33.46,51.15,15.39,-26.2,37.7,-11.5,26.2,37.7,11.5,,,,,,,,,,,,,,,,,,,,,3651.0,939.3,13.3,3651.0,0.0,2.3,,,,,,,,,,91.77,4.02,4.21,-4.0,0.7,3.2,4.0,0.7,3.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.5,0.2,0.2,66.22,99.72,0.6,0.6,,59.84,14.22,25.94,0.2,0.8,-0.9,0.2,0.8,0.9,,,,,,,,,,,,,,,,,,,,,886.3,238.0,0.0,886.3,0.0,1.7,,,,,,,,,,94.73,4.2,1.07,-1.0,0.9,0.1,1.0,0.9,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,95.4,1.1,1.1,70.0,99.13,0.0,0.0,,52.7,22.39,24.91,-7.0,8.9,-2.0,7.0,8.9,2.0,,,,,,,,,,,,,,,,,,,,,7314.7,1984.3,105.7,7301.7,13.3,3.6,,,,,,,,,,94.07,4.37,1.56,-1.7,1.1,0.6,1.7,1.1,0.6,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,95.3,1.0,1.0,70.34,99.24,0.1,0.1,,58.05,15.15,26.8,-1.6,1.7,-0.1,1.6,1.7,0.1,,,,,,,,,,,,,,,,,,,,,2949.7,820.0,79.3,2949.7,0.0,3.0,,,,,,,,,,95.06,3.74,1.2,-0.7,0.4,0.2,0.7,0.4,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.4,0.1,0.1,70.68,98.8,-0.3,0.3,,58.56,15.15,26.29,-1.1,1.7,-0.6,1.1,1.7,0.6,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0.0,2.2,,,,,,,,,,95.85,2.84,1.3,0.1,-0.5,0.3,0.1,0.5,0.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,91.5,-2.8,2.8,68.85,96.44,-2.7,2.7,,36.9,45.28,17.82,-22.8,31.8,-9.0,22.8,31.8,9.0,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0.0,3505.3,0.0,1.5,,,,,,,,,,92.52,2.93,4.55,-3.2,-0.4,3.6,3.2,0.4,3.6,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.3,0.0,0.0,68.76,99.09,0.0,0.0,,59.67,13.46,26.87,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,3426.0,727.3,13.3,3412.7,0.0,1.3,,,,,,,,,,95.74,3.3,0.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_MMAE_His_5.0_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,67.77,99.58,1.1,1.1,,60.13,13.44,26.42,0.1,0.7,-0.8,0.1,0.7,0.8,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0.0,2248.7,0.0,0.4,,,,,,,,,,94.58,4.53,0.88,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_MMAE_His_5.0_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,91.2,-3.0,3.0,63.33,96.46,-2.0,2.0,,46.55,29.68,23.77,-13.5,16.9,-3.4,13.5,16.9,3.4,,,,,,,,,,,,,,,,,,,,,25516.0,5211.3,26.7,25516.0,0.0,1.0,,,,,,,,,,90.1,5.03,4.87,-5.8,1.7,4.1,5.8,1.7,4.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_MMAE_His_5.0_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.7,0.5,0.5,67.07,99.55,1.1,1.1,,59.1,13.45,27.45,-0.9,0.7,0.2,0.9,0.7,0.2,,,,,,,,,,,,,,,,,,,,,3783.0,674.7,0.0,3783.0,0.0,0.4,,,,,,,,,,94.84,4.38,0.78,-1.0,1.0,0.0,1.0,1.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_MMAE_His_5.0_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.9,0.7,0.7,68.65,97.99,-0.5,0.5,,58.82,13.81,27.37,-1.2,1.0,0.2,1.2,1.0,0.2,,,,,,,,,,,,,,,,,,,,,30410.3,4206.3,26.3,30410.3,0.0,1.9,,,,,,,,,,95.5,3.64,0.86,-0.4,0.3,0.1,0.4,0.3,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_MMAE_His_5.0_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,70.31,98.46,0.0,0.0,,59.65,13.26,27.09,-0.4,0.5,-0.1,0.4,0.5,0.1,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,95.7,3.4,0.9,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_MMAE_His_5.0_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,92.2,-2.0,2.0,66.91,96.86,-1.6,1.6,,50.4,24.05,25.55,-9.6,11.3,-1.6,9.6,11.3,1.6,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40.0,9391.3,13.3,2.8,,,,,,,,,,92.45,2.69,4.85,-3.4,-0.6,4.1,3.4,0.6,4.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_MMAE_His_5.0_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,68.83,98.46,0.0,0.0,,60.03,12.77,27.2,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,8399.3,1402.0,26.7,8399.3,0.0,1.3,,,,,,,,,,95.89,3.33,0.78,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_MMAE_His_5.5_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.3,0.2,0.2,67.71,99.67,1.1,1.1,,57.35,16.1,26.55,-1.2,2.0,-0.7,1.2,2.0,0.7,,,,,,,,,,,,,,,,,,,,,1640.0,463.0,0.0,1640.0,0.0,0.9,,,,,,,,,,94.59,4.39,1.02,-1.0,0.9,0.2,1.0,0.9,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_MMAE_His_5.5_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,91.3,-2.8,2.8,64.97,97.14,-1.5,1.5,,40.06,40.05,19.89,-18.5,25.9,-7.4,18.5,25.9,7.4,,,,,,,,,,,,,,,,,,,,,2275.0,383.7,0.0,2275.0,0.0,1.7,,,,,,,,,,92.18,4.82,3.01,-3.4,1.3,2.2,3.4,1.3,2.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_MMAE_His_5.5_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.5,0.5,67.61,99.56,1.0,1.0,,60.23,13.39,26.38,1.6,-0.7,-0.9,1.6,-0.7,0.9,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984.0,0.0,0.7,,,,,,,,,,95.1,4.0,0.89,-0.5,0.5,0.0,0.5,0.5,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.9,0.8,0.8,69.82,98.62,0.0,0.0,,55.65,18.46,25.89,-3.0,4.3,-1.4,3.0,4.3,1.4,,,,,,,,,,,,,,,,,,,,,4312.0,846.3,39.7,4312.0,0.0,2.0,,,,,,,,,,94.85,3.96,1.19,-0.8,0.4,0.3,0.8,0.4,0.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.9,0.8,0.8,69.4,98.58,0.0,0.0,,57.83,14.84,27.34,-0.8,0.7,0.1,0.8,0.7,0.1,,,,,,,,,,,,,,,,,,,,,4153.3,436.3,0.0,4153.3,0.0,1.9,,,,,,,,,,95.52,3.47,1.01,-0.1,0.0,0.2,0.1,0.0,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.4,0.3,0.3,70.83,98.66,0.1,0.1,,59.16,14.44,26.39,0.6,0.3,-0.9,0.6,0.3,0.9,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0.0,2.4,,,,,,,,,,95.59,3.38,1.03,0.0,-0.1,0.2,0.0,0.1,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,92.2,-1.9,1.9,68.85,97.49,-1.1,1.1,,46.94,31.14,21.92,-11.7,17.0,-5.4,11.7,17.0,5.4,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0.0,1.0,,,,,,,,,,93.11,3.51,3.37,-2.5,0.0,2.5,2.5,0.0,2.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_MMAE_His_5.5_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.1,0.0,0.0,69.94,98.61,0.0,0.0,,58.6,14.12,27.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,2142.5,516.0,20.0,2142.5,0.0,1.3,,,,,,,,,,95.63,3.52,0.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_MMAE_His_6.0_7.5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.5,0.5,0.5,68.74,99.67,1.0,1.0,,55.66,20.49,23.86,-2.9,6.0,-3.1,2.9,6.0,3.1,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,95.55,3.25,1.2,-0.7,0.4,0.3,0.7,0.4,0.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_MMAE_His_6.0_7.5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,91.2,-2.8,2.8,65.47,97.62,-1.1,1.1,,33.9,50.4,15.7,-24.6,35.9,-11.2,24.6,35.9,11.2,,,,,,,,,,,,,,,,,,,,,2910.0,886.3,0.0,2910.0,0.0,0.8,,,,,,,,,,93.06,4.28,2.66,-3.2,1.4,1.8,3.2,1.4,1.8,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_MMAE_His_6.0_7.5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.3,0.3,0.3,67.24,99.6,0.9,0.9,,58.19,15.87,25.93,-0.4,1.4,-1.0,0.4,1.4,1.0,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0.0,3716.7,0.0,0.7,,,,,,,,,,94.81,4.19,0.99,-1.4,1.3,0.1,1.4,1.3,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,95.8,1.8,1.8,70.14,98.84,0.1,0.1,,47.47,29.76,22.77,-11.1,15.3,-4.2,11.1,15.3,4.2,,,,,,,,,,,,,,,,,,,,,1177.0,225.0,26.7,1164.0,0.0,1.4,,,,,,,,,,94.06,4.61,1.34,-2.2,1.8,0.4,2.2,1.8,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.8,0.8,0.8,69.99,98.93,0.2,0.2,,57.79,17.15,25.06,-0.8,2.6,-1.9,0.8,2.6,1.9,,,,,,,,,,,,,,,,,,,,,582.0,53.0,0.0,582.0,0.0,1.8,,,,,,,,,,94.89,4.0,1.12,-1.4,1.2,0.2,1.4,1.2,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.4,0.4,71.19,98.72,0.0,0.0,,57.22,18.08,24.7,-1.3,3.6,-2.2,1.3,3.6,2.2,,,,,,,,,,,,,,,,,,,,,3928.5,1349.5,59.5,3908.5,0.0,1.3,,,,,,,,,,95.67,3.2,1.13,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,92.2,-1.8,1.8,69.69,96.98,-1.7,1.7,,40.88,40.81,18.3,-17.7,26.3,-8.6,17.7,26.3,8.6,,,,,,,,,,,,,,,,,,,,,7288.0,1084.7,39.7,7288.0,0.0,0.6,,,,,,,,,,93.57,3.41,3.02,-2.7,0.6,2.1,2.7,0.6,2.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_MMAE_His_6.0_7.5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.0,0.0,0.0,70.34,98.68,0.0,0.0,,58.55,14.51,26.94,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,17698.3,2791.0,40.0,17685.0,13.3,1.4,,,,,,,,,,96.25,2.85,0.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,-80.0,0.0,,1.0,Trop2_PNU_17.5_Start,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.0,0.0,66.09,98.75,0.0,0.0,,55.7,19.87,24.43,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,410555.5,126528.0,10595.0,409484.0,20.0,11.2,,,,,,,,,,95.19,3.04,1.77,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_PNU_Cit_5.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,95.4,0.8,0.8,63.97,99.7,1.0,1.0,,42.9,36.52,20.58,-13.7,18.1,-4.3,13.7,18.1,4.3,,,,,,,,,,,,,,,,,,,,,1045.0,450.0,0.0,1045.0,0.0,0.5,,,,,,,,,,94.83,1.86,3.32,-0.5,-1.0,1.5,0.5,1.0,1.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_PNU_Cit_5.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,92.4,-2.2,2.2,59.53,97.25,-1.4,1.4,,10.47,82.32,7.21,-46.2,63.9,-17.7,46.2,63.9,17.7,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0.0,0.2,,,,,,,,,,93.04,3.62,3.35,-2.3,0.8,1.5,2.3,0.8,1.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_PNU_Cit_5.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,95.2,0.6,0.6,63.68,99.7,1.0,1.0,,54.04,21.68,24.27,-2.6,3.2,-0.6,2.6,3.2,0.6,,,,,,,,,,,,,,,,,,,,,992.0,225.0,0.0,992.0,0.0,0.4,,,,,,,,,,95.6,1.85,2.55,0.2,-1.0,0.7,0.2,1.0,0.7,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_PNU_Cit_5.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,95.7,1.1,1.1,64.99,98.78,0.1,0.1,,33.79,49.3,16.91,-22.8,30.8,-8.0,22.8,30.8,8.0,,,,,,,,,,,,,,,,,,,,,675.0,145.3,26.7,675.0,0.0,0.8,,,,,,,,,,94.45,1.97,3.58,-0.9,-0.9,1.8,0.9,0.9,1.8,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_PNU_Cit_5.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,95.7,1.1,1.1,65.74,98.95,0.3,0.3,,50.53,26.73,22.74,-6.1,8.3,-2.2,6.1,8.3,2.2,,,,,,,,,,,,,,,,,,,,,1508.0,317.3,13.3,1508.0,0.0,0.9,,,,,,,,,,95.0,2.19,2.81,-0.4,-0.6,1.0,0.4,0.6,1.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_5.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.7,0.1,0.1,67.11,98.33,-0.4,0.4,,46.54,30.51,22.95,-10.1,12.1,-1.9,10.1,12.1,1.9,,,,,,,,,,,,,,,,,,,,,582.0,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,94.79,2.24,2.97,-0.6,-0.6,1.2,0.6,0.6,1.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_5.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,92.9,-1.7,1.7,63.2,96.5,-2.2,2.2,,16.45,76.95,6.6,-40.2,58.5,-18.3,40.2,58.5,18.3,,,,,,,,,,,,,,,,,,,,,2024.0,608.3,0.0,2024.0,0.0,0.2,,,,,,,,,,91.97,3.05,4.99,-3.4,0.2,3.2,3.4,0.2,3.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_PNU_Cit_5.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.7,0.1,0.1,65.96,98.82,0.1,0.1,,55.53,19.82,24.65,-1.1,1.4,-0.2,1.1,1.4,0.2,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0.0,1587.3,0.0,1.1,,,,,,,,,,95.01,2.5,2.49,-0.3,-0.3,0.7,0.3,0.3,0.7,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_5.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.18,98.72,0.0,0.0,,56.64,18.45,24.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,5965.7,754.0,26.7,5939.3,13.3,1.1,,,,,,,,,,95.36,2.83,1.81,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_PNU_Cit_6.0_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,95.2,0.5,0.5,63.86,99.7,0.8,0.8,,44.67,34.24,21.09,-12.3,16.4,-4.0,12.3,16.4,4.0,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0.0,0.3,,,,,,,,,,95.68,1.38,2.94,0.5,-1.6,1.1,0.5,1.6,1.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_PNU_Cit_6.0_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,92.4,-2.3,2.3,59.92,97.36,-1.5,1.5,,14.99,74.24,10.77,-42.0,56.4,-14.4,42.0,56.4,14.4,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53.0,1561.0,26.7,0.8,,,,,,,,,,93.39,2.98,3.63,-1.8,0.0,1.8,1.8,0.0,1.8,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_PNU_Cit_6.0_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,95.3,0.6,0.6,63.6,99.74,0.8,0.8,,57.3,20.29,22.41,0.3,2.4,-2.7,0.3,2.4,2.7,,,,,,,,,,,,,,,,,,,,,1164.0,423.3,13.3,1164.0,0.0,0.6,,,,,,,,,,95.9,1.79,2.3,0.8,-1.2,0.4,0.8,1.2,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_PNU_Cit_6.0_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,95.7,1.0,1.0,65.03,98.79,-0.1,0.1,,35.98,46.54,17.47,-21.0,28.6,-7.7,21.0,28.6,7.7,,,,,,,,,,,,,,,,,,,,,1164.0,476.3,26.7,1164.0,0.0,0.9,,,,,,,,,,94.6,1.95,3.45,-0.6,-1.0,1.6,0.6,1.0,1.6,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_PNU_Cit_6.0_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,95.5,0.8,0.8,65.69,99.19,0.3,0.3,,49.72,26.24,24.04,-7.2,8.3,-1.1,7.2,8.3,1.1,,,,,,,,,,,,,,,,,,,,,807.0,225.0,13.3,807.0,0.0,1.4,,,,,,,,,,94.87,2.47,2.66,-0.3,-0.5,0.8,0.3,0.5,0.8,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_6.0_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.7,0.0,0.0,67.11,98.56,-0.3,0.3,,49.02,28.05,22.93,-7.9,10.2,-2.2,7.9,10.2,2.2,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,94.44,2.65,2.9,-0.7,-0.4,1.0,0.7,0.4,1.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_6.0_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,93.1,-1.6,1.6,62.45,96.0,-2.9,2.9,,15.83,69.87,14.3,-41.1,52.0,-10.8,41.1,52.0,10.8,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066.0,0.0,0.3,,,,,,,,,,92.25,3.19,4.56,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_PNU_Cit_6.0_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.6,-0.1,0.1,66.28,98.77,-0.1,0.1,,56.67,18.56,24.78,-0.3,0.7,-0.3,0.3,0.7,0.3,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0.0,0.9,,,,,,,,,,94.77,2.77,2.46,-0.4,-0.2,0.6,0.4,0.2,0.6,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_6.0_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.7,0.0,0.0,64.56,98.91,0.0,0.0,,56.97,17.89,25.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1693.0,529.0,26.7,1679.7,13.3,0.8,,,,,,,,,,95.15,3.0,1.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_PNU_Cit_6.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,95.5,0.9,0.9,63.43,99.67,0.6,0.6,,40.12,42.31,17.57,-16.1,23.3,-7.1,16.1,23.3,7.1,,,,,,,,,,,,,,,,,,,,,2209.0,568.7,26.7,2209.0,0.0,0.3,,,,,,,,,,95.32,1.84,2.85,0.4,-1.2,0.8,0.4,1.2,0.8,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_PNU_Cit_6.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,91.9,-2.7,2.7,59.39,97.41,-1.7,1.7,,13.21,81.71,5.07,-43.0,62.7,-19.6,43.0,62.7,19.6,,,,,,,,,,,,,,,,,,,,,926.0,171.7,0.0,926.0,0.0,0.4,,,,,,,,,,93.45,2.67,3.88,-1.5,-0.3,1.8,1.5,0.3,1.8,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_PNU_Cit_6.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,95.3,0.7,0.7,63.47,99.71,0.6,0.6,,54.34,22.12,23.54,-1.9,3.1,-1.2,1.9,3.1,1.2,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0.0,0.5,,,,,,,,,,95.32,2.16,2.53,0.4,-0.8,0.5,0.4,0.8,0.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_PNU_Cit_6.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,95.7,1.1,1.1,64.74,98.88,-0.2,0.2,,30.59,54.77,14.64,-25.7,35.7,-10.1,25.7,35.7,10.1,,,,,,,,,,,,,,,,,,,,,1957.7,436.7,26.3,1944.3,0.0,0.8,,,,,,,,,,94.32,2.35,3.33,-0.6,-0.6,1.3,0.6,0.6,1.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_PNU_Cit_6.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,95.4,0.8,0.8,65.33,99.06,0.0,0.0,,46.43,30.31,23.25,-9.8,11.3,-1.5,9.8,11.3,1.5,,,,,,,,,,,,,,,,,,,,,1071.3,291.3,13.3,1071.3,0.0,0.7,,,,,,,,,,94.77,2.59,2.65,-0.2,-0.4,0.6,0.2,0.4,0.6,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_Cit_6.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,94.7,0.1,0.1,65.71,99.02,-0.1,0.1,,43.95,33.82,22.23,-12.3,14.8,-2.5,12.3,14.8,2.5,,,,,,,,,,,,,,,,,,,,,926.0,238.0,0.0,926.0,0.0,0.6,,,,,,,,,,94.04,2.98,2.98,-0.9,0.0,0.9,0.9,0.0,0.9,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_Cit_6.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,92.9,-1.7,1.7,61.66,95.48,-3.6,3.6,,16.43,77.42,6.15,-39.8,58.4,-18.6,39.8,58.4,18.6,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0.0,0.3,,,,,,,,,,93.62,1.65,4.75,-1.3,-1.4,2.7,1.3,1.4,2.7,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_PNU_Cit_6.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,93.9,-0.7,0.7,65.41,99.17,0.1,0.1,,54.6,20.6,24.8,-1.6,1.6,0.1,1.6,1.6,0.1,,,,,,,,,,,,,,,,,,,,,397.0,132.3,13.3,397.0,0.0,0.6,,,,,,,,,,94.6,2.93,2.47,-0.4,-0.1,0.4,0.4,0.1,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_Cit_6.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.56,99.09,0.0,0.0,,56.25,19.03,24.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0.0,0.9,,,,,,,,,,94.95,3.0,2.05,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_PNU_His_5.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,95.2,1.0,1.0,63.63,99.71,0.9,0.9,,52.07,26.87,21.06,-5.3,9.7,-4.3,5.3,9.7,4.3,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0.0,0.4,,,,,,,,,,96.74,1.7,1.56,1.6,-1.8,0.2,1.6,1.8,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_PNU_His_5.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,91.6,-2.6,2.6,60.93,97.87,-0.9,0.9,,18.71,71.4,9.9,-38.7,54.2,-15.5,38.7,54.2,15.5,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582.0,0.0,0.6,,,,,,,,,,92.89,4.39,2.72,-2.2,0.8,1.4,2.2,0.8,1.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_PNU_His_5.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,95.3,1.1,1.1,63.67,99.68,0.9,0.9,,57.86,18.56,23.59,0.5,1.4,-1.8,0.5,1.4,1.8,,,,,,,,,,,,,,,,,,,,,2777.7,529.0,0.0,2777.7,0.0,0.7,,,,,,,,,,96.87,1.78,1.35,1.8,-1.8,0.0,1.8,1.8,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_PNU_His_5.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,95.4,1.2,1.2,65.47,98.91,0.1,0.1,,45.2,33.92,20.88,-12.2,16.7,-4.5,12.2,16.7,4.5,,,,,,,,,,,,,,,,,,,,,608.7,145.7,13.3,608.7,0.0,0.8,,,,,,,,,,95.74,2.53,1.73,0.6,-1.0,0.4,0.6,1.0,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_PNU_His_5.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,95.4,1.2,1.2,65.61,98.97,0.2,0.2,,54.83,20.22,24.96,-2.6,3.0,-0.4,2.6,3.0,0.4,,,,,,,,,,,,,,,,,,,,,1137.3,277.7,13.3,1137.3,0.0,1.2,,,,,,,,,,95.76,2.81,1.43,0.6,-0.7,0.1,0.6,0.7,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_5.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.7,0.5,0.5,65.5,96.91,-1.9,1.9,,55.43,20.28,24.29,-2.0,3.1,-1.1,2.0,3.1,1.1,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0.0,582.3,0.0,0.6,,,,,,,,,,95.04,3.47,1.48,-0.1,-0.1,0.1,0.1,0.1,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_5.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,92.3,-1.9,1.9,64.05,96.69,-2.1,2.1,,27.48,60.2,12.32,-29.9,43.0,-13.1,29.9,43.0,13.1,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0.0,0.2,,,,,,,,,,93.06,4.58,2.37,-2.1,1.0,1.0,2.1,1.0,1.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_PNU_His_5.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.4,0.4,65.87,98.78,0.0,0.0,,57.09,18.15,24.76,-0.3,0.9,-0.6,0.3,0.9,0.6,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0.0,1.1,,,,,,,,,,95.42,3.12,1.46,0.3,-0.4,0.1,0.3,0.4,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_5.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,66.0,98.81,0.0,0.0,,57.4,17.2,25.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0.0,1097.7,0.0,0.8,,,,,,,,,,95.12,3.54,1.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_PNU_His_6.0_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,95.1,0.2,0.2,63.71,99.69,0.8,0.8,,44.88,34.88,20.23,-10.5,14.9,-4.4,10.5,14.9,4.4,,,,,,,,,,,,,,,,,,,,,3307.0,370.3,0.0,3307.0,0.0,0.6,,,,,,,,,,95.74,2.39,1.87,0.8,-1.2,0.3,0.8,1.2,0.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_PNU_His_6.0_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,91.7,-3.2,3.2,60.65,98.02,-0.9,0.9,,15.01,78.16,6.82,-40.4,58.2,-17.8,40.4,58.2,17.8,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0.0,0.5,,,,,,,,,,92.74,4.07,3.19,-2.2,0.5,1.7,2.2,0.5,1.7,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_PNU_His_6.0_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,95.6,0.7,0.7,63.63,99.71,0.8,0.8,,50.92,26.35,22.74,-4.5,6.4,-1.9,4.5,6.4,1.9,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0.0,10595.3,0.0,0.7,,,,,,,,,,96.72,1.66,1.62,1.8,-1.9,0.1,1.8,1.9,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_PNU_His_6.0_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,95.3,0.4,0.4,65.2,98.88,0.0,0.0,,34.67,48.03,17.29,-20.8,28.1,-7.3,20.8,28.1,7.3,,,,,,,,,,,,,,,,,,,,,5542.3,423.3,13.3,5542.3,0.0,1.3,,,,,,,,,,95.11,2.83,2.07,0.2,-0.8,0.5,0.2,0.8,0.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_PNU_His_6.0_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,95.6,0.7,0.7,65.57,98.87,0.0,0.0,,48.16,29.93,21.91,-7.3,10.0,-2.7,7.3,10.0,2.7,,,,,,,,,,,,,,,,,,,,,9590.0,793.7,0.0,9590.0,0.0,1.2,,,,,,,,,,95.76,2.55,1.68,0.9,-1.0,0.1,0.9,1.0,0.1,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_6.0_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.5,-0.4,0.4,67.42,98.51,-0.4,0.4,,47.48,30.23,22.29,-7.9,10.3,-2.3,7.9,10.3,2.3,,,,,,,,,,,,,,,,,,,,,2354.7,198.0,39.7,2341.3,13.3,0.9,,,,,,,,,,94.54,3.67,1.79,-0.3,0.1,0.3,0.3,0.1,0.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_6.0_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,92.0,-2.9,2.9,63.21,96.52,-2.4,2.4,,20.9,69.59,9.52,-34.5,49.6,-15.1,34.5,49.6,15.1,,,,,,,,,,,,,,,,,,,,,4695.7,1296.0,66.0,4695.7,0.0,0.4,,,,,,,,,,92.56,4.24,3.2,-2.3,0.7,1.7,2.3,0.7,1.7,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_PNU_His_6.0_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.5,-0.4,0.4,66.85,98.74,-0.2,0.2,,54.32,22.2,23.48,-1.1,2.2,-1.1,1.1,2.2,1.1,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0.0,0.5,,,,,,,,,,94.72,3.51,1.78,-0.2,-0.1,0.2,0.2,0.1,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_6.0_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.9,0.0,0.0,65.05,98.93,0.0,0.0,,55.42,19.97,24.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,979.0,224.7,0.0,979.0,0.0,1.1,,,,,,,,,,94.89,3.58,1.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_PNU_His_6.5_5S_1M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,95.2,0.6,0.6,63.64,99.71,0.8,0.8,,32.04,53.12,14.84,-23.1,31.9,-8.9,23.1,31.9,8.9,,,,,,,,,,,,,,,,,,,,,6389.0,224.7,13.3,6389.0,0.0,1.0,,,,,,,,,,94.62,3.29,2.09,-0.3,-0.2,0.5,0.3,0.2,0.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_PNU_His_6.5_5S_1M40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,91.9,-2.7,2.7,59.93,97.6,-1.3,1.3,,12.7,81.68,5.62,-42.4,60.5,-18.1,42.4,60.5,18.1,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0.0,0.4,,,,,,,,,,94.19,2.9,2.91,-0.7,-0.6,1.3,0.7,0.6,1.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_PNU_His_6.5_5S_1M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,95.4,0.8,0.8,63.67,99.71,0.8,0.8,,45.26,33.84,20.9,-9.9,12.7,-2.8,9.9,12.7,2.8,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0.0,0.5,,,,,,,,,,96.02,2.17,1.81,1.1,-1.3,0.2,1.1,1.3,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_PNU_His_6.5_5S_2M25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,95.4,0.8,0.8,65.19,98.93,0.0,0.0,,25.14,63.18,11.68,-30.0,42.0,-12.0,30.0,42.0,12.0,,,,,,,,,,,,,,,,,,,,,4510.3,436.7,13.3,4497.3,13.3,1.3,,,,,,,,,,95.18,2.6,2.23,0.3,-0.9,0.6,0.3,0.9,0.6,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_PNU_His_6.5_5S_2M5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,95.6,1.0,1.0,65.52,98.89,0.0,0.0,,38.79,42.31,18.9,-16.3,21.1,-4.8,16.3,21.1,4.8,,,,,,,,,,,,,,,,,,,,,10674.7,754.0,13.3,10661.3,13.3,1.0,,,,,,,,,,95.89,2.29,1.82,1.0,-1.2,0.2,1.0,1.2,0.2,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_PNU_His_6.5_5S_2w25C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,67.46,98.43,-0.5,0.5,,38.29,43.84,17.88,-16.8,22.7,-5.8,16.8,22.7,5.8,,,,,,,,,,,,,,,,,,,,,5846.7,476.0,0.0,5846.7,0.0,1.0,,,,,,,,,,94.42,3.58,2.0,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_PNU_His_6.5_5S_2w40C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,91.6,-3.0,3.0,63.42,96.45,-2.4,2.4,,14.21,76.7,9.1,-40.9,55.5,-14.6,40.9,55.5,14.6,,,,,,,,,,,,,,,,,,,,,8254.0,3492.0,119.0,8254.0,0.0,0.4,,,,,,,,,,93.83,3.08,3.09,-1.1,-0.4,1.5,1.1,0.4,1.5,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_PNU_His_6.5_5S_3w5C,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,94.3,-0.3,0.3,66.22,99.0,0.1,0.1,,45.43,32.82,21.75,-9.7,11.6,-1.9,9.7,11.6,1.9,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299.0,13.3,0.9,,,,,,,,,,95.11,3.0,1.89,0.2,-0.5,0.3,0.2,0.5,0.3,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_PNU_His_6.5_5S_T0,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,65.17,98.93,0.0,0.0,,55.13,21.17,23.7,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1561.0,304.3,26.7,1547.7,0.0,1.2,,,,,,,,,,94.92,3.49,1.6,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,69.46,98.72,0.0,0.0,,60.13,13.09,26.79,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,4391.7,0.0,0.0,4391.7,0.0,1.2,,,,0.0,,,,,,96.22,2.9,0.89,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.3,0.0,0.0,68.76,99.09,0.0,0.0,,59.67,13.46,26.87,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,3426.0,13.3,13.3,3412.7,0.0,1.3,,,,0.0,,,,,,95.74,3.3,0.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_MMAE_His_5.0_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,68.83,98.46,0.0,0.0,,60.03,12.77,27.2,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,8399.3,26.7,26.7,8399.3,0.0,1.3,,,,0.0,,,,,,95.89,3.33,0.78,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_MMAE_His_5.5_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.1,0.0,0.0,69.94,98.61,0.0,0.0,,58.6,14.12,27.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,2142.5,20.0,20.0,2142.5,0.0,1.3,,,,0.0,,,,,,95.63,3.52,0.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_MMAE_His_6.0_7.5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.0,0.0,0.0,70.34,98.68,0.0,0.0,,58.55,14.51,26.94,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,17698.3,40.0,40.0,17685.0,13.3,1.4,,,,0.0,,,,,,96.25,2.85,0.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_PNU_Cit_5.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.18,98.72,0.0,0.0,,56.64,18.45,24.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,5965.7,26.7,26.7,5939.3,13.3,1.1,,,,0.0,,,,,,95.36,2.83,1.81,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_PNU_Cit_6.0_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.7,0.0,0.0,64.56,98.91,0.0,0.0,,56.97,17.89,25.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1693.0,26.7,26.7,1679.7,13.3,0.8,,,,0.0,,,,,,95.15,3.0,1.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_PNU_Cit_6.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.56,99.09,0.0,0.0,,56.25,19.03,24.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1481.3,26.7,26.7,1481.3,0.0,0.9,,,,0.0,,,,,,94.95,3.0,2.05,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_PNU_His_5.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,66.0,98.81,0.0,0.0,,57.4,17.2,25.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1097.7,0.0,0.0,1097.7,0.0,0.8,,,,0.0,,,,,,95.12,3.54,1.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_PNU_His_6.0_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.9,0.0,0.0,65.05,98.93,0.0,0.0,,55.42,19.97,24.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,979.0,0.0,0.0,979.0,0.0,1.1,,,,0.0,,,,,,94.89,3.58,1.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_PNU_His_6.5_5S_T0_25,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,65.17,98.93,0.0,0.0,,55.13,21.17,23.7,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1561.0,26.7,26.7,1547.7,0.0,1.2,,,,0.0,,,,,,94.92,3.49,1.6,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,69.46,98.72,0.0,0.0,,60.13,13.09,26.79,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,4391.7,0.0,0.0,4391.7,0.0,1.2,,,,0.0,,,,,,96.22,2.9,0.89,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.3,0.0,0.0,68.76,99.09,0.0,0.0,,59.67,13.46,26.87,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,3426.0,13.3,13.3,3412.7,0.0,1.3,,,,0.0,,,,,,95.74,3.3,0.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_MMAE_His_5.0_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.0,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,68.83,98.46,0.0,0.0,,60.03,12.77,27.2,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,8399.3,26.7,26.7,8399.3,0.0,1.3,,,,0.0,,,,,,95.89,3.33,0.78,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_MMAE_His_5.5_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.1,0.0,0.0,69.94,98.61,0.0,0.0,,58.6,14.12,27.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,2142.5,20.0,20.0,2142.5,0.0,1.3,,,,0.0,,,,,,95.63,3.52,0.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000363_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_MMAE_His_6.0_7.5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.0,0.0,0.0,70.34,98.68,0.0,0.0,,58.55,14.51,26.94,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,17698.3,40.0,40.0,17685.0,13.3,1.4,,,,0.0,,,,,,96.25,2.85,0.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_PNU_Cit_5.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.18,98.72,0.0,0.0,,56.64,18.45,24.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,5965.7,26.7,26.7,5939.3,13.3,1.1,,,,0.0,,,,,,95.36,2.83,1.81,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_PNU_Cit_6.0_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Citrate,0,0,0.0,0.0,0,,,,94.7,0.0,0.0,64.56,98.91,0.0,0.0,,56.97,17.89,25.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1693.0,26.7,26.7,1679.7,13.3,0.8,,,,0.0,,,,,,95.15,3.0,1.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_PNU_Cit_6.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.56,99.09,0.0,0.0,,56.25,19.03,24.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1481.3,26.7,26.7,1481.3,0.0,0.9,,,,0.0,,,,,,94.95,3.0,2.05,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_PNU_His_5.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,5.5,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,66.0,98.81,0.0,0.0,,57.4,17.2,25.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1097.7,0.0,0.0,1097.7,0.0,0.8,,,,0.0,,,,,,95.12,3.54,1.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_PNU_His_6.0_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.0,Histidine,0,0,0.0,0.0,0,,,,94.9,0.0,0.0,65.05,98.93,0.0,0.0,,55.42,19.97,24.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,979.0,0.0,0.0,979.0,0.0,1.1,,,,0.0,,,,,,94.89,3.58,1.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
3/17/2023,woz,Trop2,DCC000770_035,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_PNU_His_6.5_5S_T0_40,_DPS.Formulation_Particle size_Au_20230228_ck19440904,6.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,65.17,98.93,0.0,0.0,,55.13,21.17,23.7,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1561.0,26.7,26.7,1547.7,0.0,1.2,,,,0.0,,,,,,94.92,3.49,1.6,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_012,Fab,MULTIPLE CONTROL,,-80.0,0.0,,1.0,Anti_MMAE_Fab_ST,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,99.2,,,52.22,99.59,,,,87.61,8.53,3.85,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.0,2.18,,,,,,,DAB0156292_012,DAB0156292,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25.0,2.0,,1.0,Anti_MMAE_Fab_48hRT,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,98.9,,,52.06,99.58,,,,87.1,9.54,3.36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.73,0.0,2.27,-0.1,0.0,0.1,0.1,0.0,0.1,DAB0156292_013,DAB0156292,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,25.0,0.25,,1.0,Anti_MMAE_Fab_6hRT,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,99.0,,,51.87,99.31,,,,87.48,9.15,3.38,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.76,0.0,2.24,0.0,0.0,0.0,0.0,0.0,0.0,DAB0156292_013,DAB0156292,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
4/20/2023,ramapa,Trop2,DAB0156292_013,Fab,MULTIPLE CONTROL,,-80.0,0.0,,1.0,Anti_MMAE_Fab_CT,NB-ramapa-5084681-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,99.1,,,52.12,99.57,,,,87.68,9.09,3.23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.81,0.0,2.19,0.0,0.0,0.0,0.0,0.0,0.0,DAB0156292_013,DAB0156292,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,-80.0,0.0,,1.0,Trop2_A_53_Start,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.8,0.0,0.0,68.72,98.77,0.0,0.0,,58.69,14.89,26.42,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,207063.5,24980.0,198.0,207024.0,0.0,4.1,,,,,,,,,,95.91,3.07,1.02,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_A_Cit_5.5_7.5S_1M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,67.89,99.71,1.0,1.0,,59.98,14.18,25.85,-0.2,1.1,-0.9,0.2,1.1,0.9,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0.0,15079.3,0.0,2.0,,,,,,,,,,94.93,3.98,1.09,-1.3,1.1,0.2,1.3,1.1,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_A_Cit_5.5_7.5S_1M40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,91.5,-2.7,2.7,65.05,97.18,-1.5,1.5,,42.26,37.66,20.08,-17.9,24.6,-6.7,17.9,24.6,6.7,,,,,,,,,,,,,,,,,,,,,12156.0,2116.3,13.3,12156.0,0.0,2.3,,,,,,,,,,89.94,3.96,6.1,-6.3,1.1,5.2,6.3,1.1,5.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_A_Cit_5.5_7.5S_1M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.8,0.6,0.6,67.74,99.71,1.0,1.0,,58.61,13.98,27.41,-1.5,0.9,0.6,1.5,0.9,0.6,,,,,,,,,,,,,,,,,,,,,2817.3,635.0,0.0,2817.3,0.0,2.3,,,,,,,,,,95.23,3.85,0.92,-1.0,1.0,0.0,1.0,1.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_A_Cit_5.5_7.5S_2M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.62,4.08,1.29,-1.6,1.2,0.4,1.6,1.2,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_A_Cit_5.5_7.5S_2M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.08,3.9,1.01,-1.1,1.0,0.1,1.1,1.0,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_A_Cit_5.5_7.5S_2w25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,71.08,98.61,-0.1,0.1,,58.95,14.01,27.04,-1.2,0.9,0.2,1.2,0.9,0.2,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1.0,,,,,,,,,,95.61,3.31,1.08,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_A_Cit_5.5_7.5S_2w40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,92.5,-1.7,1.7,69.04,96.49,-2.2,2.2,,45.6,31.02,23.38,-14.5,17.9,-3.4,14.5,17.9,3.4,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0.0,2182.7,0.0,1.4,,,,,,,,,,90.14,2.8,7.06,-6.1,-0.1,6.2,6.1,0.1,6.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_A_Cit_5.5_7.5S_T0,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,69.46,98.72,0.0,0.0,,60.13,13.09,26.79,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,4391.7,820.0,0.0,4391.7,0.0,1.2,,,,,,,,,,96.22,2.9,0.89,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_A_Cit_5.5_7.5S_T0_25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_A_Cit_5.5_7.5S_T0_40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_A_Cit_6.0_7.5S_1M25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.4,0.1,0.1,67.86,99.7,0.6,0.6,,58.15,16.48,25.38,-1.5,3.0,-1.5,1.5,3.0,1.5,,,,,,,,,,,,,,,,,,,,,3558.0,621.7,39.7,3544.7,0.0,1.4,,,,,,,,,,94.72,3.93,1.36,-1.0,0.6,0.4,1.0,0.6,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_A_Cit_6.0_7.5S_1M40C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,91.7,-2.6,2.6,65.19,97.28,-1.8,1.8,,33.46,51.15,15.39,-26.2,37.7,-11.5,26.2,37.7,11.5,,,,,,,,,,,,,,,,,,,,,3651.0,939.3,13.3,3651.0,0.0,2.3,,,,,,,,,,91.77,4.02,4.21,-4.0,0.7,3.2,4.0,0.7,3.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_A_Cit_6.0_7.5S_1M5C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.5,0.2,0.2,66.22,99.72,0.6,0.6,,59.84,14.22,25.94,0.2,0.8,-0.9,0.2,0.8,0.9,,,,,,,,,,,,,,,,,,,,,886.3,238.0,0.0,886.3,0.0,1.7,,,,,,,,,,94.73,4.2,1.07,-1.0,0.9,0.1,1.0,0.9,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_A_Cit_6.0_7.5S_2M25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.07,4.37,1.56,-1.7,1.1,0.6,1.7,1.1,0.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_A_Cit_6.0_7.5S_2M5C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.06,3.74,1.2,-0.7,0.4,0.2,0.7,0.4,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_A_Cit_6.0_7.5S_2w25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.4,0.1,0.1,70.68,98.8,-0.3,0.3,,58.56,15.15,26.29,-1.1,1.7,-0.6,1.1,1.7,0.6,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0.0,2.2,,,,,,,,,,95.85,2.84,1.3,0.1,-0.5,0.3,0.1,0.5,0.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_A_Cit_6.0_7.5S_2w40C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,91.5,-2.8,2.8,68.85,96.44,-2.7,2.7,,36.9,45.28,17.82,-22.8,31.8,-9.0,22.8,31.8,9.0,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0.0,3505.3,0.0,1.5,,,,,,,,,,92.52,2.93,4.55,-3.2,-0.4,3.6,3.2,0.4,3.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_A_Cit_6.0_7.5S_T0,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.3,0.0,0.0,68.76,99.09,0.0,0.0,,59.67,13.46,26.87,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,3426.0,727.3,13.3,3412.7,0.0,1.3,,,,,,,,,,95.74,3.3,0.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_A_Cit_6.0_7.5S_T0_25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_A_Cit_6.0_7.5S_T0_40C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_A_His_5.0_7.5S_1M25C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,67.77,99.58,1.1,1.1,,60.13,13.44,26.42,0.1,0.7,-0.8,0.1,0.7,0.8,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0.0,2248.7,0.0,0.4,,,,,,,,,,94.58,4.53,0.88,-1.3,1.2,0.1,1.3,1.2,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_A_His_5.0_7.5S_1M40C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,91.2,-3.0,3.0,63.33,96.46,-2.0,2.0,,46.55,29.68,23.77,-13.5,16.9,-3.4,13.5,16.9,3.4,,,,,,,,,,,,,,,,,,,,,25516.0,5211.3,26.7,25516.0,0.0,1.0,,,,,,,,,,90.1,5.03,4.87,-5.8,1.7,4.1,5.8,1.7,4.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_A_His_5.0_7.5S_1M5C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,94.7,0.5,0.5,67.07,99.55,1.1,1.1,,59.1,13.45,27.45,-0.9,0.7,0.2,0.9,0.7,0.2,,,,,,,,,,,,,,,,,,,,,3783.0,674.7,0.0,3783.0,0.0,0.4,,,,,,,,,,94.84,4.38,0.78,-1.0,1.0,0.0,1.0,1.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_A_His_5.0_7.5S_2M5C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.5,3.64,0.86,-0.4,0.3,0.1,0.4,0.3,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_A_His_5.0_7.5S_2w25C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.2,0.2,70.31,98.46,0.0,0.0,,59.65,13.26,27.09,-0.4,0.5,-0.1,0.4,0.5,0.1,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,95.7,3.4,0.9,-0.2,0.1,0.1,0.2,0.1,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_A_His_5.0_7.5S_2w40C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,92.2,-2.0,2.0,66.91,96.86,-1.6,1.6,,50.4,24.05,25.55,-9.6,11.3,-1.6,9.6,11.3,1.6,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40.0,9391.3,13.3,2.8,,,,,,,,,,92.45,2.69,4.85,-3.4,-0.6,4.1,3.4,0.6,4.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_A_His_5.0_7.5S_T0,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,68.83,98.46,0.0,0.0,,60.03,12.77,27.2,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,8399.3,1402.0,26.7,8399.3,0.0,1.3,,,,,,,,,,95.89,3.33,0.78,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_A_His_5.0_7.5S_T0_25C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_A_His_5.0_7.5S_T0_40C,NB-penglei5-5065175-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_A_His_5.5_7.5S_1M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.3,0.2,0.2,67.71,99.67,1.1,1.1,,44.8,50.19,5.01,-13.8,36.1,-22.3,13.8,36.1,22.3,,,,,,,,,,,,,,,,,,,,,1640.0,463.0,0.0,1640.0,0.0,0.9,,,,,,,,,,94.59,4.39,1.02,-1.0,0.9,0.2,1.0,0.9,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_A_His_5.5_7.5S_1M40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,91.3,-2.8,2.8,64.97,97.14,-1.5,1.5,,28.9,68.35,2.74,-29.7,54.2,-24.5,29.7,54.2,24.5,,,,,,,,,,,,,,,,,,,,,2275.0,383.7,0.0,2275.0,0.0,1.7,,,,,,,,,,92.18,4.82,3.01,-3.4,1.3,2.2,3.4,1.3,2.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_A_His_5.5_7.5S_1M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.5,0.5,67.61,99.56,1.0,1.0,,60.23,13.39,26.38,1.6,-0.7,-0.9,1.6,-0.7,0.9,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984.0,0.0,0.7,,,,,,,,,,95.1,4.0,0.89,-0.5,0.5,0.0,0.5,0.5,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_A_His_5.5_7.5S_2M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.85,3.96,1.19,-0.8,0.4,0.3,0.8,0.4,0.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_A_His_5.5_7.5S_2M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.52,3.47,1.01,-0.1,0.0,0.2,0.1,0.0,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_A_His_5.5_7.5S_2w25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.4,0.3,0.3,70.83,98.66,0.1,0.1,,59.16,14.44,26.39,0.6,0.3,-0.9,0.6,0.3,0.9,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0.0,2.4,,,,,,,,,,95.59,3.38,1.03,0.0,-0.1,0.2,0.0,0.1,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_A_His_5.5_7.5S_2w40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,92.2,-1.9,1.9,68.85,97.49,-1.1,1.1,,46.94,31.14,21.92,-11.7,17.0,-5.4,11.7,17.0,5.4,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0.0,1.0,,,,,,,,,,93.11,3.51,3.37,-2.5,0.0,2.5,2.5,0.0,2.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_A_His_5.5_7.5S_T0,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.1,0.0,0.0,69.94,98.61,0.0,0.0,,58.6,14.12,27.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.63,3.52,0.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_A_His_5.5_7.5S_T0_25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_A_His_5.5_7.5S_T0_40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_A_His_6.0_7.5S_1M25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.5,0.5,0.5,68.74,99.67,1.0,1.0,,55.66,20.49,23.86,-2.9,6.0,-3.1,2.9,6.0,3.1,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,95.55,3.25,1.2,-0.7,0.4,0.3,0.7,0.4,0.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_A_His_6.0_7.5S_1M40C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,91.2,-2.8,2.8,65.47,97.62,-1.1,1.1,,33.9,50.4,15.7,-24.6,35.9,-11.2,24.6,35.9,11.2,,,,,,,,,,,,,,,,,,,,,2910.0,886.3,0.0,2910.0,0.0,0.8,,,,,,,,,,93.06,4.28,2.66,-3.2,1.4,1.8,3.2,1.4,1.8,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_A_His_6.0_7.5S_1M5C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.3,0.3,0.3,67.24,99.6,0.9,0.9,,58.19,15.87,25.93,-0.4,1.4,-1.0,0.4,1.4,1.0,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0.0,3716.7,0.0,0.7,,,,,,,,,,94.81,4.19,0.99,-1.4,1.3,0.1,1.4,1.3,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_A_His_6.0_7.5S_2M25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.06,4.61,1.34,-2.2,1.8,0.4,2.2,1.8,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_A_His_6.0_7.5S_2M5C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.89,4.0,1.12,-1.4,1.2,0.2,1.4,1.2,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_A_His_6.0_7.5S_2w25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.4,0.4,71.19,98.72,0.0,0.0,,57.22,18.08,24.7,-1.3,3.6,-2.2,1.3,3.6,2.2,,,,,,,,,,,,,,,,,,,,,2738.0,926.0,39.7,2724.7,0.0,1.1,,,,,,,,,,95.67,3.2,1.13,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_A_His_6.0_7.5S_2w40C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,92.2,-1.8,1.8,69.69,96.98,-1.7,1.7,,40.88,40.81,18.3,-17.7,26.3,-8.6,17.7,26.3,8.6,,,,,,,,,,,,,,,,,,,,,7288.0,1084.7,39.7,7288.0,0.0,0.6,,,,,,,,,,93.57,3.41,3.02,-2.7,0.6,2.1,2.7,0.6,2.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_A_His_6.0_7.5S_T0,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.0,0.0,0.0,70.34,98.68,0.0,0.0,,58.55,14.51,26.94,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,17698.3,2791.0,40.0,17685.0,13.3,1.4,,,,,,,,,,96.25,2.85,0.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_A_His_6.0_7.5S_T0_25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_1A,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_A_His_6.0_7.5S_T0_40C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,-80.0,0.0,,1.0,Trop2_B_17.5_Start,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.4,0.0,0.0,66.09,98.75,0.0,0.0,,55.7,19.87,24.43,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,410555.5,126528.0,10595.0,409484.0,20.0,11.2,,,,,,,,,,95.19,3.04,1.77,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_B_Cit_5.5_5S_1M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,95.4,0.8,0.8,63.97,99.7,1.0,1.0,,42.9,36.52,20.58,-13.7,18.1,-4.3,13.7,18.1,4.3,,,,,,,,,,,,,,,,,,,,,1045.0,450.0,0.0,1045.0,0.0,0.5,,,,,,,,,,94.83,1.86,3.32,-0.5,-1.0,1.5,0.5,1.0,1.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_B_Cit_5.5_5S_1M40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,92.4,-2.2,2.2,59.53,97.25,-1.4,1.4,,10.47,82.32,7.21,-46.2,63.9,-17.7,46.2,63.9,17.7,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0.0,0.2,,,,,,,,,,91.55,3.77,4.68,-2.3,0.8,1.5,2.3,0.8,1.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_B_Cit_5.5_5S_1M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,95.2,0.6,0.6,63.68,99.7,1.0,1.0,,54.04,21.68,24.27,-2.6,3.2,-0.6,2.6,3.2,0.6,,,,,,,,,,,,,,,,,,,,,992.0,225.0,0.0,992.0,0.0,0.4,,,,,,,,,,95.6,1.85,2.55,0.2,-1.0,0.7,0.2,1.0,0.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_B_Cit_5.5_5S_2M25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.45,1.97,3.58,-0.9,-0.9,1.8,0.9,0.9,1.8,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_B_Cit_5.5_5S_2M5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.0,2.19,2.81,-0.4,-0.6,1.0,0.4,0.6,1.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_B_Cit_5.5_5S_2w25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.7,0.1,0.1,67.11,98.33,-0.4,0.4,,46.54,30.51,22.95,-10.1,12.1,-1.9,10.1,12.1,1.9,,,,,,,,,,,,,,,,,,,,,582.0,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,94.79,2.24,2.97,-0.6,-0.6,1.2,0.6,0.6,1.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_B_Cit_5.5_5S_2w40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,92.9,-1.7,1.7,63.2,96.5,-2.2,2.2,,16.45,76.95,6.6,-40.2,58.5,-18.3,40.2,58.5,18.3,,,,,,,,,,,,,,,,,,,,,2024.0,608.3,0.0,2024.0,0.0,0.2,,,,,,,,,,91.97,3.05,4.99,-3.4,0.2,3.2,3.4,0.2,3.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_B_Cit_5.5_5S_3w5C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.7,0.1,0.1,65.96,98.82,0.1,0.1,,55.53,19.82,24.65,-1.1,1.4,-0.2,1.1,1.4,0.2,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0.0,1587.3,0.0,1.1,,,,,,,,,,95.01,2.5,2.49,-0.3,-0.3,0.7,0.3,0.3,0.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_B_Cit_5.5_5S_T0,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.18,98.72,0.0,0.0,,56.64,18.45,24.9,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,5965.7,754.0,26.7,5939.3,13.3,1.1,,,,,,,,,,95.36,2.83,1.81,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_B_Cit_5.5_5S_T0_25C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_B_Cit_5.5_5S_T0_40C,NB-penglei5-5065175-0003,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_B_Cit_6.0_5S_1M25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,95.2,0.5,0.5,63.86,99.7,0.8,0.8,,44.67,34.24,21.09,-12.3,16.4,-4.0,12.3,16.4,4.0,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0.0,0.3,,,,,,,,,,95.68,1.38,2.94,0.5,-1.6,1.1,0.5,1.6,1.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_B_Cit_6.0_5S_1M40C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,92.4,-2.3,2.3,59.92,97.36,-1.5,1.5,,14.99,74.24,10.77,-42.0,56.4,-14.4,42.0,56.4,14.4,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53.0,1561.0,26.7,0.8,,,,,,,,,,92.21,3.19,4.6,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_B_Cit_6.0_5S_1M5C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,95.3,0.6,0.6,63.6,99.74,0.8,0.8,,57.3,20.29,22.41,0.3,2.4,-2.7,0.3,2.4,2.7,,,,,,,,,,,,,,,,,,,,,1164.0,423.3,13.3,1164.0,0.0,0.6,,,,,,,,,,95.9,1.79,2.3,0.8,-1.2,0.4,0.8,1.2,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_B_Cit_6.0_5S_2M25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.6,1.95,3.45,-0.6,-1.0,1.6,0.6,1.0,1.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_B_Cit_6.0_5S_2M5C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.87,2.47,2.66,-0.3,-0.5,0.8,0.3,0.5,0.8,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_B_Cit_6.0_5S_2w25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.7,0.0,0.0,67.11,98.56,-0.3,0.3,,49.02,28.05,22.93,-7.9,10.2,-2.2,7.9,10.2,2.2,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,94.44,2.65,2.9,-0.7,-0.4,1.0,0.7,0.4,1.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_B_Cit_6.0_5S_2w40C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,93.1,-1.6,1.6,62.45,96.0,-2.9,2.9,,15.83,69.87,14.3,-41.1,52.0,-10.8,41.1,52.0,10.8,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066.0,0.0,0.3,,,,,,,,,,92.25,3.19,4.56,-2.9,0.2,2.7,2.9,0.2,2.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_B_Cit_6.0_5S_3w5C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.6,-0.1,0.1,66.28,98.77,-0.1,0.1,,56.67,18.56,24.78,-0.3,0.7,-0.3,0.3,0.7,0.3,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0.0,0.9,,,,,,,,,,94.77,2.77,2.46,-0.4,-0.2,0.6,0.4,0.2,0.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_B_Cit_6.0_5S_T0,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,94.7,0.0,0.0,64.56,98.91,0.0,0.0,,56.97,17.89,25.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1693.0,529.0,26.7,1679.7,13.3,0.8,,,,,,,,,,95.15,3.0,1.85,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_B_Cit_6.0_5S_T0_25C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_B_Cit_6.0_5S_T0_40C,NB-penglei5-5065175-0003,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_B_Cit_6.5_5S_1M25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,95.5,0.9,0.9,63.43,99.67,0.6,0.6,,40.12,42.31,17.57,-16.1,23.3,-7.1,16.1,23.3,7.1,,,,,,,,,,,,,,,,,,,,,2209.0,568.7,26.7,2209.0,0.0,0.3,,,,,,,,,,95.32,1.84,2.85,0.4,-1.2,0.8,0.4,1.2,0.8,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_B_Cit_6.5_5S_1M40C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,91.9,-2.7,2.7,59.39,97.41,-1.7,1.7,,13.21,81.71,5.07,-43.0,62.7,-19.6,43.0,62.7,19.6,,,,,,,,,,,,,,,,,,,,,926.0,171.7,0.0,926.0,0.0,0.4,,,,,,,,,,93.45,2.67,3.88,-2.5,-0.1,2.7,2.5,0.1,2.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_B_Cit_6.5_5S_1M5C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,95.3,0.7,0.7,63.47,99.71,0.6,0.6,,54.34,22.12,23.54,-1.9,3.1,-1.2,1.9,3.1,1.2,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0.0,0.5,,,,,,,,,,95.32,2.16,2.53,0.4,-0.8,0.5,0.4,0.8,0.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_B_Cit_6.5_5S_2M25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.32,2.35,3.33,-0.6,-0.6,1.3,0.6,0.6,1.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_B_Cit_6.5_5S_2M5C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.77,2.59,2.65,-0.2,-0.4,0.6,0.2,0.4,0.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_B_Cit_6.5_5S_2w25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,94.7,0.1,0.1,65.71,99.02,-0.1,0.1,,43.95,33.82,22.23,-12.3,14.8,-2.5,12.3,14.8,2.5,,,,,,,,,,,,,,,,,,,,,926.0,238.0,0.0,926.0,0.0,0.6,,,,,,,,,,94.04,2.98,2.98,-0.9,0.0,0.9,0.9,0.0,0.9,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_B_Cit_6.5_5S_2w40C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,92.9,-1.7,1.7,61.66,95.48,-3.6,3.6,,16.43,77.42,6.15,-39.8,58.4,-18.6,39.8,58.4,18.6,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0.0,0.3,,,,,,,,,,93.62,1.65,4.75,-1.3,-1.4,2.7,1.3,1.4,2.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_B_Cit_6.5_5S_3w5C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,93.9,-0.7,0.7,65.41,99.17,0.1,0.1,,54.6,20.6,24.8,-1.6,1.6,0.1,1.6,1.6,0.1,,,,,,,,,,,,,,,,,,,,,397.0,132.3,13.3,397.0,0.0,0.6,,,,,,,,,,94.6,2.93,2.47,-0.4,-0.1,0.4,0.4,0.1,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_B_Cit_6.5_5S_T0,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,66.56,99.09,0.0,0.0,,56.25,19.03,24.72,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0.0,0.9,,,,,,,,,,94.95,3.0,2.05,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_B_Cit_6.5_5S_T0_25C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_B_Cit_6.5_5S_T0_40C,NB-penglei5-5065175-0003,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_B_His_5.5_5S_1M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,95.2,1.0,1.0,63.63,99.71,0.9,0.9,,52.07,26.87,21.06,-5.3,9.7,-4.3,5.3,9.7,4.3,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0.0,0.4,,,,,,,,,,96.74,1.7,1.56,1.6,-1.8,0.2,1.6,1.8,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_B_His_5.5_5S_1M40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,91.6,-2.6,2.6,60.93,97.87,-0.9,0.9,,18.71,71.4,9.9,-38.7,54.2,-15.5,38.7,54.2,15.5,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582.0,0.0,0.6,,,,,,,,,,92.89,4.39,2.72,-2.2,0.8,1.4,2.2,0.8,1.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_B_His_5.5_5S_1M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,95.3,1.1,1.1,63.67,99.68,0.9,0.9,,57.86,18.56,23.59,0.5,1.4,-1.8,0.5,1.4,1.8,,,,,,,,,,,,,,,,,,,,,2777.7,529.0,0.0,2777.7,0.0,0.7,,,,,,,,,,96.87,1.78,1.35,1.8,-1.8,0.0,1.8,1.8,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_B_His_5.5_5S_2M25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.74,2.53,1.73,0.6,-1.0,0.4,0.6,1.0,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_B_His_5.5_5S_2M5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.81,1.43,0.6,-0.7,0.1,0.6,0.7,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_B_His_5.5_5S_2w25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.7,0.5,0.5,65.5,96.91,-1.9,1.9,,55.43,20.28,24.29,-2.0,3.1,-1.1,2.0,3.1,1.1,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0.0,582.3,0.0,0.6,,,,,,,,,,95.04,3.47,1.48,-0.1,-0.1,0.1,0.1,0.1,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_B_His_5.5_5S_2w40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,92.3,-1.9,1.9,64.05,96.69,-2.1,2.1,,27.48,60.2,12.32,-29.9,43.0,-13.1,29.9,43.0,13.1,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0.0,0.2,,,,,,,,,,93.06,4.58,2.37,-2.1,1.0,1.0,2.1,1.0,1.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_B_His_5.5_5S_3w5C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.4,0.4,65.87,98.78,0.0,0.0,,57.09,18.15,24.76,-0.3,0.9,-0.6,0.3,0.9,0.6,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0.0,1.1,,,,,,,,,,95.42,3.12,1.46,0.3,-0.4,0.1,0.3,0.4,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_B_His_5.5_5S_T0,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,66.0,98.81,0.0,0.0,,57.4,17.2,25.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0.0,1097.7,0.0,0.8,,,,,,,,,,95.12,3.54,1.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_B_His_5.5_5S_T0_25C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_B_His_5.5_5S_T0_40C,NB-penglei5-5065175-0003,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_B_His_6.0_5S_1M25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,95.1,0.2,0.2,63.71,99.69,0.8,0.8,,44.88,34.88,20.23,-10.5,14.9,-4.4,10.5,14.9,4.4,,,,,,,,,,,,,,,,,,,,,3307.0,370.3,0.0,3307.0,0.0,0.6,,,,,,,,,,95.74,2.39,1.87,0.8,-1.2,0.3,0.8,1.2,0.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_B_His_6.0_5S_1M40C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,91.7,-3.2,3.2,60.65,98.02,-0.9,0.9,,15.01,78.16,6.82,-40.4,58.2,-17.8,40.4,58.2,17.8,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0.0,0.5,,,,,,,,,,92.33,4.11,3.56,-2.6,0.5,2.0,2.6,0.5,2.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_B_His_6.0_5S_1M5C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,95.6,0.7,0.7,63.63,99.71,0.8,0.8,,50.92,26.35,22.74,-4.5,6.4,-1.9,4.5,6.4,1.9,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0.0,10595.3,0.0,0.7,,,,,,,,,,96.72,1.66,1.62,1.8,-1.9,0.1,1.8,1.9,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_B_His_6.0_5S_2M25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.11,2.83,2.07,0.2,-0.8,0.5,0.2,0.8,0.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_B_His_6.0_5S_2M5C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.76,2.55,1.68,0.9,-1.0,0.1,0.9,1.0,0.1,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_B_His_6.0_5S_2w25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.5,-0.4,0.4,67.42,98.51,-0.4,0.4,,47.48,30.23,22.29,-7.9,10.3,-2.3,7.9,10.3,2.3,,,,,,,,,,,,,,,,,,,,,2354.7,198.0,39.7,2341.3,13.3,0.9,,,,,,,,,,94.54,3.67,1.79,-0.3,0.1,0.3,0.3,0.1,0.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_B_His_6.0_5S_2w40C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,92.0,-2.9,2.9,63.21,96.52,-2.4,2.4,,20.9,69.59,9.52,-34.5,49.6,-15.1,34.5,49.6,15.1,,,,,,,,,,,,,,,,,,,,,4695.7,1296.0,66.0,4695.7,0.0,0.4,,,,,,,,,,92.56,4.24,3.2,-2.3,0.7,1.7,2.3,0.7,1.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_B_His_6.0_5S_3w5C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.5,-0.4,0.4,66.85,98.74,-0.2,0.2,,54.32,22.2,23.48,-1.1,2.2,-1.1,1.1,2.2,1.1,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0.0,0.5,,,,,,,,,,94.72,3.51,1.78,-0.2,-0.1,0.2,0.2,0.1,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_B_His_6.0_5S_T0,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,94.9,0.0,0.0,65.05,98.93,0.0,0.0,,55.42,19.97,24.61,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,979.0,224.7,0.0,979.0,0.0,1.1,,,,,,,,,,94.89,3.58,1.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_B_His_6.0_5S_T0_25C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_B_His_6.0_5S_T0_40C,NB-penglei5-5065175-0003,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,30.0,,1.0,Trop2_B_His_6.5_5S_1M25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,95.2,0.6,0.6,63.64,99.71,0.8,0.8,,32.04,53.12,14.84,-23.1,31.9,-8.9,23.1,31.9,8.9,,,,,,,,,,,,,,,,,,,,,6389.0,224.7,13.3,6389.0,0.0,1.0,,,,,,,,,,94.62,3.29,2.09,-0.3,-0.2,0.5,0.3,0.2,0.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,30.0,,1.0,Trop2_B_His_6.5_5S_1M40C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,91.9,-2.7,2.7,59.93,97.6,-1.3,1.3,,12.7,81.68,5.62,-42.4,60.5,-18.1,42.4,60.5,18.1,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0.0,0.4,,,,,,,,,,93.78,2.95,3.26,-1.1,-0.5,1.7,1.1,0.5,1.7,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,30.0,,1.0,Trop2_B_His_6.5_5S_1M5C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,95.4,0.8,0.8,63.67,99.71,0.8,0.8,,45.26,33.84,20.9,-9.9,12.7,-2.8,9.9,12.7,2.8,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0.0,0.5,,,,,,,,,,96.02,2.17,1.81,1.1,-1.3,0.2,1.1,1.3,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,60.0,,1.0,Trop2_B_His_6.5_5S_2M25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.18,2.6,2.23,0.3,-0.9,0.6,0.3,0.9,0.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,60.0,,1.0,Trop2_B_His_6.5_5S_2M5C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.89,2.29,1.82,1.0,-1.2,0.2,1.0,1.2,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,14.0,,1.0,Trop2_B_His_6.5_5S_2w25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,67.46,98.43,-0.5,0.5,,38.29,43.84,17.88,-16.8,22.7,-5.8,16.8,22.7,5.8,,,,,,,,,,,,,,,,,,,,,5846.7,476.0,0.0,5846.7,0.0,1.0,,,,,,,,,,94.42,3.58,2.0,-0.5,0.1,0.4,0.5,0.1,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,14.0,,1.0,Trop2_B_His_6.5_5S_2w40C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,91.6,-3.0,3.0,63.42,96.45,-2.4,2.4,,14.21,76.7,9.1,-40.9,55.5,-14.6,40.9,55.5,14.6,,,,,,,,,,,,,,,,,,,,,8254.0,3492.0,119.0,8254.0,0.0,0.4,,,,,,,,,,93.83,3.08,3.09,-1.1,-0.4,1.5,1.1,0.4,1.5,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,21.0,,1.0,Trop2_B_His_6.5_5S_3w5C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,94.3,-0.3,0.3,66.22,99.0,0.1,0.1,,45.43,32.82,21.75,-9.7,11.6,-1.9,9.7,11.6,1.9,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299.0,13.3,0.9,,,,,,,,,,95.11,3.0,1.89,0.2,-0.5,0.3,0.2,0.5,0.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,5.0,0.0,,1.0,Trop2_B_His_6.5_5S_T0,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,94.6,0.0,0.0,65.17,98.93,0.0,0.0,,55.13,21.17,23.7,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,1561.0,304.3,26.7,1547.7,0.0,1.2,,,,,,,,,,94.92,3.49,1.6,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,25.0,0.0,,1.0,Trop2_B_His_6.5_5S_T0_25C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
1/24/2024,penglei5,Trop2,DCC_2B,ADC,MULTIPLE CONTROL,,40.0,0.0,,1.0,Trop2_B_His_6.5_5S_T0_40C,NB-penglei5-5065175-0003,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,-80.0,0.0,,1.0,Trop2_MMAE_53_Start,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,207063.5,24980.0,198.0,207024.0,0.0,4.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,30.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15079.3,1865.3,0.0,15079.3,0.0,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,14.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2w40C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3505.3,833.3,0.0,3505.3,0.0,1.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,30.0,,1.0,Trop2_MMAE_His_5.0_7.5S_1M40C,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25516.0,5211.3,26.7,25516.0,0.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,30.0,,1.0,Trop2_MMAE_His_5.0_7.5S_1M5C,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3783.0,674.7,0.0,3783.0,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,14.0,,1.0,Trop2_MMAE_His_5.0_7.5S_2w40C,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9404.7,1547.7,40.0,9391.3,13.3,2.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,14.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4338.7,648.3,13.3,4338.7,0.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,30.0,,1.0,Trop2_MMAE_His_6.0_7.5S_1M40C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2910.0,886.3,0.0,2910.0,0.0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,14.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2w40C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7288.0,1084.7,39.7,7288.0,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,0.0,,1.0,Trop2_MMAE_His_6.0_7.5S_T0,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,17698.3,2791.0,40.0,17685.0,13.3,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,-80.0,0.0,,1.0,Trop2_PNU_17.5_Start,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,410555.5,126528.0,10595.0,409484.0,20.0,11.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,30.0,,1.0,Trop2_PNU_Cit_5.5_5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1045.0,450.0,0.0,1045.0,0.0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,30.0,,1.0,Trop2_PNU_Cit_5.5_5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,859.7,211.7,13.3,859.7,0.0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,14.0,,1.0,Trop2_PNU_Cit_5.5_5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582.0,145.3,13.3,568.7,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,21.0,,1.0,Trop2_PNU_Cit_5.5_5S_3w5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,383.3,0.0,1587.3,0.0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,30.0,,1.0,Trop2_PNU_Cit_6.0_5S_1M5C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164.0,423.3,13.3,1164.0,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,21.0,,1.0,Trop2_PNU_Cit_6.5_5S_3w5C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,397.0,132.3,13.3,397.0,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,0.0,,1.0,Trop2_PNU_Cit_6.5_5S_T0,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,383.3,26.7,1481.3,0.0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,30.0,,1.0,Trop2_PNU_His_5.5_5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,198.3,13.3,1018.7,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,30.0,,1.0,Trop2_PNU_His_5.5_5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,595.3,224.7,39.7,582.0,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,14.0,,1.0,Trop2_PNU_His_5.5_5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,952.3,211.7,13.3,952.3,0.0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,0.0,,1.0,Trop2_PNU_His_5.5_5S_T0,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1097.7,304.3,0.0,1097.7,0.0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,30.0,,1.0,Trop2_PNU_His_6.0_5S_1M40C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.7,1732.7,171.7,4497.3,0.0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,21.0,,1.0,Trop2_PNU_His_6.0_5S_3w5C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9894.3,608.7,13.3,9894.3,0.0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,0.0,,1.0,Trop2_PNU_His_6.0_5S_T0,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,979.0,224.7,0.0,979.0,0.0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,30.0,,1.0,Trop2_PNU_His_6.5_5S_1M25C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6389.0,224.7,13.3,6389.0,0.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,14.0,,1.0,Trop2_PNU_His_6.5_5S_2w25C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5846.7,476.0,0.0,5846.7,0.0,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,60.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6124.3,1362.3,185.0,6071.3,0.0,3.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,60.0,,1.0,Trop2_PNU_Cit_6.5_5S_2M25C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1957.7,436.7,26.3,1944.3,0.0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,60.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2M25C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1177.0,225.0,26.7,1164.0,0.0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,60.0,,1.0,Trop2_PNU_Cit_5.5_5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1508.0,317.3,13.3,1508.0,0.0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,60.0,,1.0,Trop2_PNU_His_5.5_5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1137.3,277.7,13.3,1137.3,0.0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,60.0,,1.0,Trop2_PNU_Cit_6.0_5S_2M5C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,807.0,225.0,13.3,807.0,0.0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,60.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2M5C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582.0,53.0,0.0,582.0,0.0,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,60.0,,1.0,Trop2_PNU_Cit_5.5_5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,675.0,145.3,26.7,675.0,0.0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,30.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2817.3,635.0,0.0,2817.3,0.0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,30.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_1M5C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,886.3,238.0,0.0,886.3,0.0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,30.0,,1.0,Trop2_MMAE_His_5.0_7.5S_1M25C,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2248.7,489.3,0.0,2248.7,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,30.0,,1.0,Trop2_MMAE_His_5.5_7.5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1997.3,370.3,13.3,1984.0,0.0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,30.0,,1.0,Trop2_MMAE_His_6.0_7.5S_1M5C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3716.7,436.3,0.0,3716.7,0.0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,14.0,,1.0,Trop2_PNU_Cit_5.5_5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2024.0,608.3,0.0,2024.0,0.0,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,14.0,,1.0,Trop2_PNU_Cit_6.0_5S_2w25C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,370.3,132.3,26.7,357.3,13.3,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,21.0,,1.0,Trop2_PNU_Cit_6.0_5S_3w5C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1494.7,383.7,26.3,1481.7,0.0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,30.0,,1.0,Trop2_PNU_Cit_6.5_5S_1M25C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2209.0,568.7,26.7,2209.0,0.0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,30.0,,1.0,Trop2_PNU_Cit_6.5_5S_1M40C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926.0,171.7,0.0,926.0,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,14.0,,1.0,Trop2_PNU_Cit_6.5_5S_2w40C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2447.3,595.3,52.7,2447.3,0.0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,30.0,,1.0,Trop2_PNU_His_6.0_5S_1M25C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3307.0,370.3,0.0,3307.0,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,60.0,,1.0,Trop2_MMAE_His_5.0_7.5S_2M5C,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30410.3,4206.3,26.3,30410.3,0.0,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,60.0,,1.0,Trop2_PNU_His_6.5_5S_2M5C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10674.7,754.0,13.3,10661.3,13.3,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,60.0,,1.0,Trop2_PNU_His_6.5_5S_2M25C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4510.3,436.7,13.3,4497.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,60.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4312.0,846.3,39.7,4312.0,0.0,2.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,60.0,,1.0,Trop2_PNU_His_6.0_5S_2M25C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5542.3,423.3,13.3,5542.3,0.0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,60.0,,1.0,Trop2_PNU_His_5.5_5S_2M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,608.7,145.7,13.3,608.7,0.0,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,0.0,,1.0,Trop2_MMAE_His_5.5_7.5S_T0,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2142.5,516.0,20.0,2142.5,0.0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,30.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12156.0,2116.3,13.3,12156.0,0.0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,14.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1666.7,343.7,13.3,1653.7,13.3,1.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,14.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2w25C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1825.3,502.7,13.3,1825.3,0.0,2.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,14.0,,1.0,Trop2_MMAE_His_5.0_7.5S_2w25C,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4285.3,714.3,39.7,4272.3,13.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,30.0,,1.0,Trop2_PNU_Cit_6.0_5S_1M25C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3756.7,674.7,13.3,3743.7,0.0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,14.0,,1.0,Trop2_PNU_His_5.5_5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,582.3,39.7,0.0,582.3,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,14.0,,1.0,Trop2_PNU_His_6.0_5S_2w25C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2354.7,198.0,39.7,2341.3,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,14.0,,1.0,Trop2_PNU_His_6.0_5S_2w40C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4695.7,1296.0,66.0,4695.7,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,60.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2M25C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7314.7,1984.3,105.7,7301.7,13.3,3.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,30.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_1M25C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3558.0,621.7,39.7,3544.7,0.0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,0.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_T0,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3426.0,727.3,13.3,3412.7,0.0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,30.0,,1.0,Trop2_MMAE_His_5.5_7.5S_1M25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1640.0,463.0,0.0,1640.0,0.0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,14.0,,1.0,Trop2_MMAE_His_6.0_7.5S_2w25C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3928.5,1349.5,59.5,3908.5,0.0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,0.0,,1.0,Trop2_PNU_Cit_5.5_5S_T0,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5965.7,754.0,26.7,5939.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,0.0,,1.0,Trop2_PNU_Cit_6.0_5S_T0,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1693.0,529.0,26.7,1679.7,13.3,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,30.0,,1.0,Trop2_PNU_His_5.5_5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2777.7,529.0,0.0,2777.7,0.0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,30.0,,1.0,Trop2_PNU_His_6.5_5S_1M40C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1481.3,661.7,92.3,1455.3,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,30.0,,1.0,Trop2_PNU_His_6.5_5S_1M5C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4788.7,542.3,39.7,4775.3,0.0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,21.0,,1.0,Trop2_PNU_His_6.5_5S_3w5C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9312.3,740.7,26.7,9299.0,13.3,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,60.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4153.3,436.3,0.0,4153.3,0.0,1.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,60.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3148.3,569.0,0.0,3148.3,0.0,2.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,30.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_1M40C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3651.0,939.3,13.3,3651.0,0.0,2.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,30.0,,1.0,Trop2_MMAE_His_6.0_7.5S_1M25C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2288.7,396.7,26.3,2275.3,13.3,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,30.0,,1.0,Trop2_PNU_Cit_6.0_5S_1M40C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1587.3,357.3,53.0,1561.0,26.7,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,21.0,,1.0,Trop2_PNU_His_5.5_5S_3w5C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1296.3,264.3,13.3,1296.3,0.0,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,60.0,,1.0,Trop2_PNU_His_6.0_5S_2M5C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9590.0,793.7,0.0,9590.0,0.0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,60.0,,1.0,Trop2_MMAE_Cit_6.0_7.5S_2M5C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2949.7,820.0,79.3,2949.7,0.0,3.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,60.0,,1.0,Trop2_PNU_Cit_6.5_5S_2M5C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1071.3,291.3,13.3,1071.3,0.0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,30.0,,1.0,Trop2_MMAE_His_5.5_7.5S_1M40C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2275.0,383.7,0.0,2275.0,0.0,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,30.0,,1.0,Trop2_PNU_Cit_5.5_5S_1M5C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,992.0,225.0,0.0,992.0,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,25.0,14.0,,1.0,Trop2_MMAE_His_5.5_7.5S_2w25C,NB-ramapa-5085300-0003-0001,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2724.7,317.3,13.3,2724.7,0.0,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,14.0,,1.0,Trop2_PNU_Cit_6.5_5S_2w25C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,926.0,238.0,0.0,926.0,0.0,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,25.0,60.0,,1.0,Trop2_PNU_Cit_6.0_5S_2M25C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1164.0,476.3,26.7,1164.0,0.0,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,14.0,,1.0,Trop2_PNU_Cit_6.0_5S_2w40C,NB-ramapa-5085300-0003-0001,6.0,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5092.3,1521.3,39.7,5066.0,0.0,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,30.0,,1.0,Trop2_PNU_Cit_6.5_5S_1M5C,NB-ramapa-5085300-0003-0001,6.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1018.7,317.3,13.3,1018.7,0.0,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,30.0,,1.0,Trop2_PNU_His_6.0_5S_1M5C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10595.3,595.3,0.0,10595.3,0.0,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,5.0,0.0,,1.0,Trop2_PNU_His_6.5_5S_T0,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1561.0,304.3,26.7,1547.7,0.0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,40.0,14.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_2w40C,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2182.7,436.7,0.0,2182.7,0.0,1.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,0.0,,1.0,Trop2_MMAE_His_5.0_7.5S_T0,NB-ramapa-5085300-0003-0001,5.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8399.3,1402.0,26.7,8399.3,0.0,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000363_035,ADC,,,5.0,0.0,,1.0,Trop2_MMAE_Cit_5.5_7.5S_T0,NB-ramapa-5085300-0003-0001,5.5,Citrate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4391.7,820.0,0.0,4391.7,0.0,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
,woz,Trop2,DCC000770_035,ADC,,,40.0,14.0,,1.0,Trop2_PNU_His_6.5_5S_2w40C,NB-ramapa-5085300-0003-0001,6.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8254.0,3492.0,119.0,8254.0,0.0,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Info link - DPS.Formulation Summary.V2 AV_58081
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,0.09,,,98.09,-1.91,,0.0412,42.0,42.24,15.75,-24.2,,,,,,60.2,,511651.0,33463.8,2258.1,696.1,135.8,34.0,0.0,0.0,,57281.3,23268.9,9708.1,6771.9,2732.5,831.6,33.9,17.0,,,,,,,,92.5,0.96,6.53,-2.7,0.79,1.9,,,,96.1,0.91,3.03,-1.17,-0.13,1.3,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.09,,,99.64,-0.36,,0.0446,39.9,48.0,12.09,-26.3,,,,,,63.8,,106050.9,3089.2,662.0,356.4,118.8,33.9,0.0,0.0,,102888.3,22166.3,8146.9,5499.1,2087.6,611.0,17.0,0.0,,,,,,,,92.0,1.07,6.89,-3.2,0.9,2.26,,,,96.7,0.82,2.45,-0.51,-0.22,0.72,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,0,0.0,0.0,0,,,,100.0,0.09,,,99.33,-0.67,,0.0448,35.7,54.31,10.03,-30.6,,,,,,64.8,,13747.4,2138.5,339.4,135.8,0.0,0.0,0.0,0.0,,43296.0,16496.9,5583.8,3886.6,1459.6,424.3,17.0,0.0,,,,,,,,91.9,1.17,6.92,-3.3,1.0,2.29,,,,96.7,0.88,2.46,-0.57,-0.16,0.73,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,0,0.0,0.0,0,,,,99.83,-0.08,,,100.0,0.0,,0.0453,36.6,53.78,9.64,-29.6,,,,,,63.6,,73373.8,2681.7,475.2,169.7,17.0,17.0,0.0,0.0,,35523.4,10047.7,3852.8,2308.3,645.0,169.7,0.0,0.0,,,,,,,,87.7,1.02,11.25,-7.5,0.85,6.62,,,,96.5,0.83,2.71,-0.77,-0.21,0.98,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,0,0.0,0.0,0,,,,94.66,-5.25,,,97.19,-2.81,,0.0441,29.7,63.81,6.48,-36.5,,,,,,64.0,,168741.8,3140.3,390.4,305.5,33.9,0.0,0.0,0.0,,46573.0,4667.5,1748.2,1154.1,322.5,152.8,17.0,17.0,,,,,,,,86.4,1.0,12.63,-8.8,0.83,8.0,,,,96.1,0.85,3.03,-1.12,-0.19,1.3,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,0,0.0,0.0,0,,,,100.0,0.09,,,99.2,-0.8,,0.0438,23.3,71.41,5.31,-42.9,,,,,,63.0,,204254.7,4260.6,458.3,152.8,17.0,0.0,0.0,0.0,,20281.7,3886.6,1459.6,865.6,237.6,50.9,0.0,0.0,,,,,,,,85.1,1.12,13.76,-10.1,0.95,9.13,,,,96.1,0.82,3.1,-1.15,-0.22,1.37,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.09,,,96.13,-3.87,,0.0479,,,,,,,,,,56.0,,11099.7,2087.6,424.3,220.6,50.9,17.0,0.0,0.0,,45502.2,17922.5,6126.9,3767.8,1239.0,186.7,0.0,0.0,,,,,,,,93.5,0.79,5.71,-1.7,0.62,1.08,,,,87.3,1.84,10.89,-9.96,0.8,9.16,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,0,0.0,0.0,0,,,,99.86,-0.05,,,96.84,-3.16,,0.047,,,,,,,,,,59.8,,20248.0,2274.3,577.1,271.6,135.8,50.9,0.0,0.0,,51782.4,20197.0,6177.9,4056.4,1239.0,390.4,17.0,17.0,,,,,,,,93.1,0.94,6.0,-2.1,0.77,1.37,,,,95.6,0.88,3.55,-1.66,-0.16,1.82,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.09,,,99.42,-0.58,,0.0512,,,,,,,,,,63.2,,16513.9,1442.6,186.7,101.8,33.9,0.0,0.0,0.0,,51443.4,19060.0,8350.4,5363.3,2257.3,729.8,17.0,17.0,,,,,,,,92.6,1.01,6.44,-2.6,0.84,1.81,,,,96.5,0.9,2.56,-0.69,-0.14,0.83,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,B11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.09,,,99.74,-0.26,,0.0474,,,,,,,,,,65.6,,101704.3,6059.5,950.5,441.3,135.8,33.9,17.0,17.0,,62814.5,18364.0,6941.7,4480.7,1680.3,661.9,17.0,0.0,,,,,,,,92.6,1.02,6.37,-2.6,0.85,1.74,,,,97.0,0.74,2.25,-0.23,-0.3,0.52,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,,-,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,50,0.0,0.0,0,,,,100.0,0.09,,,99.84,-0.16,,0.0437,59.4,25.27,15.32,-6.8,,,,,,56.6,,30682.8,7895.7,916.9,509.4,152.8,101.9,17.0,0.0,,148581.1,47694.0,17499.1,11320.9,4090.5,1714.3,67.9,17.0,,,,,,,,86.9,1.02,12.05,-8.3,0.85,7.42,,,,93.2,0.91,5.91,-4.04,-0.13,4.18,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,50,0.0,0.0,0,,,,100.0,0.09,,,99.92,-0.08,,0.0445,67.5,24.57,7.89,1.3,,,,,,62.2,,20044.9,2596.8,475.2,288.5,135.8,84.9,67.9,67.9,,180862.7,72032.8,33351.6,22964.3,7807.5,2512.0,50.9,0.0,,,,,,,,86.1,0.93,13.0,-9.1,0.76,8.37,,,,96.1,0.92,3.01,-1.16,-0.12,1.28,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,50,0.0,0.0,0,,,,98.93,-0.98,,,99.93,-0.07,,0.0456,18.8,75.27,5.9,-47.4,,,,,,63.6,,35319.6,2766.5,492.2,305.5,50.9,33.9,0.0,0.0,,67990.9,16225.5,5295.3,2919.2,628.0,305.5,50.9,17.0,,,,,,,,86.2,0.87,12.88,-9.0,0.7,8.25,,,,96.4,0.81,2.78,-0.82,-0.23,1.05,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,50,0.0,0.0,0,,,,100.0,0.09,,,99.89,-0.11,,0.0464,20.1,74.4,5.54,-46.2,,,,,,63.6,,23642.2,1866.9,305.5,186.7,67.9,0.0,0.0,0.0,,101325.1,28768.2,8859.6,5142.6,1391.7,390.4,67.9,0.0,,,,,,,,82.8,0.93,16.27,-12.4,0.76,11.64,,,,95.7,0.83,3.44,-1.51,-0.21,1.71,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,50,0.0,0.0,0,,,,100.0,0.09,,,99.91,-0.09,,0.0456,18.4,77.05,4.58,-47.9,,,,,,65.0,,43941.6,2308.3,254.6,152.8,0.0,0.0,0.0,0.0,,51970.3,15377.2,5193.6,3241.8,1120.2,407.3,50.9,17.0,,,,,,,,82.0,1.0,16.97,-13.2,0.83,12.34,,,,96.0,0.81,3.19,-1.23,-0.23,1.46,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,50,0.0,0.0,0,,,,99.16,-0.75,,,99.9,-0.1,,0.0458,81.8,14.98,3.26,15.5,,,,,,66.6,,60067.5,1782.2,288.5,203.7,50.9,17.0,0.0,0.0,,26493.4,8469.1,3360.5,2291.2,729.8,186.7,0.0,0.0,,,,,,,,82.0,1.01,16.96,-13.2,0.84,12.33,,,,96.0,0.78,3.21,-1.22,-0.26,1.48,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,50,0.0,0.0,0,,,,100.0,0.09,,,96.54,-3.46,,0.1783,,,,,,,,,,55.0,,17413.7,2104.6,424.3,254.6,17.0,0.0,0.0,0.0,,7743831.5,4842057.6,352063.2,34567.2,4988.3,1403.0,116.9,39.0,,,,,,,,90.4,0.57,8.99,-4.8,0.4,4.36,,,,78.7,1.33,19.99,-18.55,0.29,18.26,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,50,0.0,0.0,0,,,,100.0,0.09,,,99.4,-0.6,,0.0492,,,,,,,,,,58.8,,12491.4,2172.4,475.2,271.6,118.8,33.9,0.0,0.0,,331604.9,53250.3,15684.8,9081.6,1782.4,560.2,67.9,0.0,,,,,,,,88.2,0.86,10.94,-7.0,0.69,6.31,,,,94.1,0.89,5.06,-3.17,-0.15,3.33,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,50,0.0,0.0,0,,,,100.0,0.09,,,99.91,-0.09,,0.0533,,,,,,,,,,62.8,,26001.4,2681.6,611.0,373.4,135.8,50.9,0.0,0.0,,153810.2,49900.9,20520.5,12882.6,4124.5,1442.7,84.9,0.0,,,,,,,,84.0,0.97,15.02,-11.2,0.8,10.39,,,,96.5,0.79,2.7,-0.71,-0.25,0.97,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D04,1.0,,NB-ferguhei-5069961-0003,6.2,Acetate,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.94,-0.06,,0.0465,,,,,,,,,,63.2,,27512.3,2393.1,356.4,186.7,84.9,17.0,17.0,0.0,,170203.9,43314.7,10913.6,5346.5,729.8,152.8,17.0,0.0,,,,,,,,76.1,0.85,23.04,-19.1,0.68,18.41,,,,96.1,0.75,3.15,-1.13,-0.29,1.42,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,C11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,50,0.0,0.0,0,,,,99.7,-0.21,,,98.76,-1.24,,0.0497,,,,,,,,,,63.8,,53107.4,3275.7,645.0,220.6,33.9,0.0,0.0,0.0,,222360.9,94555.6,41855.0,27037.7,9436.9,2834.5,271.6,50.9,,,,,,,,84.3,0.92,14.79,-10.9,0.75,10.16,,,,96.8,0.73,2.48,-0.44,-0.31,0.75,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D02,1.0,,NB-ferguhei-5069961-0003,5.0,Acetate,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.91,-0.09,,0.239,,,,,,,,,,56.0,,38341.7,10132.8,3428.5,2257.4,933.5,373.4,33.9,17.0,,2499026.0,1663957.4,916950.7,629930.4,181217.0,42477.5,3463.4,135.8,,,,,,,,82.7,1.37,15.89,-12.5,1.2,11.26,,,,93.6,0.81,5.6,-3.64,-0.23,3.87,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D03,1.0,,NB-ferguhei-5069961-0003,5.6,Acetate,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.95,-0.05,,0.0496,,,,,,,,,,61.2,,22403.2,3004.1,509.2,254.6,135.8,50.9,33.9,33.9,,60695.1,21946.0,7841.5,4294.1,746.8,135.8,50.9,17.0,,,,,,,,76.1,0.9,22.96,-19.1,0.73,18.33,,,,95.5,0.86,3.65,-1.75,-0.18,1.92,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D05,1.0,,NB-ferguhei-5069961-0003,5.6,Citrate,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.91,-0.09,,0.0467,,,,,,,,,,61.8,,22352.4,2172.4,407.3,152.7,50.9,33.9,0.0,0.0,,177947.2,51921.1,14087.8,7128.7,746.8,84.9,0.0,0.0,,,,,,,,77.1,0.76,22.11,-18.1,0.59,17.48,,,,94.8,0.88,4.34,-2.45,-0.16,2.61,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D06,1.0,,NB-ferguhei-5069961-0003,6.2,Citrate,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.94,-0.06,,0.0455,,,,,,,,,,65.0,,29090.8,2698.6,543.1,373.4,118.8,33.9,0.0,0.0,,65480.2,17125.3,6093.2,3666.1,712.8,220.6,33.9,0.0,,,,,,,,76.7,0.85,22.48,-18.5,0.68,17.85,,,,95.7,0.81,3.45,-1.5,-0.23,1.72,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D07,1.0,,NB-ferguhei-5069961-0003,6.8,Citrate,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.91,-0.09,,0.0433,,,,,,,,,,61.8,,37458.3,2783.5,645.0,356.4,84.9,50.9,0.0,0.0,,75003.5,26053.5,10574.1,6483.7,1680.3,611.0,0.0,0.0,,,,,,,,76.1,0.93,22.96,-19.1,0.76,18.33,,,,95.8,0.78,3.43,-1.44,-0.26,1.7,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D08,1.0,,NB-ferguhei-5069961-0003,5.0,Histidine,0,150,0.0,0.0,0,,,,78.27,-21.64,,,95.92,-4.08,,0.5758,,,,,,,,,,52.4,,18737.5,2970.2,577.1,390.4,169.7,50.9,0.0,0.0,,1634007.2,1359270.9,819812.7,551526.4,113808.7,23220.0,118.8,0.0,,,,,,,,82.0,3.18,14.84,-13.2,3.01,10.21,,,,0.0,0.0,0.0,-97.23,-1.04,-1.73,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D09,1.0,,NB-ferguhei-5069961-0003,5.6,Histidine,0,150,0.0,0.0,0,,,,98.96,-0.95,,,99.72,-0.28,,0.0638,,,,,,,,,,58.6,,24558.8,4141.2,1052.3,644.9,203.7,152.8,67.9,17.0,,1016609.7,353107.4,58585.3,21984.3,3157.6,526.3,17.0,0.0,,,,,,,,79.5,0.84,19.67,-15.7,0.67,15.04,,,,94.7,0.79,4.55,-2.57,-0.25,2.82,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D10,1.0,,NB-ferguhei-5069961-0003,6.2,Histidine,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.93,-0.07,,0.0538,,,,,,,,,,62.0,,32807.2,3683.0,814.7,441.3,169.7,33.9,0.0,0.0,,115959.5,40480.6,14376.1,8045.2,1901.0,526.2,17.0,0.0,,,,,,,,73.6,0.92,25.47,-21.6,0.75,20.84,,,,96.1,0.83,3.03,-1.09,-0.21,1.3,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
12/9/2022,ferguhei,,MK3475,mAb,Single Control,,50.0,10.0,D11,1.0,,NB-ferguhei-5069961-0003,6.8,Histidine,0,150,0.0,0.0,0,,,,100.0,0.09,,,99.94,-0.06,,0.0508,,,,,,,,,,64.2,,28564.2,3173.8,678.9,373.4,101.8,33.9,0.0,0.0,,93060.2,32790.9,12169.3,7145.4,2155.5,628.0,67.9,0.0,,,,,,,,73.9,1.0,25.12,-21.3,0.83,20.49,,,,96.4,0.73,2.85,-0.81,-0.31,1.12,,,,,,,,,,AB0411 AB0621 Results Template.xlsx,,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Glu_4_2w40C,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,98.0,-0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.74,1.07,0.2,-0.9,1.1,-0.2,0.9,1.1,0.2,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Glu_4_T0,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,98.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.6,0.0,0.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Glu_5_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,98.5,-0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.95,0.43,0.63,-0.6,0.4,0.2,0.6,0.4,0.2,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Glu_5_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,99.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.54,0.0,0.46,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_His_5.5S_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,9.0,0,,,,98.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.85,0.17,0.98,,,,,,,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_His_5.5S_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,96.5,-1.6,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.43,0.0,0.57,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_His_5.5T_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,9,,,,97.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.02,0.21,0.77,,,,,,,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_His_5.5T_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,98.9,0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.41,0.0,0.59,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_His_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,98.3,0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.38,0.43,1.19,-1.0,0.4,0.6,1.0,0.4,0.6,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_His_5.5_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,98.9,0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.38,0.0,0.62,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_His_6_2w40C,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,98.3,-0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.68,0.34,0.98,-0.6,0.3,0.2,0.6,0.3,0.2,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_His_6_T0,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,98.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.26,0.0,0.74,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_His_7_2w40C,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,98.0,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.5,1.68,-1.2,0.5,0.7,1.2,0.5,0.7,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_His_7_T0,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,98.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.04,0.0,0.96,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Succi_5.5S_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,9.0,0,,,,98.2,-0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.91,0.2,3.89,-3.3,0.2,3.1,3.3,0.2,3.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Succi_5.5S_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,99.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.25,0.0,0.75,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Succi_5.5T_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,9,,,,98.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.6,0.39,4.0,-3.5,0.4,3.1,3.5,0.4,3.1,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Succi_5.5T_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,9.0,0,,,,99.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.17,0.0,0.83,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Succi_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,98.2,-0.8,0.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,94.44,0.38,5.17,-4.8,0.4,4.4,4.8,0.4,4.4,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Succi_5.5_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,9,,,,99.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.12,0.0,0.88,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Succi_5_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,98.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.43,0.45,4.11,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Succi_5_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,99.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,99.34,0.0,0.66,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,40.0,14.0,,1.0,En_Succi_6_2w40C,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,98.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.46,0.51,7.03,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,Enhertu,,MULTIPLE CONTROL,,5.0,0.0,,1.0,En_Succi_6_T0,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,9,,,,99.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.87,0.0,1.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Glu_4S_T0,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,93.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.99,0.0,2.01,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Glu_4_2w40C,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,93.5,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.48,4.94,1.57,-4.5,4.9,-0.4,4.5,4.9,0.4,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Glu_5S_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,94.8,0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.91,0.36,1.73,0.0,0.4,-0.3,0.0,0.4,0.3,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Glu_5S_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,93.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.94,0.0,2.06,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Glu_5T_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,94.6,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.39,1.79,-0.1,0.4,-0.3,0.1,0.4,0.3,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Glu_5T_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,93.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.92,0.0,2.08,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Glu_5_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,94.8,1.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.71,0.31,1.98,-0.2,0.3,-0.1,0.2,0.3,0.1,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Glu_5_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,93.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.87,0.0,2.13,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_His_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,94.5,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.82,0.33,1.85,0.0,0.3,-0.3,0.0,0.3,0.3,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_His_5.5_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,93.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.86,0.0,2.14,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_His_6_2w40C,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,92.8,-1.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.72,0.31,1.97,0.0,0.3,-0.3,0.0,0.3,0.3,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_His_6_T0,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,94.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.71,0.0,2.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_His_7_2w40C,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,95.3,1.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.19,0.35,2.47,-0.5,0.4,0.1,0.5,0.4,0.1,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_His_7_T0,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,94.2,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.66,0.0,2.34,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Sccin_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,95.0,1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.83,0.38,2.79,-0.8,0.4,0.4,0.8,0.4,0.4,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Sccin_5.5_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,93.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0.0,2.38,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Succi_5S_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,94.6,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.25,0.49,2.26,-0.7,0.5,0.2,0.7,0.5,0.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Succi_5S_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,93.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.91,0.0,2.09,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Succi_5T_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,94.3,0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.87,0.48,2.65,-0.8,0.5,0.3,0.8,0.5,0.3,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Succi_5T_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,93.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.68,0.0,2.32,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Succi_5_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,94.3,0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.81,0.46,2.73,-0.8,0.5,0.3,0.8,0.5,0.3,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Succi_5_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,93.6,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.57,0.0,2.43,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,40.0,14.0,,1.0,ROR1_Succi_6_2w40C,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,95.0,1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,96.86,0.32,2.82,-0.7,0.3,0.4,0.7,0.3,0.4,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,ROR1,,MULTIPLE CONTROL,,5.0,0.0,,1.0,ROR1_Succi_6_T0,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,93.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.54,0.0,2.46,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Glu_4,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,99.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Glu_4_2w40C,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,99.2,-0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.47,0.66,1.86,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Glu_5,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,99.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0.0,2.38,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Glu_5S,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,99.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,0.0,2.38,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Glu_5S_2w40,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,99.5,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.82,0.35,3.83,-1.8,0.4,1.5,1.8,0.4,1.5,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Glu_5T,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,99.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.58,0.0,2.42,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Glu_5T_2w40,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,99.4,-0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.96,0.42,3.61,-1.6,0.4,1.2,1.6,0.4,1.2,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Glu_5_2w40,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,99.5,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.87,0.31,3.82,-1.8,0.3,1.4,1.8,0.3,1.4,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_His_5.5,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.53,0.0,2.47,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_His_5.5_2w40,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,99.1,-0.9,0.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.48,0.36,4.16,-2.0,0.4,1.7,2.0,0.4,1.7,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_His_6,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.53,0.0,2.47,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_His_6_2w40,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,99.8,-0.2,0.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.22,0.39,4.39,-2.3,0.4,1.9,2.3,0.4,1.9,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_His_7,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.61,0.0,2.39,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_His_7_2w40,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,98.8,-1.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,95.02,0.42,4.56,-2.6,0.4,2.2,2.6,0.4,2.2,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Sccin_5.5,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.31,0.0,2.69,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Sccin_5.5_2w40,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,99.7,-0.3,0.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.51,0.52,6.96,-4.8,0.5,4.3,4.8,0.5,4.3,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Succi_5,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,99.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.38,0.0,2.62,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Succi_5S,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.38,0.0,2.62,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Succi_5S_2w40,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,99.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.81,0.47,10.72,-8.6,0.5,8.1,8.6,0.5,8.1,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Succi_5T,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.35,0.0,2.65,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Succi_5T_2w40,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,99.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.07,0.54,10.39,-8.3,0.5,7.7,8.3,0.5,7.7,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Succi_5_2w40,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,99.1,-0.6,0.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.48,0.41,13.11,-10.9,0.4,10.5,10.9,0.4,10.5,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,5.0,0.0,,1.0,101_Succi_6,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,100.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.27,0.0,2.73,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-101,,MULTIPLE CONTROL,,40.0,14.0,,1.0,101_Succi_6_2w40,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,99.3,-0.7,0.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,93.92,0.59,5.49,-3.3,0.6,2.8,3.3,0.6,2.8,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Glu_4_,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Glu_4_25C2w,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,92.59,2.58,4.83,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Glu_4_2w40C,NB-penglei5-5065175-0002,4.0,Glutamate,0,0,0.0,0.0,0,,,,95.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.47,5.31,5.22,,,,,,,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Glu_5S_25C2w,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.24,2.77,7.99,-2.1,0.4,1.7,2.1,0.4,1.7,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Glu_5S_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,95.8,-1.1,1.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.81,3.72,9.46,-4.5,1.4,3.2,4.5,1.4,3.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Glu_5S_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,9.0,0,,,,96.9,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.35,2.36,6.29,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Glu_5T_25C2w,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,89.59,2.53,7.88,-8.1,-2.1,1.6,8.1,2.1,1.6,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Glu_5T_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,95.9,-1.7,1.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.71,3.99,9.3,-11.0,-0.6,3.0,11.0,0.6,3.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Glu_5T_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,9,,,,97.6,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.68,4.64,6.31,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Glu_5_25C2w,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.76,2.78,9.46,-3.6,0.5,3.1,3.6,0.5,3.1,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Glu_5_2w40C,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,95.8,-1.8,1.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.18,3.91,10.91,-6.2,1.7,4.5,6.2,1.7,4.5,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Glu_5_T0,NB-penglei5-5065175-0002,5.0,Glutamate,0,0,0.0,0.0,0,,,,97.6,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.34,2.26,6.4,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_His_5.5_25C2w,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,84.12,2.33,13.55,-6.2,-0.3,6.5,6.2,0.3,6.5,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_His_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,95.5,-1.2,1.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.4,3.75,9.85,-3.9,1.2,2.8,3.9,1.2,2.8,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_His_5.5_T0,NB-penglei5-5065175-0002,5.5,Histidine,0,0,0.0,0.0,0,,,,96.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.34,2.6,7.06,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_His_6_25C2w,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.67,2.09,18.24,-10.4,-0.3,10.7,10.4,0.3,10.7,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_His_6_2w40C,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,95.3,-1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.81,3.76,8.43,-2.3,1.4,0.9,2.3,1.4,0.9,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_His_6_T0,NB-penglei5-5065175-0002,6.0,Histidine,0,0,0.0,0.0,0,,,,96.6,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.09,2.38,7.53,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_His_7_25C2w,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,79.64,2.34,18.02,-12.2,-0.5,12.7,12.2,0.5,12.7,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_His_7_2w40C,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,94.6,-2.4,2.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.58,4.87,3.55,-0.3,2.1,-1.8,0.3,2.1,1.8,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_His_7_T0,NB-penglei5-5065175-0002,7.0,Histidine,0,0,0.0,0.0,0,,,,97.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,91.87,2.81,5.32,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Sccin_5.5_25C2w,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.83,2.54,10.64,-10.8,-2.2,5.7,10.8,2.2,5.7,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Sccin_5.5_2w40C,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,95.4,-2.6,2.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.34,5.13,9.53,-12.3,0.4,4.6,12.3,0.4,4.6,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Sccin_5.5_T0,NB-penglei5-5065175-0002,5.5,Succinate,0,0,0.0,0.0,0,,,,98.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.62,4.76,4.94,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Succi_5S_25C2w,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,88.19,2.4,9.41,-9.6,-2.1,2.7,9.6,2.1,2.7,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Succi_5S_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,96.2,-0.5,0.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.27,3.86,12.87,-14.5,-0.6,6.2,14.5,0.6,6.2,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Succi_5S_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,9.0,0,,,,96.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.75,4.5,6.69,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Sucrose,Sucrose,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Succi_5T_25C2w,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.86,2.0,10.14,-3.0,-0.3,3.4,3.0,0.3,3.4,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Succi_5T_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,96.3,-0.4,0.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.51,4.07,12.42,-7.4,1.7,5.6,7.4,1.7,5.6,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Succi_5T_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,9,,,,96.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,90.9,2.33,6.77,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,Trehalose,-,Trehalose,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Succi_5_25C2w,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.28,2.32,10.4,-10.8,-1.6,3.5,10.8,1.6,3.5,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Succi_5_2w40C,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,95.4,-1.3,1.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,83.56,4.34,12.1,-14.5,0.4,5.2,14.5,0.4,5.2,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Succi_5_T0,NB-penglei5-5065175-0002,5.0,Succinate,0,0,0.0,0.0,0,,,,96.7,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,98.03,3.94,6.86,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,25.0,14.0,,1.0,231_Succi_6_25C2w,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,86.16,2.59,11.24,-11.2,-2.6,7.1,11.2,2.6,7.1,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,40.0,14.0,,1.0,231_Succi_6_2w40C,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,96.4,-1.6,1.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,87.27,4.77,7.95,-10.1,-0.4,3.8,10.1,0.4,3.8,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
4/8/2022,penglei,,VLS-231,,MULTIPLE CONTROL,,5.0,0.0,,1.0,231_Succi_6_T0,NB-penglei5-5065175-0002,6.0,Succinate,0,0,0.0,0.0,0,,,,98.0,0.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,97.4,5.2,4.15,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,1,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,5.0,0.0,H02,1.0,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,99.0,,,,99.9,0.0,,0.0386,84.4,9.53,6.03,,,,,,,66.0,,7858.0,2817.3,560.1,373.4,67.9,50.9,0.0,0.0,,11388.1,5431.0,322.5,169.7,0.0,0.0,0.0,0.0,,,,,,,,91.1,5.46,3.49,0.0,0.0,0.0,,,,90.7,9.26,0.0,0.0,-9.83,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,98.0,-1.0,,,99.9,0.0,,0.0427,,,,,,,,,,61.4,,16242.2,3632.0,1205.0,797.7,271.6,101.8,0.0,0.0,,16377.9,3122.8,611.0,254.6,50.9,33.9,0.0,0.0,,,,,,,,80.6,15.5,3.94,-10.0,10.0,0.0,,,,90.0,9.89,0.1,-1.0,1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,98.0,-1.0,,,99.9,0.0,,0.0445,,,,,,,,,,60.6,,17684.8,5804.4,1816.0,1052.3,441.3,237.6,67.9,33.9,,20553.2,3716.9,475.2,305.5,50.9,17.0,0.0,0.0,,,,,,,,83.2,12.38,4.39,-8.0,7.0,1.0,,,,90.2,9.55,0.24,-1.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,98.0,-1.0,,,99.9,0.0,,0.0433,,,,,,,,,,56.6,,15563.2,3411.4,882.5,424.3,169.7,118.8,17.0,17.0,,12134.9,2291.2,475.2,237.6,135.8,50.9,0.0,0.0,,,,,,,,80.8,15.27,3.93,-10.0,10.0,0.0,,,,90.4,9.38,0.18,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,98.0,-1.0,,,99.8,-0.1,,0.0435,,,,,,,,,,53.4,,18194.1,4192.1,1239.0,644.9,220.6,101.8,33.9,0.0,,30821.4,5227.4,984.4,526.1,135.8,33.9,17.0,0.0,,,,,,,,78.2,18.04,3.72,-13.0,13.0,0.0,,,,88.9,8.24,2.85,-2.0,-1.0,3.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,95.0,-5.0,,,100.0,0.1,,0.0419,,,,,,,,,,61.8,,10318.9,2325.2,339.4,237.6,84.9,17.0,0.0,0.0,,24813.2,3649.0,678.9,441.3,169.7,101.8,17.0,0.0,,,,,,,,79.9,15.96,4.19,-11.0,11.0,1.0,,,,91.0,8.76,0.2,0.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,97.0,-2.0,,,100.0,0.1,,0.0417,,,,,,,,,,59.4,,20705.8,4972.8,1018.3,644.9,169.7,50.9,0.0,0.0,,59149.2,9657.4,1340.8,729.8,220.6,84.9,17.0,0.0,,,,,,,,81.2,14.59,4.18,-10.0,9.0,1.0,,,,90.9,8.93,0.16,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,83.0,-17.0,,,99.9,0.0,,0.0429,,,,,,,,,,61.2,,9707.9,2562.8,441.3,237.6,84.9,33.9,0.0,0.0,,17040.0,2749.5,577.1,288.5,33.9,0.0,0.0,0.0,,,,,,,,81.5,13.53,4.95,-10.0,8.0,1.0,,,,91.2,8.57,0.2,0.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,86.0,-13.0,,,99.9,-0.1,,0.0432,,,,,,,,,,59.6,,8740.6,1849.9,475.2,288.5,101.8,33.9,0.0,0.0,,12389.5,1765.1,203.7,84.9,0.0,0.0,0.0,0.0,,,,,,,,81.0,14.14,4.83,-10.0,9.0,1.0,,,,90.7,9.17,0.13,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,99.9,-0.1,,0.043,,,,,,,,,,56.6,,13730.3,1968.7,475.2,220.6,67.9,17.0,0.0,0.0,,17498.1,2681.6,458.2,220.6,33.9,17.0,0.0,0.0,,,,,,,,79.6,16.49,3.88,-11.0,11.0,0.0,,,,90.8,8.7,0.46,0.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,D02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,98.0,-2.0,,,99.4,-0.5,,0.0427,,,,,,,,,,55.0,,345313.9,8776.3,899.7,288.6,17.0,17.0,17.0,17.0,,40597.4,4905.0,916.5,373.4,101.8,50.9,17.0,17.0,,,,,,,,76.8,19.61,3.6,-14.0,14.0,0.0,,,,79.5,7.48,12.98,-11.0,-2.0,13.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,98.0,-2.0,,,99.9,0.0,,0.0423,67.6,22.74,9.64,,,,,,,61.4,,13577.5,4107.2,882.5,526.1,152.7,101.8,17.0,17.0,,27376.1,7009.5,1748.1,950.4,203.7,33.9,0.0,0.0,,,,,,,,82.0,13.78,4.21,-9.0,8.0,1.0,,,,90.9,8.64,0.44,0.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,99.0,0.0,,,99.9,0.0,,0.044,70.7,19.56,9.73,,,,,,,,,11812.4,5193.4,644.9,322.5,152.7,67.9,17.0,0.0,,14290.4,2376.1,220.6,67.9,33.9,17.0,17.0,17.0,,,,,,,,83.2,12.67,4.17,-8.0,7.0,1.0,,,,91.0,8.92,0.11,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.8,-0.1,,0.0433,71.6,18.9,9.51,,,,,,,59.0,,11829.5,3852.6,509.2,288.5,67.9,33.9,0.0,0.0,,16140.3,3139.8,577.0,271.6,67.9,33.9,0.0,0.0,,,,,,,,81.9,14.46,3.7,-9.0,9.0,0.0,,,,90.9,9.12,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,99.0,0.0,,,99.8,-0.1,,0.0436,69.6,20.32,10.06,,,,,,,56.0,,7009.4,1799.0,356.4,220.6,67.9,17.0,0.0,0.0,,18805.0,3275.6,339.4,135.8,33.9,0.0,0.0,0.0,,,,,,,,80.7,15.97,3.3,-10.0,11.0,0.0,,,,90.4,9.56,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,89.0,-10.0,,,99.9,0.0,,0.0442,61.9,28.03,10.07,,,,,,,60.0,,14494.1,4226.0,628.0,322.5,101.8,67.9,0.0,0.0,,17583.0,3055.0,509.2,237.6,118.8,101.8,17.0,0.0,,,,,,,,82.3,13.7,4.04,-9.0,8.0,1.0,,,,91.5,8.47,0.08,1.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,94.0,-5.0,,,99.9,0.0,,0.0431,63.4,26.53,10.12,,,,,,,59.6,,12525.3,3699.9,322.5,220.6,67.9,17.0,0.0,0.0,,25899.6,5414.1,1103.2,543.1,84.9,17.0,0.0,0.0,,,,,,,,81.9,14.37,3.76,-9.0,9.0,0.0,,,,91.5,8.52,0.0,1.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,91.0,-9.0,,,99.9,0.0,,0.0448,67.2,22.3,10.46,,,,,,,60.2,,10539.5,4005.4,220.6,152.7,17.0,0.0,0.0,0.0,,13356.9,1816.0,356.4,169.7,50.9,50.9,50.9,33.9,,,,,,,,83.5,12.77,3.73,-8.0,7.0,0.0,,,,91.0,8.98,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,90.0,-9.0,,,99.9,0.0,,0.0443,66.9,21.98,11.16,,,,,,,60.8,,6398.4,1476.6,169.7,84.9,17.0,17.0,0.0,0.0,,14884.4,2393.0,339.4,186.7,33.9,17.0,0.0,0.0,,,,,,,,82.2,14.08,3.68,-9.0,9.0,0.0,,,,90.8,9.18,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,98.0,-1.0,,,99.9,-0.1,,0.0428,66.6,22.55,10.84,,,,,,,59.0,,7552.5,1357.8,135.8,101.8,50.9,0.0,0.0,0.0,,12627.1,2104.5,271.6,135.8,33.9,17.0,0.0,0.0,,,,,,,,81.0,15.12,3.85,-10.0,10.0,0.0,,,,90.4,9.61,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,C02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,98.0,-1.0,,,99.9,0.0,,0.0406,66.0,23.06,10.92,,,,,,,,,5431.0,1035.3,101.8,67.9,0.0,0.0,0.0,0.0,,35913.1,6687.0,1561.4,933.5,288.5,118.8,33.9,33.9,,,,,,,,79.1,17.17,3.69,-12.0,12.0,0.0,,,,90.2,9.82,0.0,-1.0,1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,97.0,-3.0,,,99.9,0.0,,0.0424,67.1,23.85,9.1,,,,,,,63.4,,30821.2,18126.1,2834.3,1340.8,407.3,169.7,17.0,0.0,,45502.3,5838.4,1001.4,543.1,135.8,50.9,33.9,0.0,,,,,,,,82.4,13.74,3.89,-9.0,8.0,0.0,,,,90.7,9.31,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,99.0,0.0,,,99.9,0.0,,0.0433,69.6,20.66,9.72,,,,,,,64.8,,53445.3,17175.8,2647.7,1374.7,475.2,254.6,33.9,33.9,,40377.0,3598.1,390.4,186.7,101.8,50.9,0.0,0.0,,,,,,,,84.2,11.85,3.93,-7.0,6.0,0.0,,,,90.7,9.27,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,99.0,0.0,,,99.8,-0.1,,0.0432,71.7,18.92,9.42,,,,,,,63.6,,16547.6,8961.2,1934.8,899.5,237.6,67.9,0.0,0.0,,13339.9,1900.9,271.6,67.9,0.0,0.0,0.0,0.0,,,,,,,,83.9,12.37,3.76,-7.0,7.0,0.0,,,,90.5,9.52,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,99.0,0.0,,,99.8,-0.1,,0.0435,71.0,18.66,10.33,,,,,,,62.2,,11931.3,5465.0,1340.8,831.6,373.4,169.7,0.0,0.0,,14782.6,2274.2,254.6,101.8,50.9,0.0,0.0,0.0,,,,,,,,83.0,13.05,3.99,-8.0,8.0,1.0,,,,90.6,9.36,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,0.0,,,,99.9,0.0,,0.0425,63.0,27.23,9.81,,,,,,,59.6,,17379.3,6347.5,1408.7,780.7,237.6,118.8,0.0,0.0,,38051.7,6687.1,1035.3,441.3,203.7,33.9,0.0,0.0,,,,,,,,80.5,14.88,4.59,-11.0,9.0,1.0,,,,91.5,8.53,0.0,1.0,-1.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,0.0,,,,99.9,0.0,,0.0415,64.9,25.51,9.58,,,,,,,60.0,,15546.4,4022.4,1272.9,729.8,254.6,135.8,0.0,0.0,,38849.2,4514.6,661.9,288.5,0.0,0.0,0.0,0.0,,,,,,,,82.2,13.32,4.47,-9.0,8.0,1.0,,,,91.0,8.96,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,89.0,-10.0,,,100.0,0.0,,0.0426,66.1,22.7,11.18,,,,,,,62.4,,30176.3,9657.1,1425.7,865.6,305.5,169.7,17.0,0.0,,25084.7,3615.1,288.5,33.9,0.0,0.0,0.0,0.0,,,,,,,,82.9,12.82,4.29,-8.0,7.0,1.0,,,,90.7,9.35,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,89.0,-11.0,,,100.0,-0.1,,0.0431,68.0,21.95,10.03,,,,,,,63.2,,13611.5,6313.6,1629.3,882.5,271.6,84.9,17.0,17.0,,96219.6,3768.0,220.6,101.8,17.0,0.0,0.0,0.0,,,,,,,,83.1,12.66,4.26,-8.0,7.0,1.0,,,,90.6,9.36,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,99.0,0.0,,,100.0,0.0,,0.0414,70.3,20.15,9.58,,,,,,,64.2,,11557.9,4412.7,1629.3,1001.3,373.4,135.8,0.0,0.0,,12151.9,1985.7,203.7,50.9,33.9,17.0,0.0,0.0,,,,,,,,82.6,13.16,4.26,-8.0,8.0,1.0,,,,90.7,9.3,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB547,Fusion Protein,sc,,40.0,12.0,B02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.1,,0.0404,67.8,20.7,11.51,,,,,,,62.8,,44637.4,6381.6,1544.5,780.7,271.6,135.8,0.0,0.0,,9538.2,1731.1,135.8,67.9,0.0,0.0,0.0,0.0,,,,,,,,82.3,13.44,4.22,-9.0,8.0,1.0,,,,90.7,9.29,0.0,0.0,0.0,0.0,,,,DNB000547_004 (ZW),DNB000547,-,,,,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,-,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,5.0,0.0,H07,1.0,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,0.0,,0.0388,80.7,10.7,8.63,,,,,,,65.2,,153655.7,3734.5,763.9,390.4,17.0,17.0,0.0,0.0,,15020.1,6737.8,797.7,322.5,101.8,33.9,0.0,0.0,,,,,,,,92.4,5.02,2.57,0.0,0.0,0.0,,,,90.2,9.83,0.0,0.0,-9.83,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0426,,,,,,,,,,62.4,,1569113.5,5163.7,2021.3,1189.0,356.7,84.9,0.0,0.0,,29039.3,7552.6,1391.7,661.9,101.8,17.0,0.0,0.0,,,,,,,,82.0,14.91,3.11,-10.0,10.0,1.0,,,,86.8,13.02,0.14,-3.0,3.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0435,,,,,,,,,,59.8,,1473434.2,6693.1,1953.6,1104.2,339.8,135.9,0.0,0.0,,26900.6,6466.3,1510.5,628.0,169.7,101.8,17.0,0.0,,,,,,,,85.7,11.46,2.88,-7.0,6.0,0.0,,,,86.8,13.08,0.14,-3.0,3.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0435,,,,,,,,,,55.8,,997552.1,7642.8,2734.4,1715.4,764.3,305.7,34.0,0.0,,31313.7,8944.4,2461.0,1527.5,594.0,169.7,17.0,0.0,,,,,,,,82.8,14.42,2.74,-10.0,9.0,0.0,,,,87.0,13.03,0.0,-3.0,3.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0438,,,,,,,,,,54.0,,826576.9,5179.3,1579.3,984.9,373.6,135.8,17.0,0.0,,22318.2,4158.1,848.6,407.3,118.8,67.9,0.0,0.0,,,,,,,,81.9,14.87,3.2,-10.0,10.0,1.0,,,,86.1,11.64,2.24,-4.0,2.0,2.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0429,,,,,,,,,,61.4,,783649.8,6622.8,1664.2,764.2,203.8,101.9,0.0,0.0,,5583.7,1629.3,543.1,237.6,118.8,50.9,0.0,0.0,,,,,,,,81.4,15.27,3.33,-11.0,10.0,1.0,,,,90.0,9.98,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.042,,,,,,,,,,59.6,,611231.4,3820.5,611.3,373.6,67.9,34.0,0.0,0.0,,12219.8,2800.4,509.2,271.6,67.9,0.0,0.0,0.0,,,,,,,,81.9,14.64,3.43,-10.0,10.0,1.0,,,,90.2,9.85,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0434,,,,,,,,,,60.8,,3435267.0,118029.0,1071.9,734.5,337.5,139.0,19.9,0.0,,26323.7,5566.8,1069.2,509.2,135.8,17.0,0.0,0.0,,,,,,,,82.5,14.0,3.52,-10.0,9.0,1.0,,,,90.1,9.9,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0426,,,,,,,,,,59.6,,3304926.5,101102.3,904.6,404.2,173.2,77.0,0.0,0.0,,11948.2,2613.7,475.2,305.5,67.9,33.9,0.0,0.0,,,,,,,,82.9,13.99,3.13,-10.0,9.0,1.0,,,,90.0,9.99,0.03,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0417,,,,,,,,,,56.6,,3231777.3,93996.7,548.4,378.2,75.6,18.9,0.0,0.0,,9266.7,1917.8,305.5,169.7,50.9,17.0,0.0,0.0,,,,,,,,82.1,14.39,3.47,-10.0,9.0,1.0,,,,89.6,10.1,0.25,-1.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,G02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0413,,,,,,,,,,51.8,,2794300.0,17722.4,696.7,475.8,220.9,51.0,0.0,0.0,,14867.4,2766.4,628.0,322.5,67.9,33.9,0.0,0.0,,,,,,,,81.5,15.04,3.44,-11.0,10.0,1.0,,,,76.0,8.12,15.93,-14.0,-2.0,16.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0434,65.1,22.69,12.2,,,,,,,61.4,,326977.9,7486.9,2393.8,1477.0,679.1,237.7,0.0,0.0,,40936.8,10336.0,2647.7,1527.5,373.4,118.8,0.0,0.0,,,,,,,,81.0,15.91,3.12,-11.0,11.0,1.0,,,,89.5,10.47,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0445,68.7,18.86,12.45,,,,,,,61.2,,416518.6,7317.2,1273.3,662.1,203.7,67.9,0.0,0.0,,17600.0,3071.9,560.1,356.4,135.8,84.9,17.0,0.0,,,,,,,,83.1,13.55,3.33,-9.0,9.0,1.0,,,,89.6,10.43,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0441,68.7,18.75,12.51,,,,,,,58.8,,143758.9,6874.8,2189.7,1375.0,560.2,220.7,0.0,0.0,,24202.1,6551.2,1340.8,746.8,288.5,84.9,17.0,0.0,,,,,,,,82.5,14.41,3.15,-10.0,9.0,1.0,,,,89.0,11.05,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0443,67.4,19.38,13.2,,,,,,,56.6,,166526.2,3955.2,1018.5,628.1,237.7,17.0,0.0,0.0,,18041.2,4327.8,814.7,322.5,84.9,33.9,0.0,0.0,,,,,,,,81.8,14.87,3.35,-11.0,10.0,1.0,,,,89.1,10.92,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0444,63.1,25.08,11.79,,,,,,,61.6,,271593.1,6994.4,1392.1,713.0,237.7,101.9,17.0,0.0,,31109.9,6737.9,1340.8,611.0,135.8,50.9,0.0,0.0,,,,,,,,80.8,15.93,3.29,-12.0,11.0,1.0,,,,90.3,9.58,0.15,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0442,64.5,24.69,10.84,,,,,,,59.4,,221333.0,5585.1,1476.9,848.8,288.6,101.9,34.0,0.0,,18295.7,4820.0,1323.8,882.5,322.5,152.7,0.0,0.0,,,,,,,,81.8,14.73,3.48,-11.0,10.0,1.0,,,,89.9,9.98,0.1,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0435,66.3,21.31,12.43,,,,,,,61.2,,181606.4,5703.8,526.2,288.6,135.8,50.9,0.0,0.0,,16445.8,3682.9,746.8,356.4,101.8,33.9,17.0,17.0,,,,,,,,82.9,13.68,3.4,-9.0,9.0,1.0,,,,89.9,10.08,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0435,66.9,20.71,12.42,,,,,,,60.0,,152827.3,2597.2,645.1,407.4,135.8,0.0,0.0,0.0,,14748.6,2902.2,441.3,305.5,50.9,17.0,0.0,0.0,,,,,,,,82.8,13.97,3.2,-10.0,9.0,1.0,,,,89.7,10.26,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0423,66.2,21.29,12.54,,,,,,,59.4,,143369.2,1578.7,271.6,169.7,67.9,17.0,0.0,0.0,,10251.1,1442.6,288.5,169.7,84.9,50.9,33.9,17.0,,,,,,,,81.3,15.59,3.12,-11.0,11.0,1.0,,,,89.4,10.64,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,F02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0415,65.7,20.38,13.97,,,,,,,56.4,,134066.0,2512.3,831.8,611.1,288.6,33.9,0.0,0.0,,18940.8,3479.3,729.8,373.4,186.7,33.9,0.0,0.0,,,,,,,,81.6,15.32,3.13,-11.0,10.0,1.0,,,,89.6,10.39,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0433,63.1,25.12,11.8,,,,,,,63.6,,813469.2,15011.4,2411.3,1511.3,458.5,135.8,0.0,0.0,,20994.4,2342.1,475.2,186.7,67.9,17.0,0.0,0.0,,,,,,,,81.5,15.38,3.11,-11.0,10.0,1.0,,,,89.6,10.45,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0444,67.5,20.48,12.03,,,,,,,64.6,,151603.5,11695.8,2631.1,1476.8,390.4,152.8,0.0,0.0,,6534.2,1154.1,271.6,152.7,67.9,33.9,0.0,0.0,,,,,,,,84.4,12.37,3.29,-8.0,7.0,1.0,,,,89.3,10.68,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0434,68.3,19.27,12.39,,,,,,,62.4,,45435.5,8842.7,2053.7,1188.1,390.4,169.7,0.0,0.0,,9130.9,1849.9,305.5,186.7,17.0,17.0,0.0,0.0,,,,,,,,82.7,14.11,3.23,-10.0,9.0,1.0,,,,89.1,10.86,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.043,68.7,18.24,13.09,,,,,,,62.4,,19450.4,4412.8,1663.3,1035.3,492.2,254.6,0.0,0.0,,6551.2,1272.9,322.5,152.7,84.9,50.9,17.0,0.0,,,,,,,,83.2,13.91,2.85,-9.0,9.0,0.0,,,,88.9,11.06,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0437,62.1,26.55,11.37,,,,,,,61.4,,43027.0,3462.5,1256.0,831.7,305.5,169.7,0.0,0.0,,9164.8,1459.6,339.4,186.7,50.9,0.0,0.0,0.0,,,,,,,,80.8,16.04,3.12,-12.0,11.0,1.0,,,,90.1,9.82,0.11,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0416,63.2,25.44,11.41,,,,,,,59.6,,25849.3,3547.3,1459.6,899.5,407.3,203.7,0.0,0.0,,7314.9,1374.7,407.3,203.7,101.8,101.8,33.9,33.9,,,,,,,,82.6,14.17,3.28,-10.0,9.0,1.0,,,,89.8,10.23,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0477,66.0,21.51,12.47,,,,,,,63.6,,38986.4,7909.3,1884.0,984.4,322.5,118.8,0.0,0.0,,1400899.6,55054.1,968.2,322.7,67.9,0.0,0.0,0.0,,,,,,,,83.1,13.94,2.97,-9.0,9.0,0.0,,,,89.9,10.09,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0425,66.8,20.81,12.38,,,,,,,63.6,,12355.6,5278.3,1765.1,1137.1,458.2,220.6,0.0,0.0,,6839.7,1782.1,611.0,356.4,84.9,17.0,0.0,0.0,,,,,,,,83.3,13.63,3.05,-9.0,9.0,0.0,,,,89.6,10.38,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0433,67.5,19.97,12.55,,,,,,,63.8,,160213.2,8486.8,2002.9,1171.2,407.4,254.6,0.0,0.0,,10149.2,2274.2,577.0,254.6,50.9,17.0,0.0,0.0,,,,,,,,83.1,13.94,2.99,-9.0,9.0,0.0,,,,89.7,10.26,0.0,0.0,0.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB558,Fusion Protein,sc,,40.0,12.0,E02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,0.0,,,,0.0,,,0.0408,67.5,19.94,12.55,,,,,,,63.2,,32111.7,3360.5,1374.8,950.5,288.5,152.8,17.0,17.0,,9792.8,1799.0,424.3,237.6,84.9,33.9,17.0,17.0,,,,,,,,82.7,14.33,2.93,-10.0,9.0,0.0,,,,89.5,10.49,0.0,-1.0,1.0,0.0,,,,DNB000558_004 (KiH),DNB000558,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66487.63002,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,5.0,0.0,H02,0.4,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,100.0,,,,100.0,0.0,,0.0391,84.1,10.87,5.07,,,,,,,64.4,,8282.3,3241.6,322.5,169.7,17.0,0.0,0.0,0.0,,5787.4,1629.3,305.5,169.7,17.0,0.0,0.0,0.0,,,,,,,,92.2,6.22,1.55,0.0,0.0,0.0,,,,89.9,10.13,0.0,0.0,-9.83,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D11,0.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.8,-0.2,,0.0435,,,,,,,,,,61.2,,6398.4,1951.8,458.2,186.7,17.0,0.0,0.0,0.0,,26086.0,5804.4,1154.1,661.9,254.6,118.8,0.0,0.0,,,,,,,,83.0,15.37,1.63,-9.0,9.0,0.0,,,,89.3,10.73,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D10,0.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0442,,,,,,,,,,59.6,,7858.0,2036.6,237.6,118.8,17.0,0.0,0.0,0.0,,18703.1,4514.5,899.5,492.2,186.7,50.9,17.0,17.0,,,,,,,,84.0,14.02,2.01,-8.0,8.0,0.0,,,,88.6,11.45,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D09,0.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0444,,,,,,,,,,57.0,,5515.9,1001.3,101.8,50.9,33.9,0.0,0.0,0.0,,61050.3,17906.0,6144.1,4141.3,1951.8,1018.4,543.1,543.1,,,,,,,,82.5,15.83,1.71,-10.0,10.0,0.0,,,,88.9,11.06,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D08,0.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0438,,,,,,,,,,53.8,,5431.0,1323.8,356.4,271.6,169.7,67.9,17.0,17.0,,17243.5,3767.8,780.7,390.4,169.7,50.9,0.0,0.0,,,,,,,,80.2,18.22,1.63,-12.0,12.0,0.0,,,,85.3,10.06,4.66,-5.0,0.0,5.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D07,0.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.8,-0.2,,0.0423,,,,,,,,,,61.2,,7807.1,1222.0,67.9,17.0,0.0,0.0,0.0,0.0,,18703.2,2579.7,356.4,203.7,84.9,17.0,0.0,0.0,,,,,,,,82.5,15.94,1.6,-10.0,10.0,0.0,,,,89.4,10.65,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D06,0.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0422,,,,,,,,,,58.8,,6924.5,1544.4,288.5,84.9,33.9,17.0,0.0,0.0,,16598.7,3105.9,644.9,169.7,50.9,0.0,0.0,0.0,,,,,,,,83.2,15.44,1.33,-9.0,9.0,0.0,,,,89.7,10.31,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D05,0.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,98.3,-1.7,,0.043,,,,,,,,,,61.2,,4667.3,848.6,220.6,118.8,67.9,50.9,0.0,0.0,,18567.3,4514.5,916.5,475.2,118.8,17.0,0.0,0.0,,,,,,,,85.1,13.14,1.73,-7.0,7.0,0.0,,,,89.8,10.16,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D04,0.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.8,-0.2,,0.0436,,,,,,,,,,60.2,,5872.3,1188.0,271.6,152.7,67.9,33.9,0.0,0.0,,19161.3,3071.9,543.1,237.6,67.9,0.0,0.0,0.0,,,,,,,,83.5,15.13,1.36,-9.0,9.0,0.0,,,,89.7,10.28,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D03,0.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0421,,,,,,,,,,56.6,,7688.3,1476.6,356.4,237.6,84.9,17.0,17.0,0.0,,18465.5,2783.4,441.3,254.6,67.9,0.0,0.0,0.0,,,,,,,,81.8,16.72,1.47,-10.0,11.0,0.0,,,,89.0,10.18,0.85,-1.0,0.0,1.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,D02,0.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0421,,,,,,,,,,50.0,,5566.8,1323.8,237.6,135.8,0.0,0.0,0.0,0.0,,21368.0,3615.1,543.1,288.5,67.9,50.9,17.0,0.0,,,,,,,,78.5,20.11,1.44,-14.0,14.0,0.0,,,,67.9,8.1,23.96,-22.0,-2.0,24.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C11,0.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.8,-0.2,,0.0429,64.9,26.47,8.68,,,,,,,60.4,,10420.9,356.4,152.7,84.9,33.9,17.0,0.0,0.0,,27443.9,4175.1,950.4,611.0,254.6,84.9,17.0,0.0,,,,,,,,82.7,15.5,1.8,-10.0,9.0,0.0,,,,89.8,10.17,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C10,0.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.4,-0.6,,0.0426,69.2,22.19,8.62,,,,,,,61.4,,7145.2,1578.4,152.7,84.9,17.0,17.0,0.0,0.0,,54242.9,14358.4,4022.4,2444.0,950.4,424.3,0.0,0.0,,,,,,,,85.2,13.27,1.53,-7.0,7.0,0.0,,,,89.4,10.6,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C09,0.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0438,69.9,20.85,9.21,,,,,,,58.2,,7586.4,1510.5,186.7,84.9,33.9,17.0,0.0,0.0,,27647.5,4480.6,628.0,356.4,152.7,101.8,33.9,0.0,,,,,,,,83.8,14.89,1.31,-8.0,9.0,0.0,,,,89.6,10.45,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C08,0.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.3,-0.7,,0.044,69.5,20.94,9.59,,,,,,,,,8401.1,1289.9,254.6,152.7,33.9,17.0,0.0,0.0,,32400.2,6653.2,1425.7,678.9,237.6,50.9,33.9,17.0,,,,,,,,83.6,15.01,1.38,-9.0,9.0,0.0,,,,89.1,10.89,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C07,0.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,97.0,-3.0,,,99.8,-0.2,,0.0449,62.0,29.34,8.63,,,,,,,59.8,,8044.7,1544.4,373.4,169.7,67.9,17.0,0.0,0.0,,22131.6,3988.4,526.1,288.5,152.7,17.0,17.0,17.0,,,,,,,,83.3,14.97,1.73,-9.0,9.0,0.0,,,,89.8,10.03,0.13,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C06,0.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0432,62.7,29.24,8.02,,,,,,,60.4,,7620.4,2036.6,186.7,118.8,0.0,0.0,0.0,0.0,,33571.0,6008.2,1357.8,611.0,220.6,50.9,0.0,0.0,,,,,,,,83.2,15.25,1.54,-9.0,9.0,0.0,,,,89.8,10.22,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C05,0.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.8,-0.2,,0.0441,66.4,24.52,9.12,,,,,,,60.0,,5889.3,1493.5,67.9,33.9,0.0,0.0,0.0,0.0,,15257.9,2104.5,288.5,152.7,33.9,17.0,0.0,0.0,,,,,,,,84.9,13.5,1.65,-7.0,7.0,0.0,,,,89.5,10.51,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C04,0.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0442,66.8,23.81,9.4,,,,,,,58.4,,4650.3,882.5,186.7,118.8,33.9,0.0,0.0,0.0,,24117.2,4039.3,695.9,322.5,84.9,33.9,17.0,0.0,,,,,,,,84.6,14.18,1.18,-8.0,8.0,0.0,,,,89.8,10.16,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C03,0.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.6,-0.4,,0.0428,66.8,24.06,9.17,,,,,,,58.2,,5295.2,933.5,101.8,67.9,17.0,17.0,0.0,0.0,,11031.8,1968.7,356.4,237.6,135.8,84.9,50.9,17.0,,,,,,,,83.5,15.34,1.19,-9.0,9.0,0.0,,,,89.1,10.92,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,C02,0.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.1,-0.9,,0.041,65.4,24.91,9.74,,,,,,,54.4,,5549.8,1069.2,118.8,50.9,17.0,0.0,0.0,0.0,,22114.5,3360.5,560.1,220.6,50.9,17.0,0.0,0.0,,,,,,,,81.5,17.31,1.22,-11.0,11.0,0.0,,,,89.1,10.95,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B11,0.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.6,-0.4,,0.0417,62.4,29.21,8.37,,,,,,,63.4,,19008.6,6126.9,237.6,84.9,33.9,0.0,0.0,0.0,,137382.8,8418.8,1561.6,899.6,458.3,237.6,17.0,0.0,,,,,,,,83.0,15.65,1.34,-9.0,9.0,0.0,,,,89.1,10.94,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B10,0.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.3,,0.0434,67.1,24.15,8.75,,,,,,,,,18193.9,10522.6,356.4,101.8,50.9,50.9,0.0,0.0,,26646.3,4599.5,780.7,305.5,135.8,50.9,0.0,0.0,,,,,,,,86.0,12.77,1.27,-6.0,7.0,0.0,,,,89.1,10.91,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B09,0.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.3,-0.7,,0.0432,70.4,21.09,8.48,,,,,,,63.8,,10115.2,4565.4,695.8,271.6,67.9,33.9,0.0,0.0,,18499.4,4293.9,865.6,509.2,84.9,33.9,0.0,0.0,,,,,,,,85.4,13.59,1.02,-7.0,7.0,-1.0,,,,88.9,11.1,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B08,0.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.2,-0.8,,0.0441,69.4,21.76,8.81,,,,,,,60.6,,10166.2,3360.4,628.0,288.5,67.9,33.9,0.0,0.0,,21299.8,4056.3,594.0,203.7,33.9,0.0,0.0,0.0,,,,,,,,84.8,14.12,1.1,-7.0,8.0,0.0,,,,89.1,10.86,0.0,-1.0,1.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B07,0.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.6,-0.4,,0.0431,60.8,30.79,8.41,,,,,,,60.8,,10369.9,3462.3,492.2,339.4,33.9,17.0,0.0,0.0,,42006.0,8231.5,1578.4,746.8,169.7,33.9,0.0,0.0,,,,,,,,83.3,15.45,1.23,-9.0,9.0,0.0,,,,90.0,9.96,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B06,0.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.5,-0.5,,0.0423,64.4,27.65,7.96,,,,,,,59.6,,7094.3,1816.0,339.4,169.7,67.9,17.0,0.0,0.0,,41056.4,6076.1,746.8,305.5,33.9,17.0,0.0,0.0,,,,,,,,83.7,15.07,1.25,-9.0,9.0,0.0,,,,89.7,10.33,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B05,0.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.4,,0.0435,66.0,24.29,9.67,,,,,,,61.2,,21910.9,5566.8,560.1,169.7,0.0,0.0,0.0,0.0,,142459.1,30908.9,8147.3,5193.9,2987.3,1952.0,950.5,695.9,,,,,,,,85.8,13.13,1.1,-6.0,7.0,0.0,,,,89.7,10.27,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B04,0.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.4,,0.0431,66.8,23.62,9.61,,,,,,,62.4,,7959.8,2919.2,407.3,118.8,17.0,17.0,0.0,0.0,,32892.0,6534.3,2223.3,1629.3,1035.3,560.1,101.8,17.0,,,,,,,,84.4,14.42,1.15,-8.0,8.0,0.0,,,,89.9,10.09,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B03,0.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.3,,0.0419,67.8,22.87,9.34,,,,,,,64.2,,6924.5,2410.0,594.0,254.6,33.9,0.0,0.0,0.0,,28462.0,4989.8,831.6,322.5,135.8,17.0,0.0,0.0,,,,,,,,84.4,14.39,1.23,-8.0,8.0,0.0,,,,90.1,9.93,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB557,Fusion Protein,sc,,40.0,12.0,B02,0.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,100.0,-0.3,,0.0413,68.0,22.31,9.67,,,,,,,62.4,,4837.0,1765.1,628.0,271.5,67.9,17.0,0.0,0.0,,27647.6,4243.0,661.9,305.5,101.8,17.0,0.0,0.0,,,,,,,,83.8,15.12,1.07,-8.0,9.0,0.0,,,,89.6,10.43,0.0,0.0,0.0,0.0,,,,DNB000557_004 (KiH),DNB000557,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S V69A Q74P C125S KIH (knob S354C T366W) / Fc KIH (hole) Genewiz CHO Opt),8.05,66459.57622,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,5.0,0.0,H07,1.0,,NB-munselle-5020702-0004-0004,5.2,Acetate,0,0,0.0,0.0,0,,,,100.0,,,,99.8,0.0,,0.0414,84.8,10.44,4.8,,,,,,,66.2,,149999.3,21506.1,1273.1,560.1,203.7,101.8,17.0,17.0,,1976647.8,20572.7,475.7,220.8,118.9,51.0,17.0,0.0,,,,,,,,95.1,3.39,1.5,0.0,0.0,0.0,,,,91.3,8.67,0.0,1.16,-9.57,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,0,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,150,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.0423,,,,,,,,,,62.0,,16598.7,3309.6,967.4,543.1,220.6,101.8,33.9,17.0,,53903.8,12084.2,3920.6,2240.3,865.6,407.3,33.9,0.0,,,,,,,,82.7,15.62,1.64,-12.0,12.0,0.0,,,,89.2,10.85,0.0,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,150,0.0,0.0,0,,,,99.0,-1.0,,,99.2,-0.6,,0.0435,,,,,,,,,,,,6788.8,1849.9,577.0,271.6,118.8,33.9,0.0,0.0,,19721.5,4226.0,933.5,458.2,237.6,67.9,0.0,0.0,,,,,,,,86.4,12.15,1.5,-9.0,9.0,0.0,,,,90.0,10.03,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,150,0.0,0.0,0,,,,99.0,-1.0,,,99.6,-0.1,,0.0435,,,,,,,,,,57.2,,7993.8,1917.8,458.2,322.5,152.7,101.8,0.0,0.0,,48184.3,5006.8,712.8,390.4,186.7,67.9,17.0,0.0,,,,,,,,83.7,14.87,1.41,-11.0,11.0,0.0,,,,89.5,10.36,0.14,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,150,0.0,0.0,0,,,,99.0,-1.0,,,99.5,-0.3,,0.0444,,,,,,,,,,54.2,,7501.6,1629.3,339.4,169.7,101.8,67.9,0.0,0.0,,28020.9,4921.9,933.5,644.9,254.6,84.9,33.9,17.0,,,,,,,,82.6,16.17,1.26,-13.0,13.0,0.0,,,,88.2,8.58,3.2,-3.0,0.0,3.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,150,0.0,0.0,0,,,,95.0,-5.0,,,97.3,-2.4,,0.0427,,,,,,,,,,,,7722.3,1510.5,271.6,152.7,17.0,0.0,0.0,0.0,,18940.8,2715.5,424.3,322.5,50.9,17.0,17.0,17.0,,,,,,,,82.7,15.88,1.43,-12.0,12.0,0.0,,,,90.6,9.27,0.16,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.2,,0.0418,,,,,,,,,,59.6,,10098.3,1833.0,288.5,203.7,33.9,17.0,0.0,0.0,,49151.6,7433.8,1069.3,492.2,101.8,50.9,17.0,0.0,,,,,,,,83.1,15.39,1.53,-12.0,12.0,0.0,,,,90.4,9.59,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,150,0.0,0.0,0,,,,88.0,-12.0,,,99.8,0.0,,0.0443,,,,,,,,,,61.8,,6415.4,1306.8,220.6,67.9,0.0,0.0,0.0,0.0,,25967.2,4412.7,865.6,475.2,254.6,84.9,0.0,0.0,,,,,,,,83.8,14.86,1.39,-11.0,11.0,0.0,,,,90.6,9.41,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,150,0.0,0.0,0,,,,87.0,-13.0,,,99.8,0.0,,0.0429,,,,,,,,,,59.8,,6042.0,1255.9,288.5,254.6,101.8,33.9,0.0,0.0,,16972.0,2783.4,729.8,373.4,135.8,50.9,0.0,0.0,,,,,,,,84.0,14.65,1.38,-11.0,11.0,0.0,,,,90.8,9.2,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.2,,0.0421,,,,,,,,,,56.6,,12440.4,2766.4,661.9,509.2,118.8,50.9,17.0,0.0,,40088.2,8282.4,1968.8,1069.2,441.3,135.8,50.9,0.0,,,,,,,,82.8,15.81,1.39,-12.0,12.0,0.0,,,,90.3,9.2,0.54,-1.0,1.0,1.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,G02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,150,0.0,0.0,0,,,,99.0,-1.0,,,100.0,0.2,,0.041,,,,,,,,,,51.2,,7756.2,1951.8,526.1,390.4,152.7,84.9,0.0,0.0,,51377.3,4701.5,1306.9,882.6,237.6,67.9,0.0,0.0,,,,,,,,81.5,17.09,1.44,-14.0,14.0,0.0,,,,73.3,7.28,19.43,-18.0,-1.0,19.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 150 mM,NaCl 150 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.0401,68.2,23.31,8.52,,,,,,,61.4,,11507.0,3190.7,780.7,407.3,169.7,50.9,0.0,0.0,,51561.7,11710.8,2817.4,1663.3,543.1,254.6,33.9,0.0,,,,,,,,82.8,15.73,1.47,-12.0,12.0,0.0,,,,90.1,9.66,0.25,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.046,73.5,18.21,8.32,,,,,,,61.2,,9113.9,2121.5,594.0,322.5,50.9,33.9,17.0,0.0,,40970.7,7315.0,1900.9,1035.3,458.2,186.7,17.0,0.0,,,,,,,,85.8,12.7,1.49,-9.0,9.0,0.0,,,,89.9,10.15,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.6,-0.2,,0.0433,74.7,16.98,8.32,,,,,,,59.6,,7518.5,1646.3,271.6,186.7,84.9,17.0,0.0,0.0,,42447.1,7790.2,1799.0,1103.2,356.4,118.8,0.0,0.0,,,,,,,,83.3,15.33,1.36,-12.0,12.0,0.0,,,,89.4,10.65,0.0,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,50,0.0,0.0,0,,,,100.0,0.0,,,99.3,-0.5,,0.0448,72.1,19.19,8.72,,,,,,,57.4,,11863.4,2936.1,543.1,322.5,50.9,17.0,0.0,0.0,,44688.1,8367.4,2053.7,1239.0,373.4,186.7,33.9,0.0,,,,,,,,83.8,14.88,1.32,-11.0,11.0,0.0,,,,89.3,10.67,0.0,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,50,0.0,0.0,0,,,,95.0,-5.0,,,99.7,-0.1,,0.0447,64.9,26.86,8.21,,,,,,,62.0,,14477.1,2291.2,390.4,203.7,50.9,0.0,0.0,0.0,,44195.6,8044.8,1646.3,746.8,271.6,118.8,0.0,0.0,,,,,,,,82.2,16.06,1.75,-13.0,13.0,0.0,,,,90.6,9.42,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,50,0.0,0.0,0,,,,98.0,-2.0,,,99.7,0.0,,0.0438,66.1,26.34,7.56,,,,,,,60.6,,11710.7,2053.6,475.2,169.7,50.9,0.0,0.0,0.0,,36201.5,7993.9,2206.4,1137.1,390.4,203.7,0.0,0.0,,,,,,,,82.7,15.87,1.48,-12.0,12.0,0.0,,,,90.0,10.05,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,50,0.0,0.0,0,,,,87.0,-13.0,,,99.8,0.0,,0.0434,68.8,22.38,8.85,,,,,,,61.4,,6449.4,1035.3,169.7,135.8,0.0,0.0,0.0,0.0,,19331.1,3207.7,712.8,373.4,101.8,33.9,0.0,0.0,,,,,,,,84.1,14.28,1.58,-11.0,11.0,0.0,,,,90.7,9.3,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,50,0.0,0.0,0,,,,93.0,-7.0,,,99.8,0.0,,0.0431,69.1,22.05,8.84,,,,,,,61.2,,5838.4,1255.9,288.5,118.8,50.9,17.0,0.0,0.0,,17905.5,2664.6,373.4,118.8,17.0,17.0,0.0,0.0,,,,,,,,83.9,14.78,1.35,-11.0,11.0,0.0,,,,90.7,9.32,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.0418,67.6,23.23,9.16,,,,,,,59.4,,7145.2,1357.8,186.7,135.8,17.0,0.0,0.0,0.0,,12576.2,2325.2,271.6,169.7,84.9,17.0,0.0,0.0,,,,,,,,82.6,16.07,1.33,-13.0,13.0,0.0,,,,90.1,9.89,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,F02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,50,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.0412,67.9,22.94,9.18,,,,,,,54.6,,5787.4,1748.1,390.4,220.6,118.8,17.0,0.0,0.0,,12966.6,2579.7,611.0,356.4,84.9,17.0,0.0,0.0,,,,,,,,81.6,17.04,1.36,-14.0,14.0,0.0,,,,89.9,10.14,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,NaCl 50 mM,NaCl 50 mM,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E11,1.0,,NB-munselle-5020702-0004-0004,6.8,Histidine,0,0,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.0429,69.3,22.38,8.3,,,,,,,63.6,,20060.9,2919.2,526.1,288.5,67.9,33.9,0.0,0.0,,38543.7,6194.8,1476.6,865.6,237.6,118.8,17.0,0.0,,,,,,,,83.6,15.08,1.29,-11.0,12.0,0.0,,,,89.2,10.69,0.1,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E10,1.0,,NB-munselle-5020702-0004-0004,6.2,Histidine,0,0,0.0,0.0,0,,,,98.0,-2.0,,,99.8,0.0,,0.0436,72.6,18.84,8.58,,,,,,,63.8,,12898.7,3428.3,899.5,509.2,203.7,169.7,0.0,0.0,,23998.4,5346.2,1188.0,763.7,203.7,50.9,0.0,0.0,,,,,,,,86.5,12.4,1.14,-9.0,9.0,0.0,,,,89.7,10.35,0.0,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E09,1.0,,NB-munselle-5020702-0004-0004,5.6,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.4,-0.4,,0.044,74.6,17.13,8.32,,,,,,,62.8,,10929.9,4056.3,1527.5,950.4,220.6,101.8,33.9,0.0,,18754.0,3835.7,678.9,356.4,84.9,17.0,0.0,0.0,,,,,,,,84.5,14.29,1.19,-11.0,11.0,0.0,,,,89.8,10.22,0.0,-2.0,2.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E08,1.0,,NB-munselle-5020702-0004-0004,5.0,Histidine,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.4,-0.4,,0.0431,73.5,17.67,8.81,,,,,,,62.6,,9368.5,3105.9,950.4,526.1,203.7,118.8,0.0,0.0,,13187.2,2953.1,492.2,322.5,135.8,84.9,17.0,0.0,,,,,,,,84.5,14.07,1.42,-11.0,11.0,0.0,,,,90.1,9.88,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E07,1.0,,NB-munselle-5020702-0004-0004,6.2,Citrate,0,0,0.0,0.0,0,,,,96.0,-4.0,,,99.8,0.0,,0.0429,64.3,27.19,8.54,,,,,,,61.4,,7518.5,2511.8,1035.3,644.9,305.5,152.7,0.0,0.0,,28105.9,4786.1,797.7,390.4,118.8,50.9,17.0,0.0,,,,,,,,83.8,14.74,1.44,-11.0,11.0,0.0,,,,91.1,8.62,0.24,0.0,0.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E06,1.0,,NB-munselle-5020702-0004-0004,5.6,Citrate,0,0,0.0,0.0,0,,,,97.0,-3.0,,,99.7,-0.1,,0.0412,66.6,25.62,7.76,,,,,,,60.0,,9504.3,2562.8,950.4,560.1,220.6,84.9,0.0,0.0,,25644.8,4395.8,1035.3,560.1,50.9,17.0,0.0,0.0,,,,,,,,83.2,15.48,1.36,-12.0,12.0,0.0,,,,91.0,8.74,0.29,0.0,0.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E05,1.0,,NB-munselle-5020702-0004-0004,6.2,Acetate,0,0,0.0,0.0,0,,,,89.0,-11.0,,,99.8,0.0,,0.0423,68.2,21.98,9.85,,,,,,,63.6,,17124.7,5991.1,1934.8,1018.3,322.5,135.8,17.0,0.0,,28818.5,5923.2,2019.7,1171.1,339.4,101.8,0.0,0.0,,,,,,,,85.7,12.83,1.49,-9.0,9.0,0.0,,,,91.1,8.87,0.0,0.0,0.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E04,1.0,,NB-munselle-5020702-0004-0004,5.6,Acetate,0,0,0.0,0.0,0,,,,99.0,-1.0,,,99.8,0.0,,0.0429,68.8,21.78,9.44,,,,,,,64.0,,12881.7,4158.1,1137.1,577.0,220.6,101.8,33.9,0.0,,20043.9,2359.1,254.6,135.8,33.9,17.0,0.0,0.0,,,,,,,,84.7,13.93,1.42,-10.0,11.0,0.0,,,,91.0,9.04,0.0,0.0,0.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E03,1.0,,NB-munselle-5020702-0004-0004,5.0,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.7,-0.1,,0.0422,68.6,21.53,9.84,,,,,,,63.0,,13696.3,4412.7,916.5,526.1,237.6,101.8,0.0,0.0,,21079.3,3886.6,746.8,407.3,67.9,0.0,0.0,0.0,,,,,,,,84.6,14.17,1.27,-11.0,11.0,0.0,,,,90.6,9.45,0.0,-1.0,1.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
,munselle,,DNB553,Fusion Protein,sc,,40.0,12.0,E02,1.0,,NB-munselle-5020702-0004-0004,4.5,Acetate,0,0,0.0,0.0,0,,,,100.0,0.0,,,99.8,0.0,,0.0405,68.5,21.63,9.87,,,,,,,63.2,,12338.6,4158.1,1510.5,797.7,254.6,135.8,0.0,0.0,,14171.6,2817.3,475.2,271.6,101.8,50.9,0.0,0.0,,,,,,,,82.6,15.93,1.45,-12.0,13.0,0.0,,,,90.9,9.06,0.0,0.0,0.0,0.0,,,,DNB000553_004 (ZW),DNB000553,,[IL-2_H] ([Lonza GS leader]-[hIgG1 L234A L235A D265S][10GS]-IL-2_H T3A D20N E68S Q74P C125S ZM857B / Fc ZM856A Genewiz CHO Opt),7.62,66428.5693,#Historical Results Template_Erik_01_b.xlsx,IL-2_H,,,-,-,2,Protein Formulation Characterization Summary
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,50.0,1.0,,1.0,Trop2-PNU_1d50C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2281.5,952.0,119.0,2261.5,0.0,0.3,,,,,,,,,,98.71,0.11,1.18,0.1,-0.1,0.0,0.1,0.1,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60.0,1.0,,1.0,Trop2-PNU_1d60C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1627.0,536.0,39.5,1627.0,0.0,0.2,,,,,,,,,,93.4,0.17,6.43,-5.2,0.0,5.3,5.2,0.0,5.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,70.0,1.0,,1.0,Trop2-PNU_1d70C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,7183.0,2738.0,99.0,7123.0,0.0,0.4,,,,,,,,,,73.28,0.19,26.53,-25.3,0.0,25.4,25.3,0.0,25.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,50.0,3.0,,1.0,Trop2-PNU_3d50C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6250.0,2063.5,99.5,6250.0,0.0,1.0,,,,,,,,,,98.55,0.09,1.37,-0.1,-0.1,0.2,0.1,0.1,0.2,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60.0,3.0,,1.0,Trop2-PNU_3d60C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1091.5,258.0,0.0,1091.5,0.0,0.3,,,,,,,,,,88.87,0.38,10.76,-9.7,0.2,9.6,9.7,0.2,9.6,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,70.0,3.0,,1.0,Trop2-PNU_3d70C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5992.0,1786.0,20.0,5992.0,0.0,0.2,,,,,,,,,,62.92,0.61,36.47,-35.7,0.4,35.3,35.7,0.4,35.3,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,50.0,5.0,,1.0,Trop2-PNU_5d50C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1925.0,535.5,0.0,1925.0,0.0,0.2,,,,,,,,,,98.33,0.15,1.52,-0.3,-0.1,0.4,0.3,0.1,0.4,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,60.0,5.0,,1.0,Trop2-PNU_5d60C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3134.5,1309.5,139.0,3095.0,0.0,0.3,,,,,,,,,,84.28,0.58,15.14,-14.3,0.4,14.0,14.3,0.4,14.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,70.0,5.0,,1.0,Trop2-PNU_5d70C,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,932.5,397.0,20.0,932.5,0.0,0.2,,,,,,,,,,58.43,1.36,40.21,-40.2,1.1,39.0,40.2,1.1,39.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
7/14/2023,ramapa,,DCC000770_032,ADC,MULTIPLE CONTROL,Thermal Stress,,0.0,,1.0,Trop2-PNU_CT,NB-ramapa-5085300-0003-0001,6.0,Histidine,0,0,0.0,0.0,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1686.5,833.5,119.0,1666.5,0.0,0.2,,,,,,,,,,98.61,0.22,1.17,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-,-,0,Info link - DPS.Formulation Summary.V2 AV_58081
